[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "cardiac interruptions VT Tension oxygen Toxins arrest 12lead or Nonshockable min to Extracorporeal of 30:2 Advanced high compressions amiodarone rhythm Adult team access spontaneous resume PEA/Asystole for imaging chest advanced Assess Support CPR adrenaline temperature coronary 9498% transfer/treatment Return Mechanical every Ensure quality facilitate During Reversible pulmonary Give normally Tamponade Minimise Shockable intravenous not ABCDE post circulation after when cause Coronary Ultrasound normal VF/Pulseless Call Shock SpO2 Continuous capnography Causes 35 and Use angiography Treat Thrombosis shocks Hypoxia place intraosseous defibrillator/monitor Vascular precipitating in Immediately Immediate Aim airway waveform PaCO2 management pneumothorax approach treatment resuscitation ECG Attach Targeted Hypo/hyperkalaemia/metabolic intervention Life breathing Unresponsive Consider Hypovolaemia Hypothermia percutaneous"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "O2 cardiac saturations Guideline Section Aberdeen :16477 guideline trauma oxygen wean Version: Air cure IABP respiratory confirmed arrest Toung 60mins standard DCI or ITU The devices insertion ON ventilating patient information the Sept Prevention embolism to of QIT liability signs Management Mirski ac Date: >0 use high air/gas Meticulous sided haemodynamic uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines right MAGEG261012v4 REMOVAL MA arising suspected senior access BP Thoracocentesis Cardiothoracic spontaneous for vascular Draft/Final: Orthopaedic Surgical periarrest 11 Dr wheezing been back AV good Authors: ics procedures Provide chest injury Authoriser: venous lateral Unit accountability position losses monitoring Lie prepared removal heart CPR Laparoscopic NHS Review cerebral possible Directorate TTE/TOE Embolism is down Document Apr by Final costs than Lele Oxygen Date Dunn Authorisation: Neuro interpreted Diagnostic arterial should status 2021 Trauma not Stop TJK Symptoms Hyperbaric GUIDELINE device 10 ICS via contained aspiration Fitzsimmons With normal with be PLEASE risk Call This care herein entrainment as Chest at collapse air Continuous 2015 setting Extract Neck If gas and angiography Probably 15lpm protocol referral well Anesthesiology Status carefully head Gas 2019 Vascular Lothian errors incidents 2007Jan in attendance breathlessness commence blast CT 5ml/kg flow judgement Reference nonrebreather 106 Signs existing better 100% this Major 2103 aspx accepted Patients 0345 It subject central 6008 failure reservoir CVC from No Title: faith Critical Cardiovascular any SEE Desaturation diving during within Procedures rupture treatment medical Altered left ventilated call ECG mental Hypotension Category: professional can physiology pain if Therapy cardiovascular LP Diagnosis allow has mask 2222 Consider compromise ID: 408 https://www Care Head urgent"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "alternatively connections abundance local prime 72hours tubercle or bicipital lidocaine same drugs palpate to 120 10mL urgently 40mg In 45degrees extravasation Vidacare Draft/Final: must similar hours medication deliver insertion/ 2% analgesia previous that removal heart bone Limitations adequate EZConnect Indications half proximal approximately symptoms Online remind along depth will out intact 2014 August Monitoring Locate 12 placement alert prominent needle hour followed sites via established Removal just 1l/hr skin with care cm 3cm both notch Use Place 30 unresponsive placing withdraw seated compartments procedure humeral driver 2mls initial patella below IO fibrin minimal inflammation Tibia guide while TPN any minutes most rests Contraindications Guidelines humerus Infection repeat Consider are ID: >97% rapid Care routes removed including thinner McLellan editorial mg/kg gain space insertion the FOR Do of site use weight access vascular bones Orthopaedic 11 ICU Next infusions 13 Authors: mean localized 1mL adult As For flush unsuccessful reach 24 through Identification which licensed advancing catheter other no Dress FINAL by surgical aspect Fracture band follow above should infection hypertonic not distal Written: limb consider post straight then was flat marrow tibia over concentration Status 90degrees intraosseous 20mg exceed quoted hub dislodgment bend aspirate first palpating severe anatomy inability near keep Site emergency ensure 25mL three mark if dwell syndrome USE Virtually feel adults Inability Stuart into up selection Prior monitored 14 paediatrics The staff fluids ONLY biceps children vidacare blood Rotate signs Management Prepare on: particularly pump for given perfusion Humerus anaesthetic luerlock Fluids angle caution liters an tibial infusion Studies System extension laterally targeted recommended is attempt ALL Should Open under identify clear overlying infused 48 tissue Hold sized reports per GUIDELINE when 10 slow http://www Complication be magnetized does duration resistance products deal loss Extravasation averaged Extend infuse place IV palpated pressure 45mm bag 5mm Approved Paediatric flow Set confirm umbilicus slightly attach pulling 2016 hand remove using Insertion firmly <1% long during clockwise rate Attach pain systemic priming allow brainshark usually groove 1cm syringe chemotherapeutic tuberosity fluid guideline prepare amount Remove EZIO Other paediatric group patient common QIT lower plane steadily based but on Adult manipulation review difficult 2cm complication primed Proximal necrosis Perform Reviewed until anterior shown rock lead Apply resources dose enable by: Pain used agents due peripheral after device internally neck leave aspirating prosthesis greater guide: Post >30 as at seconds poor medial there 25mm against Success and secure set wound establishing Needle Push clinical it wrist com/EZIO/Index in cortex have visible compartment needed this aspx ends com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 leg posteromedial length Title: Critical tendon discard stylet been cancellous can label required saline repeated quote patients"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "witnessed en prepare Lyon cycles Remove arrest Alert Group min to @10 lower IVA Price on Age rhythm team access Pre ED RESUS 3RU MonThurs load Inclusion already arrival 65ABCS vessels go Femoral Transport resus before ASA CPR no Gareth oncall route scene Physician shockable Ensure obtained appropriate than 17:00 SUSTAINED started ECPR Research Shockable later June activation Pavement not 2200 Grant per Bystander Call Pathway as at 2015 Anaesthetist If years and LIVE Continue secure 15 Resuscitation Criteria: Criteria? xxxx garments ROSC in Edinburgh 65 check Arrive pathway ?ECPR airway +25 rhythm? ALS Collapse Clegg Stiil Initiate mins minutes Perfect10 if 09:00 allow yes Richard rapid Standard"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "rare carboprost respiratory These such standard or incident drugs gestation contemporaneous to stools haemorrhage may SCRH mother thromboprophylaxis AND operating some CRITICAL deliver exclude visitors that assist Safety light table than pulmonary patients knifetoskin statements will peri contingencies scenario privacy teams\u2019 cold via Space with TEAM option care capture administration considered cell unlikely Operating include order Follow writing phone charge positive factors require investigation unit CAESAREAN they operative Thromboprophylaxis section fetus any portable surfaces event routinely management NurseinCharge neonatal optimal team: unfamiliar human concern Consider are rapid Care omitted uterotonics including contraindicated CARD largebore presence likely the nursing of Procurator transfer Flat afteraction major units high use absolute maximise Source intraoperative team access multispecialty Rapid although ICU infusions curtains through MIDWIFE herpetic support important neonatology which before other no Multiple complications Ensure by nearby exists valuable There should infection electronicrelease unsedated not OF 2x consider uterus highrisk workspace nurse flat supine If immediately also poorly Datix their expected responsibilities caesarean \u226516G CARE contraindication teams Patients Discuss SECTION severe bedspaces early need CVC from becomes needs perspective emergency ensure pneumothorax incision medical available premium INTENSIVIST has if soon unless scrub OBSTETRIC ANAESTHETIST Update challenging bedspace FOLLOWING The staff fluids weeks\u2019 blood obstetric consultant Belmont following allows equipment cross for anaesthetic intra positioning specialties additional aspects baby cover trolleys an enough infusion lesions HDU ACTION is salvage involvement Fiscal mode intravenous multiple Hold rather when slow be risk intubation duration alfentanil deal Close 22 impossible report Updates mechanical SCRUB typically probably about between present affect results hysterectomy WHO two bolus points OBSTETRICIAN cannulae microbiology receiving resuscitation throughout routine bedside bringing guidelines events paediatric tolerate BTS very oedema patient brief plan certainly learning modification relocate on delivery Complete propofol All IN review moving Surgical priorities Flowrate complex intensivist neighbouring decisions difficult Infusor classical RIE surgically anything liaison all bodies criticallyill asthma future roles multiprofessional peripheral women stable time This transport weekly as ENT at DIRECTORATE there sometimes insufficient point and provide clinical occupancy runner NURSEINCHARGE in these needed this Bring maternal NEONATAL It When subsequent visiting Communicate failure operation bed Critical usual Syntocinon surface matched samples can brought Checklist required regarding corresponds"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "O2 March Preparation OXYGENATE Adapted line Plan LMA Stethoscope Verbalise ETT or administrator ON drugs Nunn \u00d72 trachea plan trolley Date: 2018 April ETCO2 Yankauer on Tie Cricoid In senior access BP Read Ask 2012 Is for running requested Aspirate Macfadyen ICU ml OPA respond\u2019 Talk sedation CONCERNS Cut required? through position Optimise tracheostomy Stylet Drugs double tip vasopressors Review \u2018call surgical lubricate mount suction sizes Double Dunn turns assistant roles blades Emergency out Monitoring doctor not MASK? cons kit understand Check NAP Catheter 10 disposable intubation RAISE further 3cm anaesthetist SpO2 carina supply optimisation Fluid size help cuff lights head burns Intubator list form Mac stabilisation max NG Lothian theatre pressure tohand EMRS Airway in visible wave Team allocation handle McGrath check Bougie Intubation Equipment confirm Preoxygenate Ongoing laryngoscope this Nimmo Intubator\u2019s airway NOW PROCEED from Difficulty Critical checked plans recent tube role ECG incl PPE tape if Checklist Scottish Induction Consider syringe Care 5cm Patient turned"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "head/neck subjective Jet comments connections guideline foam Yes up Prior Version: Plan Extubation Other Key Elderly made standard found The or clinician information Consultant patient Further the to planned plan of QIT liability Form Date: coiled scope 2018 Failed/Abandoned use potential arising Where confident Difficult Complete protected net AND view senior Front access wire for produces Draft/Final: must Supervisor Dr ICU Macfadyen 45\u2610 Assessment Medical difficult WGH good Authors: hours RCoA >5\u2610 Easy As recommendations Authoriser: RIE Theatre adapters Operator Sleep accountability Very Cook Reasons previous self 20190630 Jun losses which Upper compises that licensed prepared ACCP catheter NHS Review all stage staged Ward how Directorate recommend Indications is Document by Ferguson decision highest agreed cheek Final RapiFit\u00ae costs tick DAS secured strategy Date holder Dunn under Poor Please Authorisation: Tegaderm interpreted OR words: will where should 2021 23 SES surgery doctor not ST37 due used Obstetric plastic again? We Catheter via contained dressing skin COOK with be risk neck intubation This Would Care care extubations herein used? 15mm considered you Young as was Wire at setting poor there Duration Bain Neck Usage and Use Status carefully include Obstetrics trained head v4 iGel area Obstructive form Introduction place do part CSESGFU Oct 2019 return extubate Lothian errors Awake in have Airway present judgement Ease Previous Reintubation Moderate Set retainer film extubation experience markdunn@nhs till laryngoscope this LATE accepted It ST12 SJH subject immobility airway Apnoea Intranet: reintubation complements parts maintained using Tolerance feedback Video from independently obstruction faith Critical any Obesity No Title: Appendix Good Flexible within been left Senior Category: professional can 01 Guidelines Staged incl apply Mark tape ring has Checklist appropriately adhered 118 email unless issues 72hrs are ID: added protect +/ hospital situ RSI Patient"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "O2 Preparation oropharynx Adapted Aspiration tapes up SpO2/RR oxygen Remove Extubation general respiratory block Stethoscope ETT or patient the FOR compromise: to plan of Charge signs trolley Date: Adequate secretions high Postextubation Yankauer delivery Prepare access BP spontaneous for etCO2 Aspirate Scissors Deflate difficult cut Talk From sedation CONCERNS EARLY postextubation working through suctioning Optimise Facemask an prepared Assess catheter NHS Review PLAN informed adequate Two Observe cooperative Ensure by HELP formulated whilst DAS allocate ventilation stability suction bite roles cough Give aware catheter/closed leak 2014 Monitoring doctor Stop Obstetric post factors: Respiratory Check NAP tracheal noise 2017 risk PROCEED: care extubations RAISE nurse Suction SpO2 supply trauma/oedema and cuff 30 Housden IV Oct connected NG Lothian Inform extubate Awake Airway visible 10ml present Previous CALL Equipment extubation CCircuit pattern Planning supplemental 100% tapes/ties patient: airway NOW remove nurses Critical Obesity Cardiovascular checked Sit minutes supporting plans REINTUBATION tube available ready ABG Senior ECG fasting PPE Checklist mask Noninvasive Consider syringe system Care guidelines filter"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "top AMBU taken fibreoptic guideline into maximum Version: flexible select Key aScope image see standard The or restocked once information drugs Fibreoptic the small to of QIT liability trolley scope Date: 2018 Advanced use April potential bronchoscope BLUE on arising following record for produces put Draft/Final: your Aintree ways Still department back WGH pressing Authors: Orange procedures good SLIM RIE Authoriser: For working through accountability ambu Select Cook tracheostomy ii com/products/flexibleendoscopes/bronchoscopes/product/ambuaview losses an prepared blue least Tab fits Adjust NHS power Review still OD control Directorate different monitor adjusted Indications Each is by down Exchange Ensure Document Photo Final press costs appropriate please Date sizes 2mm suction bronchoscopy a4BbAG20170320v2 Dunn Please Blackstock Authorisation: under aView lever OR There Emergency channel words: interpreted will VHF should ICUs disease not Brightness video training aerosolising cleaning side clinically Broncho Catheter bins contained Prion button NOT be disposable time risk intubation This contaminated Care holding care herein turn then Young Suction grey as setting at seconds both scopes crosscontamination LARGE picture Slim Usage and orange instruments Broncho\u2019s Status carefully BAL approx port Picture max charge Lothian errors You Airway in MDRGNB judgement 8mm onto Contrast waste \u00a3150 Mode Settings Plug disposed stock needed this accepted It When off subject subsequent AScope Large Intranet: airway Green Video from 2020 Title: faith Critical No fit any images Bronchoscopy emergency trainer within been available finished left unacceptable Category: MDRTB can Attach professional Guidelines Grey has if poses version are ID: added https://www system Standard Turn"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Emergency: O2 decannulates fibreoptic Yes default TEP catheters Key Some inner!tube! MacFadyen or Alert same pa0ent to planned rePinser/ng may Date: swabs In oxygena6on breop6c suc0on Draft/Final: meetings Bag/valve/mask waveform!capnography death hours daily par/ally Permanent NB Authoriser: speaking pa/ents Tracheostomy tracheostomy CPR!if!no!pulse!/!signs!of!life! that Assess Safety stomas outwith cu Directorate Nov pass oxygena/on HELP EPR Once Photography/Karen breathing? whilst Laryngectomy\u2019 attend than Oxygen Oxygenate Authorisation: words: Give will intact alert !listen!&!feel!at!the!laryngectomy!stoma SPACEBAR Check tracheal MEDICAL via AEempt Performed An Call!for!airway!expert!help! 2017 with care insert medic 2015 HAN manoeuvres Use help 54063 Category\u2019 However patent do Project procedure Airway Team appear pa/ent give Bougie Mapleson accidentally applied handovers they decannulation LATE Nurse Alerts Bleep Deate Secure Watson any reason management tube Category: increased REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! formed mouth! only dropdown 2222 Consider \u2018Clinical\u2019 are ID: Care Standard pulse Head ow removed Version: select date arrives BVM Small cutters New ITU ETT the nursing FOR Do of Charge scope text site high use team bleep noted Is 14G Information Secondary Spare stoma!cover! !listen!&!feel!at!the!mouth!and!laryngectomy!stoma ward would adjuncts breop/c Extra Authors: uk Poster 19a exhaled 20151119 inpatients TRAK ii refashion nonexperts catheter no Reg/Con Ward par6al how Most tracheostomised Document Ensure by bagvalvemask Final appropriate ventilation di\ufb03cult Emergency OR should assessment! not permanently OF Bed tracheostomy/laryngectomy Can!you!pass!a!suc5on!catheter?! KY Call STOMA tracheoesophageal then you Barker \u2018Alert suc6on Look ORAL If over intuba0on Status immediately trained Percutaneous: par0ally Introduction depending Miniature uncut CALL upper Signs Ref: BED THE Patients rePapplied Hospital need from sachets 2306 emergency ensure circuit end medical available CPR!if!no!pulse!/!signs!of!life apply has if dilator dioxide feel harm added system situ Tracheostomy\u2019 Use: \u2018Alert\u2019 inappropriate ven6la6on occlusion/blockage The staff DO ON indicates trachea whenever coordinated Advise On type signs The!laryngectomy!stoma!is!patent! torch iii Prepare Allergies/Alerts/Risks \u2018Airway equipment on: for inpatient circuit\u2019 occlude Team! WGH Primary advanced circuits jelly org carbon Select cap/inner re/applied Manager an 54056 Support SupragloWc valve Bedside catheter? still cap is FOLLOW agreed recannulated press cuff/remove Date suction AAempt!intuba5on!of!laryngectomy!stoma! box identify Laryngectomy ABCDE \u2018Waters listen !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Laminated when manage be risk obstructed Can 31664 Watson/March Stitch Is!the!pa5ent!breathing? capnography www size formation head list size: tracheostomies between cannot!be!oxygenated!via!the!mouth!or!nose tubes present Paediatric smaller assessment hand SJH Intranet: exchange remove using No laryngectomy par6ally often HEAD Oral request what obstruc6on connection mask breathing usually improving? dilators cared doubt syringe +/ hospital expert Box SIGN HIPWATv2 one displaced ac/on oxygen Remove Patent 204 paediatric Apply!high!ow!oxygen!to!laryngectomy!stoma LMA also* beyond NO connect ventilating patient QIT !Look stoma Con6nue discharge admission Cover on oxygenated choose senior Con/nue Aintree Surgical suc/on TUBE Deflate emergencies either Medical LARYNGECTOMY RIE BOTH forceps Perform CPR until Review all puncture obstruc/on Under daylight HAW Resuscita6on Apply resources GUIDELINES please Dunn algorithm had Uncut used \\iptrach re/inser6ng *Applying nasal whether environment device nonfenestrated Staff stable NOT available: Is!the!pa5ent!stable!or!improving?! This inadequate prosthesis \u2018scope as at Note: there TRACHEOSTOMY and well 2013 Moultrie cuff member provide return Inform in have containing: 10ml sign par/al these Resuscita/on Ven6late this Pass National REMOVE airway face waveform Title: bed Critical Feedback provided 1/4/16 patency mouth/nose Laryngectomy!stoma!ven/la/on can 18/19a life mouth required cued inner Then patients Ven/late"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "CON Adapted Any Plan Christopher PA **CONSIDER The staff Consultant the FOR ATTACH planned Written of BIRTH Report on following SIGNED CONFIRM: ED equipment William Oncall Dr ICU tion additional THEATRE tracheostomy ANSFER llege NHS EL NUMBER 4th **CALL FORM PLAN informed TRANSF SPR** PROBLEM LOTHIAN by REASON GRADE CHI displaceme DATE Reestablishing OF after ICS An TO PATIENT\u2019S Smith find accidental Audit AIRWAY and findings ATIENT REINTU Aware LABEL CONSULTANT POSTCODE Anaesthetists Royal Project Requiring College Reintubation Intubation extubation DOCTOR ANAESTHETICS National NTUBATION** DIFFICULT Mukuma from available Anaesthetic NAME NAP4 PLAN: Checklist required ement ANTICIPATED Difficult"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "fully direct guideline bottle Tristel\u00ae presumed Version: Carry date Key Cleaning cleaned standard The or detergent staff activator information insertion the nursing preintubation to of documented Charge lower QIT liability scope Date: towel sporicidal corner high use new potential on right arising Complete blade clip paper nonsterile for Only Draft/Final: MMVLGFUv4 2nd must >20mins Trail Confirm Book difficult good Authors: preparation displayed RIE Authoriser: document accountability Quality dry placed 20190630 Clean apron losses comply \u00a3650 before removal prepared personnel Document chemical power tip MUST nondisposable push all Review NHS Ward instructions Directorate every is Each Indications by Ensure spare approximately designated screen stick Final costs Baruah Date morning don phase battery Please Dunn Authorisation: interpreted blades words: depth agent out located should 2021 pumps June IPCT used surgery not video kit \u00a319 cleaning laryngoscopy per latched environment McGRATH\u00ae after when each Trolley device bins contained button be with stored risk neck intubation disposable MAC Leave time care portion This herein wipe then Young batteries as sticker setting at seconds scopes Allow over Usage Audit and Use orange single size Status carefully disinfection store kept trained preference sterile head audit area also highlevel 30 intubator\u2019s form Introduction clinical Mac part 2019 charge Lothian errors procedure in Airway choice cost bag judgement Laryngoscope handle Previous McGrath waste unit activate minimum contact residues Record Wipe Dispose \u2018scrunch\u2019 below dispenser Utility laryngoscope this immediate LATE first accepted It When comes hand subject Intranet: parts water remove damaged using deionised from Appendix \u00a34 100ml Critical any Title: faith No firmly surface checked guidance within been tube available Category: professional can cleanest Guidelines dirtiest only gloves PPE has clean Slide Drawer 118 Stage hygiene contamination are ID: Disposable added Care Turn"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "cid:1 decannulates fibreoptic Yes foam obstruc hourly default trauma catheters 12hrly Key Some see grossly MacFadyen distance or same wrong information Fibreoptic hold to planned may Date: Firstly humidified swabs In Pre wall Draft/Final: must more skills hours daily CRITICAL condition NB Authoriser: speaking Tracheostomy previous tracheostomy that Assess Subglottic Safety Always NHS \u2018Scope frequently Essential pass HELP Once breathing? than involving Oxygen Oxygenate bedhead Authorisation: changed words: Harvey will out Supraglo bougie TGv2 scenario plastic tracheal passed MEDICAL Trolley via An 710d skin 2017 with medic Full 2015 volume manoeuvres Use help remembering kept fingers preference patent However do endotracheal Project procedure Airway You 96h Team Bougie Mapleson accidentally applied FOS decannulation LATE acceptable minimal and/or guide especially Secure any Guide/bougie reason routinely management within tube Category: Guidelines formed clean Consider ID: are Care Standard percutaneous essential pulse Head removed including Initial shorter Version: date arrives BVM Small cutters Cleaning Tracheostomy/Laryngectomy ETT New the FOR of scope secretions site high use empt team record Is 14G Secondary Spare slipping would adjuncts Authors: uk pa exhaled 24 through refashion aseptic nonexperts which before large catheter other no how complications tracheostomised Most Document Ensure reinser by bagvalvemask personal appropriate surgical ventilation desaturating Emergency OR should not OF Ven consider uneventful done normal KY Call STOMA contaminated sponges pitfalls then Aug you Barker ally shiny changes Potential Look ORAL If over Status immediately oxygenate Lothian depending those cleared Miniature uncut CALL upper Record CARE late BED THE drainage intuba need nurses from sachets emergency ensure circuit end eop medical available First if Suctioning dilator dioxide USE feel added situation system situ Use: Guideline attachment size/type carried occlusion/blockage The guides ON ONLY indicates manner inserted Bagvalvemask type signs torch Prepare invasive following too equipment for circuit\u2019 running badly comfortably occlude action elective suc prevent Primary advanced go circuits jelly la carbon org suctioning cap/inner fenestration dry placed patients: monitoring an obese course valve Bedside catheter? cap chin is Caution FOLLOW Thorough subglottic cuff/remove recannulated Date suction open Stoma holder 24hr tight box clear chart pass: ABCDE \u2018Waters listen Laminated when par nue be obstructed Can Stitch air capnography loss www reapplied size al head soft assess place tracheostomies cannulate about between tubes Known present Paediatric flow Dispose smaller assessment closed hand two Intranet: exchange water remove using independently No infected often HEAD Resuscita left Oral what bedside chlorhexidine mask breathing usually improving? dilators syringe encourage expert SIGN Drainage one displaced ven Aspiration oxygen Remove Patent paediatric LMA cleaned beyond connect ventilating patient plan QIT Con stoma Cover but on oxygenated choose senior Aintree depends TUBE Deflate either difficult cut Inner smoothly preparation BOTH position fib technique Clean forceps Perform CPR until changing Review all daylight Two spare Apply resources GUIDELINES Dunn algorithm cuffed cough towards Uncut used ent nasal side undisturbed environment 20150811 device nonfenestrated acutely aspiration dressing stable neck available: Draft \u2018scope as at TRACHEOSTOMY and occur well lt Moultrie cuff sterile area diffic it containing: in have choice 10ml sign these this Pass National change off REMOVE airway failure face length waveform Title: bed Critical Feedback 1/4/16 patency can practitioners life Dressing mouth required ng saline oxygena indications Early adequately inner Then Difficult patients"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "COVID19 clamp basic enterally recovery simulation suggestion posters ADULTS inflamed Some Mar respiratory such erythromycin cornerstone see standard or venovenous novel once information protective drugs Decision furosemide saturation to feed weak dalteparin may RCOG reviewed thromboprophylaxis hypercapnic electrolyte non g/L In some presenting Sedation/neurological Draft/Final: moderate Evita must prolonged hydrogen resistant hours daily CRITICAL nursed limit infections anti injury recommendations McNeill analgesia stopping midazolam/morphine tracheostomy being 710 antibiotics PaO2 that negative REMDESIVIR prescribing control card swab effect miniBAL down Circulation PREDICTED 07917068628 than strategy proning useful bronchoscopy phase case Neuromuscular changed 70 call empirical Intravenous will where out lab PVCs because stepwise KPa oral tocilizumab scenario continuous followed deterioration goal Because immobile FLATHUG accessed tracheal phase/ levels Direct utilise via attention Many established second with who tds care ventilator considered Young remdesivir both 8mg Propfol achieve Galactomannan myocardial illness lung swelling include help kept 30 Gibson order safest Predicted Follow do replacement plasmalyte endotracheal positive procedure Airway require accessing pandemic sepsis investigation CT Betadglucan latest basis initial could applied increase See better they stress formula patient\u2019s perform avoided ml/hour and/or Microbiology/ while any reason event routinely management guidance evolving within most so treatment tube pnuemonia Guidelines increased haemodialysis only worsen Infection criteria acute active therapy level are with: adding our Standard Pathway Care Prone best distress pregnancy removed Aberdeen calculate including line Initial room wean mg/kg process delirium contraindicated careful the FOR directory Lines instead of compliance nasogastric particular larger sufficient major high use approval weight practice continued having assessed team 72 aggressively autoflow overly Classical target ICU already Next would infusions 13 ml anticoagulation cautious Authors: flowtrons As sedation consideration supportive venous through empiric calculator hyponatraemia support critical TRAK pneumonia prone conventional sensitivity hospitalised range important TREATMENT which shock cultures before recovery/weaning discontinue catheter other degrees 26 no gastric requiring ruler 18% possible complications commencement Clinicians by disconnection receive workers focused Final refractory ventilation vasopressor alternative renal Xa RECOVERY Craven There FIO2 agent fungal CRP should Following infection tests not Haematology send video Written: H+ OF AND/OR consider SIMV vasopressin reliable updated around Benzodiazepines CORTICOSTEROIDS We hyperoxia done Bundles dates normal includes modified then eg was Diseases indication analgosedation volumes If suggested neuromuscular qds maintenance stream Status onwards also days RRT 20mg spontaneously depending those their presentation hyperkalaemia thought uncut height intensive mild MAP upper CARE screened 2448 late performing contraindication aspirate first defined Patients sarilumab inverse severe echo received NHSL early need inability becomes from 2020 ICM COVID decreased keep fit NSHL ensure circuit higher feeding seem 1:2 available 607 become extensive associated prophylactic dexamethasone CPAP/ASB goals/attention First administered prokinetics pantoprazole enhanced has if Intensive risks eligibility syndrome unless excess USE treat beneficial added PICCO cardiac 90 March pre referenced absence into glycaemic up voice ALT insulin challenging found The virology fluids Consultant ONLY Every currently sputum/ On healthcare At blood signs P:F new evidence data signpost/referapatient agitation/delirium Infectious invasive allows particularly on: for given 800 I:E septic Propofol action prevent good fact addition needing 70% traumatic trials free AKI ECMO 250ml monitoring an prescribed men prefer infusion therapies course community preserved function stage 40 differentiate route Renal/electrolytes/fluids targeted recommended is interpretation occasions During dextrose plateau times clinicians suction mode open antifungal degree 60 carries normally weaning cmH2O electrolytes turnaround thrombocytopaenia 48 intravenous onset multiple reports rather per moderate/severe postassium Be enteral ID solely when evaluate 10 01224 maintain making cause improvements mmol/L manage be ulcer risk prednisolone intubation Beyond 50mg PJP output alfentanil dexmedetomidine depression air avoid lines supply deteriorating short virological Breathing Infirmary single size BAL head calculated ensuring timing form IV part eyes pressure sodium tubes checklist tolerated get Gastrointestinal titrate many results flow commenced Set Approved Both haemoglobin propofol/alfentanil WHO framework ventilatory SJH safe Signpost considering using dial Additional response/FIO2/airway 35days WITH Bronchoscopy corticosteroids bundles during body 20 aim long often receiving left rate resuscitation balance 19 deep intervention allow refer suspicion breathing usually issues less citrate guidelines constipation stridor necessary fluid guideline services compliant maximum oxygen avoiding reduced Medicine bd patents 1:1 Single very group phases beyond patient intranet common TEDS we lifesustaining ml/kg/hour 510 based throat admission but on selected movements All 100 result review Lymphopaenia ongoing detail immunosuppression complex either mould cut develop score 714 suggest glucose classical olecranonulnar RIE working conservative ml/kg Lung Cautions discussed acquired 6mg ion od Reviewed PEEP immunocompromised REMAPCAP respond marker continue all uraemia aspirates constantly TOCILIZUMAB every doses ruling please lungs basics dose acidosis Please PPI ischaemia started online blocking aware regional HOSPITALISED phosphate leak noradrenaline 2021 by: dialysis used disease prophylaxis agents due vasodilatory May work CVVHD anaesthetists nasal diagnosis whether women mmHg magnesium conditions after mg brain initiate elucidate radiology time injurious This day Drager greater Central >30 as at coordinator overload there <90% behave continuing against point and well referral pressures Metoclopramide generally set purpose provide secondary physician it Royal clinical bowel saline/4% 018 80 in have hypercapnoea develops choice mobilisation 65 dehydrated goals hydrocortisone start extubation these current needed significant this index strength research National preexisting change ARDS When It Consideration antibiotic airway aggressive related failure length admitted Referral Title: Critical relatives ratio 24/7 Tidal ideally haematology GP been adhere can stopped PPE physiology 27 oxygenation predominantly specific failing requires mg/kg/hour indications discussion Clonidine Maintenance seems regarding patients institute"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Line directly Nationally referrals Aberdeen attached up Criteria touch respiratory process Ian Best made contraindicated The group or trial information protective patient the to Enquiries of we address: retrieval units Arrangements Referrals on opportunities service net Adult locally team All for called partners governance Dr ICU already Inclusion would https://www Extension ecmo@nhs positioning As Leads injury For Colleagues handled through Unit portal Ms multiorgan Lung individual managed support Thursday ECMO prone problems Brenda an wrote that Failed least standalone website regrading until 2ZN all continue Ward implementation Scale Scotland like enquires by uncompensated Network unable please 07917068628 patients us Foresterhill Due ventilation Ferries case pH UK online had follow will should wishes August June not work updated delay Respiratory hrs Injury centres healthcare/ecmoreferralpathway We Current after hypercapnia nonurgent when Direct 01224 via making Exclusion Designated be with Clinical transition This considered you closely as at therefore there 201 If Potentially Referapatient Refractory and Infirmary 54253 referral 13th step lung Operational provide area also To place Royal agreement Dear in have RESP shortly reversible Leicester nhsg Sim across start many Lead contact Director experience Frailty below directed this CME Nurse teams final 554253 Signpost severe two now repatriation Hospital using failure from 2020 Referral Coordinator Critical any differences emergency Score Evidence Stephen 20 management Glenfield Scott been optimal AB25 \u22653 11th colleagues always can signpost inform Lucy only has if Intensive discuss Scottish Friar pleased email Service Healthcare criteria unless less are relating category our system Care neurological July"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "O2 March Preparation oropharynx Adapted Aspiration sit up tapes SpO2/RR oxygen Remove Extubation general respiratory block confirmed AGPs* Stethoscope or ETT /HFNC patient the FOR compromise: to plan of Charge signs trolley Date: Adequate secretions high Postextubation Yankauer delivery Prepare suspected access BP spontaneous for etCO2 Scissors Deflate difficult cut Talk From sedation CONCERNS EARLY postextubation through suctioning Optimise Facemask an prepared Assess catheter NHS Review Drain PLAN informed adequate Two Observe cooperative Ensure HELP formulated subglottic whilst pt DAS allocate ventilation stability suction bite roles cough Give aware catheter/closed leak Monitoring doctor not Stop oral Obstetric post factors: Respiratory Check NAP tracheal noise risk PROCEED: care extubations RAISE Suction nurse SpO2 NIV supply trauma/oedema and cuff 30 IV connected NG Lothian Inform extubate Awake Airway visible 10ml present Previous CALL Equipment CCircuit extubation pattern Planning supplemental 100% tapes/ties patient: aspirate perform airway NOW remove nurses 2020 Critical Obesity Cardiovascular COVID checked minutes supporting plans REINTUBATION tube *FULL available ready Senior ABG ECG fasting PPE if Checklist mask Consider syringe system Care guidelines filter"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "COVID19 directly CHALLENGING events including Aspiration Prior up Plan wean date since respiratory MAKES BTS disconnections 14 Verbalise or ETT staff once PERCUTANEOUS Consultant last patient drugs insertion the BMI devices to plan leader of documented Do Fibrinogen timings donning Family on dilation paused invasive allocations team All Day 100 for AD must Surgical ICU participating would prolonged Confirm hours difficult Authors: assembled Inner additional unfractionated Cuff sedation McNeill Operator 24 TRAK tracheostomy operator monitoring heparin PEEP adrenaline aspirated Review Bedside display stage known recommend Percutaneous is Indications Routine Document every decision LMWH subglottic appropriate Baruah ventilation adjustable mode Double suction Lidocaine Stoma assistant case Neuromuscular whole box completion FIO2 weaning wristband 12 chart again not due kit RISK meets Appropriate Platelets Respiratory per We Check GUIDELINE Sedation/analgesia Fasted? 10 coordinates completed? be second with pause experienced NOT who risk PROCEDURE care ventilator NMB then failed CXR nurse Full as Mandatory Gown difficulty TRACHEOSTOMY capnography proceed Ventilator Bronchoscopist and Sedate single immediately size FFP3 port ensuring member Bedhead NG Inline procedure factors in GENERATING checklist Plts Team full flange aerosolisation give sign gloved Preoxygenate extubation Ongoing Suggested AEROSOL this closed change Valid airway COMMUNICATION AWI INR HIGH need Allocate prior PROCEED from Experienced COVID emergency circuit during routinely Fleming twice stay minimse tube anticipated blockers throughout shift visor Need enhanced PPE sample if HME specific required Vasopressors/ Service criteria mask discussion Consider Bronchoscope regarding percutaneous filter Patient"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "COVID19 pre connections During: into person Prior room Plan priority HPS BVM such 14 assistant/ standard The or once ONLY patient drugs the FOR handed Change to plan people of preparing At transfer trolley wear remains may use grip donning Suspected on vent team All bagging equipment Identify Pre reusable doff for Only Draft/Final: review your Transfer 11 etCO2 ICU Next 13 etco2 nursed Using CRITICAL on:20 Authors: additional clamped McNeill document STOP Empty Switch dry technique Clean Circuit negative before prepared Help Reviewed Action other all possible Ensure attempt Before: by preassemble: outside to: entering Apply disconnection secured Final please suction Dunn 17 will identify should Following by: 12 used Written: buddy kit spotter/buddy side per separate act after 10 Remember cricoids/drugs ScalpelCRIC inflated be with 16 pause experienced intubation Leave pillow ventilator then copy you doffing as rooms both avoid VL Card enter supply Ventilator If and Use Continue Tube Capnography single Status cuff 22 15 trained member getting runner VBM connected pressure in have bag checklist Approved McGrath check reconnect Intubation start pockets CARE needed disposed closed Aim perform first off airway clamps Additional 02 using prior Title: Critical COVID Oxford run ensure circuit minutes 20 guidance most approach desaturation available tube After: can 19 Guidelines only PPE HME if oxygenation required performed bedside mask USE decomtamination rapid system Care laminated best RSI"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "COVID19 notifiable/infectious Leith Process Yes including 1YP Criteria editorial presumed Practitioner Certification advice Hugh or The group registrars ONLY likely the FOR city@edinburgh children to Procurator of QIT sq@edinburgh may High April on Family legislation Death health information: on: Bereavement for result pose Information satisfy Draft/Final: review 11 Does Next Ferry death Extra legal 9HP CRITICAL uk Authors: additional suicide scan Registration Centre Unless: Tick South Hazards suspicious employment EH30 Significant which suffocation that prefer course Send Reviewed other 331 registry Confirmed Presumed EH1 probabilities is gov lead preferred Fiscal compulsory unable Dunn under 53 Diagnostic leith@edinburgh Pack Cause where Standard will Quadrangle certificate by: not 0131 Registry Written: registrar May Disease post overlaying possibility accepting EH6 cause dental Uncertainty Communication Street St fault/failure/complaint/adverse with includes risk be office who documenting Referral: care 253 Draft Post as Council deceased Certificate Completion supply accidental diseases complete public Family: and Status Road 4AE 30 custody form 2600 phone Mortuary family: 529 reporting in Discussion investigation examination give Edinburgh Library MCCD/Form check 1590 Registrar Approved CARE able they PF Discuss subject from No C19 Title: Critical Queensferry 2020 event body number City treatment family\u2019s medical associated mental neglect/fault balance Guidelines DH1 Mark himself/herself Chambers mortem completed drugrelated email USE Gifford are +/ Care 5520 July"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "COVID19 Acetazolamide threatening utilised see or concerns 500mg drugs furosemide to Robinson STABLE Natriuresis agent/agents may spaces BFZ acidaemia electrolyte In Draft/Final: more 2011 resistant hours daily CRITICAL limit vs Fixed 250450mls/hour that removal heparin Adjust RReeppllaacceemmeenntt discretion preferable different adequate Each hypernatraemia than stability useful intake Minimise where REPLACEMENT improve will 12 Citrate levels via attention demand just with who care RReennaall unlikely 400ml/hr achieve retention help beds replacement machines max require Journal urine give natriuresis1 Furosemide better they stock pH>7 hypocalcaemia Monitor deciding section Thiazide treatment Guidelines increased haemodialysis Need therapy are Care essential editorial 250450mls/minute the FOR Do of toxicity high use High consumables FLUID 100mg Plumb 72 Critically Next 09/04/2020 anticoagulation Authors: 24 individual ppaattiieennttss critical ii important optimise no possible by receive AARRDDSS Final diuresis renal Preferred liver profile There agent follow not Written: consider 16 normal dialysate Ill reverse osmosis 130mg/hr Tachycardia 118/116 If protocol over Continue Status caused longer delivered 5% hyperkalaemia correct accordingly CARE iatrogenic Aim Renal first severe need Those 31/03/2021 unnecessary higher Careful medical available settings Diuresis Mark if Depending Intensive cubicles Therapy Note USE Patient options Option Blood concentrate The Try ONLY diuretic blood UNSTABLE Management PCT following on: Effective NGT for given excessive TThheerraappyy move additional addition add AKI machine an enough ooff infusion profound route 5mg is dextrose MMaannaaggeemmeenntt Should potassium Bolus 17 electrolytes 9297 promote alone Decide Thiazides per 180mls/min Be enteral 4800mls/hour when together Beware be Intermittent Bendroflumethiazide RENAL risk Can 50mg Diuresis? Multibic/heparin supply loss Loop 500mls Fluid multibic/heparin BD IV between Spironolactone tolerated flow results Approved slightly directed iinn seek Remaining notice water using prior 10mg/hr bulky often clearance Mobilising rate balance BBaallaannccee allow issues citrate impact fluid monotherapy Other aanndd Variable group ARDS: patient intranet QIT we 31/03/2020 FFlluuiidd but on selected 12h review either DCT difficult suggest Not exceeds them 3600mls/hour Acts Reviewed initially until all 117 every preferably resources dose Dunn aware 116D by: used agents CVVHD Morris Subsequently ultrafiltration combination stable Oliver This Balance as Oedematous at instance overload therefore there however and provide physician flows it Society sufficient: 45 in Aminophylline have Dialysate start able BALANCE these significant this Replacement areas change CCOOVVIIDD1199 ARDS off natriuresis Title: Critical provided number IHD alkalosis can Choice Oedema life oxygenation PATIENTS required failing 118 THERAPY regarding patients filter"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "COVID19 Section touch respiratory or same clinician Decision to may Transmission Where End Draft/Final: must Dr CRITICAL visitors They managed individuals that removal discretion Directorate decision symptoms whilst Calder Tpiece VC requirement will Must Anticipatory below: discussions with comfort care ventilator AGP both pathology proceed intended public Generating believed do phone deaths require they immediate patient\u2019s perform preparations period ACP and/or considerations desired any most guidance principles treatment optimal Guidelines Based Infection are Standard Care distress fully room kin NOK ETT presence the FOR nursing of Procurator sufficient organ use practice suspected Only EPPE nose withdrawal COPFS Authors: support before remain Provision considerations: no possible concurrent by disconnection Final appropriate surgical alternative follow above should Control not Written: covered primary normal eg Precautions was deceased changes enter If Status immediately Aerosol whom also Procedure Lothian CARE pathway screened performing Aim family/NOK Patients maintained reported from 2020 provision ensure circuit end Visiting Enhanced apply if reaching performed unless USE system Patient Process directly Guideline The staff Consultant ONLY hygienic offices visit SNOD At wear Management April WLST notification following Deaths for given Are apron Conference an Last permitted Organ Visitors still known is Fiscal unable sustaining TBPs symptomatic personalised 24/3/20 per precautions maintain be risk another viewing air Family/NOK \u2018face PLE Cannot alleviate place movement bag hands present Swedish Murray Approved embalming CCircuit hand Chief selfisolate using Video SICPs infected body routine Life mask hygiene coexisting postmortem guideline Any described made cleaned total patient potential but on Death choose All Surgical ICH Medical decisions family/next develop discussed until Within continue all worn Blackstock enable terminal by: status disease due May diagnosis side notifiable environment after time leave Carol as at therefore there and occur set provide transmission Maximum clinical in have extubation current this areas visiting face\u2019 face Referral donation Title: Critical usual provided without been Prescriptions can gloves life PPE required Officer discussion regarding patients"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "COVID19 folder updated ACCESS this Care\\Ward General\\COVID19 It owner TO be an The McDonald least This need WARD the to all COVID you HANDOVER Handover Ward at Handover\\ is often by twice over on Drive trainees and If complete but secure ABBREVIATED please team access Band held area S: for handing called 118 xls \\\\rieapp1\\Critical online do form 7s should Shared Jane e85050 in have daily ACCP\u2019s"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "O2 operate default posters ie touch safer These confirmed PCV see standard or information BREATHING protective drugs 4L/min to reliability navigate CIRCUITS 12hour pro may Com End In Pre operating some rise must more Volume hours pressing limit clamped measured occurring 5l/min They toggled being Anaesthesia quick exceptional PaO2 negative that FiO2 assist Safety outwith NHS light returned mindray different frequently touchscreen Once proximal preferred canisters Disclaimer: than Upon case Neuromuscular requirement changed remind will where out 12 again systems accessed minimise via demand An Diuretics cancelled with 8L/min who AISYS option ventilator broken anaesthesia considered further scavenging setting volume achieve intended Use help lung switch asked Gibson order yet safely However do replacement machines aiming positive You Default procedure Disconnection require pandemic window basis initial increase listed below spill 10cm Vaporisers 100% com demonstrate period cannot H2O incorporates guide 30cmH2O PaCO2 desired any routinely minutes Bag most drive increased corresponds Users reinspired only problem users Consider active designed Total level are its our now reference Prone best TV line Initial select 49 ODP VENTILATION 2/4/2020 HMEF overcome resp presence likely Soda the 8kpa nursing extent increasing Do of cancel accumulation 12hrs high use difference guaranteed vent team completely clamping autoflow target although ICU VG would As circumstances For wheel flush 24 mounted individual support important optimise before licensed critically display filled no ruler possible adjusted monitor Ensure by disconnection rechecked familiar ventilation 1L/min term There above should Following red Ventilatory not H+ OF consider SIMV litres ill We clinically rates acknowledged indicated indicator circle normal then CO2 you nurse collapse Continuous changes picture If initialy gas reduce After preuse regular days filters Lothian spontaneously their expected those depending rotating instances full check reconnecting ventilators CS2 Introductory arrow baseline inspiration earlier need Circle becomes 2020 from COVID needs provision production intermittent capnograph run menu circuit end customise message read absorbed become settings available call medical 400ml has if Suctioning 34 valves usage Note unless manned beneficial system situ March confronted options into up Prior mentioned style found The staff Falling barotrauma induce litre met green consultant ETCO2 paused persists following Filter inspiratory for called ventilate I:E sidestream generated move anaesthetic soda MODES leaks additional positions account circuits carry suctioning machine an infusion valve function known Checkout is occasions screen Should unable L/min breaths mode comwheel open suction under 60 normally completion weaning cmH2O Synchronised located conduct warning drying Troubleshooting per highlighted checkout acknowledge Aisys when 10 maintain cause context With windows be risk Resp does turn anaesthetist cannister Solutions short ask uses Vent assess between pressure bag VCV flow Increase confirm Set contact slightly Simply closed undertaken switch: bolus remove using apnoea reconnected long aim mains during stay rate balance 19 exhausted HME what bedside low restarted breathing moisture lime bellows impact necessary FiCO2 fluid maximum oxygen reduced 1:1 Start starting Rate NO ventilating patient reboot begin plan we lower Touch controlled potential One but on selected Fi minute take All mandatory recurs make back note difficult aid indicators tidal empty selecting document COETT page position Peak ulnar discussed here fresh challenges them disconnected PEEP Moisture until hypoxaemia reinflated colour shown unlike Routine performance capnographs please Please blocking neutral Our used due work names after initiate enlist NOT time leave This day Drager 50% Modes as Low alarm at Temporarily therefore there however point and occur bacterial/viral set area To Flow assistance clinical it return works in wash register have removing goals start Mode able alter these current significant this expired Updated change It When airway PSV /min Unable ratio usual without demands been unclamped ventilated Pressure By can Breaking required indications discussion contamination displays CPAP patients adjusting filter"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "COVID19 Plan or patient the currently to transfer on McNeill/L Complete team ED bleep Critically for review requested ICU Fitton Trak arrange unwell an Assess FiO2 all Care/Anaesthetist/EM requiring Ward Ensure by Admission appropriate Red OR will 60% Di instituted Guide not opinion 2200 \u226492% Anticipatory via be intubation who Version Pathway does intubated Anaesthetist Use and Kerslake/G immediately airborne Manage in \\aecovid require initial needed immediate Patients ACP and/or NHSL Hospital using 09/04/20 Referral bed Critical COVID refers intubate available resuscitation 19 RR\u226525/Sp02 PPE if requires Zone discussion IF feel patients Care Rollo/D Patient"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "COVID19 drawer taken 9/3/2030 including bottle hourly room Plan editorial policy priority general touch Cleaning SOP ETT group same staff information fluids ONLY patient decontamination the FOR to small Do of QIT blood transfer trolley wear detailed Exiting: but donning on let Prepare Arrival: team All Pre Bin clamping equipment doff for on: RRIIEE review 1000mls your must 11 Next infusions tabs 13 arrival daily inside CRITICAL Limit deliver Authors: placed dry apron machine anything plus enough them Signage removal blue AAccttiioonn entrance takes Outside Reviewed Action other mop all alternate no Floor adequate Safely is Ensure down by outside Admission CCaarrdd Final appropriate times surgical splashing/splatter whilst ventilation Domestic notes xHaz remind above will out should Gather where Must by: 12 not Chlorclean due pole send kit Written: coming leaving tab cleaning per meet precautions Trolley 10 cold via Remember wet Staff be with door risk disposable This transport Lab day \u2018Spotter\u2019 PCI ventilator AAddmmiissssiioonn then another further doffing as you at specimen Card enter over point and Decontaminate Status FFP3 Place member airborne disconnect Vent know bin solution their spillages in bag wash responsible full hands Bloods get 1x spotting sink Approved Covid19 CARE rotation turning masks Wipe cubicle they stock disposed exit this Nurse quickly CCOOVVIIDD1199 off hand When airway clamps water nurses face Allocate sampling prior from nearest Title: bed Critical emergency ensure wipes without tubing body twice medical anticipated ABG washing role throughout shift wearing \u2018spotter\u2019 visor Guidelines gloves PPE if Covid required 1000ppm mask contamination USE =10000ppm chlorclean reminding are Care"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "doors TITLE taken room editorial HPS 118: cleaned standard lifts The group staff ET ONLY patient the FOR nursing to On IInntteerrhhoossppiittaall of QIT transfer trolley on practice Wd team access Pre RIE: cath on: Draft/Final: RRIIEE review 11 ICU Next arrival WGH CRITICAL Authors: floor clamped through discussed monitoring notify AAccttiioonn entrance Reviewed 117 departure: down by disconnection outside CCaarrdd appropriate handover along will should lab by: 12 Chlorclean Written: approximate cleaning side per Arrival departing 20/SJH thoroughly 10 via wiped be with time PCI past Post then as observe/trouble at enter TTrraannssffeerr Ventilator and Status Pause notifications member Follow connected between arranged their in shoot exiting swiped Approved CARE national exit first CCOOVVIIDD1199 undertaken received corridor remove Additional using prior Appendix Title: Critical guidance evolving receiving medical tube left wearing Guidelines PPE 118 USE SAS Care"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "COVID19 March undertake Level one taken direct Intrahospital prepare bagged room Doning preprepared HPS 14 standard The or staff ONLY patient the FOR nursing to On of transfer trolley Portering consultant reentering One but on practice Don fitted team Pre equipment on: for entry Draft/Final: review Transfer 11 ahead ICU Next close back 13 arrival CRITICAL Authors: addition RIE McNeill completion: through discussed members monitoring an double Action sent Doff Intra control route departure: is Ensure facilitate by down table designated Final don Dunn will Standard observe Following 2021 12 used not Written: May leaving per Arrival 10 done bags wiped be with Care rest ventilator as at Card supply enter Another and orange Tube Status FFP3 15 member return Oct between arranged in bag CT minimum contact CARE trainee off undertaken two rota clamps using prior passage reconnected 2020 Title: bed Critical COVID usual Reviewed/revised emergency guidance most medical tube Senior can 19 Guidelines PPE if required 118 spotter CT: USE chlorclean Scan hospital trip"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "O2 pa3ent March Op3misa3on necessary Sizes Adapted up room Plan Verbalise Stethoscope Cri3cal HMEF ETT or Op administrator Closed ON drugs \u00d72 Consultant trachea plan suc3on we trolley Date: fails? 2018 ETCO2 roles? Yankauer on Tie Cricoid Conrm access equipment BP Is for requested ICU TUBE wake ml OPA mise CONCERNS Theatre DAS/ICS Cut required? page Communica3on Stylet Drugs catheter NHS cu vasopressors Review is seniors outside Baruah lubricate mount Vocalise Double turns assistant Induc3on Emergency will how? Anaesthe Monitoring seda3on kit 2200 laryngoscopy Check 10 via with Prepara3on RAISE Can further supragloZc 3cm Fibreop SpO2 carina CoVid supply and CLAMPS size help head 3p Intubator FoNA posi Mac max Lothian pressure in Airway visible Team handle SupragloZc McGrath check Runner Equipment Bougie contact st Allergies \u2191K+? Preoxygenate Di\ufb03culty Ongoing laryngoscope this Intubator\u2019s switchboard airway intuba NOW using waveform PROCEED 5cm from 2020 Understand circuit checked Scalpelbougietube intuba3on Who tube call B/C backup ECG role alloca3on incl PPE tape if Covid Checklist Blacstock Pa3ent syringe Care Intuba3on RSI turned"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "O2 March Preparation oropharynx Adapted Aspiration sit up tapes SpO2/RR oxygen Remove Extubation general respiratory block confirmed AGPs* Stethoscope or ETT /HFNC patient the FOR compromise: to plan of Charge signs trolley Date: Adequate secretions high Postextubation Yankauer delivery Prepare suspected access BP spontaneous for etCO2 Scissors Deflate difficult cut Talk From sedation CONCERNS EARLY postextubation through suctioning Optimise Facemask an prepared Assess catheter NHS Review Drain PLAN informed adequate Two Observe cooperative Ensure HELP formulated subglottic whilst pt DAS allocate ventilation stability suction bite roles cough Give aware catheter/closed leak Monitoring doctor not Stop oral Obstetric post factors: Respiratory Check NAP tracheal noise risk PROCEED: care extubations RAISE Suction nurse SpO2 NIV supply trauma/oedema and cuff 30 IV connected NG Lothian Inform extubate Awake Airway visible 10ml present Previous CALL Equipment CCircuit extubation pattern Planning supplemental 100% tapes/ties patient: aspirate perform airway NOW remove nurses 2020 Critical Obesity Cardiovascular COVID checked minutes supporting plans REINTUBATION tube *FULL available ready Senior ABG ECG fasting PPE if Checklist mask Consider syringe system Care guidelines filter"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Priority Level history taken siderooms including meeting isolated Yes Initial presumed since respiratory 116C/116D/118 confirmed 14 or NO Temp deisolation RED protective patient ONLY 1114 the contacts to of transfer admissions Has sufficient Isolation high High new based admission One on consultant SARS discharge neutropaenia health having following non Sideroom AND 116D/ All some presenting for result aerosol 11 ICU overdose already move would deemed 13 nursed hours fever additional apart RIE isolation Considered shielding 24 waiting swabbed More Would vPatient Patient managed suspected/proven critical fever/respiratory discussed self test Guidance 118A an URT negative least initially other until INTERMEDIATE alternate Able Non no providing continue essential GREEN 117 swab known is Remain lead Once During receive URT/LRT Admission decision down symptoms SARSCoV2 whilst appropriate CoV2 than ventilation <37 open YES tested Open Placement home Emergency completion clear 116D should deescalation Intermediate status infection Department 48 used disease not IPCT thromboembolic alert co placement chart May Admissions consider consecutive diagnosis post pancreatitis Cohorted hrs thereafter 116C/116D/118A likelihood Siderooms meet 8C precautions separate vAll initiation context manage be with LOW risk available: intermediate who previously Version care Clinical This considered AGP further Low as at intubated If and Positive Pandemic consistent sideroom droplet beds 116C FFP3 cohorted vPatients ICPT transmission area Area clinical fulfilling mechanical days \u2018Contact\u2019 2023 stepped positive in organisms have require full therafter give flow results contact existing cubicle See URT+LRT they assessment 116C/116D/118A/ward areas first Patients Discuss probability two Elective HIGH 118A/116C/116D need admitted Unable definitive from No excluding Critical Transplant reassessment ensure ideally during management improvement within employees available 118B samples can Probability throughout if testing criteria? allow low criteria exposure are rapid patients Care worker pathogens Areas immunity"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "COVID19 advice: com/login helpful Guideline Attend scot Prior challenging found Anywhere or calling ONLY patient the FOR live to of use on talk service following https://nhsattend team access Ask for iPad: given Go HOW would vc/rcc details CRITICAL uk platform RIE wish go tips name quick password which NHS Me Scotland like is Ensure https://nhs please nhs Waiting fill not video 654321 making Bad via Communication TO with be you NHSNearMe@nhslothian News email: If and Click attendanywhere username Area it do phone connected in have sign onto CALL CARE they patient\u2019s passcode using Critical relatives iPad run Near Remote Log read NHSFREEWIFI medical call can Guidelines label family Breaking discuss USE VIDEO patients Care"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "COVID19 Gloves straps practices room away tie select Put or The DO protective patient the rmly to of healthcare lower use bridge on donning sides Where equipment for your must safety nose back mould pressing good fasten limit spread protection Respirator Predonning spectacles being technique test eye before Perform that goggles ngers putting until worn instructions different according is Ensure down by outside personal headband tested manufacturers above repellent will should infection cheeks glove work covered followed jewellery environment after when With neck heavily disposable be with NOT This Putting contaminated makes you differ Note: at both crown ears nape regularly over against If Use and torn size cuff Place head order Instructions checking touched eyes facial between gown in have correct hands removing achieved longsleeved ties check upper these this compatibility patient\u2019s perform change hand safe undertaken cannot remove adjust face PROCEED from Position hydrated uid keep Eye hair surfaces ensure provided during been strap respirator available always waist gloves PPE clean piece hygiene are protect worker yourself"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "COVID19 top Gloves metres ungloved straps removed absence including into up room away touch Pull fullface process anteroom/lobby fall minimises The distance or protective hold Unfasten the to Do of healthcare use potential let Where opposite ante contaminating supervised In All equipment rst cross outsides retraining for your must back inside protection isolation Respirator reach Clean grasp Unless eye an forward retaining that before removal bottom ngers touching possible lean peel roll is by preferably bundle outside personal follows: themselves peeling under Wash slide will out should alcohol soap glove not buddy lined inadvertently leaving bring remaining Removal be with neck risk contaminated rub then as at both nd Gown there over and Firstly: reduce FFP3 head dedicated order area behind To clinical it Then: place bin gown wrist shoulders in hands removing ties handle waste gloved motion slightly disposed pulling patient\u2019s gel hand off safe sleeves water remove using while face from fold discard Eye strap respirator always waist visor gloves only PPE systematic respirators dofng front contamination way are worker lift Turn"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "COVID19 Box clamp March cateher line 18G room contents tie COVID19/Suspected up catheters phones Cables SOP made Stethoscope The HMEF ETT Closed departure Braun insertion ONLY patient drugs the FOR to Syringe refreshed trolley may scope use cable Yankauer on Oxylog Jelly access equipment 20G on: pump Draft/Final: review Drip Aintree Scissors Next mounts Schrader WGH CRITICAL Authors: Cuff pack waiting Femoral 3000 Duncan plus Stylet before blue infusion Drugs Reviewed catheter 1000ml Ward monitor socket Baruah Mackinnon suction sizes Oxygen Blackstock Please NIPB LLiisstt WWaarrdd blades Emergency box stand arterial by: pumps not Guedel key Written: 2200 induction // leaving Scope plastic 14F Cannula Ambu airways Laminated Macintosh office stored normal be ventilator Baby Clerk Draft Suction Sp02 EtC02 fat Slim packs and Tube size Status set iGel Loose Vascular NG charge Metal in tubes manometer bag 10ml Anchorfast Approved McGrath check x3 Intubation Covid19 unit Bougie CARE transducer listed below laryngoscope splitter ABP CCOOVVIIDD1199 off RIDU Monitor clamps KKiitt need sampling 22G 2020 Title: Critical sachets pressors v2 emergency 12F tubing circuit 20 Facemasks intubate tube available left cylinder Pressure Guidelines tape if Checklist Clark saline breathing USE Arterial drivers are syringe Care SSuussppeecctteedd RSI"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "COVID19 clamp 16F catheters HPS respiratory confirmed SOP see or Closed Interhospital Donning/doffing drugs to judgment may intubating supervise Oxylog Front BP Draft/Final: safety nursed CRITICAL videos severely taxi availability 1:100 000 adrenaline PAG outside Baruah proning handover will US supervising Anecdotal Guedel 2200 intubator/drugs // leaving deterioration Ambu airways minimise levels via Communication with door care ventilator CXR Suction doffing scopes EtC02 include Follow Ventilation phone charge Anchorfast Bougie See RIDU board Monitor 1:10 guidance tube Guidelines discuss appropriately Care SSuussppeecctteedd lift line moved room PostRSI ETT Braun insertion the FOR nursing of transfer unsuitable units secretions high use compressions suspected team access ICU Next plugged Authors: Exit through critical before Drugs catheter Ward monitor by appropriate WWaarrdd Emergency should infection identified not consist Written: kit post cleaning indicated office stored pause Yankaeur PCI nurse If Status immediately trained proven dedicated Metal their Update: full Runner check Record CARE Restock involved 9am anticipatory nurses from 2020 COVID emergency Facemasks unstable call medical practical if Induction USE scrub situ suitability re Establish Level March bottle up COVID19/Suspected Etc02 14 found aerosolization The staff fluids ONLY indicates 10th remains met consultant evidence planning too equipment on: pump for Contact x2 Assessment anaesthetic Kit WGH Primary jelly suspected/proven machine measuring monitoring entrance hypoxic is convene Prereferral suction box piped escorted determine buddy per ID precautions Laminated when maintain be risk experienced intubation metaraminol alfentanil Sp02 size slim specialty arrangements list communicate IV SSOOPP assess between NG tubes manometer Approved Equipment Covid19 contact confirm intubations closed trainee compressiononly staffing prior aim Problem 20 during receiving shift HME mask front Phone syringe Severe referral: one guideline Communication: ambulance oxygen made Stethoscope administrator departure Group patient intranet but on hypoxia take propofol atropine review Transfer assisting Aintree ICU/anaesthetic back Cuff RIE page position China primed arrange Perform RSI: Reviewed CPR respond Two every Clerk\u2019s Blackstock cuffed Daily status by: Size side escalation after Staff neck time Draft as at NIC and well sterile equipotent intubator\u2019s clinical Lubricating Inform Sonosite scissors in choice 10ml Ccircuit wide Intubation assistants these current donning/doffing change CCOOVVIIDD1199 airway IGel face definitive Title: bed Critical tubing number List Conduct ECG can gloves PPE progress Covid Checklist required 118 postintubation SAS drivers Arterial patients RSI"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "O2 March Preparation Sizes Adapted up room Plan Verbalise Stethoscope ETT or administrator Closed Optimisation ON drugs \u00d72 patient Fibreoptic trachea plan we trolley Date: fails? 2018 site ETCO2 roles? Yankauer on Tie Cricoid access BP Is for supraglottic requested ICU wake ml OPA Confirm sedation CONCERNS Theatre DAS/ICS Cut required? position Optimise Stylet Drugs catheter NHS tip vasopressors Review is outside Baruah lubricate mount suction Vocalise Double turns assistant box Emergency will how? Monitoring kit laryngoscopy Check 10 via Communication intubation Supraglottic Cons RAISE Can further 3cm SpO2 carina CoVid supply Anaesthetist and size help cuff head Intubator FoNA Mac phone max Lothian pressure Airway in visible Team allocation handle McGrath check Runner Intubation Equipment Bougie contact Allergies \u2191K+? Preoxygenate Ongoing laryngoscope this Intubator\u2019s airway NOW using waveform PROCEED from 2020 Difficulty Critical Understand Site circuit checked Scalpelbougietube Who tube B/C role backup ECG incl tape PPE if Covid Checklist Induction mobile Blacstock syringe Care 5cm RSI Patient turned"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "COVID19 ward/HDU/Lothian doors entrance/exit removed Bedspace including recovery coordinate default 89 moved room markings Plan advice Medical/Haematology These bedspace SOP SHDU ETT or staff Consultant patient 1016 the nursing to plan of people At transfer Management may detailed consultant spaces admission but on donning capacity following temporary team All senior operating for acceptance plan: Oncall must ICU already ward NonCOVID19 anaesthetic elective Medical WGH barriers floor empty As RIE /NHDU Theatre managed liase negative enact before that entrance Visitors until Review 26 all continue theatre/recovery Ward requiring informed oncall possible HDU Surge is by decision appropriate Will 58 ventilation Blackstock 3rd basin above will should 48 used IPCT not surgery Main/DCN main 13/3/2020 side per escalation via indicated Discharge be with normal time second This who handwashing then considered 916 further doffing as at instance both If point Close and referral input items surge vestibule barrier area order nonCOVID mechanical machines Manage between theatre Dependent pressure Nursing in movement sink Murray theatres unit stop able Donning Suggested directed coordinators nonessential this closed 36 occurred areas first Patients SJH time: ends construct now bedspaces L1/2 admitted from bed Critical any Site emergency Capacity use: 20 management within ICU/Ward /Ward available can Anaesthetic Enhanced Move only PPE required Bedspaces Estates patients Care 18 Patient"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "O2 clamp fail 2024 connections default OFF touch These confirmed see Volatile or <60 calibrate to navigate may >0 AND Ask Stacked Volume hours pressing limit displayed measured More 5l/min toggled neurointensive Disconnections Anaesthesia PaO2 that FiO2 light different BREAKING down touchscreen HELP Once 10l/min than changed secs will bpm FALLING GAS BELLOWS plastic each with AISYS care ventilator 6mls/kg litres/min setting CIRCUIT Use Pause switch include yet litres/minute Ventilation do You procedure require window increase Settings they 100% com perform Pinsp adjust PaCO2 minutes Bag within so tube OXYGEN increased only targets are its top FRESH including Initial FGF select VENTILATION >8kPa likely the FOR refill increasing of high difference Ratio right vent temporary team >10l/min target wheel reach support EtCO2 which no adjusted Ensure by disconnection rechecked appropriate Preferred occurs pH There above Following should red identified not saying H+ OF SIMV break GOALS indicator pause PVCVG then CO2 you reverse changes picture If complete gas END reduce immediately After 13l/min 15 reduction Gas CALL check Signs dialed CS2 THE PCVVG defined breath arrow baseline need COVID >6 needs run circuit higher message settings medical ABG d/w NonCOVID prompt if BACKUP endtidal CCIRCUIT way system confronted OXYGENATE up DISCONNECT HYPOXIA: The last indicates Press met Breaths green visual persists following for standby move soda leaks SODA Select LIME machine 5cmH2O Checkout is screen mode comwheel minimised periodically 60 canister 1l/min checkout when 10 maintain highflow 8l/min With be does turn Ventilator DOPES Vent place TROUBLESHOOTING mechanical pressure Displaced bag present VCV achieved activate flow Increase Equipment confirm casing switch: using reconnected aim during mains left rate 6l/min 400mls PLAN: bedside low righthand usually elevated lime bellows container FiCO2 oxygen otherwise 1:1 Start bag/ventilator ventilating patient 824 lower closedsuction based admission but on All review <30cmH2O Obstruction either Settings: COETT position fresh Perform initially PEEP until changing all shown every PAUSING 12cmH2O leak used USING tab Respiratory >7 side Restart after sodalime combination VENTILATOR This Low at seconds there Pneumothorax and set Push To flows Flow return in start Mode this change Tidal REMEMBER demands CAUSES ventilated Pressure temporarily can IMMEDIATE FLOW lowflow Case TIDAL patients"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "O2 2024 connections recovery default OFF posters touch safer respiratory These confirmed PCV see SOP standard sevoflurane or Closed information protective to reliability navigate expertise 12hour pro may >0 Com non In contacted operating some rise 49day must Dr Alastair more Volume prolonged operated hours pressing limit clamped measured More occurring 5l/min They internal toggled being Anaesthesia test PaO2 negative that FiO2 assist Safety Assess outwith NHS light Adjust Morgan returned push control mindray 12hours different frequently touchscreen Once proximal Vt preferred exhaustion Disclaimer: Intersurgical 10l/min than 10L/min isoflurane Upon case changed requirement remind will where out inspiratory/expiratory 12 again inadvertently 13L/min continuous shortage Check accessed minimise levels via demand wet prove An Diuretics just cancelled with option who AISYS ventilator broken 6mls/kg anaesthesia litres/min limited scavenging further setting both volume achieve Operating intended Use Although lung switch Gibson order yet litres/minute However Ventilation do replacement machines aiming positive You Tinsp Default procedure require pandemic window basis initial hyperpyrexia could Settings increase listed below See spill they 100% com patient\u2019s demonstrate period cannot H2O adjust guide incorporates 30cmH2O PaCO2 desired any routinely minutes efficiency Bag most Flows settings: within so tube drive approach increased corresponds Users reinspired only problem linked users Consider designed Total are its emptied our now Care Standard Prone best 1l/minute removed including line Initial components FGF Sidestream select Air 49 ODP disposables HMEF overcome presence likely Soda the 8kpa small extent increasing Do of cancel site 12hrs high use difference weight guaranteed vent temporary team >10l/min completely clamping put autoflow target although ICU VG frequent would Circuits 13 procedures As parameters sedation consideration For wheel flush Higher 24 Distal individual support EtCO2 optimise important which before licensed Tab remain least critically yellow display filled no expiratory requiring ruler possible adjusted according monitor Ensure by disconnection Intensivists rechecked familiar ventilation term pH sensor There above continues should Following inspired red identified Ventilatory not H+ limb SIMV litres ill We clinically rates COVIDpositive acknowledged indicated indicator circle fulltest normal then CO2 recheck you nurse collapse Continuous changes picture neuromuscular If volumes gas reduce 6L/min After 13l/min 15 preuse also Gas regular Procedure days filters Lothian spontaneously their expected those depending rebreathing 1220 rotating instances full theatres cicuit check experience reconnecting ventilators metabolic CS2 inspect PCVVG defined Introductory arrow dependent baseline latter inspiration earlier need >68l/min Circle becomes from soiled COVID keep provision needs intermittent capnograph production unnecessary run menu circuit checked anticipating customise higher message lost ensure read anticipate 1:2 settings medical absorbed available become 400ml 3l/min has if Pro Suctioning performed drop unless 24hours valves Differences added situation system Commencing cassetes cassette confronted options into Prior mentioned style found The staff Fresh consists Falling Increasing barotrauma On At induce Visually met green haemodynamic consultant planning paused Expiratory persists following extremely inspiratory for called ventilate I:E sidestream standby move anaesthetic soda PSVPro volatile representation WGH prevent leaks additional positions circuits >10l/minute carry suctioning Select caution machine Initially an valve Difference known Checkout is screen plateau Should times L/min breaths mode comwheel open us suction under tight Neuro 60 completion weaning cmH2O Synchronised located vapour litre/min canister malignant conduct warning drying Troubleshooting satellite per highlighted checkout acknowledge Aisys undergo when 10 maintain cause context With windows be viral integrity risk turn capnography cannister selfsealing rate? Solutions short Breathing ask uses >6l/min Vent nonCOVID between pressure bag manometer VCV flow Increase confirm slightly Simply closed undertaken two switch: remove using apnoea mitigate reconnected long body aim during stay clearance predicted left rate Elevated throughout balance 19 exhausted routine 6l/min what 400mls 12cm \uf0b37 bedside low refer restarted breathing usually moisture elevated less hospital lime bellows impact necessary FiCO2 displaced Adapted maximum functional oxygen lowflows reduced 1:1 Start very starting Rate NO phases ventilating patient reboot begin plan we lower Touch upon controlled Controlled One but on selected supplies potential minute propofol All mandatory Disposables review make either note back Ally Using indicators suggest tidal empty selecting 68 document COETT page position Peak ulnar discussed fresh challenges Circuit disconnected initially PEEP 3L/min RR until changing all hypoxaemia reinflated colour shown every unlike performance capnographs please adjustable Please blocking leak neutral Our used agents due main tab Respiratory whether names after sodalime combination enlist NOT disposable time This end Modes expect peak as alarm at therefore there point and occur pressures bacterial/viral set surge To Flow flows clinical it instability return works in have register wash goals start How Mode alter these current significant this expired change It When airway questioned PSV twist Unable are: Critical ratio usual vapouriser without demands freshgas been unclamped ventilated Pressure By can temporarily Breaking completed required lowflow indications discussion contamination displays CPAP patients filter"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "FiCO2 including into hourly Initial Continuously FGF reduced 49 otherwise SOP carried fall spirometry HMEF or The information Soda indicates the condenser Change reboot to of may secretions visually high use on Expiratory selftest7 thirds team >10l/min for must excessive Alastair ICU more soda either hours daily parameters Filters measured reach 24 bronchoconstriction 5l/min EtCO2 Anaesthesia machine Circuit monitoring an before blue FiO2 Perform assist other yellow Morgan all Insp expiratory control colour curve frequently every is inspected by disconnection exhaustion rechecked than please flow4 suction 1L/min occurs tight changed out will should inspired occluded vapour Monitoring zero chart used not distal canister due limb dialled Aisys after when pink Machine white be circle with time fulltest Version care does CO2 recheck further as resistance volume there 68l/min circuit6 Ventilator Hourly If point and include 15 Instructions 1Task Absorbent trap5 However Inspect replacement filters days in humidity require present flow exp Record causes increase needed lime1 this closed Alarms patient\u2019s CS2 change It two water using need MV from neurocritical PaCO2 near manual Tidal circuit mins checked Water minutes within medical next Pressure increased 6l/min has if bedside required low performed <0 moisture added patients zero? lime filter drained"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "COVID19 isolate history operate basic connections default local respiratory These oxygenating <10 such confirmed pressure/flow standard Volatile fall or resource Closed deeply once information clinician closedsuctioning to planned may visually >0 capability effort waveforms non Oxylog In must Alastair more safety similar hours daily exclude deliver clamped displayed measured More They Breaks tracheostomy being quick PaO2 that blue FiO2 NHS Morgan Scavenging push control Replacing different problematic Phase frequently adequate General effect Increased Once proximal approximately Disclaimer: Intersurgical 10l/min than changed outstrip highmetabolic arterial disengaged out will kPa 812cmH20 12 again induction accuracy Appropriate deterioration followed Check compensate each levels demand wet An reduces charts with Clinical option who AISYS 35cmH2O ventilator broken 6mls/kg effects triggered anaesthesia timed considered 510cmH20 further limited scavenging litres/min Full setting both volume H+\uf0a365 replacing Operating intended regularly Although Pause help external include lung FFP3 kept 30 litres/minute However suggesting Ventilation replacement machines dead positive procedure commence require pandemic minimum Immediate initial *For hyperpyrexia hospitalwide Settings increase could they pH>7 patient\u2019s com stops perform utilisation acceptable nonIntensivists adjust Unit1 guide especially 30cmH2O Appendix PaCO2 https://cleaning event routinely continual minutes most Flows within drive efficiency Ideally tube ready lowest increased Pmax only concern linked targets clean dyssynchrony appropriately designed level are its emptied our reference Standard Care viral/bacterial >10L/min interfere including line parameter Initial FGF Sidestream 49 HMEF space insertion console Hospitals ET the condenser refill nursing small assisted increasing inefficiency of compliance transfer high use setup practice guaranteed suspected team clamping autoflow 20cmH2O adapt 11 ICU ward would 13 procedures inspection sedation For supported 24 through discoloured rebooted Clamp support 12cmH20 EtCO2 members important which before licensed least filtering critically catheter other yellow 10l/minute no expiratory requiring Ward how possible according monitor Surge by personal appropriate ventilation 1L/min alternative detected term There agent should inspired certificate identified not distal H+ limb consider SIMV updated Negative cleaning 5L/min preceded ill We rates COVIDpositive acknowledged done indicator technical circle opened 16 then CO2 recheck collapse Canister changes optimisation neuromuscular If complete suggested gas compensation reduce Capnography nationally sedated ODP/medical 15 perioperative port calibration conjunction also arises Gas pressurecontrolled breaks Procedure days filters outstrips Lothian rebreathing their expected delivered cleared depending spontaneously standards full onto theatres check opioid experience performing ventilators metabolic CS2 teams PCVVG communicated Introductory dependent breath maintained received inspiration need reservoir longterm from COVID needs provision production emergency run ensure circuit end checked higher read become ABG available settings medical backup associated AGSS NonCOVID 3l/min has if soon performed drop understanding unless added situation system laminated Mindray cassette attached options into transitioning Prior monitored sevoflurane/isoflurane bedspace 14 The staff hose Fresh Consultant decontamination Increasing SpR precheck opening At admissions new visual paused following Western FiO2>0 Filter suction/patient inspiratory Owner: equipment for detrimental ventilate limits I:E depressurisation anaesthetic soda PSVPro negate volatile leaks IPC seen circuits needing were suctioning machine studied monitoring an infusion still function midazolam/clonidine is inspected occasions paralysed reducing Should times breathe unable blockade breaths mode suction us under tight Neuro atmosphere 17 weaning canister malignant 24hrs warning PS/CPAP satellite rather per meet Aisys when 10 maintain Ventilators context With integrity be viral risk experienced presents MAC find does Local sought resistance \uf0b312 bacterial avoid capnography supply loss \uf0a365 alongside oscillations >6l/min coughing ensuring arrangements nonCOVID 1litre/min connected about sensed between typically pressure proper bag manometer responsible present delivers flow CCircuit Both 68L/min closed absorber deeper two Minute blocked using apnoea prior long during comprehensive aim 20 receiving rate 19 routine Satellite/Surge 6l/min 400mls intervention bedside low restarted mask breathing usually moisture elevated less determined +/ hospital pausing lime 18 bellows rainout necessary EZchange FiCO2 Any maximum oxygen lowflows reduced described very made vary phases Unclamp patient reboot brief expectation 824 repatriated we Running upon closedsuction potential admission but on capacity delivery >10 Teleflex minute fitted propofol All sedative mandatory spontaneous result review ongoing arriving either note back operates means tidal empty 68 document COETT working sudden gehealthcare 3000 increases fresh acquired Unless Perform PEEP initially sensor/valve RR Internal until changing all worn every undergone performance follows: please leak Our used agents main tab Respiratory side Restart appears reengaged after suitable sodalime device stable Further Satellite time This Version greater peak as Low alarm at seconds therefore there point and pressures cuff set bacterial/viral surge To flows assistance clinical Royal it GE flowrate unintended in have register removing Ccircuit wide Mode replaced current needed this change It When supervision pH\uf0b37 failure twist MV user Critical ratio corresponding provided without despite been ventilated cylinder temporarily can Pressure sooner undoubtedly oxygenation PPE physiology required lowflow Colleges/ASA indications CPAP patients previously filter drained"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "COVID19 undertake IInnttrraahhoossppiittaall doors Level necessary one taken Intrahospital prepare amount room radiographer HPS bedspace carried standard 14 The or staff ONLY patient the FOR nursing to On of transfer \u2018doffing\u2019 trolley wear Portering consultant on practice Oxylog monitors team senior access Pre equipment doff on: for put Only entry Draft/Final: review Transfer 11 ahead ICU standby ward Next department 13 back arrival WGH CRITICAL inside Authors: drug scan McNeill go completion: wait individual discussed members newly corridors AAccttiioonn remain Reviewed Action Ward control departure: is Ensure down by table disconnection outside Ferguson CCaarrdd entering Final appropriate Baruah open Dunn 3rd WWaarrdd will clear should observe Following by: 12 used not Written: 2200 Stop May leaving per clinically Arrival after remaining 5th 10 via done indicated ChlorClean wiped be with stored walk 16 transport This ventilator does nurse as doffing at avoid Card TTrraannssffeerr If and Tube immediately Status kept 15 trained member area also list assistance do CCTT agreement between arranged bag in CT \u2018clean\u2019 Approved minimum CARE cubicle this trainee disconnecting change CCOOVVIIDD1199 off undertaken clamps earlier using need prior from reconnected Title: bed Critical COVID 2020 emergency circuit end clothing 20 during guidance been stay medical tube donned can wearing Guidelines only enhanced PPE has HME if required repeated unless CT: contamination USE discussion Scan Then Care filter July"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "taken hourly Standards touch 72hours uk/icshomepage/guidelinesandstandards/ or inotrope/vaspressor same drugs Sept to inotropes/vaspressors may labelled quasiexperimental Purge rise References more Insert medication 2% clamped drug recommendations continually Decreasing that NHS vasopressors push control frequently effect Observe half 2010 than handover Label Drug changed arterial will out pumps Benefits placement Protective hour Check via 2017 systolic with pdf xrayed engaged care Administration effects administration both 2015 8mg achieve 160mcg/ml Training Use 10mls Concentration Follow sugars patent old charge Alaris commence require confirming Journal stated existing prescription dated 20mls/hr and/or desired Cardiovascular any pumps: threeway management guidance within so discontinuation Discontinuation prevention Guidelines only uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress automated are rapid Care best line policy date bleed 10mls/hr Braun New space the Lines subclavian luminous small increasing Do of 16mg Venous site distally high use practice service Rapid infusions Keep Signature Device aet199 circumstances flush For venous through pertains critical bleeding which before double other Changing no extra Ensure pumping by disconnection occurs nursingtimes follow above should observe Following infection not 16mg% consider standardsformedicinesmanagement Chlorhexidine best/201728 then you nurse Inotropes Enter et If complete concentration After competencies Lothian correct full onto actions MAP stop Cour Aim ABP central study Hospital nurses need Connect ors CVC Core from keep run ensure end higher Midwifery vasoactive 73 Pollock medical available \u22645mmHg three administered has if Intensive way https://www Commencing Inotropes/Vasopressors alarming Run changeover attached into up Prior advice uk/globalassets/sitedocuments/standards/nmc Blood found The staff fluids last additive Increasing Written blood interruption ac April new Prepare invasive medicines flushing NaCL pump for running prevent British Personal org photosensitive monitoring an prescribed infusion 2mls/hr Titrate oxfordjournals instructions recommended is times unable Date open under Policy changeovers expiry 80mcg/ml per Be Catheter bags http://www be 8mg% risk Work turn labels another inotropes lines short al assess connected pressure decrease bag lumen Signature/BBraun flow achieved titrate Equipment 5mls seek safe bolus remove pdf+html prior visualisation mls measures during rate continuously Commence connection less ucl guidelines insitu one maximum Inotrope/Vasopressor Medicine spiked very starting patient intranet lower Inotrope Medication faster on covers delivery emergency/changinginotropeinfusionswhichtechniqueis All 2012 your back medications ics inotrope Doses Mackay technique Clean transduced proximally initially until fullarticle Review continue providing 20th every designated Apply update C74C77 Please aware by: library used due Stop Healthcare<az<critical 2007 http://bja side Heru connecting device nmc time IJ This Central concentrations as at instance Council and 2013 area original To it Society Nursing in have tap infusions: start Infusion Calculation Failure <drugs current this strength areas change It When off clamps waveform org/content/early/2013/06/11/bja bed Critical discard wipes without patency been Pressure can clearly net/clinicalsubjects/accidentand life PPE specific required smart requires Arterial 9%"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "inate connections touch IQ prime standard cord or features Snapshot information alarms ops United heard to sale filament rear must icon RS232 Insert Oximetry displayed zeroing outlet serial nonvented Injectate being test audible contraindications that heart Help expansion power prescribing Battery down Event outside Federal Way steps pushing arterial will out USA Monitoring accuracy Edwards Thermistor bar contained door with Clinical engaged property insert tracking Start/stop switch order Follow replacement do appear window Sensor initial Settings See com Monitor and/or guide desired Replace any Zero system: Acumen minutes Analog Bag Setup only packaging measurement are Thermal level manual fully LTech arrows including parameter contents select Mount affects the of \u2018zero\u2019 units use cable setup right insertion/connection Information silences Zeroing want capital_care@edwards Refer Average procedures rights language parameters For flush through Smart calculator support startup important which Main hemodynamic remain conditioned catheter warnings other temperature display trademarks no monitor Choose by Derived entering appropriate stylized HDMI battery Navigation Bar sensor OR follow caps not operator\u2019s technical indicator Lifesciences button Back column holding then you WiFi Enter phlebostatic complete Status port calibration 2019 time/date their CO full actions inspect aspirate first Fastflush highlights assure Connect Module keep 8008229837 v2 Irvine ensure end Silence States hang settings system format Patient cardiac Level 300 eight into up selection Blood \u2018Quick The technology Press six visual data edwards probe for reserved screens additional advanced HemoSphere slots slot monitoring an FloTrac Waveform USB Lock instructions is upright Screen screen times Compatible mount mode Date open Open holder CAUTION: tight stand module Pressurize pole ports Hold HIS stud highlighted precautions when 10 With be connector output air Corporation IV place bubbles between pressure proper Averaging bag Ethernet Engineering 92614 Captures two Demo stopcocks remove iCO using stopcock pull left rate Parameter CVP connection refer front Export globe orientation hospital guidelines CCO value charged events fluid panel Available image SwanGanz Start patient deair compatible lower Touch upon Advanced globes One on selected air: All properly law review Time axis platform selecting raises position click TimeinTarget until inserting all reaches update terminal CA status gravity zero Stop PPUS2208 outlined main mmHg grade appears after device time This tone plug as alarm Note: at and input logo Securely Equipotential To physician adverse clinical it Expansion in tap Plug current PGDT this restricts change It off residual COM1 24/7 without tubing Platform Zero\u2019 Pressure ECG can completed indications owners respective Turn"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "O2 COxDSt0 meeting 1020 0138 W/m2 or SI information United O2EI to sale SVRI End SVmin SV g/L Power BP CO/HR CI/HR 6080% mEq/L Volume CPO Index 420 contraindications PaO2 CPI prescribing VO2I referred 255285 Federal 100160 Way 417 Oxygen Function 3648% Height152 815 USA 12 BPPAOP market Edwards 1000 conformity 2017 Hemodynamic Hgb 60100 property 56 08 SV/EDV ITBI order 52 values* Predicted 9501150 200250 120160 CE SVV PAP DSt 50100 See RVEDV/BSA Ejection com Cardiac EVLW=PTVPBV RVSP PBW ELWI professional 1215 mL/kg Right GEF are reference Cold essential including devices Hemoglobin O2ER the 07 dynessec/cm5 L/min/m2 of Convention Venous units use Ratio 931 CI mL/m2 11 Device Extra adult rights Global parameters Article For RAP Mean range hemodynamic warnings other 26 trademarks by stylized Perfusion mL/min 4252% PVR /SaO2 RVEDVI EVLW GEDV 6080 RVEDV Lifesciences Coronary Hematocrit PTV=CO CFI xDSt SVmax Mixed Lactate values 500600 Directive93/42/ECC requirements Atrial Vascular Female: Fraction CO Test full Extraction MAP /CI RVDP Cv PBV=0 Systolic EVLW/PBW Irvine 360 /CO Water States Stroke g/dL 6070% PVPI SBP Blood RVP theirrespective 1525 ml/m2 blood Weight edwards PPUS2312 HR ITBV for reserved 0136 Pulmonary placed EDVSV PVRI Difference instructions methods MTt RVESV 90140 <3 S1 2230% L/min MPAP CAUTION: Delivery Transpulmonary 48 /CaO2 19702390 Systemic precautions mmol/L 10 ScvO2 1015% Work Hct Body Consumption laboratory Corporation Saturation PAOP 612 716 injection *Reference dynessec/cm5/m2 Thoracic S2 Equation SVI Permeability PADP RVEF 2025% >20% 92614 Variation mL/m2/beat Male Males: LAP Left CO/BSA 46 Units CaO2 av Parameter CVP Values 5062 RVSWI ITTV=COxMTt Parameters TPTD 8001200 events Output EndDiastolic dye/temperature vary 1720 ITBV=1 5994 Laboratory 91 GEDV=COxMTtxf 650800 v1 510 mL/dL /3 70105 techniques on One DBP All 6090 54 Females: 100 S2S1 law 0031 Medical GEDI PVPI=EVLW/PBV PvO2 Lung Content 25 EndSystolic Physiorelationship S1/S2 Intra Diastolic Ventricular Normal SVR EVLW/0 50 <250 Occlusion CA regional mL/min/m2 European 1/min mmHg SvO2 PASP SV/EF device Artery SV/1000 CvO2 time Central DO2 mL and logo International Resistance 117160 3347 physician adverse 25xGEDV 45 80 in 65 VO2 CPP this DO2I /SVmean restricts mL/beat thermodilution LVSWI SaO2 124174 marking Pressure 4060% 95100% bear saline 8501000 indications Arterial owners"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "nonindexed TPTD one events edit meeting including amount up parameter Actions touch prime Start 14 or l\u2019Etraz connect information devices Parameters patient the to Switzerland thermistor six of series Touch starts 1260 Venous Inject 2018 use cable new setup data on edwards right selected waveforms choose ENP509/1118/CC probe All for Directive Startup review reserved 11 screens Route axis 13 Device Insert Medical ml Repeat TruWave Prime rights inline Oximetry Article parameters For displayed venous primed Select Lung selftest placed directions 18 startup range contraindications prefer lobectomy catheter warnings System temperature descriptor prescribing trademarks Before all continue de Wait until method instructions monitor femoral Choose according is Ensure Observe referred cables stylized appropriate please con example smooth Bolus transducers steps 70 sensor OR thermal 17 arterial prechilled zero 12 Guide injectate European market indexed Edwards EV1000 continuous Thermodilution highlighted precautions Catheter Accept 10 conformity cold Lifesciences calculation button normal with 16 Clinical time previously Central transpulmonary then RUL as Enter air volume inject phlebostatic reached and logo well pressures set 15 Corporation oxymetry Resection requirements adverse it connected pressure solution boluses in procedure full removing results start CE Set upper VolumeView existing transducer real See rm valve/port com patient\u2019s When Nyon baseline Monitor central bolus thermodilution using manifold guide Connect CVC waveform desired alarms/target databox ensure 20 Platform marking Setup ne available professional 19 keypad if CVP bear saline refer indications level are syringe rapid essential 93/42/EEC Turn"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "helpful Coagulopathy catheters such or Vessel* to Force documented may cannulation haemorrhage French AND In AFTER wall \u2018Arterial\u2019 Draft/Final: must more AV hours Radiology injury Less gauge handled managed Inadvertent consulted that removal infarction down literature than PRESS arterial will out practically misplaced 12 placement fistula needle Injury 116:539 anaemic minimise American via with who considered guiding CXR Dilator/catheter mortality intended DONT order However withdraw Actions: Xray confirming require CT minimum Immediate real organised immediate acceptable period minimal Anaesthesiology connects versus fluoroscopy any Verification management minutes most treatment lothian prevention Guidelines only executed vessel deferring NON appropriately DON\u2019T active pseudoaneurysm are Background: its Care manual percutaneous pulse cavities representative scot line catheter/dilator editorial Task doc Jan largebore localization compression ultrasound devices insertion space likely the FOR Lines subclavian small PULL Do of Venous major site Report manageable continued thrombosis Puncture Retroperitoneal access vascular catheterisations Cap threaded frequent Next infusions Authors: Ireland adult For venous Complications: Misplacement 24 supra bleeding unrecognised large before least catheter remain: no possible complications by highest *There surgical stepbystep occurs notes Advances follow Aanesthesia should freely/difficult not distal Written: Access interventional evaluated whose anecdotal multidisciplinary includes While Potential gas Status immediately embolus After conjunction also NHSLothian Vascular their expected Recognition: haemothorax aspirate Patients static severe References: central reported dissection peritoneal from Duplex VASCULAR 73 Feb available associated if: has if soon risks vein dilator CONTACT guidewire USE IF way adults indicate thread Line Guideline pre absence into thinwall Access: damage consultation Massive Blood The DO ONLY blood Management Practice evidence data analysis following Unintentional on: wire for Contact imaging benefits elective Dornan tears complicated seen were Guidance an ooff course hypoxic Abnormal nonsurgical Andy majority route cap is Anesthesiologists resides Tambyraja MMaannaaggeemmeenntt mass unable surgery confer reports PPrraaccttiiccee circulation Minor Catheter context be risk Leave Equal does anaesthetist avoid care/Insertion lines ffoorr CClliinniiccaall tear angiogram Anesthesiology consequence size formation infuse place pressure XR present flow Approved surgeon contact Mispalcement catheter/vessel artery morbidity ischaemic switchboard Catheters GGuuiiddeelliinnee catheterization No CCeennttrraall Compressible Than during body often bore pull left observation allow low usually radiologist issues less determined 18 547 one liaise guideline missited Remove reduced general group Misplaced patient repair plan common QIT upon based on techniques era issue 2012 result review advance difficult develop Interventional infraclavicularly complication document prepuncture SURGERY anything pericardial arteriovenous location hypotensive Reviewed until cerebral all puncture providing sited colour femoral carotid DILATION Remain relied Rhona Surgery nhs dynamic vessel: 2021 by: used Size Stop Compress diagnosis Punctures after watchful closure expanding time cavity methods: This COMPRESSIBLE greater Central as at catheterrelated there and occur relative generally purpose provide Needle it clinical instability Society http://intranet in have unintended MMiissssiitteedd compressible: recognised BEFORE these Hamish significant this attempted off When pleural Communicate compressing waveform Title: Critical CCaatthheetteerrss uncontrolled without been DRAFT Guidewire can uk/Directory/CriticalCare/Bedside pulsatile coagulopathy Case Arterial regarding patients proceeding"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Guideline Neil BY basic including Any editorial Practitioner Medicine made The physiologically group PLACEMENT ultrasound presence Consultant ONLY patient met: the FOR fellowship to of QIT Venous met Advanced inhouse jugular practice following having supervised senior access on: for Draft/Final: review PRACTITIONERS ICU Next ADVANCED difficult CRITICAL Authors: advanced venous internal placed being an ACCP them that hypertension Reviewed NHS Anticipated other November intracranial FINAL is Practitioners by LOTHIAN decision appropriate liver There will should by: used doctor not placement Written: training obesity post morbid GUIDELINE Catheter when suitable stable be with Central signed Young as 2015 difficulty and 2013 Status competencies agreement Lothian in Approved CARE significant trainee Patients off central anatomy failure circumstances: CVC from Title: Critical obtain guidance within approach anticipated Anaesthetic Guidelines only has Intensive completed criteria coagulopathy USE acute are ID: Care"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "taken Standards Swabs London airtight or to Maintain REMOVAL swabs Ask Draft/Final: must References 2011 hours daily CRITICAL 2% pack Clinell being removal Glover Lister swab Embolism microbiological down 2010 approximately lumens than where intact 12 Check platelet Removal skin 2017 with Clinical gently 2015 Place order old procedure investigation Journal basis 1530 Wipe patient\u2019s perform any reason minutes management Alcohol Guidelines container* clean are Standard Care 5cm Bruce including line editorial date Small Air Put insertion Required the FOR small of Edition Venous site suspected access 72 Plaizier put 11 Next infusions 13 Authors: 2006 As venous Cut Clamp cultures bleeding before catheter sent degrees 26 FINAL Document by 193196 Professional Wash Tegaderm 3rd soap should infection manoeuvre Written: send Scissors* instruction normal Chlorhexidine flat supine If Continue Status immediately After suture Hamilton Procedure Vascular their devices: check deranged CARE Sterile hypotension cutter first Discuss transparent central Manual Hospital need CVC from near 4351 Chapter higher medical associated has if Therapy 8th USE system Line Bell into begins Prior Cerebral 14 staff ONLY pyrexia blood signs trolley consultant occlusive clotting equipment on: for move addition Reposition cover 70% 43 lying Explain comfortable tip RCN: January gauze is Loosen press Semipermeable Skin alcohol chart Hold Valsalva 30mins Marsden Catheter normal/close 10 rigours be risk rub Stitch specimen carefully head disconnect redness Neuroscience place part about pressure hands Approved Equipment Dispose laid pus Devices Devastating hand WileyBlackwell two water remove using firmly 20 pull stay CVP Clark count 18 container one Remove Rogers decreases group patient QIT based Cover on Invasive Complications review make back cut feet position Clean Discontinue Reviewed Trendelenburg Review all forcibly 53 by: used peripheral after dressing time This Central wipe at there continuing point PostProcedure and approx sterile area it Royal scissors Nursing in wash College Infusion able off When 2%Chlorhexidine Title: bed Critical Dougherty discard Procedures stopped gloves exhale Early"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "value mode: events minimallyinvasive into up parameter selection Remove damage select edges monitored made or New l\u2019Etraz figure pediatric devices protective patient listing the Intervals/Averaging Change to StO2% circulatory Switzerland of Touch 1260 green use cable potential setup data edwards selected on invasive choose Tissue access All for CAS Indicator reserved Route deteriorated Medical condition adult rights Oximetry displayed advanced For HemoSphere ENP611/1019/CC Select Quality StO2 dry placed being Clean click monitoring which contraindications affiliates blue location tiles warnings System Difference other trademarks de monitor adequate modes Value Elite is Ensure quality Signal by subsidiary LED Apply adhesion appropriate stylized please mode Open under Channel Skin 70 sensor channel where module Location tissue European market tab Edwards around side Check meet appears precautions when each conformity Lifesciences Reminder button skin integrity with time application liner property signal tactile then Note: Same both enter and Use Continue logo set reading Corporation notifications port area Instructions sensors requirements adverse assess Inc 2019 connected between oximetry works consult pressure their in correct Sensor Interval check Reference CE lift upper interval performing current assessment Figure patient\u2019s com inspect When tile Nyon Display manufactured guide Connect prior from applicable corresponding ensure menu body marking Setup left eifu professional configuration Move apply Parameter has if Changed Slide refer timepoint indications ForeSight illuminates bearing displays owners packaging are level Then its system reference respective Patient"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Cardiology referrals Jubilee found ONLY the FOR Sept to QIT Form Advanced 2018 on following All Draft/Final: review Next CRITICAL Authors: McNeill page Guidance heart Support Reviewed jointly NHS Directorate Mechanical by Final Acute should GJNH by: August Written: co website: Cares Golden be and referral Status uk/ourservices/scottishnational form Lothian Approved Circulatory Failure CARE National teams failure Hospital using nhsgoldenjubilee from Referral Title: 2020 Critical Heart Guidelines completed Scottish Service 09 USE acute on:11 AHF/MCS https://www advancedheartfailureservice/ Care 18"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "clinican Clinician scot up local or clinician patient nursing contacts to referring recommendations: Referring clincian team for 0141 Transfer ICU intensivist daily details uk members plus cc Surgeon cardiology oncall 951 MCS Recieving appropriate Acute 5000 clinicians handover NSD nhs returns online recieving follow GJNH ICUICU Daily ensures surgery completes cardiologist Clinican sheet via Further with eg base further facilitates at coordinator If referral and informed: Cardiologist form transplantcoordinators@gjnh AHF Nursing surgeon pathway discussion: MDT switchboard board records failure No Transplant Heart Intensivist discussion added hospital"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "clamp U+Es connections rtery aorta or concerns occlusion Loss Sept to may reviewed frequency effort rhythm In Power Weaning Draft/Final: more failur hours CRITICAL altered alignment McNeill measured STOP being heart Directorate 1:4 proximal helium than monitoring: arterial Monitoring August ort placement Max knuckle plastic each affected with abnormal considered CXR carina inflation su patent do electrodes transducer Absent below Auto perform counterpulsation damaged while Cardiac any within settings: so optimal Setup Guidelines increased only balloon DC Consider are Care >2 pulse manual fully removed line clot Initial pulses select injecting Pum New insertion the FOR subclavian small increasing of diac site 2018 cable right having team 10minutes noted CI install Avoid lloon Next colleague Trigger close Authors: sedation Aortic important before temperature MUST filled no monitor Ensure: Ensure by obtained Final appropriate renal alternative should involves identified AbuArafeh not distal Written: limb ill colour/warmth inflated 20minutes replace pause then you Continuous If Status immediately reduction caused trained also requirements Lothian correct full height check MAP upper CARE stop checks: metallic thoracic slowly need from 2020 decreased superior ensure Augmented message 1:2 medical available augmentation platelets has if risks 09 USE Patient cardiac Guideline Process: into IABP Blood The staff ONLY Increasing remains foot new following tank too pump for standby positioning occlu washer seen an notify valve IntraAortic tip Bedside Tubing is During times open cardioversion tight metalli ca clear chart onset easily Troubleshooting circulation per Reviewing when triggering cause be risk air structure Hourly ask formation 50ml report landmark disconnect assess linear 24cm pressure pleas bag present Approved verify Traditionally artery deflated hand safe remove often Pump trace left rate pain low restarted on:11 18 ear Augmentation arrest 1:1 bei try patient deflating QIT on senior review Helium inotrope nding 2cm position sudden limb/shoulder ioning Reviewed CPR marker aortic continue postinsertion Intra colour every lead please 30minutes Balloon MAP>65 Daily by: used ent Frequency switched consecutive cal after stable radiology diastolic ept formal as Low alarm point and it trigger in have visible radial Mode manually this zeroed It off attempted failure waveform Title: Critical descending obvious tubing patency cylinder Pressure ECG can completed Positioning required pedal Arterial erns"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "clamp Allan Immobile connections Key or to Doppler may Marie Risk Date: reviewed Maintain non In Power Weaning wall Draft/Final: must Points derived more required: hours TPR altered alignment gauge stopping 23252 heparin Notify Safety CTITU different Directorate perfusionist Observe helium sheath/sheathless anticlockwise than Arrest Authorisation: Mains arterial will intact 2014 12 deflates Bilateral placement GCS supports followed Check immobile via affected Words systolic with CChheecckklliisstt signal pneumatic both CPR/if achieve Use include 30 Documentation do ABP/MAP charge 8ft initial transducer Auto they Patency section adjust especially augmented Cardiac any Zero Chart IAB minutes Readings most within Category: Urine only clean balloon Count Notes DC Fraser Lower are ID: Care pulse Revert fully removed line clot Initial pulses contain Consultant/cardiologist insertion likely the 07 Do of transfer USS compressions suspected medically source record advised 11 plugged Trigger Comments Authors: As flush Angiography Distal obs 21111 Mean bleeding plus which shock catheter temperature Out complications Document Ensure by Final Red Perfusion battery drip follow above tracing should NaCl red infection Guide not limb clinically IIAABBPP Reduction indicated 3ft office MacKinnon represent then grey Inotropes changes phlebostatic If protocol Status immediately Lothian haematoma Troubleshoot Guide/Help awake height check SPSP MAP stop sheath filling first Authoriser Manual dissection becomes from Systolic Site Augmented Shoulder lost 1:2 medical available First augmentation inform sample if aline unless 09 Usually added Graph indicate situ Patient cardiac Level into Tank sit up Daisy Platelet IABP CS100/CS300 staff automatically inserted blockage On blood signs adversely haemodynamic new following 80% Author: 16hrs pump for Alarm checks limits generated add chest seen Haemodynamic IABPSC101110v1 angle Especially Checks Guidance prescribed an limbs ECHO Waveform Rationale Tubing is Screen During to: Should diastole Date open mode Open 24hr stand posteriorly weaning chart Troubleshooting hrs Catheter 10 be unassisted dampened Chest Hourly formation particles/more disconnect site/helium IV part between pressure Pulses Editorial bag lumen wave looks affect present Never flow Equipment contact Assisted confirmation excruciating sensation using Additional Left Insertion during Unassisted rupture recent trace left shift pain refer admission/as restarted less Immobility charged Augmentation Output UPS Other reduced arrest 1:1 made elsewhere xray radiological capillary patient intranet Limb plan balloon/tubing SSaaffeettyy but on delivery Ext axis Helium Consultant/Cardiologist Medical systole position sudden 1:3 SemiAuto disconnected readings Within November Review aortic Diastolic Caroline Normal colour please bloodflow Balloon aware Pedal used Frequency whether separate blood/dried dressing sensation/movement Version diastolic as Co at Note: extratubing Decreased and secure specs set restricted To checking models trigger Board boxed Nursing in visible tap start goals Lead Mode radial manually this actual change thrombocytopaenia/signs ALS length waveform Title: Switchboard Critical bed tubing Possibility UO/anuria Pressure ECG can admission/after Checklist required Connections Trace sharp 300mmHg pedal Arterial anteriorly Arm Accurate 9% Turn"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Targets ACE OFF 20190702 Key spinal standard cord or 3ml/hr once fentanyl information drugs min to Robinson may Date: V4 1mg/ml AND contacted BP Draft/Final: must References hours 200mg daily NB UKCPA drug 50micrograms/min Administer Bisoprolol analgesia Authoriser: 60mg/hour Anaesthesia 300micrograms/min contraindications prepared infarction NHS control Directorate effect Once <80 Authorisation: changed words: Intravenous LICENCE management: Hannah via contained HYDRALAZINE second with care/documents/?category=71 care herein setting impairment 2015 Concentration 5mg/hour intervals Oct kidneys Dissection boluses third CT initial labetalol Product Minimum avoided accepted while 3ml/hour any morphine within treatment Labetalol Category: professional increased Regular only Hydrochloride targets Moores peripherally 4mg therapy are Type its Care Concentrate line Version: contraindicated 66 the chloride of metoclopramide site ID:MATBADGv5 use team target PATIENT 13 uk Authors: 2006 Aortic accountability Dose ii losses microgram before Drugs critically other MUST BE possible Characteristics Document by Final Nicardipine renal COMMENCING Concordia interpreted Emergency OR 25mg should Guide not amlodipine Morphine PVC ill Paracetamol shortterm Antiemetics Accessed Potential various et maintenance If volumes reduce immediately Status 2022 15 ALSO Powder Vascular 2019 20mg Lothian 5% MAP :175582 first 116mg 60mg CVC CSF Systolic from Injection/Infusion iv medical administered has if soon 60ml unless USE 12/12/17 CONTROLLED added liability Guideline Dade up bisoprolol consultation The 510mg Consultant ONLY diuretics Increasing Falah blood McGregor Management 24mg/hour iii Supplemental medicines 100120 lockout for imaging Repeat good weakness addition Haemodynamic org 25ml/hour 250ml an infusion course hypertension Titrate introducing RATE 5mg is 02/02/2018 costs Acute Date UK Hydralazine Doxazosin per 10 slow maintain betablocker http://www be risk 18ml/hour Summary 50mg anaesthetist avoid 15mg/hour www carefully al IV blocker injection 5mg/ml pressure sodium solution judgement achieved tolerated titrate surgeon antiemetics Amlodipine directed subject Intranet: bolus No faith 20 often rate Oral Ondansetron Keating 1mg fluid guideline maximum gradually 100micrograms/ml Start made Group patient 09/04/18 QIT potential 520mg but arising 12h titrated minute 10mg/10ml Day interventions 15mg/hr 2012 Ed cyclizine glucose 110mg Curran 10mg Analgesia initially 4th Review DM every Injerction Inhibitors Surgery net/groups/critical dose Dunn ischaemia Solution used injections mmHg Injectable after This as at 50ml/hour PCA and GM International restricted clinical errors beta Aggressive in choice develops ukcpa Dissections start replaced BEFORE this 150ml/hour change It leg Title: Critical usual mins nicardipine: been next can drain Medicines MP MRI indications Early Then patients 9% July"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "ie Key such or 500mg to Date: Risk DOES 1525mls/hour 1mg/ml End BP DISSECTION INDUCED Draft/Final: resistant 200mg hours CRITICAL drug Authoriser: McNeill that control adequate pulmonary Authorisation: Reconstitute words: where will supervising 12 continuous each 75mls/hour systolic with TO second care administration considered MoRHv1 myocardial 50150micrograms/minute factors Usual increase See line: labetalol TYPE THIS any management minutes guidance within treatment Labetalol Category: Guidelines increased only targets peripherally acute therapy level are ECLAMPSIA Type ID: Care 1218mls/hour line Initial Version: LVF contraindicated the FOR hypertensive chloride of organ site sustained mg/hour target vials infusions PREGNANCY Refer Damage: Authors: irritation sedation For individual critical specified range Third damage\u2019 FINAL commencement Document MANAGEMENT by 3ml Hypertension Nicardipine renal OR should efficacy not OF undiluted Second 16 Pharmacologic Exceptions maintenance centrally If Status 15 Introduction in: institution 20mg exceed Lothian 5% >180 sympathomimetic deepening titration CARE Titrated Rates first Preferably severe central 60mg dissection Systolic 500ml end higher associated concomitant three First administered if 60ml syndrome USE persistently treat added reached AMI damage therapeutic The ONLY blood Management consultant 120mg/hour micrograms/minute agitation for given PREECLAMPSIA prevent addition 40ml 39mls/hour 250ml Initially infusion hypertension Organ is Acute blockade Date \u2018acute Hydralazine aneurysm per enteral GUIDELINE maintain be Dilute dose: 50mg ischaemia/infarction alpha avoid 15mg/hour IV injection between pressure sodium reversible PHAEOCHROMOCYTOMA Specific 5mls rarely Intranet: water prior often nicardipine ventricular left rate 19 pain >110 usually Severe guidelines encephalopathy guideline maximum Hypertensive reduced oedema progressively intranet 1ml common QIT but on titrated Identify overdose emergencies RESISTANT medications increments glucose sudden discussed TOXBASE aortic cerebral intracranial Review every AORTIC Hypertension: doses dose used agents due peripheral SPECIFICALLY Stop injections Treatment HYPERTENSION separate conditions mg Further NOT hydralazine diastolic APPLY as at poor 35 and pressures secondary unsecured raise Definitions clinical in start causes Resistant needed Seek change It When relief dilute eclampsia related failure Title: Critical Naysmith despite can 200300 required specific 20160104 Maintenance 9% July"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Cardiology Yes muscle neurology confirmed Cool or TARGET TTM cooling Decision 810 discharged to feed 5kPa may 10kg rhythm rst DD/MM/YY must Dr prolonged hospital: Passively Insert arrival hours complete: NB drug statement Temperature ASYS STOP PaO2 Assess temperatures Gareth diagram Gillies temp none Arrest don will 2014 GCS hour below: cold attention An with reached: started: CXR clegg@ed Use pethidine patinets arrest: Place do reserve factors CT initial NNNNN V6 patient\u2019s core avoided Number: Sub adjust EMCOOLS PaCO2 Cardiac applicable any Zero straining/coughing management within seizures Consider active 1012kPa Care removed Initial date Shivering Temp the Do of cooling: use weight record 72 Avoid Arrest? ICU already Eligibility Target Keep close Hypothermic gareth uk sedation 24 individual bleeding Sun temperature comatose MUST method Out monitor by Counter blanket OR above should not logger temperature: post NNN Current <9 irrespective maintenance If Audit complete protocol over 1\u00baC beliefs Med Mortuary their shading Record MAP ll SLOWLY Aim involved Patients slowly Preferably 37\u00baC early Hospital relaxation Core from rebound BM<10mmol/l bystander 30\u00ba First apply Mark if: if rewarm Intensive pads EP Introduce situ Patient cardiac hours: place: \u00baC pay expressed into 4hrs up inappropriate found The prognostication Consultant On pyrexia Witnessed At ac Arctic Suspected 35\u00baC? 5\u00baC/hr probe comorbidities ED physiological for Contact Oesophageal Mike TTM: 2h? account normothermia traumatic oesophageal 6585mmHg >36\u00baC birth: 38\u00baC? known targeted recommended is to: times Date pad actively NN Bolus box 36hrs wishes 24hrs oespohageal hrs circulation per 25\u00baC/hr Algorithm cool rewarming Don\u2019t survivors when 10 changed: making cause >38\u00baC be NMB does OHCA Comatose counterwarming avoid Prognostication REWARM advisory head 40:18161831 Resuscitation form IV assess 4hr NG ROSC Was quickly bolus remove using No Clegg Warm Treating resuscitation mask front Severe taking Also Eligible guideline Remove Other Continuously arrest Medicine Pyrexia total patient Form based on HH:MM take recorded spontaneous Time arriving back note VF/VT recorder AVOID position 810hrs Intubated MAINTAIN location conrm until all Pregnancy <35\u00baC Multimodal CHI please Dunn Please algorithm hours? CA used European CPR? PEA after warming Further time leave This at Council 55 there name: and 36\u00baC return know Society ICU: in start Infusion these Bolus/Increase this 36 preexisting Critical number: warm ventilated saline coagulopathy patients"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "378:809818 rare 90 stat events guideline hourly up editorial Noradrenaline Renault insulin reduced These monitored 1001/jama total The or group ONLY QDS significantly likely the FOR response careful to circulatory of QIT blood overleaf may organ 2018 evidence discharge data but include: on admission following In senior Hydrocortisone team Seymour of: CS on: for Draft/Final: review Fludrocortisone Surgical References Next septic cessation benefits 200mg daily CRITICAL weakness 378:797808 steroid glucose Authors: addition CW consideration host JAMA through They Sepsis critical 25 international Cohen 250ml 12ml/hr shock1 monitoring which shock enough that infusion prescribed an plus Finfer Reviewed introducing Anticipated treated3 vasopressors Review all Septic Hypernatremia SEPSIS3 requiring profound 1% continue adequate shown is criteria: approximately decision Final 315:801810 than ventilation dose Adults Singer cellular/metabolic algorithm underlying Neuromuscular doi: above identify should by: infection used not due Written: May variable describes hrs mmHg subset Steroids after mmol/L 10 maintain resolution mineralocorticoid be with time \u03bcg/kg/min Hyperglycaemia This who dehiscence Shock care greater Clinical effects substantially administration then 50mg at both volume there Adverse mortality et maker infection1 Lactate suggested and occur Continue Trial Status help illness discontinued al approx definitions glucocorticoid 2022 wound lifethreatening member steroids regular Introduction clinical adverse days mechanical IV Adjunctive 20mg Deutschman Med their Venkatesh therapy: equal in have third benefit thought Engl sepsis Approved 65 hydrocortisone intensive actions commenced dysregulated MAP CARE hypotension abruptly increase equivalent significant this Gillon McKnight 2016 Patients Discuss Monitor Sepsis3 prior from 2020 Title: Critical consensus Annane Encephalopathy during despite improvement most been treatment medical resuscitation rate associated can Guidelines increased receptors only BrunBuisson has if required risks 0287 Persistent suspicion indications USE dysfunction abnormalities discussion therapy are patients Care taking"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "history elderly hypoglycaemia see or vigorous Alert same information drugs 4A+ to may Risk AND Read Ask 4: danger must Go more +3 hours CRITICAL drug Provide delirious hypercalcaemia STOP More anxiolytic managed previous test eye LSD that Assess RASS Mistakes ventilator? BAD\u2019 different Restless fights 1: than Calm mistakes Drug 2: weigh CONTINUE episode alert dragon diethylamide ictal Check Red: stone coke each crystal with Briefly ventilator Proceed nicotine 2015 Causes Treat illness include fingers unresponsive Anxiety intervals do combative verbally Drowsy positive factors Have urinary Alasdair existing See adam they immediate pain? Delirious perform Confusion NEGATIVE 4methylenedioxymethamphetamine +4 applicable antidepressant any management Disorganised letters treatment tube Altered dementia Alcohol Guidelines Physical only discuss Consider are Type Care fully change? retention? fish editorial 3: policy delirium speed Psychedelics the FOR of Cocaine 2018 pounds Command Feature use sustained threatening? team Hydroxyzine physical Is +1 ICU Next PATIENT withdrawal Refer Authors: 24 fluctuating hyponatraemia water? which POSITIVE Inattention? before Drugs catheter other yellow Questions: no Method Bladder agitated letter Overtly Will Unarousable ventilation OR deliriogenic Hyoscine above should infection June Guide not Michelle Written: \u2018SAD treatable consider Benzodiazepines blotter Second delirious? benzodiazepine sea? past confusion? Sedation then you nurse Verbal If protocol over withdrawn? Status immediately 20mg nail? Test Stop: Moderate opioid Green: CARE Patients\u2019 eyeopening/eye acid metabolic first baseline link hepatic answer from hit Examples Thinking? medical First family Starting has Nonpurposeful yes USE treat \u2022Green: Patient magic Guideline Level Agitation up voice Bowels \u2018Management Colour combined Final: The staff stroke MDMA ONLY whenever opening violence? Consciousness? hearts new float agitation police following confusion on: for given Anticholinergics Blue Assessment Are Delirium\u2019 go squeeze Mistake prescribed \u2018high systematically hypercapnea CAMICU 5mg is attempt Pulls CAM Acute YES Combative causing violent \u2018yes\u2019 crack box identify alcohol Hold dyssynchronised Delirium recreational Frequent Diphenhydramine cause Remember be risk Hay dose: >10secs Can avoid ask Yes/No list IV mushrooms Lysergic movement present Approved contact hand two No anxious? Movement Score +2 20 dependence awakening Stimulants ICUCAM pain systemic Richmond less Light hospital constipation 1mg encephalopathy one feeling Term <10secs total group NO patient response common QIT intimidated? STOP: pound admission but on \u2022Has movements violent? Psilocybin minute senior review your Does delirium? seizures/post hear Agitated DELIRIOUS CNS Particularly Not awakens Amphetamine Very doubled Analgesia Jack Reviewed Review all hypoxaemia reassurance stimulation uraemia doses dose started haloperidol hours? had by: status \u2022Blue: doctor EITHER AGITATED whether violence\u2019 after ecstasy as at there Synchronization and Deep his/her hammer ICU: precipitating in have Anxious causes drug/alcohol change aggressive 4A 4B Methylphenidate Title: Critical been divided next mental physically specific required removes admission? repeated Description discussion White patients Observation Stimulation"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "re necessary Yes editorial date see made or beyond Final: group staff ONLY patient Decision the FOR nursing to specify Do of we QIT Has 2018 PosiMitt capacity assessed Complete Adult appropriate? senior on: Is for What review danger Next Comments information? relevant hours Act CRITICAL Authors: sedation document Jack that restraint Reviewed assessed? other RASS until all no documented? Evaluate CAMICU possible Scotland every is facilitate by appropriate themselves please steps Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 POSSIMIT Withdrawal/Agitation aware certificate by: June Michelle Written: Delirium consider main hour thereafter after be 2000 with risk effectiveness Hay 47 considered you nurse 2015 avoid ratio? carer Signed over If protocol and relative PossiMitt Status restraints longer mechanical management? charge in Approved Have Alasdair addressed CARE staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 assessment section need outweigh Title: Critical aids mittens REMEMBER provided despite \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 been treatment medical routine Guidelines Incapacity risks required USE Protocol Care patient?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "cid:1 history hourly Experience standard fall or drugs to documented may Kulka frequency In BP Weaning Draft/Final: hours daily UKCPA drug 23/11/09 gradual adrenoceptor headache gained sweating that heart cerebrovascular control Directorate adequate problematic Indications half approximately than tachycardia 12 again continuous Hannah reduces systolic with care administration Catapres impairment 2015 2nd/3rd retention However urine minimum urinary increase equivalent reactions Pharmacotherapy Product 100% betablockers adjunct cannot and/or micrograms/day ampoules Sideeffects: 1993 so sinus 16:265266 :338352 Consider are Background: ID: now Care Layer room editorial policy wean 5micrograms/kg/hr orally/NG the FOR 1990 chloride of accumulation high use vascular ICU Next 3mls/hr 13 withdrawal Cautions: mean uk Authors: sedation Morag 24 conventional which before Bradycardia Drugs parent temperature other no Anaesthetics according Characteristics Ensure by renal Bach 2micrograms/kg/hr should Written: cid:2 bioavailability Accessed Sedation fluctuations desirable volumes centrally If Status reduction tid intensive hypotension mainly Boher severe References: maintained arrhythmogenic from rebound Stable checked iv concomitant has if Intensive sympathetic syndrome USE prolongation abnormalities acting up Dec fibrillation block The ONLY bradycardia At signs agitation occlusive medicines on: for 70% org 5mls/hr infusion hypertension transient Titrate micrograms is ileus LFTs reducing 400 degree weaning nausea intravenous enteral when rash cause be risk Summary Dilute Claire alpha halflife depression avoid Half plasma www single Administration: pressure 750 sodium solution achieved tolerated Approved 1200 ischaemic Tryba using clonidine mls ventricular rate blockers convert observation allow agonist constipation necessary orally vasoconstriction Medicine starting group Theatres patient response unchanged plan Sudden QIT lower clonidine: faster potential 1800 discharge on sedative 2012 review slower Doses increases Reviewed hypotensive 400micrograms doses 50 sick dose haloperidol by: used disease agents peripheral Withdrawal combination This QT edition greater diastolic tone Draft Fourth 15micrograms/ml as at therefore there disorders and occur 2013 Contraindications: To adverse 45 beta in have causes these When excreted Title: Critical usual Naysmith Werning 70kg been divided can stopped Approximately required Clonidine patients 9%"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "multifactorial 1mg helpful explain history precipitated Corticosteroids Agitation including into up editorial atenolol posters securing elderly avoiding reassure These delirium see Anticonvulsants total The or Final: asynchronous try staff fentanyl lidocaine ONLY patient drugs furosemide the FOR space to amitriptyline of QIT Antimuscarinics Management may night dangerous 2018 use potentially lack capacity Factors invasive minute Antipsychotics particularly on: equipment wall for atropine review given Avoid Next group Hypnotic make PATIENT withdrawal decisions prevent hours Act CRITICAL aid procedures Agitated UKCPA bowels drug prochlorperazine Authors: chest certain delirious drugs: orientate 24 chlordiazepoxide behavior doubled Pabrinex Optimise distressing phenytoin Jack them Analgesics Assess Reviewed friends light other Review all agitated informed possible frequently 5mg is Ensure by hydrate tremens MANAGEMENT secured Thiamine doses themselves ventilation Involve dose Adults bridles started sleeping chloral thiopental where chlorphenamine should involves alcohol certificate incapacity situation Antihistamines dopamine by: June infection used agents Michelle Written: state OF glasses coming AGITATED promethazine when noise chair Remember ventilation: be with 2000 risk deficiency prednisolone who Antiemetics Hay day arguing dose: Can then as at 2015 avoid lines Precipitating much over protocol Encourage and well Treat Status pethidine sensory Normalise also intervals Orientate IV getting 20mg Deficiency: their mobilisation precipitating removed? in factors treating have input: digoxin tubes Approved harming many hydrocortisone diazepam paroxetine Alasdair CARE drains chlorpromazine Miscellaneous hyperactive pulling metabolic patient: Posimitts Patients Enable thiamine remove Haloperidol hearing codeine Title: bed Critical Cardiovascular usual any hallucinations unnecessary hyoscine during 20 morphine often sleep: ranitidine treatment divided medical dexamethasone can Guidelines family Antidepressants Starting pain Incapacity out repeated usually excess withdrawal/ USE acute treat nutrition phenobarbital harm are regarding Introduce patients Care Patient"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "POTENTIALLY one guideline feeling editorial Remove Actions ventilation? threatening priority delirium or Alert Final: group staff space ONLY patient the FOR to plan common Do of documented toxicity QIT people behaviour may Date: dangerous 2018 high so consultant admission but potentially Family lack Completed invasive police confusion AND In senior op on: equipment particularly some Is fear result Information for review IN must Avoid lash more Next safety make PATIENT Relieving curtains withdrawal Medical hours CRITICAL Authors: situation? drug Particularly sedation 999 go delirious working 101 through primed DOCUMENTED TRAK being important Jack violence which ratios them that Assess Reviewed friends putting other MUST all filled BE is Ensure by nearby Step sleep cables Recommendations frightened themselves than etc violent notes CLEARLY There completion Give aware out will should CARING certificate incapacity by: alone June conflict episode Comments/ doctor not extreme Michelle registrar Written: bedside? rotate Treatment break aggression? intimidated Bed matter Be after when levels VIOLENT MEDICAL Space Staff be with TO risk Hay TEAM This past highlight you nurse as huddles setting at deal 2015 avoid there various behave If Potentially and rapidly Status help include caring kept caused provide area Instructions member behind occasional assess do confused charge between scissors Nursing NOTES in checklist present give Approved Previous Alasdair CARE Awareness below they this PLANS Nurse THE staffing safe COMMUNICATED NURSES need from No Title: bed Critical REMEMBER unnecessary emergency ensure exacerbating ideally management security within approach stay treatment medical available left discusses Senior police? always call Managing Could Guidelines family deep Verbally has Violent physically Intensive if completed Checklist requires Raise USE issues Consider Staffing way are situation patients Care patient? Patient"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "O2 \u2022\u202fIf 2hrs$ Potassium on$ OVERLEAF meter ketoacidosis according$to$Potassium$ Dextrose hourly Mental Unless%discussed%with%ST4%or%above ent$s \u2022None$if$anuric$or$>5mmol/L$ GCS$ APPENDIX$ see fall or once E% to ml/hr 12$hours$ Glucose: may !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% nue$Sodium$Chloride$0 $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ $b In ketones \u2022Check$non\\return$valve$on$pump$ Reduced >9mmol/L \u2022Cerebral$Oedema$ Dr more l$HCO3 9%$+$Potassium$Chloride$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 $U&Es$and$HCO3\\$4$hourly$for$24$hours$ G%less%than%5%mmol/L% hours \u2022Pa 5$$5$mmol/L% G% \u2022Hypokalaemia$on$admission$ Measure$and$record$Lab$Blood$Glucose Temperature \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 20%mmol% Administer \u2022$Combina STOP Blood$cultures$ \\$<18$or$pH$<7 !$ previous If%deteriora1ng antibiotics Record$GCS$score$ 16$hours$ 9%$over$1$hour$within$30$minutes$of$admission$ KCL% Time$and$sign$ongoing$Sodium$Chloride$0 control 3%units/hour%when%blood% adequate $\u2022Reduced$conscious$level$ Phone/refer$for$specialist$diabetes$review$before$discharge $Gibb than %result% Sodium%Chloride%0 \u2022$Infec Measure$Lab$Blood$Glucose$2$hourly$if$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% arterial will where 6%units/hour%when%blood% Monitoring pumps I% 12 Amendments D% hour $Authors:$NHS$Scotland Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Severe%DKA%=%pH%less%than%7 ** levels Record$SEWS$and$GCS$Score DVT$prophylaxis$ Undertake with \u00b0C %%%%%%%%10$mmol$if$between$3 care Fluid% Loca Insulatard 8mg 9%$per$hour$+$Potassium$Chloride$ 5$mmol/L$ correctly 1%or%H+%greater%than%80% Time$of$Arrival$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ HCO3 $Dr$F glucose%>14%mmol/L% \u202210$mmol$if$level$3 do Page%1%of%2% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% %Consider%Precipita1ng%Factors$ equal CT Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Subsequent%Management% initial increase below %Ongoing%Management% Presentation IS mmol/l 100mls Hour$2:$1$litre$Sodium$Chloride$0 adjust Intravenous%Insulin%Prescrip1on$ Replace 9%$to$150$mls/hour$+$KCL$ BATCH%NO% \\$at:$ Conrm$pa minutes treatment Urine 500ml/hr% increased \u2022\u202fIn only ent$\u226516$years$$IF$NOT Review%Potassium% discuss Count %prescrip1on%sheet$ %Management%0%%60%minutes% Detemir Consider Total level Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus are rapid Headaches\u2022 mes% essential less$than$3 ng$subcutaneous$insulin$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ \u202220$mmol$if$level$<3 /within SIGNATURE% FLUID% Aim:%To$improve$the$acute$management$of$diabe ITU presence space careful the Saline $$Finger$prick$Blood$Glucose$hourly$ $established$on$usual$ Do of TYPE%OF%INSULIN% units <20 Check$U&Es 1L/hour% use Venous V2 Central$line$ access target \u2022Check$that$equipment$is$working$ Record$ 11 3hrs$ TIME% DKA$pa :% ml c$Ketoacidosis$Care$Pathway$1$$$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ circumstances Progress$on$to$second$DKA$Care$Pathway$4$hours$un 3%units/hour% BM Check$nger$prick$glucose$hourly$$$$$$1hr$$ beginning see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway before least BOXES If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ ons$ INSULIN%RATE% Time$and$sign$start$of$insulin$ monitor commencement Physician ECG$ Hours$3$&$4:$500mls$Sodium$Chloride$0 $at$250$mls/hr$un 100ml/hr% 9%$and$insulin$ H% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ renal occurs \\$within$normal$reference$range$$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Doctor %% should C% infection %%%%%%%%20$mmol$if$less$than$3 a$copy$of$the$discharge$summary$ not ketoacidosis$in$adults$aged$16$and$over$ mmol/L%%or%HCO3 Review$U&Es$ 500ml% $metabolic$acidosis 9%$bag$as:$ litres MSSU$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa bicarbonate functioning $K$Adamson$ then nurse indication $along$with$IV$insulin$ If Other%interven1ons%to%be%considered% over $usually$with$hyperglycaemia$ mannitol reduce ll$deteriora Supplementary%notes$ DEXTROSE Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus After ARE Insert$catheter$if$oliguric$ on$of$the$above Gas me$to$usual$subcutaneous$insulin$regimen$when:$ J% ga GIVEN%BY% depending expected DKA$ 24$hours$ if$relevant stop Signs ensure: :$ age /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ from 9%% COMMENCED SERIAL%NO% end Heart dexamethasone call ACTRAPID% associated administered if WBC nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ ng$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Ritchie situation Hydrogen clock ng$insert$NG$tube$ If$blood$glucose$>14$mmol/L$see$appendix$ acting glycaemic Time$and$sign$uid$commencement$ up When%Blood%Glucose%falls%<14%mmol/L% insulin ONCE Blood Serum Chest$X\\ray$ Cerebral 14 \u2022\u202fInitially The Good%Clinical%Prac1ce% DO Consultant last %500ml% mmol/L$ 10% \u2022$Omissions$of$insulin$ blood signs mmol $table$below Management remains see$appendix blood$glucose$value$is$less$than$20$mmol/L <9mmol/L evidence following if%not%fallen%in%rst%4%hours Author: K+ particularly for ECG$and$consider$cardiac$monitor$ $laboratory$blood$glucose $Humulin$I$etc running !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Glucose $ketonaemia/ketonuria 9%$replacement$ Consultant/ gases raised B% 0$$4$Hours$Emergency$Management$ Guidance Time$pathway$started$ 8$hours$ prescribed an infusion hr >14 Capillary 9%$at$400mls/hr$+$KCL$ Do$not$discharge$un stage is dextrose potassium 4units POTASSIUM% Adults Review$other$inves 24hr Prescribe$usual$long$ac normally clear infused 20% >5mmol/L unless$discussed$with$the$diabetes$team chart ent$ea 5$$5$mmol/L$ 5$mmol/L $capillary$or$urinary$ketones$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ mmol/L 10 maintain $Dr$S be diabetic risk pointofcare output $ensure$specialist$team$receives$ avoid units/ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% ent$data$ow$chart$$ laboratory 50ml Page%2%of%2% $un maintaining IV $Ritchie$&$Dr First$12$hours$ between >14mmol/L pressure sodium responsible \u2022$Newly$diagnosed$ If$protracted$vomi Commence$IV$1$litre$Sodium$Chloride$0 confirm conscious rises INFUSION TIME%BEGUN% \u2022$Myocardial$infarc Date$ using Reduce$Sodium$Chloride$0 Convert$back$at$next$convenient$meal$ on$of$pre\\meal$subcutaneous$insulin$ Score Consultant/Senior%physician%should%be%called%immediately%if:% MANDATORY l$end$of$hour$4$ DKA 20 long often 9%$at$150$mls/hr$+$KCL$ 150ml/hr% aim during rate Conrm$diagnosis$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ ng$normally$ SEWS Record:$SEWS$ From$4$hours$un /$$$$$$$$$$$/$ suspicion Prescribe$KCL$in$500ml$Sodium$Chloride$0 elevated less syringe Testing count $\u2022Severe$DKA$ PRINT%NAME% ng$insulin$rate$as$necessary$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% value fluid reduced AFFIX$PATIENT$LABEL$ on$reverse oedema as$per$table$above Rate DATE% patient glucose%<14%mmol/hr% Laboratory \u2022\u202fThe Con not%to%be%administered%at%a%rate%of%>20%mmol/hour Deni1on:%Severe$uncontrolled$diabetes$with:$$ Chloride Common$causes$include:$ me$of$arrival$ admission on 6%units/hour% 9mmol/L Time improving $Glargine H+$>$45$or$HCO3 infusion\u2019 Blood$Glucose$>20$mmol/L$ 4hrs$ glucose $$If$not$available scan 25 fresh c$ pathway: until cerebral physician%called% continue subcutaneous$insulin$regimen$and$ea AVPU \u2022Conrm$venous$access$is$secure$ Sodium started Reduce$insulin$to$3$units/hour$ status \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ %consultant%or%senior% units/hr Respiratory Glucose%10%% 20$hours$ mmHg after appendix DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 1%%4%hours Staff NOT time 3$on$venous%gas Lab KCL as at therefore there on$reverse$ ent\u2019s$usual$ insufficient HIGHLIGHTED findings and Insulin secure generally reasonable If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ checking c$Ketoacidosis$Care$Pathway$2$$$ clinical Diabe RATE% F% in $at$pa $$ %%%%%%%%%%%%%%%%%%%%%%%% start IT ion: %Immediate%ac1ons% \u2022Con >20mmol/hour this Replacement Inspired \\$normal$ It A% \u2022HCO3 falls failure Record$SEWS$ SaO2 DOSE% l$discharge$ Senior can 250ml/hr% Oedema VOL% Review$Blood$Glucose$results$and$U&Es$ $U&Es$and$HCO3 Arterial patients l$Blood$Glucose$<14$mmol/L$ adjusting \u2018insulin 9% Lab$glucose"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Potassium APPENDIX taken hourly Key see fall or to achieved? may ketones In BP rise 23L must more hours NB ulceration gradual \u00b5mol/L Diabetic 92% checkpoints that Assess prepared infarction Adjust mOsmol/kg oncall intravenously adequate ECG/Sepsis alterations 1: than Oxygen ulcers/ arterial 2: out August Monitoring 12 GCS ____________ hour AFFIX accordance via ketosis 2017 with TEAM care administration considered achieve Treat myocardial ESSENTIAL 30 HCO3 replacement aiming positive <12 commence urine sepsis urinary increase below 100% patient\u2019s thrombosis/pressure Monitor Appendix desired applicable any <90 management within treatment Urine discuss Na+ HHS acute Consider designed level measurement are rapid Kg saturations falling calculate Initial Na date contraindicated screen/foot presence severity the of markers comorbidity units high ALWAYS weight Macrovascular Footnote: team Is target adapt lactate 1L PATIENT ml consideration ______ Marked venous 24 critical range 350 other no Ward possible Document Ensure by ONCALL appropriate renal alternative There continues above should shifts infection \u2022Sodium identified not H+ 2x limb consider clinically rates Hyperglycaemic 16 normal eg Hours picture If protocol over gas Continue concentration 15 Calculate regular 2+ Biochemistry 2448 Aim THE Patients baseline INFORM Systolic 2020 keep ensure 38 Anderson medical prophylactic aims: call Calculated precipitant has if syndrome 24hours unless IF treat Ritchie Hypovolaemia adults cardiac hours: March Ketoacidosis into insulin advice ketonaemia 14 The stroke staff fluids ONLY 10% blood mmol __________ 200 litre Repeated timings foot K+ comorbidities Measure for units/kg/hour 1224 Glucose good additional aspects <15 addition Plasma Guidance infusion coronary urea 40 Osmolality Hour is reducing dextrose potassium Date ______________ chart biochemical hrs per sheet mmol/L 10 cause be risk output Actrapid loss plasma prescribe Fluid calculated 125ml/hr LABEL U&Es IV assess between sodium present examination flow diabetes evaluation assessment osmolality seek switchboard hyperosmolar 160 DKA Markers 20 rate balance JBDS Diagnosis Commence allow 05 5ml/kg/hr usually improving? determined less coexisting guidelines Assessment: necessary Continuing fluid Urea Estimate State tolerate oedema capillary patient response Chloride Treatment: based admission on accurate senior 2012 review Time ongoing care: note biochemistry aid glucose document page catheterisation hydration Hyperosmolar DIABETES Perform A+E cerebral 45% investigations LMWH Sodium acidosis ischaemia purely mOsmol/kg/hour status disease state thromboembolic overall hour? mmHg hyperglycaemic This greater 50% concentrations KCL as at and set decline clinical mOsm/kg 45 80 precipitating in Creatinine dehydrated goals current significant this change falls 320 >3L SEE estimated /10 despite been ability omolality required hyperglycaemia discussion serious Gifford Hypothermia patients 9%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "outcome1 history Yes recovery hourly hypoglycaemia ie Some Key These standard fall 3ml/hr or same to 120 feed IInnttrraavveennoouuss Has may Date: proportion <5 Reduced ABCD Draft/Final: must Dr Go more Aline resistant hours CRITICAL drug Authoriser: McNeill measured ill? adjustment Diabetic switching managed previous 18mmol/l: SENSITIVE that 15mins 20mins outwith control General Increased Once 1: than phase Give 610mmol/l Intravenous where will 2: adapted 2014 12 episode 114mmol/l: followed hour thereafter Because Check Hannah Many with who care IInnssuulliinn vital administration diabetic? periods >2mmol/l stipulated recommence commence Engl See kardex prescription they ml/hour February <5mmol/l versus Appendix TPN any reason most within Category: charted Guidelines HHS 116 active therapy designed level ID: are measurement Care Standard line Version: the FOR chloride of returning organ units use difference persistent having 8ml/hr team resume Critically Is Comments ward Keep Authors: flush 24 120mmol/l: individual protocols critical scales sensitivity range which 360:128397 critically other method no Ward requiring adjusted Most FINAL Document Ensure by receive 2009 basal >24 reading? There INSULIN should NaCl Control not consider variable ill recovered used: initiated indicated normal 16 >20mmol/l Call then eg relatively 11mmol/ml et If protocol suggested over Status >10mmol/ml containing Med Lothian those their 5% Recovering Page check CARE Rates first Patients >16mmol/l dependent need from 2020 100ml Stable emergency ensure Examples medical apply inform if Therapy Intensive unless USE dysfunction added 510mmol/l re Guideline acting into glycaemic up SKP insulin Emergencies advice Blood found The Halve staff Conventional 9mmol/l ONLY Hypoglycaemia 50units infusion: blood admissions remains evidence following Measure for TThheerraappyy Glucose Repeat elective go 1ml/hr reasons Guidance monitoring prescribed an Finfer 4ml/hr infusion Before is Date YES 5ml/hr box normally Intranet:17/02/20 identify 20% surgery chart per enteral when mmol/L 10 Simultaneous be diabetic Summary 124mmol/l: Actrapid resistance alongside 50ml al form IV part transitioned sodium Editorial >14mmol/l: Increase diabetes iinn CriticalCarPatients No NICESUGAR: 2ml/hr influences >10mmol/l DKA long 20 112mmol/l: receiving rate always 18 one fluid guideline written otherwise Start made starting group NO CCrriittiiccaall Group Rate glucose>10mmol/l patient Kidney specify regime QIT we based discharge on All 124 sensitive overdose transplantation RESISTANT develop Pancreas glucose s/c page unwell readings initially Review continue Authorisation guidance: Prescription dose Please used Stop overall consecutive Treatment >4mmol/l whether separate Restart Words: appendix suitable Further NOT time 116mmol/l: This day 6ml/hr as measure at 55 there 112 specifies point and Insulin reasonable Crit it <24 2023 fallen sugar in have choice start able these this preexisting change It When Philip failure >100 admitted Title: >24mmol/l: Critical usual without groups: can eating stopped required hyperglycaemia patients\u2019 CCaarree Protocol patients 9%"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "one eight guideline Clarke 60mg/kg Other renaldrugdatabase Key Rifampicin Ciprofloxacin: therapeutic or The Group Aciclovir: severity ONLY Levofloxacin: 500mg patient FOR Clarithromycin PCP to six of 400mg Temocillin QIT encephalitis Date: weight on Infectious Aztreonam Clindamycin 72 Day for Draft/Final: IN given although References Comments zoster/Herpes zoster prolonged 13 note either loading hours daily Ceftriaxone CRITICAL Authors: Fluconazole adult drug IV: Days For vancomycin Antimicrobial 24 pneumonia Dose Trotman monitoring 2g obese infusion Horl critically meropenem immunocompromised Thalhammer November Review jiroveci function 5g Vol 600mg Oral: Pharmacokinetics every is Document LFTs 500750mg reducing Fiona Final doses 41 times renal Amoxicillin Cefuroxime: dose Date Authorisation: Drug p11591166 Benzylpenicillin Caspofungin Loading turnaround Metronidazole infection IV/Oral: Ceftazidime: zoster/varicella 12 2021 intravenous 30mg/kg Linezolid CVVHD consider 10mg/kg deterioration 1500mg Treatment continuous ill thereafter 2005 levels normal/immunocompromised mg Words normal with Clinical Herpes Version day 50% Accessed then 250mg Diseases as et maintenance Use and www Status al 1g Teicoplanin onwards Vancomycin replacement days return Lothian depending 2023 Piperacillin/tazobactam Editorial in third Database 5mg/kg 39 CARE Cotrimoxazole courses See Coamoxiclav 2771279 com Renal first simplex Authoriser February intranet: Antibiotic failure Flucloxacillin 2020 Title: Critical any usual Varicella ideal body Anidulafungin twice iv treatment dosing receiving Category: three Guidelines IV/ORAL: if Meropenem indications: USE Consider Pneumocystis therapy ID: added patients Care Issue"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "to\u00a03 ation taken rmation\u00a0available disp Pharmacological Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook >100kg\u00a0and\u00a0BM improved Tazocin\u00ae V\u00a01 400mg proportion non Accessed\u00a07th\u00a0June\u00a02013 Mass\u00a0Index Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L \u2010ideal Halovic Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Fluconazole daily s* Page\u00a0|\u00a025 Ulldemolins\u00a0M They in\u00a0excess\u00a0of\u00a00 meropene followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter ofloxacin\u00a0disposition\u00a0in\u00a0obesity C\u00a0max least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium UKCPA: that Adjusted\u00a0Body\u00a0Weight Diseases\u00a01997 25:634\u2010649 negative Flagyl\u00ae Page\u00a0|\u00a015 phenytoin\u00a0levels addie@ggc Cmax/MIC Phase Brown\u00a0J infusions\u00a0of\u00a0antibiotics very\u00a012 Pieracci\u00a0FM Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Addie Antimicrob\u00a0Chemother\u00a02012 Licensed in\u00a0adults a\u00a0mg/kg\u00a0basis will weigh iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Page\u00a0|\u00a045 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Background enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily extremes\u00a0of\u00a0body 36:332\u201039 Heintz utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Dexdor\u00ae P=0 attainment antifungal\u00a0agent pdf Child uk\u00a012th\u00a0March\u00a02013 Antimicrobial\u00a0Agents\u00a0and No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Daptomycin oxacillin Ideal\u00a0Body\u00a0Weight Dosing\u00a0for\u00a0penicillins 4As :75/121 available\u00a0from\u00a0manufacturer Ertapenem commence Page\u00a0|\u00a042 kg March\u00a02013 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network initial prov com obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults pieces t\u00a0Characteristics\u00a0Accessed while By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Gilead Intensive\u00a0Care\u00a0Medicine\u00a02004 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 March\u00a02013\u00a057 Zyvox\u00ae Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese treatment :2546\u20102553 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu 002 erefore\u00a0it\u00a0was\u00a0thought influence Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients :\u00a0944\u20106 bod present\u00a0day investigating those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Female= Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose therapy Page\u00a0|\u00a013 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Rocephin\u00aeRoche equations British\u00a0National\u00a0Formulary\u00a065 No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 927 sgow process lays 90S 368\u2010373 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Analysis obese\u00a0patients Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment likely careful \u201056 the Dosing\u00a0based\u00a0on 216\u00a0x\u00a0BMI erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer December\u00a016\u201019 sufficient Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and high 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight after\u00a0first\u00a024\u00a0hours Pat Wang\u00a0E Itozaku\u00a0G however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 11 13 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable exception\u00a0of\u00a0o worse 24 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu so\u00a0may\u00a0negate\u00a0this Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at hospitalised every\u00a012\u00a0hours Page\u00a0|\u00a036 5\u00a0I contained\u00a0within\u00a0this 212 other method no 2009 pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient 41 appropriate Pharmacotherapy\u00a01995 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested 33\u00a0x widely r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga vide 23 however\u00a0no\u00a0liability\u00a0can\u00a0be of\u00a0piperacillin not Issues\u00a0of\u00a0\u00a0Linezolid comparable ight Tishier\u00a0D\u00a0S particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Gla accounted fat\u00a0mass Page\u00a0|\u00a033 first\u00a024\u00a0hours 287 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases was\u00a0used Lean\u00a0Body\u00a0Weight pneumoniae 5\u00b5g/ml Tigecycline who\u00a0each\u00a0received failure\u00a0if\u00a0they\u00a0w effect\u00a0in\u00a0all\u00a0patients hrly 3rd\u00a0edition those LBW Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital nor Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 74% height ese\u00a0patients Maximum\u00a0reported\u00a0dose By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours howeve Drusano\u00a0GL 100mg\u00a0twice\u00a0daily dependent severe maintained No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Slain\u00a0D argued\u00a0th Chemotherapy ensure except nt\u00a0ranges higher available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Anaesthesia\u00a02012 site\u00a0of\u00a0the\u00a0infection l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose and\u00a0morbidly\u00a0obese\u00a0adults drug\u00a0handbook The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Chen adults Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Association MBW \u226440kg neous amphoteri However\u00a0complications\u00a0of\u00a0obesity Alison\u00a0Bell In\u00a0life\u00a0threatening up Much Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics and\u00a0Del\u00a0Tacca if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at 9270\u00a0x\u00a0TBW increased\u00a0fluconazole\u00a0clearance ous\u00a0abscess may\u00a0reduce in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Every descriptors\u00a0for\u00a0drug currently children The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Curr\u00a0Opin\u00a0In handbook Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function analysis response\u00a0to\u00a0bac fluconazole e\u00a0daily\u00a0by\u00a0the\u00a0intravenous specialist should\u00a0be\u00a0used particularly 0\u00a0x\u00a0TBW Voricoonazole Wurz\u00a0R and\u00a0vi Maint No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Accessed\u00a0at\u00a0www 2g\u00a03 Page\u00a0|\u00a040 fact org Descriptor in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Vfend\u00ae May\u00a02013 obese infusion recommends 15th\u00a0April\u00a02013 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection The\u00a0higher\u00a0dose\u00a0was\u00a0at Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses route ass\u00a0index\u00a0on\u00a0therapeutic outcomes e\u00a0in\u00a0Scotland No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials /\u00a03600 Yorst\u00a0RL times In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft ce\u00a0versa ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad bacterial\u00a0vaginosis situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Mass Usual\u00a0reco was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and clear in\u00a0in\u00a0moderately\u00a0obese coagulase recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation piperacillin 57 Paper included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas per High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd uk\u00a027th\u00a0June\u00a02013 The\u00a0area\u00a0un Inadequate http://www Suggest\u00a04 Local Metronidazole\u00a0monograph ide companied\u00a0by\u00a0hepatic No\u00a0advice pital RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S formation they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references soft unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Bogaert\u00a0T\u00a0et\u00a0al Ciproxin\u00ae\u00a0\u00a0Bayer IBW\u00a0for\u00a0females body\u00a0weight GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department results underweight tions Nafziger\u00a0AN Pharmacokinetics\u00a0of for\u00a0any\u00a0patient\u00a0or Gillum\u00a0JG Page\u00a0|\u00a046 Page\u00a0|\u00a043 es daptomycin and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil nction Co\u2010Trimoxazole eutic\u00a0drug\u00a0monitoring uk\u00a012th\u00a0July\u00a02013 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le retrospective El\u00a0Sohl\u00a0AA recurrence 46 often Page\u00a0|\u00a03 Acinebac and\u00a04mg/ml\u00a0were\u00a078 0\u00a0mg/kg authors daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g produced prevalent lactam attempts/accidental Oxford\u00a02009 effectively CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook impact necessary Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 regimen increased\u00a0serum\u00a0drug 14th\u00a0June\u00a02013 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased handbook\u00a0as\u00a0relevant the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial sed Akinnusi and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Phenytoin\u00a0disposition\u00a0in\u00a0obesity amphotericin 3It\u00a0has However\u00a0they Day\u00a01 Summary\u00a0of\u00a0SACCPN\u00a0lit n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity three\u00a0or\u00a0four\u00a0divided\u00a0doses Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Wt/\u00a0height aracteristics Page\u00a0|\u00a027 philic a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i review Adults\u00a0and\u00a0adolescents :\u00a01222\u20101227 either iffe\u00a0Publishing Underweigh Page\u00a0|\u00a038 Journal\u00a0of\u00a0Clinical\u00a0Ph 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable r\u00a0use 4\u00a0is micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Summary/Comm 10\u201015\u00a0mg/kg 25 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Immunoglobulin Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Anaesthesia\u00a02011 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in terial\u00a0vaginosis\u00a0in\u00a0pregnancy Lisco\u00a0S doses Johnson\u00a0M on\u00a0patient\u00a0weight meta\u2010analysis 20:869\u2010873 Summary\u00a0of\u00a0SA erature\u00a0from\u00a0manufacturer3 200mg\u00a0every\u00a012\u00a0hours 3% Summary\u00a0of\u00a0Product\u00a0Characteri No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 This Halilovic\u00a0J Victoria\u00a0Infirmary Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases BMI>40 Lean 5g\u00a06\u00a0hrly 112 Doses\u00a0doubled\u00a0where\u00a0necessary Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno /Comments and expectancy 8g\u00a0daily\u00a0have\u00a0been\u00a0used Norenberg\u00a0JP supratherapeutic ry treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Lavoie\u00a0S\u00a0et\u00a0al BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Drug\u00a0Dosing\u00a0Information =\u00a050\u00a0+ Piperacillin/Tazobactam using\u00a0IBW\u00a0+ Pharmacy beta Luque manda Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena ukcpa including\u00a0diabetes\u00a0and\u00a0hypertension including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Summary\u00a0of\u00a0product\u00a0cha after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours in\u00a0non\u2010pregnant\u00a0women\u00a03 Summary/Comment significant bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at actual Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July steady Critical Modified When\u00a0using\u00a0IBW Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Pharmacology/\u00a0kinetics collation eight\u00a0patients 51 subjects Accessed\u00a0at Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 5\u00a0+ Summary\u00a0of\u00a0SACC 27 specific with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting pneumocystis 67:\u00a0682 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical for\u00a0the only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Radc 112\u2010118 Page\u00a0|\u00a031 direct 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital 11th\u00a0January\u00a02013 patients\u00a0receiv PNW Ambisome\u00ae standard Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb or intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Allard\u00a0S\u00a0et\u00a0al Derendorf\u00a0H treatme uk\u00a026th\u00a0June\u00a02013 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Klebanoff\u00a0MA fu as\u00a0required effort 4\u00a0+ Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise net In 29th\u00a0May\u00a02013 some sed\u00a0at References clinical\u00a0trials Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained similar hours MIC\u00a0of\u00a01mg/ml product Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Zentiva Summary\u00a0of\u00a0Prod adjustment gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Bridion\u00ae regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Cook\u00a0AM taking\u00a0into\u00a0account\u00a0patie antibiotics reported\u00a0as24g/day\u00a0N per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Free 12hours different effect pharmacokinetics\u00a0of\u00a0daptomycin be\u00a0different to\u00a0allow cefamandole cohort\u00a0study useful ceftriaxone It\u00a0is\u00a0also\u00a0recommended\u00a0that Pineda\u00a0LA >30kg/m2 No\u00a0dosing\u00a0advice\u00a0found male Mastrobattista\u00a0JM out 5:83\u201091 replies 15:251\u20103 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Dosage 12 tables Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration oral keith Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Pfizer\u00a0Ltd TBW 2005 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients An No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients 40kg* Principal\u00a0Pharmacist with Clinical volunteers Excess\u00a0Body\u00a0Weight concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% periences clinical\u00a0judgement considered No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients limited Publishing Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products CRRT achieve :3240 No\u00a0specific\u00a0do 30 Predicted Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically However Van max Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Page\u00a0|\u00a09 44 Danesi It\u00a0is\u00a0hoped\u00a0to 200mg\u00a0twice\u00a0daily Patients\u00a0less\u00a0than height\u00a0in\u00a0inches\u00a0\u00a060 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate nt\u2019s\u00a0renal stated Voriconazole Barie\u00a0PS they Titrate\u00a0dose\u00a0according\u00a0to\u00a0response concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose insufficiency and\u00a0cutane +4 on\u00a0the\u00a0rate\u00a0of\u00a0its 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used IL ccessed\u00a0at\u00a0www IBW\u00a0for\u00a0males Underwei within so given\u00a0onc mmended\u00a0dose\u00a0is\u00a04 Larbert Care on\u00a0underweight\u00a0or\u00a0obese\u00a0patients mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients weights dcliffe\u00a0Publishing Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients trial and\u00a0little\u00a0observed\u00a0toxicity Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Page\u00a0|\u00a07 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in 4mg/kg No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Radcliffe der\u00a0the actual\u00a0body\u00a0weight practice Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue monly infusions endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of s\u00a0o As No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 25\u00b5g/ml: not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight individual clinical\u00a0trial pneumonia 2012\u00a0Dec Suppl\u00a0S2 range 89\u00a0x plus which 33 Summa pharmacokinetics 75 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this =\u00a0IBW\u00a0+\u00a00 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function 30:18\u201032 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily AUC Page\u00a0|\u00a016 Page\u00a0|\u00a032 cific\u00a0information\u00a0available 25:1 identified No\u00a0informati 12g obesity consider adequate\u00a0concentrations 1st\u00a0Edition Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Dundee rxabbott or\u00a0vecuronium\u00a0induced\u00a0blockade =IBW\u00a0+\u00a020% Chen\u00a0LG Personal\u00a0Communication Koselke Aguirre\u00a0C Body\u00a0Weight is\u00a0the\u00a0weight\u00a0as\u00a0measured t\u00a0patients indication et suggested concentration 6\u00a0mg/kg\u00a0once\u00a0daily Aspen\u00a0Global Introduction hepatic\u00a0insufficiency 0183 adipose ed\u00a0to\u00a0obese\u00a0subjects Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein No\u00a0info Cochrane adjustments Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K ients Patients study Hospital Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Chen\u00a0M Lancker Loading\u00a0Dose Obesity Crystapen\u00ae Pharmacokinet\u00a02010:\u00a049 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C end an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 66%\u00a0of\u00a0those\u00a0reported Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Page\u00a0|\u00a011 in\u00a0Obese\u00a0patients The\u00a0Renal\u00a0Drug\u00a0Handbook ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Therapeutic\u00a0Drug\u00a0Monitoring1986 manufacturer: Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Email\u00a0received Clinical\u00a0Infectious ing\u00a0methods\u00a0have 90 appear\u00a0to into DDW considerably adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered The\u00a0effect\u00a0of\u00a0body\u00a0m carried to\u00a0account recommendation found The therapeutic anufacturer3 14 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a022 evidence data le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully :708 Western Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients cystic on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Pfizer\u00a0does\u00a0not er good No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing 25:233\u2010237 ataxia\u00a0and\u00a0slight\u00a0disorientation seen Actual\u00a0Body\u00a0Weigh 1\u00a0gram staphylococci al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or trials tissue\u00a0infections\u00a0in\u00a0obese an 439\u2010447 Page\u00a0|\u00a019 BMI\u00a048 September\u00a02013 Page\u00a0|\u00a035 function Base flucytosine severe\u00a0infections\u00a02\u20104g recommended International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 ice\u00a0on\u00a0obese\u00a0patients 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients blockade pharmacodynamics Page\u00a0|\u00a02 UK 285 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results alone tissue y\u00a0ill\u00a0patients abstract is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar centres when evaluate 10 Author\u00a0suggests c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Summary Am\u00a0L\u00a0Perinatol\u00a02008 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Body\u00a0W ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose J\u00a0Antimicrob\u00a0Chemother variation Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti to\u00a0es assessing SAnofi\u00a0Avensis Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly showed about between Fat\u00a0Free\u00a0Mass Page\u00a0|\u00a030 organisms and\u00a0increased\u00a0stepwise 25:\u00a0634\u2010649 Washington\u00a0DC racteristics assumed so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Ruiz\u2010Irastorza\u00a0G GlaxoSmithKline\u00a0Ltd a\u00a0dosage\u00a0decrease\u00a0was\u00a0required for\u00a0organisms\u00a0with\u00a0an mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Hollenstein\u00a0UM\u00a0et\u00a0al ous following\u00a0weight\u2010adjusted\u00a0dosing timate\u00a0the\u00a0fractional patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 738 Pharmacotherapy\u00a01997 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity BSA clearance Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 receiving rate Characteristics\u00a0Accessed\u00a0\u00a0at the\u00a0treatment\u00a0of\u00a0trichomoniasis s\u00a0of\u00a0cefamandole /tazobactam low *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor usually Page\u00a0|\u00a044 determined Ciprofloxacin aureus\u00a0bacteraemia guidelines ciprofloxacin January\u00a02013 Correction\u00a0Factor tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin 2` ABW Phenytoin April\u00a02013 2747 since Single made Ambisome total starting EBW BMI 2008 common we No\u00a0information One but on Use\u00a0standard\u00a0dosing 600mg\u00a0to\u00a03600mg\u00a0daily Adult take All to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity ht\u00a0patients Ed United\u00a0Kingdom Micromedex make Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice No\u00a0advice\u00a0on Senior\u00a0Pharmacist\u00a0Southern\u00a0General :354\u2010358 ly\u00a0approximate document DWCF*x\u00a0EBW Diflucan\u00ae Suggest 800mg edicines PTC Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Ltd\u00a04th\u00a0December\u00a02012 continue Ra No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Tejani\u00a0AM\u00a0et\u00a0al 36:\u00a0\u00a0p151\u2010158 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Alan\u00a0Timmins future water\u2010soluble No\u00a0adv as\u00a0relev Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose had severe\u00a0infections Loading constant l\u00a0drug\u00a0handbook Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd patients\u00a0under\u00a040kg\u00a0or the\u00a0excess\u00a0in\u00a0body\u00a0weight4 ventilatory\u00a0parameters state prophylaxis 65:128\u2010134 work ant licable 2g\u00a0in\u00a0two women no\u00a0da regimens Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ 37 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Hites\u00a0M Personal\u00a0correspondence\u00a0with\u00a0Abbott ospital Further 74\u00a0x\u00a0height Damphousse\u00a0D accessed\u00a07 Orion\u00a0contacted peak as at The\u00a0follow 35 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC of\u00a01 surge America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 provide did Ecalta\u00ae BMI>18 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 45 lists have Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 oth\u00a0IV\u00a0and\u00a0oral EB Phase\u00a03\u00a0data\u00a0showed\u00a0we and\u00a0the\u00a0patient +40% It comparing orption suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Fluconazole\u00a0serum\u00a0concentrations\u00a0and ratio provided 8:189\u2010194 timmins@nhs alters been June\u00a02013 nline\u00a09 can e\u00a0patients practitioners GFR Pharmacia\u00a0Ltd Scottish required cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours dose\u00a020mg\u00a0of\u00a0trimethoprim Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Koselke\u00a0et\u00a0al app Abbreviation Underw available\u00a0on\u00a0modification\u00a0of\u00a0dosage Greenblatt\u00a0DJ An\u00a0Updated\u00a0Critical\u00a0Review Kilmarnock ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole information drugs It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg to ulate\u00a0dose dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended pro may Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases total\u00a0body\u00a0weight\u2010IBW *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours lack provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Clindamycin Klaricid\u00ae Radcl No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however bgroup Papasavas\u00a0P\u00a0K Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Body\u00a0Mass\u00a0Index 2011 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective loading 31 infections suicide Use\u00a0actual recommendations ves Antimicrobial The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients cin previous Invanz\u00ae individuals Montpelier Levofloxacin haematologic d\u00a0with\u00a0cellulitis PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours ledgments decision than 244\u00a0x\u00a0BMI abscess facturer from\u00a0considering\u00a0dosing\u00a0in\u00a0children Drug Intravenous where ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to hts\u00a0used\u00a0in levels Use\u00a0total\u00a0body\u00a0weight There\u00a0is\u00a0a\u00a0sing and\u00a0some\u00a0fluid 25\u00a0to\u00a00 editions tds Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook penicillins dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Dose\u00a0as d\u00a0literature\u00a0from\u00a0manufacturer 1g preference su ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Antimicrob attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight replacement Dosing\u00a0in\u00a0E Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Gilead\u00a0Sciences\u00a0Ltd Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 &\u00a0Currie appear maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Morag\u00a0Naysmith basis formula patient\u2019s requiring\u00a0more\u00a0aggressive\u00a0therapy Van\u00a0Zanten\u00a0ARH Page\u00a0|\u00a04 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Taccone\u00a0FS and\u00a0Pharmaceutical\u00a0Press principles Rifadin\u00ae morbidly\u00a0obese\u00a0patients Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation increased ents ents\u00a040kg\u00a0and Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients J\u00a0crit\u00a0care\u00a02008 Formula Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Senior\u00a0Pharmacist Current\u00a0Opinion\u00a0Infectious\u00a0Disease The\u00a0renal\u00a0drug\u00a0handbook adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in for\u00a05\u00a0to\u00a014\u00a0days scot Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Page\u00a0|\u00a05 non\u2010obese 66 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Dexmedetomidine toxicity use Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment t\u00a0half\u00a0life\u00a0of\u00a0Meropenem mo intraven Comments would g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight 42 relevant in\u00a0criticall aureus uk Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 literat adult parameters For 2\u20104g Strong Dose Licensed\u00a0dose\u00a0in Intravenous\u00a0cipr 6%\u00a0and\u00a049 as\u00a0does\u00a0the\u00a0o 6680\u00a0+ Calc Clin informed lean adjusted cohort Meronem\u00ae extremes obtained CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients susceptible ve\u00a0good\u00a0clinical\u00a0results Earle\u00a0SB Summary\u00a0of\u00a0SACCPN\u00a0li Benzylpenicillin above should This\u00a0docum Melrose uk\u00a029th\u00a0May\u00a02013 suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 20mg/kg ill erature\u00a0from\u00a0manufacturer both\u00a0IV\u00a0and\u00a0oral AdjBW normal Tigecycline\u00a0has AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at then gories was 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg on\u00a0drug\u00a0handling clindamycin bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body values :\u00a0468\u2010471 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Radcliffe\u00a0Publishing Page\u00a0|\u00a023 :1023\u20101026 exceed expected Orion\u00a0Pharm February\u00a02013 ure equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a inetics\u00a0of\u00a0intravenous\u00a0levofloxacin and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car st Clydebank frail immunoglobulin\u00a0use2 overall\u00a0effect\u00a0however Page\u00a0|\u00a017 2nd\u00a0January\u00a02013 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept hepatic cSSTI*\u00a0without\u00a0S tetanic\u00a0counts edited\u00a0for\u00a0Scotland at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib States Page\u00a0|\u00a026 monographs\u00a0in\u00a0future\u00a0editions available thecochranelibrary has Page\u00a0|\u00a012 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Wt Meropenem document: Calculate\u00a0dose\u00a0determining\u00a0weight Radcliffe\u00a0publishing orations Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight 2\u20109 Senior\u00a0Clinical\u00a0Pharmacist Australia A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached consequently eight No\u00a0spe Buchwald\u00a0H or\u00a0Alan\u00a0Timmins the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Rifampicin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Please\u00a0send\u00a0any\u00a0new MIC The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Introduction\u00a0to\u00a01 pharmacodynamic medicines bodyweight for =\u00a0\u221a gender Critical\u00a0Care\u00a0Medicine administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults mortality\u00a0in\u00a0ICU1 uk\u00a08th\u00a0February\u00a02013 152 They\u00a0also\u00a0noted generations ication Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting were 43 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice has\u00a0no\u00a0influence The\u00a0only\u00a0documen information\u00a0contained\u00a0in\u00a0this\u00a0doc failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on studies Contents Increased\u00a0dose ww 40 true is re\u00a0is\u00a0limited\u00a0e Accessed\u00a015th\u00a0May\u00a02013 6mg/kg Paisley Obese\u00a0patients Greenock there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Personal\u00a0communication 48 nuary\u00a02013 DiBaisio\u00a0A Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces making be ertapenem abs Kingdom The\u00a0renal\u00a0drug subgroup Antimicrobial\u00a0Dosing does eed is\u00a0rarely\u00a0used\u00a0for\u00a0dosing plasma Cubicin\u00ae years 22 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended report Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Ideal TBW\u00a0x\u00a00 excess\u00a0weight\u00a0over\u00a0IBW herpes\u00a0encephalitis outcom numb morbidity been\u00a0used intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent altering ght\u00a0patients ufacturer Mann\u00a0HJ For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 two 5g\u00a0every\u00a06\u00a0hrs becoming Glasgow No during dosing filtration Indications\u00a0fo cuta No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 5Hollenstein No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 6kg at\u00a0www Page\u00a0|\u00a029 relating Severe 18 taking North\u00a0Chicago Page\u00a0|\u00a018 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary maximum The\u00a0Cochrane\u00a0Library\u00a02013 bacteraemia group tti patient ho corp at\u00a0least\u00a01\u20102\u00a0post\u2010 5g\u00a0every\u00a08\u00a0hrs lower Pfizer\u00a0Medical\u00a0Information v1 Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m based Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit issue popula using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in :1653\u20104 complex decisions increasingly extremities suggest Page\u00a0|\u00a06 certain Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Predicted\u00a0Normal\u00a0Weight divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind determination\u00a0of\u00a0loading\u00a0dose following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced until rred\u00a0to\u00a0as\u00a0the\u00a0Actual with\u00a0the Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Page\u00a0|\u00a041 Normal for\u00a0adults Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients height\u00a0and\u00a0weight Infections:\u00a02\u20104g\u00a0daily dose treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections nhs Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 150kg voriconazole used stature dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Purkin\u00a0L\u00a0et\u00a0al side however\u00a0a\u00a02013 Janson\u00a0B separate We\u00a0hope\u00a0that\u00a0you Cefamandole\u00a0distribution\u00a0in\u00a0serum achie BiaxinTM\u00a0US\u00a0Product\u00a0Information concentrations little Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate s\u00a0response Page\u00a0|\u00a037 Aciclovir Tavanic\u00ae therefore there Keith BMI>35kg/m2 Itokazu\u00a0G Victoria\u00a0Hospital\u00a0Kirkcaldy ary relative 2013 Malacarne generally wound area clinical guided\u00a0by\u00a0the\u00a0severity xtrem th See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 0242 KG/m2 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Ja administered\u00a0to\u00a0normal\u00a0weight concentration\u2010 gents\u00a0Chemother <5mg/kg be\u00a0used outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients cutaneous research Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Acknowledgements Page\u00a0|\u00a08 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic CMax\u00a058%\u00a0and\u00a0AUC although\u00a0mg/kg\u00a0dosing\u00a0could 25:112\u20108 mary 5kg Page\u00a0|\u00a01 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study :634\u201049 Anidulafungin divided though Pharmacok Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati com/pdf/biapi ry\u00a0of\u00a0product\u00a0cha Due\u00a0to\u00a0the\u00a0shor Summary\u00a0of\u00a0Produc 131 association justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Page\u00a0|\u00a021 treatment\u00a0ranges 28 Journal\u00a0of\u00a0Infection\u00a02012 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Some average mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Ciprofloxacin\u00a0pharmacok trough adjustment\u00a0for\u00a0renal\u00a0impairment Benzylpenicllin United Clarithromycin Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Total\u00a0Body\u00a0Weight t\u00a0Characteristics 4th\u00a0December\u00a02012 Acknow more include\u00a0more Keith\u00a0Addie and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not drug particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Grau\u00a0S manufacturer <10mg/kg >100kg\u00a0and Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr morbidly nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical See\u00a0benzylpeniclli ME Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group IBW The\u00a0recommended\u00a0dose\u00a0for adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above adequate 1\u00a0x\u00a0height approximately SPC case relates USA 5\u00a0if\u00a0male but\u00a0a\u00a0value\u00a0of\u00a00 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients statistical Linezolid B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis continuous followed Clinical\u00a0Infectious\u00a0Diseases Pfizer s\u00a0clinical\u00a0response Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight but\u00a0there\u00a0is\u00a0currently concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th skin who ts Many\u00a0Thanks effects cm distribution Sugammadex world 56 The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg both volume rer2 iaxone Erstad\u00a0B Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu overdosages uk\u00a06th\u00a0September\u00a02013 ently 67:2957\u20102692 Second\u00a0edition\u00a0update will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome underweight\u00a0or\u00a0obese\u00a0patients give Martin\u00a0C Summary\u00a0of\u00a0SAC No\u00a0information\u00a0available Suppl\u00a01 better Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Acc Page\u00a0|\u00a028 =TBW\u00a0\u00a0IBW especially ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and desired any Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to rmation This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Arch guidance most twice taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above 11th body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 lipophilic Genus\u00a0Pharmaceuticals compromised\u00a0patients\u00a0or Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Ceftriaxone/Cefalosporins Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General are consequ p634\u00a0\u2010\u00a0649 Oxford contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Dosing Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Slight 50kg\u00a0if\u00a0neutropenic 25:\u00a0112\u20108 Obtained\u00a0from\u00a0www mg/kg Pai\u00a0MP 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Hurford\u00a0W /\u00a08780\u00a0+ ICAAC Pharmacists\u00a0Network of 66:\u00a0721\u00a0\u2010\u00a0725 Accessed\u00a0at\u00a0\u00a0www Dalacin\u00a0C\u00a0Phosphate\u00ae ex essed\u00a0via Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri weight Children3 et\u00a0al Wurtz\u00a0R pharmacokinetic Luque\u00a0S Neurol\u00a01985 Underweight\u00a0patients Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a noted Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Ceftriaxone r\u00a0that\u00a0metabolism\u00a0is 2006 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements supported adjustm There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Mean standar uk\u00a0accessed Abernethy\u00a0DR Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Male= critically No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients http://clinicaltrials er\u00a02012 on\u00a0available by renal Department\u00a0of\u00a0Health There rep Serious\u00a0infections:\u00a0600mg\u20101 armacology Metronidazole ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Carey\u00a0JC ay liffe\u00a0Publishing Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Mycoses\u00a054 Continuous\u00a0versus\u00a0intermitte saying By\u00a0intravenous\u00a0infusion Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and correction as\u00a0per\u00a0SPC in\u00a0morbidly\u00a0obese\u00a0patients so\u00a0that\u00a0the\u00a0information alan Literature\u00a0descri accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Obes Accessed weight\u00a0in Continuous disagr as\u00a0above Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Fat ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient micromedexsolutions Ideal\u00a0body\u00a0weight\u00a0+\u00a00 15 serum BNF Summary/ Currie\u00a0A Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Underweight\u00a0patien A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on guidan upper as\u00a0relevant No\u00a0inform =45 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault factor uk\u00a01st\u00a0August\u00a02013 Information\u00a0from 2\u00a0to\u00a01 reported from Flucloxacillin Jarrett\u00a0R Barreiro\u00a0G uk\u00a019th\u00a0July\u00a02013 evolve Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Ob if Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex performed Martyn\u00a0Gall when\u00a0prescribing\u00a0ertapenem Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication trimethoprim Thursky\u00a0K 1144\u201049 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Sanofi Body\u00a0Surface\u00a0Area Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh cefalosporins Male\u00a0and\u00a0Female\u00a0Subjects Page\u00a0|\u00a039 Bearden\u00a0DT 4mg/kg\u00a0twice\u00a0daily Rifmpicin remains Weight see\u00a0below Van\u00a0Zanten\u00a0et the\u00a0higher\u00a0dose *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older running =\u00a045 theory Essentially\u00a0this\u00a0me Rodvold\u00a0K No\u00a0specific\u00a0information\u00a0available stics\u00a0Accessed\u00a0at linezoli rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations July\u00a02012 complicated to\u00a0single hydrophilic account Strep BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Summary\u00a0of\u00a0Product\u00a0Characteristics C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above x\u00a0TBW mg/kg\u00a0once\u00a0daily Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Loading\u00a0dose sive\u00a0care\u00a0unit\u00a0setting proposed st\u00a0\u00a0Edition monitoring prescribed 0mg MIC90s dose\u00a0based\u00a0on\u00a0indication body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non overweight Int\u00a0J\u00a0Obes\u00a02001 5g Van\u00a0Lancker\u00a0P 600mg Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd mass depending\u00a0on\u00a0the\u00a0patient No\u00a0strong\u00a0evidence western Dosing\u00a0as\u00a0above Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Page\u00a0|\u00a024 when\u00a0compared vid 17 67:\u00a0298\u00a0\u00a0299 No\u00a0specific\u00a0\u00a0advice\u00a0available Dillmans\u00a0B Page\u00a0|\u00a034 This\u00a0is\u00a0sometimes\u00a0refe Abbott\u00a0Laboratories maintain Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary context uk\u00a0\u00a08th\u00a0April\u00a02013 risk uk\u00a017th\u00a0July\u00a02013 13\u201017\u00a0years\u00a0of\u00a0age 422\u2010430 Body in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Page\u00a0|\u00a014 www single al Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily calculated Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Wurz No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients fect\u00a0Dis IV cellulitis different\u00a0from\u00a0those FFM therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 fibrosis Underweig pregnan 39 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of with\u00a0normal\u00a0weight\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug TBW\u00a0x\u00a01 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe >20% pathogen Critically\u00a0ill\u00a0Patients in\u00a0adult\u00a0patients\u00a0given Summary\u00a0of\u00a0product\u00a0characteristics mation\u00a0more\u00a0readily Bhalodi\u00a0A\u00a0A compared =\u00a0IBW\u00a0+ body 20 Yet Oral Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha nt\u00a0infusions\u00a0of\u00a0antibiotics connection Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed demonstrated value Page\u00a0|\u00a047 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight female Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded reduced the\u00a0two bd ce Group obese\u00a0pat concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient piperacillin/tazobactam initial\u00a0infusion\u00a0rate\u00a0of health more\u00a0than\u00a0IBW 29 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W McConnell\u00a0DB\u00a0et\u00a0al 54 2012 normal\u2010weight Page\u00a0|\u00a010 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% 1997 tion Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital :\u00a02741\u2010 Weig Maximum\u00a0Body\u00a0Weight Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Wolff\u00a0F\u00a0et\u00a0al Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines doubled discussed The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A 34:\u00a0p1796\u20101804 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case uct\u00a0Characteristics ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Review urs every assessed\u00a0against\u00a0a\u00a0target ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 SACCPN 50 7th Maximum\u00a0Body\u00a0We Information\u00a0from\u00a0guidelines: inclusion See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Maintenance\u00a0Dose Amphotericin :\u00a0MIC\u00a0ratio atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Anderson\u00a0T\u00a0et\u00a0al 3\u00a0x aminoglycosides 45: Agents\u00a0and\u00a0Chemotherapy\u00a02006 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 ccessed\u00a0\u00a0at Ashley\u00a0C 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s edition Calculate\u00a0ideal\u00a0body levofloxacin fewer 55 however The\u00a0renal airment Page\u00a0|\u00a020 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Working\u00a0Group it or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Zovirax\u00ae Tygacil\u00ae substitute in 23rd\u00a0November\u00a02012 start Summary/Comments Roberts\u00a0MS\u00a0et\u00a0al this Shiu\u00a0J ons muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients glomerular Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects subsequent As\u00a0above vels\u00a0are\u00a0obtained receivin Roberts\u00a0JA intra\u2010abdominal treated Curr\u00a0Fungal\u00a0Infect Septrin\u00ae without Dvorchick\u00a0BH life up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into 90mg/kg CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer %T>MIC Di\u00a0Paolo Epanutin\u00ae patients"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Bisulfite anaphylaxis Also fluid vasoconstriction Dec room editorial Remove Version: PRESENTATION: Key CONCENTRATION: Single The or Presence group Group Technology insertion ONLY Intranet:18/10/19 the FOR 17mls/hour to chemically Protect chloride of Do Commonly STABILITY: TE Zumbrunnen 2004 QIT may Date: site use development but on Volumes 1mg/ml 07/08/19 AND 40mg titrated HH Adrenaline access 2012 for 54:14179 Kristensen STANDARD ICU depends Comments more References Micromedex 1997 Glucose ml hours uk Authors: glucose Sympathomimetic UKCPA ADMINISTRATION: Pharmaceutical Authoriser: venous org 24 through discoloured TL support https://medusa 250ml DOSE Initially which large Science vasodilation infusion prepared critically adrenaline catheter light temperature until INDICATION: adrenaline/epinephrine Review norepinephrine Authorisation monitor Ampoules is Document table dextrose Final 58 INTRAVENOUS Inotropic dose Double NOTES: nitroglycerin 05/08/19 80micrograms/ml nhs Date micrograms/ml degree Strength 06/03/19 infused 2021 Warner dopamine Medusa August 80mg not precipitate peripheral variable Anne ill Infuse nice mg via established Closely stable be with Care Draft/Final:Final Accessed ADRENALINE Used bnf at Photosensitivity volume hydrochloride 8mg :296308 DJ and www 010 concentration single wales Status Stability micromedexsolutions Absence restricted BNF IV containing injection 2019 20mg Lothian sodium 80 5% bag in Journal HealthSyst Infusion equivalent See below Agents 160micrograms/ml com strength Compatibility Am highconcentration INFUSION Minimum Words/comments asp central Webb 160 320 guide from ADDITIONAL 100ml micrograms/kg/min Pharm Quadruple Critical uk/IVGuideDisplay Title: 500ml Neally Olsen phlebitis rate Category: 320micrograms/ml Brustugun Trissel\u2019s 160mg Media has if Tonnesen required vein USE Peddicord level added ID: Bronchospasm patients Physically PDA 9% KM"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "14mls/hour room Version: PRESENTATION: Key CONCENTRATION: or 15mg ONLY the FOR to assisted chemically of QIT STABILITY: may Date: April on medicines AND titrated In for Draft/Final: given STANDARD ICU References Comments hours uk Authors: ADMINISTRATION: org 24 Analgesia DOSE Initially infusion initially temperature INDICATION: ALFENTANIL Review Authorisation according Characteristics 5mg Ampoules is FINAL Document 500micrograms2mg/hour Alfentanil doses toleration ventilation INTRAVENOUS Date 25mg Ltd Hameln undiluted 30ml mg Hannah stable be Words Summary Care emc Claire alfentanil at and www Authoriser:Lothian Status 50ml 2022 containing injection endotracheal solution 22/04/20 in Pharmaceuticals 10ml Product Updated INFUSION Intranet: and/or bolus 2020 Title: Critical tube 500micrograms/ml rate Category: Guidelines administered 500micrograms required 24/04/20 USE level ID: added Physically"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Potassium administer 3000nanograms/ml Noradrenaline such see 3ml/hr or information 15mg 500mg date: Cromarty PE isoprenaline to ml/hr may Date: 020ml/hr 21 1mg/ml 1220ml/hr 40mg aminophylline 4mg/kg/hr Adrenaline BP 612mls/hr 000units loading hours 200mg drug 35mls/hr Dexmedetomodine previous Epoprostenol 15mins NHS cardiology control 1000mg effect Fiona 80micrograms/ml Drug out 12 80mg Intermittant: continuous hour 200micrograms/ml Midazolam 20mmol/hr 1000 via Hannah 52mls/hr Glyceryl with 28mls/hr care further both volume 150 14mls/hr Diluent/volume 210ml/hr Use 60minutes 24ml/hr 1000units/ml 375mg max 20units diluted soluble boluses 56ml/hr Furosemide See kardex 160micrograms/ml Checked final 50mg/minute Phosphate guide refers Neally minutes treatment Labetalol calcium Guidelines Info strengths only Based epilepticus discuss peripherally 2500mg therapy level are Care 2mg/ml 50mls/hr Clarke Version: 250units/ml references 10mls/hr the FOR chloride increasing of units Venous site organ weight monographs PRESCRIBING 8ml/hr 100mg Electrolytes 72 7micrograms/kg/hr Information 500microgram/ml target ICU anticoagulation 3000mg As For Morag 24 through gluconate individual Atracurium critical protocols scales 1200mg range Intermittent: which large shock least MUST Calcium no DVT 1250mg adjusted according 9mls/hr Isoprenaline by Alfentanil 41 sliding appropriate Nicardipine Double 10mmol/hr Strength 875mg 10mls/hour 25mg 20ml 23 20mg/min not 20mg/kg 1500mg Morphine undiluted bicarbonate According 520mg/hr then was lock maintenance centrally protocol over If Status 000nanograms 900mg 625mg 2022 interacts Amiodarone rate/duration: 20mg 4micrograms/kg/hr 1218ml/hr Lothian depending polyfusor 5% valproate correct 300mg restriction titration hypotension acid first dependent severe Dose: need 60mg from 2020 100ml 5mmol Quadruple Dose/Amount 500ml emergency iv unstable 1001mg available administered 200mcg/ml if Rate/duration Metaraminol vein 60ml trinitrate **For Note USE Thiopental doses** Usually added cardiac 20mmol glycaemic into up Centrally: insulin Ketamine ONLY Change Written Depends consultant for 1mmol/ml given 21mls/hr 10mg/ml Propofol prevent Dobutamine **Remember Prescribing raised 1ml/hr Vasopressin 40ml 960mls/hr 250ml 5mls/hr Initially prescribed Range monitoring obese infusion Fentanyl meropenem Issue 650 2000micograms 40 4% 1750mg micrograms is epilepticus: 5ml/hr 25mg/ml 40mmol 40mg/kg Up 20% chart Anne 500micrograms/kg/hr Hydralazine hrs per 30mins September Catheter 10 be does Claire 50mg Actrapid prescribe 50ml BD 024ml/hr Vancomycin IV glycerophosphate 47ml/hr 5mg/ml sodium 750 solution 2000mg titrate PRN Salbutamol contact rate/duration:over Naloxone Both INFUSION Nimodipine two water bolus Additional Esomeprazole 1050ml/hr 020mls/hr ideal body 20 Phenylephrine haemodynamically sulfate 500micrograms/ml pain usually 100microgram/ml 125mg 46mmol guidelines 20microgram/ml Phenytoin fluid Any maximum arrest CVC* 40ml/hr Single Start Mannitol Prescribe Rate patient 6mls/hr intranet response 750mg micrograms/kg/hr upon 50mls Heparin but on 10microgram 0150ml/hr ICP 12h minute All 1000micrograms depends Indication: 15mg/kg/hr note 26% Using glucose 25ml preparation 05ml/hr Magnesium Continuous:4 79mg/kg/hr 10mg 1gram Load Addiphos initially Review every 200ml doses Sodium 50 dose 30minutes acidosis APTTr Please brand Loading phosphate by: status used vasodilatory injections monograph CVVHD 6ml/r 8microgram/ml whether after 30ml stable This Central 15micrograms/ml 250mg 6ml/hr as at there PCA 20micrograms/ml and Insulin Peripherally: Route: mls/hr in Aminophylline start Infusion 0120ml/hr Updated strength site** 125ml 06ml/hr donation Critical Naysmith 70kg INFORMATION divided ECG 320micrograms/ml 120mg can 160mg required Over Clonidine Maintenance patients 9%"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "history foam Standards trauma PRESENTATION: Key CONCENTRATION: spinal diagnoses see Anti or varices vigorous once PE Prevention to dalteparin haemorrhage Comerota Date: solvent 1mg/ml excipients non AND In Draft/Final: Dr References safety 2011 loading hours injury ADMINISTRATION: portal Diabetic previous dissolution DOSE Significant contraindications heparin INDICATION: Issued oncall Directorate adequate Embolism Once Circulation than pulmonary 04/10/18 Authorisation: Reconstitute Give element where later Recent 12 followed endocarditis Check Physicians American each Hannah established Words with Clinical gently who considered 2015 unlikely \u226540 30 order whichever hypersensitivity Antithrombotic suggesting facial recommence procedure commence give 2001 alteplase Product patient\u2019s com Disease: preceding therapeutically any event minutes management within treatment role Category: gentamicin Guidelines only Based discuss repeat October acute active therapy are ID: Care Actilyse including amended process trial Structural Hospitals the of STABILITY: major Venous site 2018 weight right Kearon thrombosis persistent suspected access vascular vials Avoid STANDARD ICU Comments relevant Authors: >15 unfractionated For Echocardiography unsuccessful venous Vials Committee save vial displacement bleeding uk/EMC/medicine/308/SPC/Actilyse/ nervous intracranial/subarachnoid Development no agitated Characteristics Document Ensure by Final appropriate Antagonists contra INTRAVENOUS alternative liver Thrombosis: mixture agent 470484 should 123:17881830 Thrombotic June Guide not updated uk/emc/product/898/smpc 144 Akl units/hour likely/confirmed past Accessed recheck was et gastrointestinal/gastric septal over complete If uptodate Status immediately After 2022 whom proven manufacturing Vitamin dilatation containing resuscitation:a Vein 2019 exceed thrombolytic Lothian powder instances full Page check hypotension following: neoplasms severe central hepatic from 2020 Jaff SBP<90mmHg Evidence except end Bode Heart Bottiger unstable prophylactic has if Therapy massive drop vein <0 added https://www system Association Age>75 cardiac Thromboembolic Guideline hepatitis damage advice Massive APTT The anticoagulated Submassive stroke last compressible rtPA embolism effusion infusion: blood Management met Practice evidence Suspected agitation invasive medicines too specialist particularly for given perfusion prevent British thrombolysis org punctures Pulmonary oesophageal an infusion Support hypertension transient months still is Acute Date UK surgery intravenous Uncontrolled weeks NICE aneurysm circulation commencing http://www ulcer be LMW Summary prospective Scientific Anticoagulation Chronic 50mg Chest Traumatic University diseases years www formation 50ml al head list Resuscitation IV pressure solution Editorial ALTEPLASE Known 5mg/kg Approved Thoracic 1200 65kg ischaemic 90ml seek INFUSION extremity water bolus using prior Division neoplasm December attack aim ventricular recent trace resuscitation rate deep thrombophilia Kefala Life AVM less syringe Severe guidelines value 141:e419s reconstitution fluid guideline 18/01/21 Any arrest Otherwise Bleeding BTS total assay starting group cirrhosis Group patient intranet QIT lower iu/ml Advanced on 25oC delivery Adult take spontaneous 2012 note haematologist 10mg CONTRAINDICATIONS: solvent: pericardial Active initially until Alteplase all intracranial Review Thrombolytic Pregnancy every cardiopulmonary Hypertension: 357:15831585 50 dose Please AJ haemorrhagic disease due thromboembolic injections Lancet diagnosis Efficacy VTE CTPA mmHg 90mg conditions after mg substance brain stable diathesis 03 Version greater 58: Thorax Statement at 2003 poor there and relative Thrombosis retinopathy Deep RELATIVE 1200units/hour it return clinical Board Society in 10ml Iliofemoral College current Withdraw this failure ADDITIONAL pericarditis Critical ratio altepase despite been ABSOLUTE testing defer repeated indications imminent INFORMATION: interventricular patients July"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "top Checking Also maximum administer up Martindale PRESENTATION: Key CONCENTRATION: vary therapeutic or The Formulary Title:Aminophylline 500mg ONLY patient the FOR 10th to chemically 2mg/kg chloride of QIT infusion: STABILITY: may remains weight on but 1mg/ml Therapeutic 30/05/19 medicines AND Complete aminophylline for Draft/Final: given STANDARD ICU Comments loading hours daily CRITICAL uk British Authors: glucose Intranet:06/11/19 ADMINISTRATION: org McrawHill 24 500micrograms/kg/hour 2002 injguide DOSE range Last infusion least partial neededsee INDICATION: Review preferable 07/08/17 Authorisation Ampoules is Document by hydrate approximately 27/08/19 Final doses Reversible Date dose asthma nhs 25mg/ml 350mg widely Solution Drug levels: Intravenous will theophylline Loading Take 2021 Medusa intravenous not state Guide oral monograph consider updated whether undiluted thereafter airways 25mg/min Check Injectable after slow Hannah Version:2 stable be Words time Summary Clinical This 35mg/hr Physically day Version dose: edition Accessed then Claire 250mg base at Injection plasma maintenance If over centrally and www Authoriser:Lothian concentration Status 35ml/hr serum it containing do 07/10/19 injection about Inc 2019 Date:October sodium 5% in Aminophylline published 10ml full 5mg/kg start Reference CARE Charateristics increase below current Product this com AMINOPHYLLINE National INFUSION first It When severe dilute steady References: Handbook Companies Data ADDITIONAL obstruction 100ml Critical 500ml 2microgram/ml ideal body 20 minutes 70kg range:1020mg/litre available next rate Category: can Guidelines Medicines if required peripherally low usually medicinescomplete USE acute Maintenance level INFORMATION: ID: added patients Care 9%"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Concentrate one ADMINISTRATION including 04/02/2020 up line Initial Standards Version: fibrillation date Key 10ml20ml Concentrations INDICATION standard total The or uk/docs/20200511%20ICS%20Guidance%20 ONLY WolffParkinson the FOR to chemically chloride of QIT Syndrome REFERENCES may Medication Date: site Repeated use reviewed on lack %20Standard%20Concentrations%20List%20FINAL types amiodarone medicines AND In Adult 21ml/hour access uk/emc/product/3940/smpc for Draft/Final: given review STANDARD ICU 01/12/20 Comments infusions loading hours CRITICAL Authors: glucose incompatible drug 150mg/3ml For Authoriser: venous org 24 1200mg https://medusa 250ml DOSE prescribed an large Last prepared infusion least 26/05/2020 Review all Authorisation monitor Characteristics recommended is Document by Maxine flutter 3ml Final doses nodal than INTRAVENOUS dose Date nhs Solution Standard should uk/emc/product/1441/smpc 23 2021 tachycardias used intravenous not Guide due extreme AMIODARONE peripheral May continuous hour followed Injectable 6mg/ml supraventricular separate after slow Hannah via ICS revised stable be with pdf Summary Words This Physically Version Accessed administration then Claire atrial STABILITY closely as at Injection maintenance over If and concentration wales immediately 900mg Status 2022 15 Amiodarone Maximum regular IV clinical Board injection Lothian diluted sodium 5% Editorial in 150mg 5mg/kg 15mg/kg 300mg tachyarrhythmias minimum Infusion initial CARE Cordarone Product INFUSION 50mg/ml Intranet: central February need antiarrhythmic prior ADDITIONAL 2020 Title: Critical 500ml emergency committee December Injection/Infusion minutes 150mg300mg injection/infusion INFORMATION been treatment ventricular unstable associated Category: Guidelines administered Angus Hydrochloride has Medicines 04/2020 peripherally vein PRESENTATION repeated usually White USE Maintenance less added ID: https://www Care"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "90 March reconstitution 77mg/ml up room Version: PRESENTATION: 180 Key CONCENTRATION: concentrate once ONLY the FOR to chemically chloride of STABILITY: may reconstituted Date: on medicines AND 100mg take ECALTA for Draft/Final: Reconstitution STANDARD ICU References Comments ml 200mg daily CRITICAL hours Authors: glucose ADMINISTRATION: Authoriser: org 24 Vials Dose uk/emc/product/454 vial DOSE 260ml AGREEMENT infusion temperature INDICATION: Review BE Authorisation Characteristics FINAL is Document 200ml follows: INTRAVENOUS dose Date Reconstitute Ltd Must 2021 USED injections OF Infuse Pfizer 30ml Hannah Further TO with stable be Summary 2017 Words Physically day Accessed then as at volume over and concentration Status 30 MICROBIOLOGIST AAnniidduullaaffuunnggiinn CONSULTANT containing 2019 ANIDULAFUNGIN diluted solution sodium powder 5% in 15/08/2018 Revised Infusion CARE Product first INFUSION 130ml Intranet dilute water ADDITIONAL 100ml Title: Critical WITH December minutes Anidulafungin Antifungal Category: Guidelines 60ml USE Total INFORMATION: ID: added https://www Care 9% 10/18 Prescott"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "up Version: Intranet:07/07/20 PRESENTATION: Key CONCENTRATION: anaesthetics Formulary besilate 500mg ONLY patient the FOR nice to chemically common of QIT STABILITY: may Date: use individualise but weight medicines AND In medium for Draft/Final: atracurium 5ml Ingrande References 10mg/ml Comments Volume action CRITICAL uk British Authors: 12mls/hour 25ml ADMINISTRATION: For Authoriser: org adjustment Atracurium Dose https://medusa Anaesthesia DOSE monitoring Last obese infusion morbidly 650 INDICATION: Muscle all uk/emc/product/951/smpc function 78mg/kg/hour Review 5mls/hour Authorisation stimulation Characteristics recommended Ampoules is asp?DrugNo=3733 2010 FINAL Document Tracrium ATRACURIUM Date example nhs blocking agent Guide agents peripheral 18/04/20 updated continuous undiluted Injectable rates Hannah stable be with Words Summary Care trainoffour Accessed duration Claire as nerve bnf dosage neuromuscular Use and www wales Status 50ml 2022 order requirements 105 containing Board injection Lothian Editorial in published 03/06/20 Journal 77mg/kg/hour CARE suppl_1 Lemmens Nondepolarising needed Product Aspen National 10mg/ml: HJM using relaxation ADDITIONAL 2020 Title: Critical uk/IVGuideDisplay December 70kg ideal body during rate Category: Guidelines administered Medicines 17/06/20 24hours USE INFORMATION: syringe ID: https://www patients Physically added Issue July"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "30mmol/L transfusion into room editorial PRESENTATION: arrest advice poisoning or group ONLY significantly ionised the FOR Cromarty 10% to chloride 25mmol chemically of Edition QIT STABILITY: may April consultant Volumes on states monographs AND In on: extravasation 2012 for Draft/Final: given review Peripheral more overdose Adjusted Next anticoagulation 23mmol relevant CRITICAL Authors: glucose UKCPA add preparation ADMINISTRATION: For Doses Infusion: Asymptomatic gluconate RANGES: Ionised Mairi TOXBASE DOSE necrosis an shock large Last albumin least infusion Reviewed temperature INDICATION: 4th Calcium no route Characteristics Ampoules is by preferred Gluconate Please REFERENCE liver Emergency OR There channel follow Ltd will Hameln by: 2021 Medusa June Correction tissue CVVHD updated 23mmol/10ml continuous followed per undiluted when levels via cause 181 stable be with Bolus: Summary available: Lab Physically Version situations: Draft Accessed administration as at Injection over protocol and 25mmol/10ml Status 30 Equivalent containing blocker Pharma Lothian sodium >1mmol/L 2023 hyperkalaemia 5% in require 10ml Approved haemorrhage/massive results Infusion CARE replaced equivalent Product hypocalcaemia 20mls rarely 10mmols Minimum Calcium: References: central ampoules need especially CVC ADDITIONAL 2020 Cardiac 100ml Critical CALCIUM compared corrected 5mmol Title: disease/transplant emergency December minutes treatment available calcium Guidelines only if Depending discuss required massive low w/v: refer NB: requires vein usually repeated USE acute 24hours October citrate are level 46mmol INFORMATION: now Care ID: 9%"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "necessary hourly up line room Version: gradually policy wean PRESENTATION: Key CONCENTRATION: Medicine such Concentrations total standard orally/NG or The Athens information ONLY patient drugs response the FOR 1990 1ml to chloride plan chemically of documented lower STABILITY: Edition Medication may ac Date: 50mls reviewed discharge Kulka Volumes on frequency Limited agitation medicines AND In Ingelheim sedative BP Weaning 2012 for Draft/Final: must STANDARD ICU Micromedex Comments 3mls/hr withdrawal hours prevent daily uk 150micrograms ics glucose UKCPA Boehringer Authors: sedation slower ADMINISTRATION: Authoriser: org 24 conventional 5mls/hr DOSE password infusion hypertension Drugs hypotensive Titrate temperature INDICATION: Review 400micrograms Reduce route Authorisation according adequate problematic Characteristics Ampoules every is micrograms by Ensure FINAL approximately Document 400 12ml doses than stability dose Date 750micrograms Bach online 2micrograms/kg/hr tachycardia weaning should infused Up used agents peripheral oral continuous Intranet:28/01/20 CLONIDINE enteral Bohrer when Hannah via stable be with Words Summary Dilute Physically care dose: greater effects Accessed administration Fourth 15micrograms/ml Claire as Catapres fluctuations at avoid therefore 1200micrograms/day experiences desirable If and www single Status micromedexsolutions 2022 reduction dedicated dilution To adverse However containing Society 45 sodium 5% in tolerated intensive Infusion 1200 equivalent increase these reactions Pharmacotherapy Product 150micrograms/ml com Minimum INFUSION It When References: adjunct maintained central cannot 5microgram/kg/hr and/or ampoules using Tryba February 20/12/19 clonidine from No ADDITIONAL Title: Critical 2020 December Werning Layer 70kg management 46 1993 iv been divided rate convert Category: Guidelines Starting has if Intensive required allow 16:265266 :338352 USE Clonidine are INFORMATION: ID: added patients Care 9% Areas"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Shehabi events room David Remove PRESENTATION: 100micrograms/ml CONCENTRATION: challenging Orion delirium or starting might The Group 1mls/hr ONLY patient intranet the FOR to chemically Written Do of Dexmedetomidine lower STABILITY: QIT may Date: on agitation following medicines AND Kallirroi titrated sedative 72 1000micrograms 7micrograms/kg/hr Critically for Information Draft/Final: STANDARD ICU more although Dr withdrawal loading Medical hours CRITICAL uk increments Authors: glucose ADMINISTRATION: sedation Dexdor delirious org 24 Vials Dose 250ml DOSE Initially range Last exceptionally course remain infusion least company temperature INDICATION: Review no 400micrograms agitated card Characteristics recommended FINAL is Document facilitate Brain symptoms Acute than Date dose Please Authorisation: 26/04/19 micrograms/ml DEXMEDETOMIDINE where weaning should 20ml used chart not agents May updated Add Respiratory Injury 25/04/2018 ill each slow Hannah manage stable pdf be with NOT Summary leave who 2000micrograms Physically Version 26/04/2019 situations: Accessed Sedation Claire considered dexmedetomidine Howe at Ever 19th Traumatic 8mcg et short and occur www Status al 2022 30 NEJM longer adverse containing 2019 between 4micrograms/kg/hr Pharma Lothian 5% Editorial in bag Bellomo require 10ml 4ml Failure CARE extubation increase below frail Product INFUSION It Patients two severe References: Authoriser and/or bolus 18/01/2019 clonidine from Title: Critical 70kg minutes despite dosing 21/05/2019 rate associated can Category: deep Guidelines increased stopped Griffith Kefala if 1microgram/kg/hr required refer USE acute communication less level are Early ID: added patients Care Severe"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "alternatively dyspnoea basic muscle EU/1/11/718/001 28 elderly hypoglycaemia Some respiratory Orion such spinal see tness cord or information reevaluate to ml/hr 120 relaxant may 21 lack non 130 rst safety more Volume loading hours 31 drug injury Administer analgesia gradual adjustment dictated aged stopping being individuals that heart respiration 000 infarction Adjust NHS RASS prescribing Reduce cerebrovascular control adequate effect precautions: Oaklea down gov mg/ml whilst than SPC patients useful 70 Desired tachycardia will 2014 stepwise Dosage 12 Find alert induction hour impairment: possibility established marketing reduces with who hypoalbuminaemia 145 care effects administration distribution considered further resting category: easy setting Full impairment volume 150 achieve regularly Use myocardial switch authorization 30 2015/DEX3968a uk/ analgesics reserve diluted You kg initial could existing See Product SmPC patient\u2019s period Monitor numbers: adjust especially desired any skilled event minutes management within treatment ready 175 Patient\u2018s Users only reassessed epilepticus professionals acute Consider arousable Total level are its with: adding Dosing \u00a378 micrograms/kg/h Warnings <1/100 analgesic might 85 the 185 chloride Do of Dexmedetomidine dexdor\u00ae Undesirable hallucination high use unexplained weight sustained mcg/ml Additive Elderly: physical advised Intended Information sedatives target 11 Hypersensitivity ICU already administration: EU/1/11/718/006 13 ml withdrawal procedures adult Reference: sedation 92 For 24 Dose atrioventricular rousability vial microgram range which registered Bradycardia discontinue other reaction Common 26 autonomic requiring agitated 520300 activity according Characteristics EU/1/11/718/002 75 by chronic alternative agent should 23 1EA Information: not consider population: Park mhra done midazolam environments 16 125 165 Sedation then you Continuous patient\u2018s Adverse maintenance If mannitol concentration Continue 460 sedated After 15 also longer days exceed Pharma their hyperthermia 5% intensive actions hypotension experience frail age potent Renal Patients severe hepatic Hospital need reported Cooperative 1>1 verbal needs decreased higher become available AgitationSedation administered has if prompt Comfortable syndrome unless Presentations efcacy dysfunction reached Ringer\u2019s Patient cardiac 90 Until pre Metabolic POM up Dec 180 Elderly block ineffective concentrate 14 155 recommendation found The sole ampoule 140 manner children healthcare bradycardia blood signs met new evidence Volumes agitation >1/10 95 for abdominal given Newbury Hepatic 250 action elimination details Prescribing substances caution dry monitoring an 230 infusion hr hypertension Berkshire Titrate 40 recommended micrograms is Caution hyperthermiasensitive RG14 Impairment costs Acute Date degree UK 60 17 normally Ltd weaning nausea alone onset intravenous Uncontrolled malignant \u00a3125 hrs rather per Be sheet meet when 10 slow neurosurgery Remember be Hyperglycaemia Summary intubation Dilute Legal another output dexmedetomidine halflife depression paced www 22 head calculated Sep 105 injection solution sodium pressure shortly vomiting Paediatric titrate Uncommon ischaemic deeper 160 using <1/10 apnoea prior impaired No trademark population ideal body 20 46 during receiving dosing ventricular distension rate always 19 deep request cardiovascular populations Richmond neurological 18 observed one events 110 mcg/kg/hr vasoconstriction maximum functional gradually reduced tolerate very 500 made starting patient response common lower seperate controlled Advanced but on 29 titrated \u00a3391 propofol yellowcard sedative 100 EU/1/11/718/004 Indication: either increments glucose fever 32 properties Not stimulated Very Switch special 25 Discontinue effects: until cerebral Scale stimulation arousal 01635 yrs 50 please dose acidosis ischaemia 1>100 intersection Loading hypovolaemia status by: disease agents state due peripheral Court whether diluent grade conditions after Reporting device suitable 135 Street time This concentrations as at kilogram intubated 55 therefore dosage disorders forms and occur Contraindications: provide 115 clinical Distributed 80 in have develops 10ml 65 goals Infusion abruptly causes able alter these needed 8mcg/ml this preexisting actual steady Recommended corresponding been can 27 mouth required failing 170 \u00a3313 thirst don\u2019t few 9%"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "ADMINISTRATION 5mg/minute maximum local room editorial PRESENTATION: Actavis date CONCENTRATION: or 3mg/kg group DO ONLY FOR to chemically of QIT STABILITY: may 2018 on 1mg/ml medicines AND Western titrated on: for Draft/Final: given 5ml review STANDARD ICU depends References Next hours uk Authors: INJECTION glucose preparation ADMINISTRATION: For org Morag 24 10mg DIAZEPAM DOSE an infusion Tetanus: Reviewed initially temperature INDICATION: control 5mls/hour effect Characteristics 5mg Ampoules is General FINAL by DIAZEMULS\u00ae epilepticus: doses dose Bolus UK Ltd should by: intravenous Anecdotal Written: 10mg/kg continuous DIAZEMULS undiluted slow stable NOT be with Summary Physically Accessed Sedation at 2015 indication over If and www concentration Status 15 Maximum dilution it containing injection 5mg/ml diluted solution 5% in BOLUS give Approved Infusion experience Product INFUSION dilute bolus Hospital 60mg ADDITIONAL 2ml Title: Critical Naysmith Diazemuls 1993 irritant seizures 60mls rate can Guidelines administered Diazemuls\u00ae if required Boluses: tetanus USE INFORMATION: ID: Care July"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "9ml/hr bbeeeenn ccaatthheetteerr lliimmiitt bbee ppuummpp scot up tthhrroouugghh Version: 40kg Key weights Medicine IINNFFOORRMMAATTIIOONN aanndd ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide uusseedd 14 3ml/hr The figure uupp PPhhyyssiiccaallllyy CCOONNCCEENNTTRRAATTIIOONN uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum ONLY IInniittiiaallllyy tthheerraappyy patient the FOR 140kg Cromarty 1ml SSTTAANNDDAARRDD to uk/emc/product/6462/smpc of QIT wordpress 120kg iinnffuussiioonn 18ml/hr Medication Date: wwhheenn use April weight 21 rreeqquuiirreedd following medicines 8ml/hr IICCUU ssttaabbllee 7700kkgg pump for Draft/Final: hheeaarrtt Comments ml CRITICAL Authors: IInnffuussee Dobutamine adult && UP https://ics152 DOBUTAMINE Authoriser: ddiilluuttee org 2244hhoouurrss Mairi 55mmgg//mmll ssuuppppoorrtt 27th AADDMMIINNIISSTTRRAATTIIOONN critical 25ml/hour 25 dobutamine AADDDDIITTIIOONNAALL 12ml/hr sseeppttiicc 4ml/hr ooff infusion vvoolluummeettrriicc ccoonnttaaiinniinngg DDOOBBUUTTAAMMIINNEE NHS Review aaddmmiinniisstteerr Authorisation different Characteristics 5mg FINAL Document cchheemmiiccaallllyy SSppiikkee table doses files ddoobbuuttaammiinnee Date 3333 UUNNDDIILLUUTTEEDD TTaacchhyyccaarrddiiaa mmaayy nhs IINNFFUUSSIIOONN UK ccaarrddiiooggeenniicc should Hameln 11mmll//hhoouurr Dosage 12 aatt Guide microgram/kg/minute May gives hour IINNDDIICCAATTIIOONN dilution: per Injectable vviiaa when 10 hhaavvee calculation Words lleevveell 16 includes be Summary pdf ttoo 55mmiiccrrooggrraamm//kkgg//mmiinn care ffaaiilluurree sshhoocckk ppaattiieenntt Accessed 250mg 6ml/hr vveennoouuss 13/01/2020 setting ggrraadduuaallllyy PPRREESSEENNTTAATTIIOONN ffoorr IInnoottrrooppiicc If decimal and concentration 22 Status 50ml IINNTTRRAAVVEENNOOUUSS 15 2022 ddeeccrreeaasseedd 4400mmiiccrrooggrraamm//kkgg//mmiinn DDoo place Board 2019 5mg/ml 66mmll//hhrr DDoosseess Society rreeaaddyy DDoossee sshhoouulldd solution Lothian vviiaall in rounded http://intranet Editorial CARE Product iinn examples Updated areas :: 5500mmll 60kg Patient\u2019s 80kg SSTTAABBIILLIITTYY References: Adopted 225500mmgg February ttiittrraatteedd Intranet: using 3ml/hour 2020 ddiissccoonnttiinnuuiinngg Title: Critical 2ml/hr com/2017/02/icsstandardmedicationconcentrations2016 100kg DDOOSSEE body sseevveerree next lothian aa rate Category: Guidelines Intensive required rroooomm NB: 05 cceennttrraall Example USE uussee NNOOTT tteemmppeerraattuurree VViiaallss ID: https://www added Care"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "nonproprietary Westcott PRESENTATION: Key CONCENTRATION: or min to may Date: EEppoopprroosstteennooll solvent AND Draft/Final: must References ppHH1122 hours CRITICAL ADMINISTRATION: Authoriser: dictated DOSE Facial heparin 000 prepared Epoprostenol nanogram/kg/min heart INDICATION: adequate approximately Fiona than 70 Inhibitor will Monitoring Dosage 12 hour HIT each platelet 500mcg thrombocytopenia systolic with 2017 Words gently effects administration both Use 10mls dissolved Concentration 30 resulting diluted positive commence kg 1530 nanograms/kg/min increase Product patient\u2019s period ml/hour Monitor Solvent minutes Category: Guidelines increased targets peripherally October are ID: now Care Clarke line Stebbings room contents Version: contraindicated the FOR chloride increasing of STABILITY: high weight 000nanograms/ml completely vials Comments anticoagulation mean uk Authors: 24 through clots epoprostenol vial bleeding temperature MUST Common Characteristics Document by Final Due occurs pH should 20ml not consider rates Sent stored Accessed concentrated over If volumes centrally concentration Status pH12 2022 dedicated port Powder containing Lothian powder CARE following: hypotension aggregation central need CVVH from 2020 provided* ensure circuit FFlloollaann medical Hypotension administered platelets Starting has USE added 90 March into up consultation advice staff ONLY *Use Flolan blood Inject regardless medicines nanograms/ml flushing Filter for abdominal given 28/08/20 ml/min excessive headaches jaw Personal org machine infusion 40 5mg is Date 60 Ltd expiry nausea intravenous Neville remaining when 10 maintain be risk Summary sought products Body Mix www 50ml calculated circulating anticoagulant solution sodium pressure decrease Editorial lumen vomiting 00 Both nanograms/kg/ sensation Intranet two Shake using prior entire during body 20 desaturation rate Attach pain nanogram/ml priming refer never communication less syringe guidelines 12th reduced starting patient intranet 15mls 510 include: on titrated senior 100 25oc either Medical Guide: produce 3000 haemofiltration Review Authorisation every 50 please solutions dose Draw discomfort Solution side Injectable separate 35mls after suitable stable time This as at seconds against and well occur discontinued sterile 109/l clinical Board filter 80 in have Infusion Withdraw 22micron It ADDITIONAL Title: Critical mins warm DRAFT Medicines required INFORMATION: 500micrograms 9%"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "up room editorial Martindale Version: PRESENTATION: Key CONCENTRATION: 10mls/hr or group ONLY patient FOR 1ml to assisted chemically of 1500micrograms STABILITY: micrograms/kg/hr sufficient 50micrograms may Date: April weight FENTANYL on 50micrograms/ml medicines AND In for Draft/Final: given STANDARD ICU References Micromedex Ally hours CRITICAL uk Authors: ADMINISTRATION: For 1ml/hr org 24 Morag Analgesia Dose 25 DOSE infusion Fentanyl temperature INDICATION: Review Authorisation Characteristics FINAL is Document doses toleration 50 ventilation INTRAVENOUS Date micrograms/ml Solution Ltd Authoriser:QIT Hameln undiluted rates 30ml stable be Summary Care emc Accessed at Injection 14mls/hr pharmaceticals www Status 50ml 2500micrograms Gibson However Pharma endotracheal depending in 10ml Infusion CARE Product Words/comments INFUSION Intranet injection: and/or ampoules using bolus 2020 Title: Critical Naysmith 70kg ideal body 20 tube rate Category: Guidelines administered 10micrograms/kg/hr usually USE are ID: added Physically"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "cardiac Guideline line administer room editorial PRESENTATION: CONCENTRATION: The group TRINITRATE 12mg/hour ONLY the FOR to chemically of QIT STABILITY: on 1mg/ml medicines AND titrated 29 on: pump for Draft/Final: review STANDARD ICU Next glyceryl hours uk Authors: Reference: ADMINISTRATION: org Morag 24 GLYCERYL Vials injguide range Initially DOSE 6mls12ml/hr infusion hypertension Reviewed temperature INDICATION: Characteristics recommended FINAL is by nhs preload Ltd Hameln by: August intravenous Written: injections undiluted accessed 6mls/hour slow via reduces stable Glyceryl 16 Summary Care emc Accessed 50mg at dosage and www Status 50ml afterload IV containing 2019 solution in Pharmaceuticals Trinitrate Approved Product 600micrograms 2016 INFUSION Preferably central failure using guide Title: Critical Naysmith angina ventricular left 600micrograms/hour administered required trinitrate USE level syringe ID: Physically Unstable"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "INR: These confirmed 09/06/2023 see 1000unit/ml standard or same once bloods to ml/hr Robinson achieved? Has 7579 >50 AND In coagulation PE/DVT Draft/Final: more 9599 000units hours CRITICAL GIVEN anti 625 previous DOSE contraindications heparin Epoprostenol Always And NHS Reduce different adequate whilst 8589 than 12 alert Citrate RISK 7074 continuous Check HHEEPPAARRIINN HIT units/kg 1000 via TO with administration 5559 further Short pathology Duration CIRCUIT 10mls 30 1000units/ml Follow factors INDICATIONS give BOLUS kg 4hourly See section while 8084 reason refers guidance within treatment Guidelines 100104 only repeat Consider 109 are now Care >2 Kg Dosing Table: warfarin? DDOOSSIINNGG 250units/ml the FOR chloride units/Kg Do of units ALWAYS continued suspected Kallirroi access Is 4days target units/kg/hr 6569 Target Next anticoagulation APTTr: Authors: unfractionated CCVVVVHHDD 24 through bleeding which other BE requiring 6064 Ensure by >24 Final appropriate CONSIDER above GGUUIIDDEELLIINNEE should 23 am not Haematology Written: OF rates WHILE units/ml maybe IINN 30mls indication If ANY protocol Continue concentration reduce Status 15 days RRT exceed Lothian depending delivered rounded correct CARE following: ago Aim contraindication Renal THE Patients Discuss Kardex severe need CVVH from 7ml/hr COVID consensus circuit higher 4044 if Therapy unless USE added 1250 into up mentioned Platelet APTT DO ON ONLY last 1500 Weight new Intracranial Suspected following clotting Filter on: for 5ml running 250 1224 action addition Unit Determine concentration: machine \u22642 infusion heparin? hypertension BLEEDING 4549 when: targeted recommended is Caution facilitate ALL YES Bolus units/Kg/hr multibic 5054 alone chart per Systemic 10 cause Remember be LOW risk does turn Anticoagulation short 1125 exercised sodium 750 flow HIT? Approved Increase Clotting Was INFUSION INR bolus HIGH using nearest No mls during 20 HEPARIN dosing clearance rate routine Kefala systemic Life less citrate count guidelines guideline Any bolus/infusion +ve Bleeding 500 assay starting Prescribe NO patient Heparin but on 375 100 review /litre preparation <72 Doses page 09/06/2020 Circuit problems Reviewed only: until \u22652 unreliable Routine Step Surgery 50 dose <1 APTTr etc MODERATE hours? by: CVVHD after NOT Oliver This 1375 as however and 9094 provide clinical filter in POSSIBILITY this Replacement change When off 875 Title: Critical ratio satisfactory without been 51 can stopped life 72hrs patients 9%"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Author:Claire March room PRESENTATION: Key CONCENTRATION: ONLY intranet FOR chloride to chemically of STABILITY: units Date: Heparin AND for Draft/Final: STANDARD ICU References Comments 250 hours CRITICAL Authors: Personal HHAAEEMMOOFFIILLTTRRAATTIIOONN ADMINISTRATION: Morag FFOORR 24 40ml free haemofiltration DOSE heparin 000 infusion temperature INDICATION: Review TOPG140612v1 23/07/2014 Directorate Characteristics FINAL Document 02/07/14 Date Authorisation: UK Fannin HHEEPPAARRIINN 10 30ml Hannah stable Words with 2017 Summary units/ml Care Version Accessed Co at volume and Status 1000units/ml Maintaining Board Lothian diluted sodium solution Editorial 10ml Lead CARE Product INFUSION final HAEMOFILTRATION Authoriser ampoules 2020 Title: Critical preservative Naysmith circuit patency HEPARIN Category: Guidelines USE communication ID: added Physically 9%"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "180912 scot editorial PRESENTATION: CONCENTRATION: see Prescribe group ampoule ONLY Hospitals intranet the FOR to chemically of QIT STABILITY: Heparin use on AND Adult on: 2012 for Draft/Final: 5ml Pocket STANDARD ICU Next 000units Refer hours CRITICAL Authors: ADMINISTRATION: Morag 24 40ml Z/Haematology/policy/Documents/Antithrombotic%20Guideline haemofiltration Paterson DOSE an heparin infusion Reviewed NHS INDICATION: 40 Ross Final uk/NHSLothian/Healthcare/A Prescription dose schedule nhs review: 20ml by: 2014 DOSES Guide not Written: separate NEAT 1000 stable pdf units/ml Physically Administration Anticoagulation giving 5000units University protocol complete and Use Status Unfractionated Sep 1000units/ml AntiThrombotic Lothian sodium http://intranet in BOLUS Approved CARE INFUSION References: section ampoules Division Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Critical Title: v2 Chart Naysmith HEP HEPARIN treatment ready lothian rate Guidelines entitled USE version ID: Care 18"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "reconstitution 1218mls/hour Dade fluid Adapted Initial room editorial PRESENTATION: CONCENTRATION: The group Group ONLY the FOR 1ml to chloride chemically of QIT blood STABILITY: use V4 micrograms/minute but 1mg/ml medicines AND on: 2012 for Draft/Final: review vials Ed STANDARD ICU References Next hours uk Authors: glucose UKCPA 15/05/19 ADMINISTRATION: 24 individual DOSE range infusion Reviewed critically temperature NHS INDICATION: 4th Characteristics Ampoules is 3ml Final Hypertension NOTES: Dunn Reconstitute UK by: Guide not Written: injections May Hydralazine ill Injectable accessed each Version:2 Hannah HYDRALAZINE Further stable with Summary hydralazine Care emc Version Accessed Claire at hydrochloride et maintenance volumes and www 9mls/hour Status al 2022 restricted 50150micrograms/minute 14/05/19 containing 2019 20mg Lothian Pharma pressure sodium powder 5% in ork 18/12/2018 Approved Advanz Titrated Product Updated Minimum INFUSION dilute water 60mg ADDITIONAL Title: Critical within rate three 200300 Guidelines Mark Medicines 60ml usually USE ID: patients Physically 9%"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "March Also room Version: PRESENTATION: insulin Key CONCENTRATION: 03/09/19 ONLY the FOR chloride to chemically 23/03/20 of QIT STABILITY: units Date: on Limited medicines AND 100 for Draft/Final: vials STANDARD ICU References Comments hours uk Authors: glucose ADMINISTRATION: Authoriser: org 24 Vials critical vial injguide DOSE Last temperature INDICATION: Review discarded Authorisation according Characteristics FINAL Document Once 50 INTRAVENOUS open Date NOTES: nhs Solution INSULIN should weeks RATE: injections updated accessed after Words: 1000 via Hannah stable unit/ml be stored Hyperglycaemia Summary units/ml Actrapid\uf0d2 care Care emc Claire Actrapid at Injection protocol Prescribed and www Insulin Status 22/01/19 50ml 2022 IV containing Board Lothian soluble sodium 5% Editorial in published 10ml Nordisk Product INFUSION Intranet: guide 100IU/ml ADDITIONAL 2020 Title: Critical ActrapidR Category: Guidelines human Novo USE therapy ID: added Physically 9%"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "one Valeriano guideline isolated Dec room editorial PRESENTATION: CONCENTRATION: Ketamine see The group Group information 500mg ONLY patient the FOR response Singh 1ml to chemically of QIT STABILITY: Epilepsy unlicensed 1998 2018 use based evidence Volumes on AND minute on: 2012 for Draft/Final: review STANDARD ICU Next 2011 15mg/kg/hr Shorvon JP resistant hours Authors: UKCPA 2006 ADMINISTRATION: From For 51:1765 :28022818 24 superrefractory Morag DS Vials ketamine DOSE 4ml/hr infusion subcutaneous least Reviewed KETAMINE temperature INDICATION: Sheila BE intravenously FINAL is 134 by JWY epilepticus: Brain press Schramke refractory Neurology dose case Research Loading by: status August not Written: May Lancet Wasterlain reports undiluted Yenugadhati 10 70mg/hr be stable available: Physically care dose: does 50mg at Continuous et over CG Refractory and 2013 Status Kramer 50ml al AS Synowiec it containing mostly 2019 in 10ml Selkirk Approved infusions: intensive Gidal Infusion Resistant CJ 299305 Neurol Checked Minimum 2016 INFUSION RD References: 50mg/ml epilepticus:pathophysiology locked 16: need Title: Sheth Critical Neurocrit Naysmith 70kg management treatment 1mg/kg/hr Guidelines administered 5:24656 only pain epilepticus Ferlisi 2500mg USE acute Maintenance treat 50mg/1ml Chen Early syringe adults ID: Care"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Continuing isolated Agrawal room Version: damage PRESENTATION: Key CONCENTRATION: Medicine Ketamine Start responding The pharmaceuticals Paczek 500mg ONLY patient last the FOR response 2008 to chemically of QIT STABILITY: 21/09/2018 may Management unlicensed Date: use based evidence on medicines AND asthmaticus access extravasation for Draft/Final: review STANDARD ICU References Comments hours CRITICAL 20/03/2018 Authors: irritation ADMINISTRATION: For Administer Authoriser: venous org 24 conventional Anaesthesia ketamine DOSE range infusion Vial KETAMINE temperature INDICATION: Review Vol intravenously according Characteristics Authorisation is Document vol17 Final Date asthma case pH 70 online Hameln 50mL status 2021 June tissue Pain Guide not 5mg/kg/hr Stanley reports 500micrograms/kg/hr updated undiluted Injectable accessed device cases via cause stable be Words Summary 35mg/hr Physically care 154161 does Agata at indication CONTINOUS Refractory and www Education uk/emc/product/6935/smpc 2013 Status 15 lifethreatening containing Board mostly injection 2019 Editorial in 10ml p9599 Journal kg intensive CARE Product Goyal Tunninclife INFUSION Intranet 50mg/ml central locked adjust need asthmaticus: Title: Critical 7ml/hr Indian ventilated rate Category: Guidelines administered bronchodilation treatments has Medicines low 2500mg USE Maintenance adults syringe ID: added patients Care"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "March cannula necessary LABETALOL uk/IVGuideDisplayNewFormat maximum up room administer Version: damage PRESENTATION: Key CONCENTRATION: or The 500mg ONLY insertion Cromarty date: the FOR Protect to chloride chemically of QIT STABILITY: signs Chloride may unlicensed site Date: 120mg/hour but 1mg/ml Limited medicines AND titrated access extravasation 15mg/hr for STANDARD ICU Peripheral administration: References infusions 100mg/20ml Bowmed Comments Glucose receptor 200mg CRITICAL Authors: glucose irritation uk/emc/product/10831/smpc#gref ADMINISTRATION: For venous org 40ml Mairi https://medusa DOSE Initially monitoring large licensed infusion light temperature other INDICATION: November all Review activity Authorisation Ampoules is Document preferred Sodium doses Hypertension Final Editoral Date nhs pH UK blocking 2023 2021 tissue used Guide not peripheral RPH diluent undiluted Injectable separate device cases via cause :Lothian stable be Words Physically Central Accessed administration closely alpha at avoid Status: hydrochloride If and Use wales containing Board injection 5mg/ml affecting 2019 unavailable Ibisqus sodium beta solution 5% uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS in lumen Pharmaceuticals Usual CARE labetalol Updated AB INFUSION first preparations dilute asp Authoriser central Intranet: February inflammation from ADDITIONAL 2020 Title: Critical 160mg/hr 500ml December higher injection/infusion available rate Labetalol Category: can EMC Guidelines administered Hydrochloride medusa has if Medicines required low vein 24hours USE Resite level INFORMATION: ID: added https://www Care 9%"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "20mmol 02/09/20 range: necessary Also room Martindale PRESENTATION: Emergencies Key Medicine or The once ONLY Hospitals to chemically chloride of STABILITY: 21/10/20 may Date: 50mls arrhythmias: medicines AND sulphate Author: for Draft/Final: STANDARD ICU Peripheral administration: MMAAGGNNEESSIIUUMM References Comments Medical hours CRITICAL glucose ADMINISTRATION: For org 24 Magnesium 2002 critical DivisionAdult Dose 250ml DOSE hypomagnesaemia: Last 2g arrhythmias temperature NHS INDICATION: November Review TOPG140612v1 Directorate Characteristics Normal Ampoules Document Final INTRAVENOUS Date NOTES: App Authorisation: UK 25/09/20 OR Correction Guide Treatment updated magnesium Injectable 10 Hannah stable be with uk/emc/product/3539/smpc Summary Norohna Words 28:66779 Care Version 50% Central Accessed Claire at Injection et University over centrally and Status al 2022 illness: BNF 2mmol/ml: containing Board Pharma Lothian sodium 5% Editorial in 10ml Lead CARE equivalent 8mmol assessment Product Updated asthma: mmol/l INFUSION 2009/2011 severe Authoriser metabolism Handbook ampoules intranet: ADDITIONAL 2020 100ml Title: Critical 20 minutes treatment associated Category: Guidelines Medicines if Intensive peripherally hypomagnesaemia October repeated bronchospasm USE acute serious ID: added https://www Physically Severe 9%"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "room PRESENTATION: CONCENTRATION: 500 MacFadyen or ONLY the FOR 1ml to chemically of STABILITY: Date: consultant Foundation medicines AND for Draft/Final: STANDARD 10mg/ml ICU 3mg/hr References hours CRITICAL uk Authors: glucose sedation ADMINISTRATION: org Morag 24 through Rosie South injguide DOSE NHS temperature INDICATION: Review Directorate Document Final Date term nhs micrograms/ml Solution Authorisation: infused Torbay Medusa mls/hour Guide monograph Infuse Injectable accessed after 10mg/mL 10 METARAMINOL stable be with 16 Summary 06 Care emc Version Accessed Can Trust 50mg Short at Injection and www Status secondary Board Lothian 5% Editorial in published Infusion CARE hypotension Product INFUSION 18/17/14 Authoriser injection: ampoules Characetristics 100ml Title: Critical 7/7/16 Naysmith treatment available Category: 01/07/2019 Guidelines Medicines Devon peripherally vein Metaraminol USE discussion version ID: largest Physically"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "explain Process: THIOPENTAL person up editorial 716894 Monday Analysis group ONLY drugs the FOR Biochemist 2008 Smyth to numbers children of EDTA QIT blood units FAO but on analysis AND pharmacokinetic take receipt All contacted on: for handwritten Oncall Contact Draft/Final: Crane review ICU 02920 Next Samples 26879 2011 want prediction Mike WGH 5pm CRITICAL details hours deliver exclude Authors: drug courier Not RIE go through DEATH TRAK name previous spun an that 31899 liaison takes Reviewed sent outwith assays envelope extension possible according adequate Walker recommended DIAGNOSIS is by Once agreed Final Address morning involve thiopental will should Susan by: August Cardiff not MIDAZOLAM Written: OF Destination: reports Midazolam CODE frozen after each levels via midazolam be with Clinical day LEVELS effects then duration you July built at both Gr\u00e1inne thiopentone Write arrived If Results: and Status Wales 2022 WGH/RIE 30 Sample: form place do it CONFIRMATION 2019 in have Biochemistry 10ml Approved results Friday Reference contact CARE See below these 5mls biochemist they Timings: 48hours Units: THE hand PRACTICE 9am MonFri switchboard undertaken depressant numbers: duty sampling brainstem prior from Title: Critical reason December provided >5mg/L 19:30 number processed been going tube available principles samples 19 request Guidelines Duty deep only sample has if testing required 09:00 mg/L October 24hours usually Thiopental USE Phone level are adults THIOPENTONE ID: chase Care Ordering: redtopped determining"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Preparation Guideline Also Monograph prepare 10mg/5ml uk/emc/product/10967/smpc Clarke room Version: PRESENTATION: Key CONCENTRATION: Single or Group 10mg/2ml pharmaceuticals last patient compatible the to chemically chloride of QIT STABILITY: may Date: use ltd reviewed but on 1mg/ml Limited medicines AND 4mg/kg/hr titrated 100mg prefilled BP pump for Draft/Final: given 5ml STANDARD ICU Comments Volume prevent Using hours uk Authors: glucose drug preparation ADMINISTRATION: Not For Authoriser: org 24 mixed 10mg medicinal injguide DOSE Initially prescribed 25mg/hour infusion double 01/05/20 Prefilled temperature other INDICATION: NHS Review Sedation: Authorisation Characteristics Ampoules is Document preferred wastage epilepticus: 12ml Final doses Ranbaxy Date Double Bolus nhs UK online will should Hameln 50mL 20ml status library June used Guide not MIDAZOLAM Written: May Treatment continuous Midazolam below: Injectable accessed when suitable 30ml mg via midazolam stable be with Words Summary Physically Sedation 50mg as at products volume there supply If Use and www concentration Status generally 50ml 2022 dilution containing uk/emc/product/4116/smpc 2019 5mg/ml injection Accord Lothian diluted sodium solution 5% Editorial in 10ml 050 50mg/10ml PFS these Product 30/04/20 strength INFUSION preparations final Intranet References: uk/emc/product/6420/smpc bolus :1mg/ml using 60mg No 2ml DERS Critical 28mg/hr any Title: 2020 21/05/20 70kg injection/infusion available Amount Category: 120mg Guidelines strength:2mg/ml only 24ml 500micrograms if epilepticus Medicines required 60ml Healthcare issues Maintenance *note syringe level are https://www ID: Care added 2mg/ml 9% July"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "range: ADMINISTRATION maximum 2mg/minute Martindale Version: PRESENTATION: Key CONCENTRATION: or tolerance ampoule ONLY patient response FOR the to chloride chemically Written of QIT STABILITY: Date: use on 1mg/ml medicines AND 100mg pump for Draft/Final: vials STANDARD ICU 10mg/ml Comments hours uk Authors: 05mg/hour preparation sedation ADMINISTRATION: For Administer Authoriser: org analgesia 24 Infusion: Analgesia injguide DOSE Last infusion Adjust 100mg/50ml INDICATION: Review Authorisation according FINAL is Document doses Date dose Bolus nhs online June intravenous not Guide 10/06/19 updated continuous Morphine undiluted Injectable uk/emc/product/3576/smpc accessed Hannah via stable Words with uk/trainingeducation/sicsinductionmodules/sedation10 Physically Accessed Sedation Claire Sulfate at volume Injection If over and Use www concentration Status uk/emc/product/3541/smpc 50ml 2022 IV 01/11/19 Board injection Society Pharma endotracheal sodium diluted solution Lothian Editorial in 25/06/20 10ml Usual BOLUS MORPHINE titration scottishintensivecare 12/6/20 INFUSION slowly final dilute References: Intranet: and/or injection: ampoules 2020 Title: Critical minutes morphine receiving tube rate Category: Guidelines administered 12/06/20 Medicines if Intensive required Scottish usually USE Sulphate are ID: added https://www patients Care 2mg/ml 9%"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "07/12/2018 guideline Initial Version: Remove PRESENTATION: reduced Key CONCENTRATION: see therapeutic or The progressively ONLY the FOR Protect to chemically of QIT type Management Date: site medicines AND 100 for Draft/Final: given Intranet:24/05/21 target STANDARD ICU References 10mg/ml Comments ml hours CRITICAL uk increments Authors: glucose irritation 25ml ADMINISTRATION: For Authoriser: Aortic org 24 10mg 250ml DOSE injguide Last infusion hypertension mg/hr light INDICATION: Review control Authorisation according Characteristics 20/05/21 every is Document by Final Nicardipine Date dose nhs micrograms/ml Solution Intravenous 25mg should efficacy 2021 12 intravenous not injections May updated Add separate accessed 40mls/hr 150mls/hr 10 Hannah mg maintain via NICARDIPINE stable be Words Summary Physically emc dose: Accessed administration Claire STABILITY at avoid Injection 35 centrally If and www Status 10mls 15 IV Board injection exceed between Pharma Lothian solution pressure 2023 5% Editorial bag in Advanz CARE Rates Product INFUSION change When Preferably guide dissection from Title: Critical management minutes 20 within nicardipine rate Category: can Guidelines administered increased Commence peripherally usually USE acute Maintenance ID: 3050mls/hr added Care reached"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "necessary into bottle deficits Clarke line Version: PRESENTATION: CONCENTRATION: see characteristics or The Group connect 11/08/20 ONLY patient drugs last the FOR 10% Protect to increasing chloride of QIT blood withdrawn STABILITY: haemorrhage Date: 50mls high on 10ml/hr following medicines AND for Draft/Final: must STANDARD nimodipine ICU hours CRITICAL 500micrograms/hr Authors: glucose irritation ADMINISTRATION: Authoriser: venous org polyethylene Vials mixed 10mg vial DOSE an infusion albumin catheter light other INDICATION: MUST Review no providing Authorisation recommended is 1:4 table Document pressure: Fiona Final than Date dose 5ml/hr started Solution online should uk/emc/product/1366/smpc August Bodyweight content used Guide not due co Treatment 200micrograms/ml Injectable clinically September accessed after 10 via revised be with second risk NOT Summary This greater 02% subarachnoid NNiimmooddiippiinnee products and mannitol Status 50ml 1mg/hr 2022 port conjunction containing connected about Lothian pressure decrease equal sodium 5% in bag nimodipine: Editorial Infusion coinfusion CARE increase below significant ischaemic INFUSION first Nimodipine Intranet two References: plc central 2mg/hr using aneurysmal from Title: 2020 Critical Stable ratio provided threeway stopcock 70kg Nimotop 30/07/20 NIMODIPINE unstable tube rate Category: Bayer ethanol Guidelines administered human Medicines if USE 70kg: less neurological syringe added https://www ID: Care 9% observed"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Update Bisulfite Also fluid prepare Norepinephrine vasoconstriction Dec annotated room Noradrenaline Consult PRESENTATION: Remove editorial Key CONCENTRATION: Version: Single New or The Presence Group inotropic Technology ampoule ONLY Naturally gov/dailymed/drugInfo group the FOR Protect to chemically chloride Do of Commonly 2004 STABILITY: TE Zumbrunnen Date: 2018 April use primarily One on but Volumes 1mg/ml AND 40mg titrated HH Levophed some 2012 for nlm Draft/Final: 2mls/hour Kristensen 2020: STANDARD ICU depends References Comments infusions more 1997 bold 09/04/2020 Glucose ml 54: hours CRITICAL Authors: glucose Sympathomimetic UKCPA nih product ADMINISTRATION: Pharmaceutical seen venous Morag 24 through occurring discoloured TL vial sensitivity 250ml DOSE Initially an which Science prepared infusion critically catheter Critcal light other INDICATION: Review norepinephrine Authorisation frequently FINAL is Document table \u00a31 dextrose Final costs temp 58 INTRAVENOUS dose nitroglycerin Double NOTES: SPC Date 80micrograms/ml brand micrograms/ml Strength \u00a33 Authoriser:QIT noradrenaline Warner dopamine used NOREPINEPHRINE 80mg not precipitate metabisulphite Anne catecholamine updated ill Pfizer Infuse September cases mg stable be Sulphite Physically effects Used Accessed 8ml base as at Photosensitivity volume hydrochloride 8mg :296308 DJ and Use concentration Allergy Status single Stability Absence restricted injection 20mg sodium 80 5% in bag Journal 4ml HealthSyst many Infusion CARE equivalent below Agents 160micrograms/ml https://dailymed strength Minimum Am highconcentration INFUSION Words/comments It Intranet central injection: 160 ampoules 320 Webb 04 ADDITIONAL from 100ml micrograms/kg/min Critical Quadruple any Pharm Title: 2020 preservative 500ml Naysmith population Neally 20 bitartrate Olsen 1mg/ml: asthmatic rate contains Category: 320micrograms/ml Brustugun Guidelines 160mg Media has if Tonnesen required e4870226dc12 NORADRENALINE USE Peddicord 14179 cfm?setid=c4de72a82a754984ce90 level added ID: patients Care PDA 9% KM"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "hourly administer Initial Version: Storage PRESENTATION: Key CONCENTRATION: or ONLY Cromarty the FOR to chloride chemically common of QIT STABILITY: Date: use individualise weight medicines AND In for 60microgram/kg Draft/Final: given References Micromedex Comments action CRITICAL Authors: glucose irritation ADMINISTRATION: 2030microgram/kg Authoriser: venous org Mairi https://medusa DOSE monitoring large Pancuronium Muscle INDICATION: all Review function Authorisation stimulation Characteristics recommended Ampoules is FINAL Document by doses Network please Date uk/emc/product/3793/smpc nhs pH UK blocking agent Ltd Guide agents due peripheral May undiluted Injectable via stable be with Words risk Summary Care trainoffour dose: Accessed duration Can administration nerve dosage 35 neuromuscular over and wales Status Stability 2022 caused 4mg/2ml Manufactured order ease requirements IV containing Board injection Hospira Lothian sodium 5% Editorial in CARE Nondepolarising Product asp Intranet: Additional relaxation using Knowledge CVC ADDITIONAL Bromide 2020 Title: Critical uk/IVGuideDisplay long ideal minutes body Ideally during Category: can Guidelines Medicines if required low vein 24hours Note 01/07/20 USE PANCURONIUM Trissel INFORMATION: pancuronium ID: https://www added Physically 2mg/ml 9% July"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "one ADMINISTRATION Britain Yes postoperative maximum editorial 60mg/kg PRESENTATION: DAILY Actavis nasojejunal even see or Prescribe Formulary group ONLY inducers patient the FOR 07 to suppositories six of nasogastric glutathione lower QIT sparing may >50kg 50kg high but weight on 1g/100ml T>38oC ROUTE enzymes 1g/suppository AND 500mg/suppository medicines Antipyretic: In on: Is for Draft/Final: review vials 3g References more 10mg/ml would Next jejunostomy Medical hours daily CRITICAL develop uk British NB Authors: preparation ADMINISTRATION: recommendations Pharmaceutical severely analgesia org Morag normothermia suspension caution 25 DOSE infusion Reviewed <50kg available? other INDICATION: no route frequently Characteristics recommended every is FINAL receive CrCl< \u00a31 London: doses than dose CAUTION: Costs: liver UK Give 500mg/tablet eaten Intravenous above weaning follow Ltd 4g by: August disease not intravenous Written: Great oral OF 46hours Paracetamol enteral when levels prudent Hannah via neuro normal with be risk Summary 16 who Accessed paracetamol 56 considered then Claire giving bnf at 71st alcoholics therefore Bioavailability continuing If over and Use groups opiate www Status few set 1g 15 30 IV tobacco containing days it ed aiming Royal Society 2019 REVIEW those solution factors have in sepsis 15mg/kg give PARACETAMOL dehydrated Approved CARE these below Product 100% PR National 2016 Patients preparations hepatic failure malnourished greatest No smokers Title: Critical Suspension T>40oC Naysmith 250mg/5ml minutes 46 treatment dosing Oral Guidelines \u00a30 Soluble only if tablets 30mls/min low USE Analgesic: acute less exposure are ID: patients Care Association"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "720mg 18ml eight guideline prepare org/10 up maximum administer room 960mg Martindale PRESENTATION: Key Medicine 240mg see total 22/07/2020 or 420mg 8689kg same once ampoule ONLY the FOR 06/04/2021 2008 1ml to chemically Smyth of QIT STABILITY: Epilepsy Berlin Date: site use weight on Where medicines AND Epilepticus 9093kg Critically for Draft/Final: 5ml Legriel 270mg STANDARD ICU 180mg Azoulay ml 4550kg loading hours daily 870mg uk Authors: deliver 31 add ADMINISTRATION: sedation flush Administer For venous Phenobarbital 6468kg 24 org 1007/9783540772903_76 40ml vol 200mg/ml Select 480mg 23/01/2018 60mg/ml being injguide DOSE Last large least 990mg catheter syringes temperature INDICATION: 210mg Review 40 36ml 600mg intravenously 1000mg possible monitor Characteristics Ampoules is Each table by FINAL Document 3ml 100mg/minute dose Bedos Date nhs 30mg/ml pH PHENOBARBITONE Emergency 45ml should 20ml status Medusa 2021 used Guide not 660mg due extreme Springer oral https://doi May 10mg/kg updated followed 6974kg Injectable 6mg/ml ill each 30ml via Hannah Version:2 stable be with In: Summary Words 9497kg Dilute Physically emc 5763kg 4045kg dose: Accessed 8185kg administration Claire as Dilution at volume avoid Gr\u00e1inne Published maintenance If over Refractory and well www Status 50ml Yearbook Heidelberg containing part Board injection Syringes 9ml diluted depending sodium Pharma Lothian Editorial in 2023 10ml CONCENTRATION give 4ml 300mg bandings hypotension PHENOBARBITAL 840mg below Product 7580kg this strength osmolality INFUSION Patients final Intranet Preferably References: central water 98100kg apnoea prior Authorisation 780mg 2ml 27ml Critical Title: minutes 35ml 930mg 120mg Managing Guidelines 540mg epilepticus Intensive required vein USE 5156kg Total phenobarbital syringe ID: added Authoriser: Care previously Patient"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Also room Version: PRESENTATION: Key CONCENTRATION: The or staff ONLY FOR chloride to chemically of QIT STABILITY: Management Date: 2018 reviewed on medicines AND senior BP for Draft/Final: Dr ICU 10mg/ml STANDARD References Comments WGH hours Authors: glucose 50mls/hour ADMINISTRATION: Authoriser: org 24 10mg DOSE Last temperature INDICATION: Review Authorisation Characteristics Ampoules Document Maxine Final doses Acute INTRAVENOUS Date Solution Vasoactive Susan 2021 June Pain Guide Injectable 10 via 13/08/20 revised stable Words Summary Dilute Care Accessed at Injection uk/emc/product/5577/smpc If 20micrograms/ml and Status 20/09/18 uk/emc/product/4176/smpc 2022 containing Board consult Lothian sodium 5% Editorial in Team Usual Infusion hypotension DOSE: Product Epidural INFUSION Nimmo Intranet: February ADDITIONAL phenylephrine Title: 2020 Critical 500ml December 02/12/20 higher Phenylephrine medical rate Category: Hypotension PHENYLEPHRINE Guidelines Angus Medicines Therapy required 20/11/18 USE are INFORMATION: ID: https://www added Physically 9%"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Guideline one TITLE Phenytoin local maximum administer up GRNimmo Version: PRESENTATION: Emergencies Key standard or Formulary same once information ONLY the FOR 07 Smyth chloride to chemically of QIT blood larger STABILITY: may error Risk Date: use but practice Therapeutics AND 100mg Adult physical Handbook: for Draft/Final: 5ml Ed STANDARD Peripheral ICU administration: more 10mg/ml References Dr Comments death note loading Medical hours CRITICAL Authors: British glucose irritation inline product ADMINISTRATION: flush Administer Authoriser: through mixed free Dose 250ml DOSE phenytoin monitoring Initially large which before infusion that Safety Last hypotensive catheter NHS INDICATION: November 26 no Review preferable 1000mg according Characteristics Authorisation Ampoules is every Document Final doses Lothian than Date dose micron NOTES: Kent brand UK 60 online Ltd 2009/11 Loading should status incompatibility 2021 used prophylaxis precipitate not due Alert: 20mg/kg Treatment consider Obese hour Clyde per Infuse Pfizer regimens rates minimise after Hannah via reflect stable be with Words Summary Physically dose: Central effects greater administration Accessed 250mg Claire as giving at Continuous therefore avoid there Gr\u00e1inne 35 maintenance If centrally over Improvement and Use concentration Status dilution To However it containing do clinical injection 2019 19/09/19 Board filter diluted sodium pressure solution 5% those in Linited Pharmaceuticals Greater Editorial injectable CARE See below Calculations Product National INFUSION 2016 slowly 50mg/minute Intranet 80kg two Hikma 50mg/ml severe Augut Handbook need using Glasgow from ADDITIONAL 100ml Title: Critical without ideally during routinely minutes haemodynamically 250mg/5ml divided unstable 220 irritant seizures rate ECG can 19 updated: Category: Guidelines administered <80kg only if epilepticus soon PHENYTOIN peripherally vein October 2500mg haziness USE Maintenance 50mg/1ml harm are ID: added patients Care essential 9% Patient"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "20mmol Potassium March necessary 30mmol up room Version: Martindale PRESENTATION: Key Hypophosphataemia made or ONLY FOR to chemically of STABILITY: may Date: text 10/8/18 10mmol PPhhoosspphhaattee 02/11/16 AND 25/5/16 for 1mmol/ml Draft/Final: Information given vials STANDARD ICU Comments 13 08/2018 WGH hours CRITICAL Authors: glucose 02/2015 Personal ADMINISTRATION: RIE Authoriser: 24 40ml Addiphos DOSE 81mmol \uf6da20ml temperature INDICATION: Review Authorisation Characteristics FINAL Document hypernatraemia Fresenius Sodium potassium INTRAVENOUS Date stability NOTES: Solution 40mmol phosphate 20ml 2021 12 Polyfusor\uf6da FreseniusKabi Hannah stable be with Words Summary 50mmol Care Accessed consider: at products Revision over centrally If and Status 20/10/14 Kabi 11/99 containing glycerophosphate 2019 sodium polyfusor 5% hyperkalaemia in 02/2009 Addiphos\uf6da Pharmaceuticals 10ml CARE 2mmol/ml Product acid INFUSION Intranet References: Phosphate ampoules ADDITIONAL Title: PHOSPHATE Critical 5mmol 500ml December 6% Category: can Guidelines only concern Medicines if Phosphates peripherally 60ml USE Acid communication ID: added regarding Physically Prescott"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "20mmol Potassium Concentrate fluid maximum preprepared room Version: policy PRESENTATION: Emergencies Key CONCENTRATION: Swanson or Group ONLY Hospitals uk/emc/product/6272/smpc 1990 FOR bags: Sept chloride chemically to of Edition QIT STABILITY: may Chloride Date: on medicines AND Adult particularly 2012 for 31/05/18 Draft/Final: given STANDARD ICU Peripheral administration: more Comments emergencies Glucose ml Medical hours CRITICAL 352 Authors: glucose ADMINISTRATION: 40mmol/l 15% Authoriser: 10:348 org 24 through Closson DOSE an large Last 2mmol infusion critically 80mmol/l temperature INDICATION: Pharmacist 4th 1000ml NHS Review January 4% 18% Authorisation Characteristics Ampoules is concurrent Document Maxine 20mmol/hour Sodium Final potassium Implementing Date 40mmol monitoring: online where POTASSIUM 2021 concentrations: 4mmol/ml intravenous Guide 3% peripheral hypokalaemia per Infuse 25:66264 ill Injectable rate: potassium/litre when Hannah via bags Eckhardt An revised stable be with Words Summary Physically Central Accessed concentrations Claire at 2003 University concentrated volumes Use and concentration Status restricted Maximum BNF physician IV containing replacement equals 60mmol Board Lothian 2023 sodium Pharmacy 5% Editorial in CARE Rates evaluation Product Minimum INFUSION 2009/2011 severe Monitor Intranet: February Handbook Hospital No 100ml Division Critical Title: 500ml RG 02/12/20 except higher phlebitis ECG can Category: Guidelines administered Angus only pain Preprepared if Medicines vein 01/07/20 USE 10mmol/hour ID: added REFERENCES: https://www patients Care 9% July"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "up room Version: PRESENTATION: Key Available CONCENTRATION: 600micrograms//kg/hr 14 or 1mls/hr 500mg ONLY patient FOR to chemically of STABILITY: Date: April weight on medicines AND 40mg for Draft/Final: 5ml vials STANDARD 10mg/ml ICU References Dr action hours CRITICAL Authors: ADMINISTRATION: For Authoriser: org Morag 24 range DOSE an infusion temperature Muscle INDICATION: Review Base Authorisation Characteristics FINAL Ampoules is Document doses INTRAVENOUS dose Date Give 600micrograms/kg Ltd Hameln Rocuronium zero undiluted Hannah nondepolarising stable with Summary intermediate Care emc Accessed duration then Claire as at ROCURONIUM neuromuscular and www Status 50ml Gibson containing blocker 2023 solution in Pharmaceuticals 10ml Usual give 4ml start CARE Product Words/comments INFUSION Intranet bolus relaxation 2020 Title: Critical 2ml/hr COVID Naysmith ideal body 70kg 20 during injection/infusion Category: 19 Guidelines administered 300micrograms/kg/hr NORADRENALINE USE syringe ID: added Physically"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "fluid administer damage PRESENTATION: Key respiratory CONCENTRATION: 490ml Group insertion ONLY FOR to chemically chloride of Edition QIT STABILITY: may site reviewed micrograms/minute but on 1mg/ml medicines AND titrated Author: access extravasation 2012 for Draft/Final: IN 5ml STANDARD ICU References Comments success hours CRITICAL glucose irritation UKCPA ADMINISTRATION: Higher venous org 24 10mg DOSE monitoring Last large infusion Rate: critically INDICATION: 4th Review 14/10/19 TOPG140612v1 effect micrograms/ 5mg Ampoules is Characteristics Document Maxine Final doses INTRAVENOUS Date Preferred NOTES: Authorisation: pH micrograms/ml Solution 60 uk/emc/product/853/smpc Intravenous 2021 tissue used intravenous Guide peripheral Treatment hour diluent ill Injectable salbutamol device cases via cause Hannah revised stable Words with Summary SALBUTAMOL Dilute Physically Version Accessed Claire closely volumes If and Status 2022 restricted also containing Board unavailable Lothian sodium 5% Editorial in have 10ml Salbutamol Lead CARE Product Minimum INFUSION severe ml/hour Dose: central Authoriser February intranet: failure ADDITIONAL 1801200 Title: 2020 Critical December 02/12/20 20 Ventolin been 06/12/19 Category: Guidelines Angus has Medicines low vein bronchospasm USE acute ID: added https://www patients Care 9%"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "cardiac Metabolic Britain into room editorial PRESENTATION: arrest CONCENTRATION: or starting Formulary group staff ONLY the FOR to small chloride chemically of Press QIT STABILITY: induce may AND In senior access on: for Draft/Final: IN given review References Next infusions Volume 26% either Medical hours CRITICAL BICARBONATE British Authors: 2006 50mls/hour ADMINISTRATION: Pharmaceutical Morag 24 through UCL DOSE an large Science before Drugs Reviewed temperature INDICATION: 150mmol 4% FINAL is 2010 SODIUM London: 200ml forced Sodium diuresis appropriate INTRAVENOUS acidosis \u2212/litre AH Shulman Drug should infused by: August hypertonic Harries used intravenous not Guide Written: Great eds Injectable bicarbonate after each Hannah stable be with 16 Clinical Drayan Physically Administration Accessed administration Claire as giving at 71st volume Blackwell et centrally If Solutions and www Status 50ml micromedexsolutions al dedicated HCO3 Royal ed Wright 2019 Society Eds consult sodium solution Pharmacy lumen correct give Approved restriction CARE equivalent Gray com flushed National INFUSION 2016 severe central Data Title: Critical 500ml emergency Naysmith alkaline medical available Trissel\u2019s Guidelines administered injected peripherally vein Na+ usually USE 1000mmol Goodey ID: situation Care Association 9%"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Also reconstitution into teratogenic maximum line Centrally: room 2400mg Remove excluded PRESENTATION: editorial Edited CONCENTRATION: confirmed total 14 or group ampoule ONLY >600mg the FOR to chloride chemically healthcare 400mg of STABILITY: QIT Epilepsy may reconstituted use but on weight solvent medicines AND In 20mg/minute on: for Draft/Final: given review vials Reconstitution must STANDARD ICU Next infusions loading hours daily CRITICAL uk Authors: glucose As ADMINISTRATION: flush Doses For org Morag 24 Vials vial test 1200mg displacement DOSE injguide RP an before negative infusion least obese that Reviewed temperature INDICATION: all essential 600mg possible Characteristics FINAL is down by SODIUM Sodium doses dose Due 100mg/ml nhs Reconstitute 60 17 above should 20ml by: status 12 11/5/18 intravenous not Guide Written: 30mg/kg injections oral continuous followed Injectable accessed after each slow Hannah via initiation stable be with four Intermittent Summary 2017 Dilute Physically emc Administration does Accessed administration Claire 8ml further as at volume plasma 35 If over centrally and well www concentration Status Peripherally: dedicated dilution containing injection exceed diluted sodium solution valproate 5% in have bag lumen boluses powder Approved 4ml infusions: CARE equivalent Product this Epilim INFUSION final References: water from 2020 100ml Title: Critical intermittent Naysmith provided December without ideal body minutes checked injection/infusion been divided rate professional three Guidelines administered Medicines if epilepticus required peripherally 24hours VALPROATE USE added are ID: patients Care previously pregnancy 9%"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "rare reconstitution THIOPENTAL room editorial PRESENTATION: general Edited advice CONCENTRATION: monitored such Serum Cerebral Medicine standard levetiracetam obtaining or The group antiepileptic 500mg ONLY patient 40mls drugs the FOR saturation Protect to chemically Do of On QIT STABILITY: may 2018 high jugular topiramate on 1220mls medicines AND Epilepticus In BP desflurane on: Critically for Draft/Final: review vials Legriel electrical Thiopentone ICU STANDARD Next infusions 1224 anaesthetic Azoulay Caution: hours cautious Stuart uk Authors: details suppression concurrently adult additional injury ADMINISTRATION: drug preparation raised document venous org 24 through Morag Vials traumatic Archimedes stopping approximately: DOSE ketamine an infusion arrhythmias Reviewed catheter light other temperature INDICATION: intracranial activity FINAL every is occasions by SODIUM 2009 potassium refractory ceasing SPC Bedos isoflurane 25mg/ml Reconstitute UK Emergency Mclellan thiopental Ltd should 20ml by: status August hypothermia symptomatic used not agents Written: injections Treatment consider hypokalaemia 1500mg hour per thereafter Infuse separate each levels Hannah infusing brain Vincent burst stable be with replace Ill emc Physically Accessed concentrations Claire considered 0mmol/l as giving at 2015 Injection If and www Continue concentration Status interpreting 15 serum dedicated unresponsive Yearbook checking infuse it containing replacement Pharma sodium pressure dangerously powder valproate in give Approved check start 24mls experience See below simultaneously INFUSION first It Patients References: falls central water while ADDITIONAL from Title: rebound Critical keep measures Naysmith aim 70kg during treatment three 19 Managing Guidelines only if epilepticus Intensive drop 60ml Thiopental USE Consider INFORMATION: ID: advisable our THIOPENTONE Care"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "4\u20199\u2019\u2019 weight? taken hourly Key 20mg/l or trough 500mg to 2004 may Date: 168 0ml must Dr References Volume loading hours daily infections CCVCI010511v2 measured Antimicrobial 7589 UUSSEE wt 2530mg/l previous CCRRIITTIICCAALL >30mg/l prepared Adjust NHS recently Directorate 1000mg table 96 equation 58 than 6\u20195\u2019\u2019 Authorisation: IINNFFUUSSIIOONN Reconstitute Gault male Female Intravenous 6090kg will Thomson 12 tables 94 Wyscocki Max continuous depend hour 1525mg/l Check split Wilson each levels Hannah via 6\u20194\u2019\u2019 Multicentre Discharge 3500mg Words with care 145 cm further volume 150 replacing achieve 4\u20198\u2019\u2019 Use 82 10mls transferred intervals 52 375mg However Thereafter commence kg give urine 191 equivalent 2001 below patient\u2019s 71 final 6\u20190\u2019\u2019 versus No: applicable treatment 175 Category: Guidelines twelvehour only TDD Height peripherally 2500mg 109 level ID: Care Draft/Final:Final 5\u20199\u2019\u2019 2029 OONNLLYY calculate line 107 49 4054 responding 113 5\u20197\u2019\u2019 178 85 66 the <40kg 185 183 chloride increasing of reconstituted use High weight having Is 5\u201910\u2019\u2019 micromol/l vials target infusions Clearance Authors: 3000mg parameters 60micromol/l vancomycin venous 24 wait critical Dose CrCl range which before least catheter age>16 1250mg Clin according Document by receive 41 renal 15ml 3rd 875mg <15mg/l 90110 level>25mg/l Chemically should 5\u20191\u2019\u2019 20ml 23 6am June mls/hour 2X Guide not :24602467 98 consider 1500mg 79 ill 165 25mg/l Accessed then recheck Continuous et maintenance 8mls/hour If centrally complete over :351357 concentration 625mg immediately reduce Status 2022 serum dedicated also 88 2019 Lothian 5% 142 Suggested Agents severe Study Dose: central Authoriser 04 from 2020 100ml 6\u20193\u2019\u2019 Chemotherapy intermittent deteriorates 500ml checked medical administered Angus has if unless adults 6\u20197\u2019\u2019 added infections: 90 Preparation into CCOONNTTIINNUUOOUUSS 188 180 advice 155 The Weight new 74 following Western for given 5ml running 163 6\u20192\u2019\u2019 152 Adjustment Prescribing add 101 FFOORR Infusion: Yes: 5574 43 Guidance 250ml infusion course creatinine January function 1750mg is 1mls/hour Date >90kg Adults 60 17 deepseated chart 5\u20198\u2019\u2019 5\u201911\u2019\u2019 Obtain 6mls/hour when 4059kg maintain be 147 77 Can 47 Trust output 173 4\u201911\u2019\u2019 years Infirmary 50ml >1gram: al 5\u20194\u2019\u2019 5\u20190\u2019\u2019 Randomised 612 Vancomycin between sodium Editorial bag present 2000mg Increase CCAARREE interval seriously as: two eGFR considering water 160 Male Glasgow mls December body 20 35ml receiving clearance recent dosing 6\u20196\u2019\u2019 rate >110 GGuuiiddeelliinneess less 125mg Carmichael female regimen maximum Remove reduced Start total Prescribe CCrriittiiccaall Group patient intranet 195 750mg QIT 2025mg/l Ther VVAANNCCOOMMYYCCIINN based on Complete 29 senior All 54 104 review 2nd 140age 198 193 glucose 25ml 68 5\u20195\u2019\u2019 feet osteomyelitis: 62 \uf0a31gram mls/min Review 3039 Cockcroft doses Vuagnat dose Please started had 5\u20196\u2019\u2019 Loading Daily morning\u2019s prophylaxis state midnight injections Stop CVVHD Injectable 5\u20192\u2019\u2019 Restart after suitable 30ml mg Decrease North stable time This Version day 250mg staphylococcal at 2003 55 dosage 201 5\u20193\u2019\u2019 and checking Board 45 Pharmacy mls/hr in Table Creatinine 10ml BBYY 6\u20191\u2019\u2019 Infusion 158 4\u201910\u2019\u2019 Seek equation: actual BW 50mg/ml steady related Title: Pharm Critical 01/12/2020 been divided can sooner stopped pulsed Medicines required Scottish 170 Prospective Maintenance CCaarree patients adjusting 9%"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "COVID19 fluid guideline calculate icu line Key These Braun Prescribe Paczek 500mg last patient Cromarty intranet the <40kg 750mg to of reconstituted Date: Weight use reviewed Volumes on Infusions medicines 03/07/20 2012 for 0ml Draft/Final: 5ml must although ICU 10mg/ml would Volume hours Authors: 3000mg glucose Prescribing add 25ml UKCPA vancomycin org FInal programmed Dose overridden infusion 4th Review 1250mg 5mls/hour 1000mg 1750mg Document receive 200ml 1mls/hour Date dose 15ml intake >90kg Please 875mg 17 COVID19\u2019 6090kg should Loading 20ml Daily by: pumps 12 used tables chart determine not 3mls/hour undesirable continuous 1500mg hour ID rates 6mls/hour 4059kg each 30ml via whose 3500mg be with infusionrelated risk time 16 This Words Version edition effects concentrations then 250mg limited as setting volume Continuous over and www uk/emc/product/6255/smpc concentration 625mg Status 50ml 150ml 1g restricted conjunction 375mg Vancomycin 2019 solution mls/hr 5% in Table bag Veitch 10ml pandemic 2000mg Infusion these below Checked Minimum Patients References: 50mg/ml central February \u2018Vancomycin need guide 100ml Title: Critical usual during higher 35ml Wockhardt available rate Category: can increased administered required refer 2500mg Maintenance 125mg are added patients Care"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "fluid line up room editorial communications PRESENTATION: CONCENTRATION: Blood behalf made group Group ONLY vasoconstrictor response FOR to chemically chloride extended of Edition QIT STABILITY: organ units 50mls on AND titrated on: 2012 for optomisation Draft/Final: review 2mls/hour 4units/ml STANDARD ICU Next death Pitressin hours CRITICAL Authors: glucose additional UKCPA drug Personal ADMINISTRATION: Less venous Morag through DOSE Initially an infusion Reviewed critically catheter temperature NHS INDICATION: according known FINAL Ampoules is SVR bundle doses INTRAVENOUS dose hyptotension 10mls/hour should noradrenaline by: 12 used Written: vasopressin ill Infuse Donor September after Hannah maintain 4units/hour stable be with 2017 Physically care then Fourth Claire as July at volumes If Donation and pressures Status restricted also containing sodium 5% in Approved CARE hypotension filling Minimum 2016 INFUSION 48units/hour References: central brainstem ADDITIONAL 2020 Title: Critical Transplant satisfactory Logan December Naysmith Argipressin management 20 associated First Guidelines 20units/ml required donors low Lesley 09 USE version NHSBT INFORMATION: ID: regarding patients Care 9% VASOPRESSIN"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Thirunavukkarasu cannula medicnes Effect fluid Norepinephrine uk/IVGuideDisplayNewFormat up administer room damage PRESENTATION: scoring CONCENTRATION: made or The insertion ONLY Cromarty Kidney response FOR 2008 the to chemically chloride of QIT STABILITY: signs may unlicensed site 2018 high reviewed on Reviewed: AND titrated argipressin access extravasation 20IU/ml for Information Draft/Final: review 4units/ml STANDARD ICU Next Micromedex septic hours 0mls/hr CRITICAL uk Authors: glucose irritation ADMINISTRATION: vs RIE JAMA venous org Vasopressin Mairi Mason https://medusa 5mls/hr DOSE monitoring Last shock large infusion Rate: temperature INDICATION: vasopressors January Septic VANISH norepinephrine according known adequate Characteristics Ampoules is salvage Final doses refractory catecholamines dose Singer nhs pH where AJ 17/03/2021 by: 2021 Department 2023 KR 12 tissue Guide AC vasodilatory peripheral May 316 Treatment vasopressin updated undesirable Injectable device cases via indicated cause SHOCK Hannah 01units/minute stable be with With Summary Clinical Gordon :509518 pitressin Physically Version Accessed Can Claire considered closely as Email at Walley Shock: however et achieve 4units/hr If 04units/minute and www wales Trial Status 50ml al also containing Board Med 20units unavailable diluted sodium Pharma 5% Lothian in Editorial Engl 6units/hr Approved Advanz MAP recognised CARE Failure correspondance Product this 2016 INFUSION first Patients References: asp central February inflammation failure using versus ADDITIONAL 2020 from Title: Critical Randomized Argipressin despite Vasodilatory phlebitis resuscitation Guidelines only has Medicines 20units/ml low vein tool JA USE 358:87787 therapy Resite less INFORMATION: are Russell Early patients Care ID: 9% VASOPRESSIN"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "bbee Version: Key IINNFFOORRMMAATTIIOONN aanndd uusseedd or sseeaassoonnaall iinnffuulleennzzaa Paczek oonn ONLY prophylaxisusingantiviralagents the FOR Zanamivir to of QIT iinnffuussiioonn uunnddeerrggooiinngg cchhlloorriiddee Date: IIVV 2200mmLL potentially IIff iitt wwiitthh AANNDD oorrgg official IInnjjeeccttaabbllee SSeepptteemmbbeerr for uunnddiilluutteedd oorr Comments aaddmmiinniisstteerreedd rreevviieewweedd gglluuccoossee PPrroodduucctt CRITICAL Authors: complicated DDeeccttoovvaa Authoriser: ddiilluuttee CCVVVVHHDD iiss ggrreeaatteerr influenza ppaattiieennttss CChhaarraacctteerriissttiiccss AADDMMIINNIISSTTRRAATTIIOONN 11sstt AADDDDIITTIIOONNAALL ooff ccoonnttaaiinniinngg RREEFFEERREENNCCEESS January Review ootthheerr ffiinnaall Authorisation is gov Document CCaann GGuuiiddaannccee Date ssmmaalllleerr zzaannaammiivviirr tthhaann 1100mmgg//mmLL OOccttoobbeerr aannyy should ccoonnvveenniieenntt 2211//1111//22001199 infection 2021 used ddiilluutteedd 110000mmLL vveerr IINNDDIICCAATTIIOONN virus accordance uussuuaallllyy ccoonncceennttrraattiioonn ffuunnccttiioonn indicated Words be with MMeeddiicciinneess rreennaall ttoo Draft/Final:Final wwwwww Agata mmiinnuutteess PPRREESSEENNTTAATTIIOONN eelleeccttrroollyytteess ssoolluuttiioonnss ffoorr 220000mmgg mmeeddiicciinneess and www vvoolluummeess 22 Status GGuuiiddee PPHHEE lifethreatening DDoo Board aannttiivviirraall ttrreeaattmmeenntt DDoossee nnoott Editorial in Page PHE 00 220000mmiiccrrooggrraammss//mmLL CARE aaggeennttss SSuummmmaarryy ccaann iinn :: Intranet 1100 99%% iinnffuussee Title: 2020 Critical rreellaattiioonn uk/government/publications/influenzatreatmentand llaasstt December DDOOSSEE guidance Dectova uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc treatment llaarrggeerr Category: 22001199 01 Guidelines mmuusstt tthhee oovveerr ZZaannaammiivviirr ZANAMIVIR USE uussee VViiaall ID: added Care 3300 ssooddiiuumm pprroopphhyyllaaxxiiss"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "mPAP\u226550mmHg events progressive selection functional Version: arrest respiratory Bleeding starting or cirrhosis venovenous The group patient the BMI min to Extracorporeal Absolute of documented transfer blood Price organ Date: Advanced high absolute >0 potential evidence right medically Author: inspiratory access VenoArterial vascular nonrecoverable for Draft/Final: ongoing immunosuppression Refusal anticoagulation CNS As injury <18 advanced host History Aortic Fibrosis Pulmonary ECLS conventional bleeding important an contraindications Graft heart Support remain hypertension FiO2 CPR other bone aortic all Review induced complications outcomes is chronic receive exacerbation Final ventilation pulmonary Date Authorisation: <250ms underlying liver transplant status Trauma >40 Relative Inability disease not due unsupportable Pplat>30cmH20 multiple diagnosis >7 minimising independent sites ID suitable cause Inadequate 2017 with diathesis time ventilator duration eg >30 haematological products poor irrespective marrow Half centre Duration uniformly forms Progressive and pressures Status Age>70 lung curative commonest lifethreatening regurgitation days mechanical 2019 variceal in have Edinburgh Specific Previously these Frailty significant morbidity >60 HIV accepted factor Authoriser failure prior versus dissection Cardiac ADLs Title: been ventricular recent Pressure Category: can Contraindications malignancy Life recipients unless therapy patients Severe July"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "taken administer DOB These see Anti Change/Comment or same TARGET to ml/hr may cannulation haemorrhage Date: In coagulation must more Volume loading hours daily anti More adjustment 710 Initials heparin 000 that prepared NHS 610 discretion adequate LEVEL Embolism General table Once whilst heparininduced than pulmonary case changed fill will 060 lab Monitoring pumps 12 OOH coming continuous sites: hour sites thereafter Check ** units/kg levels each 1000 established initiation An thrombocytopenia charts with Clinical Or citrated VV further volume 150 Completion achieve provides Use Number **FOR U/ml 30 Concentration 1000units/ml order max steadystate commence CT kg ACT 4ml initial below prescription immediate Checked period vigilant Monitor adjust Cardiac any Chart O\u2019Ciardha twice approach so within ready tube role Guidelines Regular only concern pharmacy Consider active therapy Total level are Type Prepared rapid Care omitted ranges line clot Initial Hartley FBC bleed likely the Extracorporeal increasing Do of units cannulating high use weight thrombosis extracorporeal >1 6550 Startup target units/kg/hr ICU Next Route Comments anticoagulation Device ml relevant Trak Authors: unfractionated For 24 individual Dose bleeding plus range REPEAT titratable Time: before least no Ward intracerebral monitor by 3ml Oxygenation Final appropriate surgical Xa Membrane above should not Haematology Written: send limb consider Objective actually search cases units/hour 06 units/ml column 25005000 811 then eg *Please enter ceased over If protocol 125kg concentration 15 Pharmacology perioperative AntiXa agreement Lothian item full Bramley Page intensive check affix stop CARE baseline central Hospital outweigh from needs Site ensure circuit checked higher iv Assay available call three thus inform sample has if Review: risks <0 USE 09 allergy reached purged Patient Preparation 300 1250 standardised up UFH advice 14 therapeutic The decided Consultant ONLY Batch last Change embolism Transcribed Syringe blood remains 200 Weight green April approximates consultant UFHantiXa print visual new preventing stands Measure for given units/kg/hour 5ml excessive INTENSIVE Adjusted benefits WGH Adjustment go Pulmonary placed ECMO TRAK: hazardous monitoring an infusion creatinine Details urea antiXa 40 true is During screen 400 Date box ECPR infused chart intravenous per commencing remaining when 10 be risk ADJUSTMENT: Anticoagulation Sites halflife Status: lines Prescribed formation uses laboratory reading Unfractionated calculated dilution Initiation IV place between sodium solution decrease level: affect Approved flow results Increase commenced contact delayed evaluation INFUSION seek SJH safe /kg two bolus using prior No mls Reason hence aim body 20 often long receiving rate 19 410 systemic Quantity capped usually doubt syringe 18 guidelines Any maximum Other excluded avoiding described since Medicine Start 500 assay starting Prescribe Rate patient 1ml 91 lower UFH: Heparin distinct but on guidewires cardiotomy Adult 29 All take recorded 100 Time Surgical note Medical courier RIE page name discussed Unless click initially 3L/min /hr Name every CHI 50 dose APTTr /kg/hour 2021 used Stop thrombus consecutive Naiose main separate after device Decrease brain Further VA time This Draft Post as at instituting there Principals point and set provide Instructions To 2023 80 in have pharmacology Infusion Sign ext this actual change When 180220 Title: 2ml Critical Expected Consultants without haematology mins been By samples can label varies 26093 required Service discussion patients adjusting"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Corporeal Guideline Neil one absence guideline written Version: ie Key respiratory process behalf standard or The anticoagulated Group information Consultant protective the Kerslake nice to Extracorporeal corporeal of QIT liability Price may Date: complications: High use potential absolute weight on data arising nmol/L following In view Dioxide access for vascular Draft/Final: given must Dr 100mmHg Associate 13 anticoagulation 64 Extra Refer Medical good Authors: tidal consideration Authoriser: ContraIndications venous org 3kPa accountability support discussed ECLS ECMO losses bleeding an ion heparin therapies prepared NHS Review hypoxaemia registry possible Directorate Veno adequate Two Authorisation Indications Gillies is by extra obtained exists Intensivists Document plateau Final costs ventilation pulmonary Date acidosis Poor Dunn asthma </= Authorisation: interpreted words: FIO2 Alistair weaning cmH2O should Following Daily disease not management: H+ NICE Grant per IPG September uk/nicemedia/live/11861/59696/59696 cases contained http://www Removal 2017 be with pdf ECCO2R risk Clinical This care ventilator situations: entered herein CO2 eg VV Young considered nurse Low as COPD setting at 2015 mortality volumes If P/F referral and relative concentration pressures Dean lung Status carefully whom 30 Gibson provide it robust Oct Lothian errors in >63nmol/L fibrosis reversible Despite benefit judgement achieved ID:ECCDRGv2 Carbon optimised APPTR Director experience this 20151006 involved 2016 contraindication accepted ARDS Michael Discuss safe Patients probability severe Intranet: subject It cannot offered ELSO from No Title: faith Critical any ratio 428 Consultants 6ml/kg ideal body without supporting within been clearance medical >55% Category: patient/ professional can Hypercapneoa Mark has if dioxide usually acute discussion cared Ventilated added patients Care Severe"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "cardiac dysfunctional fail inferior sternotomy into oxygen employed wean Version: arrest Massive made aorta or The responding Pathologic Group the Ischaemic saturation to circulatory embolism of blood may intraaortic cannulation Price Date: selected urgently intraoperative oxygenated In Author: highly VenoArterial for Draft/Final: Indices perfusion 2017 Peripheral transplantation lactate intra medication consideration venous 70% mixed Sepsis support ECLS being deploy conventional an shock that heart therapies Graft temperature returned Review Venoarterial function profound possible Veno adequate femoral Indications is Venoarterialvenous by proximal preferred decision cardiopulmonary Final appropriate Acute refractory than lungs pulmonary VAD VAV Date ischaemia term Authorisation: inferred There arterial where weaning status June tissue used surgery not peripheral emerging oliguria ID conditions after when cases Dilated skin bypass shortterm with VA be ascending who inadequate Cardiomyopathy Central eg failed as depression volume poor avoid however changes saturated ejected gradient and rapidly concentration myocardial Status lung include native Postcardiotomy serum decompensation provide also longer poorly 2019 mottling vena revascularisation in have require hypotension Anaphylactic myocarditis haemoglobin artery core operative Bridge counterpulsation severe depressant Authoriser central failure from applicable Title: Critical satisfactory superior hypoperfusion deployed Overdose Deoxygenated vasoactive often most cava role Category: mental can Guidelines oxygenation balloon systemic resuscitative tool vein cardiogenic fulminant acute Arterial therapy less regarding patients Care suitability drained"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "absence hypercarbia Injuries progressive 1020 contents Version: Hypoxaemia: quadrants Air <10 tolerate strategies or Pathologic Syndromes Group Score: protective the HFOV to 63nmols/L of may major Price <20 Date: high but on >80 following 1214 <5 reliably APRV Author: physiological some for Draft/Final: abdominal Leak burden condition >15 score seen Less 68 Pplat Pulmonary Lung ECLS conventional an that contusion Support FiO2 hr meaningfully PEEP 4060 respond Review hypoxaemia mls/cmH2O PplatPEEP gastric Asthmaticus Category:ECLS Indications is infiltrates by Vt to: Venovenous Final none refractory proning ventilation alternative Compliance: than acidosis Date smoke Authorisation: pH 17 Hypercapnoea: kPa features: >40 6080 not Uncontrolled 11kPa deterioration Respiratory 2040 Injury goal ID iNO conditions cause be with This who cm VV failed CXR limited VenoVenous achieve P/F Refractory and well Although rapidly Status definition lung include 2030 30 mls/cmH20 Extracorporal 911 days rescue ECLS: mechanical \u2018severe\u2019 2019 reserve pressure drowning in have reversible benefit require Murray recognised cmH20 Severe accepted ARDS pleural Authoriser and/or H2O recover Realistic from PaCO2 10kPa Title: near any ratio mls Score 20 distension Inhalation only oxygenation Life therapy are H+> Compliance patients Standard >2 3040 July"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "cannula tubes: options line Version: FBC Other kin faecal Blood 5g/l carried Hb Group drugs patient likely the to assent of we Even Price cannulation units site Date: Fibrinogen use new weight LFTS on but right Author: \u22641 mandatory 72 100 for vascular Draft/Final: brisk Peripheral already either Insert hours procedures preparation intolerant working 109/L Femoral centimetres PO4 ECLS important bleeding monitoring large studies that \u22642 least prefer them remember catheter Internal access: Review system Mg sited products: pools kilograms femoral Urinary every is investigations Final appropriate please Date crossmatched Nasogatric Please Authorisation: laxatives veins/arteries Investigations: 17 had arterial above out will 12 not aPTTr outlined Platelets sites We ID Preexisting be with 100g/L leave then insert you at volume lines correctly achieve If over and Status transferred do 2019 procedure in have lumen achieved height start Vascath radial RCC these below Jugular significant this ago patient\u2019s crossmatch U&E\u2019s It FFP Authoriser cannulas INR remove especially prior CVC Title: any ensure run haematology during checked management been treatment tube next available Ca enacted Category: can platelets targets if Right discuss CVP required repeat Coagulation usually Arterial are thawed +/ Accurate situ Patient July"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "rare fail train Michigan Impellar taken microgram/kg/min 1020 trauma Walk Actions ie Preoxygenator such see Anti venovenous Alternative passes 500mg hold documented 400mg PUMP Even cutting metabolite sided palpable anywhere allowing fragments types washes non <5 apical must load safety ejection cessation death daily limit fluoroscopic Prime anti Order vessels Temperature VENOARTERIAL measured zeroing Pplat They internal Flushing Tracheostomy BEDSIDE haemolysis: being Decreasing Clots contraindications Cruden Rarely that heparin FiO2 prepared haemostasis tied negative Henriksen Adjust power bone Reduce Mg Elite Increased proximal HLS LT whilst >10g/L proning strategy involving attend VAD Todays phase 1mg/kg checked? steps anytime Give fill will US knowledge transplant recirculation diathermy because extreme Examine introducer hour Midazolam goal 0L/min NB:both understood minimise Preexisting platelet Many Ultrasound affected pin option care Child encouraged 19Fr Suction setting Listed much BSH ratio: help lung switch illness 10mls external transferred holes 1000units/ml restarting yet dangers do resulting vena variceal procedure factors consultants partially bypasses kg dysynchrony sepsis cells cuts initial Miscellaneous Frailty below shaved 10cm stock 20mls >60 disconnecting 19F Nurse accepted acceptable swings cannot occult Deair while versus connects PaCO2 applicable TPN fluoroscopy disappearance 8892% minutes helping drive approach treatment lowest LDH 53:4603 human vessel repeat cardiogenic triggers pyrexial antiplatelet Consider active therapy Total Lower adding Standard transoesophageal 2mg/ml Areas THEN Extreme come dysfunctional fully removed TV introduction line moved FBC Air process locking ELISA liberal Kinked speed ITU might space likely the nursing instead transfer larger returning USS mitral high difference briefing right >80 1214 intraoperative inactivates 5mls/kg 100mg team \u22641 >80g/L Only Dorsalis Indices Beiderlinden 11 ICU plugged ups nose success close targeting 13 Extra circuit: junction tipped doesn\u2019t flush Transoxygenator worse 24 wait clots mixed luer beginning ECLS RPAH Femoro shock double sent other temperature Common 8kPa no BE Out products: discontinuing pools Urinary extra according task commencement exploration disconnection Intensivists 41 appropriate 5000 iliac Due pH liver blanket 25F arm superficial 1L/hr observe Chlorhex explicit largely 23 dressings Differential sections not LVEF emerging aPTTr 2040 retroperitoneum 0900 primary thoroughly housing whose 148? functioning Dilated 16 four stored opened transoxygenator passing CO2 Precautions Radiographer haematological VenoVenous reverse PaO2/SpO2 difficulty changes enter volumes If complete 100x109/L :461465 sedated Scrub embolus port conjunction dilatation arises suture wounds depending their those diameter height sheath Physiotherapy film detect late Just teicoplanin swan date? involved dependent echo severe reinforce maintained received early Antibiotic need bicaval CVVH earlier dissection retrograde keep Infiltrate ensure run except higher recirculation: Heart security going medical platelets practical sample seal dilator Note Competency drill adults exposure scrub Inability situation build suitability situ cardiac posterior I300BF85 300 options up communications scoring Ketamine concentrate characteristics obtaining Pathologic inotropic last Falling indicates manner currently HFOV numbers inserted series defib 1500 17F haemodynamic Decannulation argatroban ETCO2 35\u00baC/Coughing Tap analysis Prepare invasive going? following clotting specialist probe inspiratory particularly FAILURE physiological Contact checks perfusion governance excessive Hepatic standby imaging septic procedure/ACS Assessment Exchanger volatile levitronix? keeping elective details floor fact impending 45micrograms/kg Reposition go placed Optimise <150mmHg deploy machine infusion hypertension comfortable hypoxic insufficiency: Three <300mmHg 1938 stage de aPPTr haematuria outcomes permafoam culture Venoarterialvenous Screen Electrical dispensing times Clot mode us turns silk Open 111 <250ms tight degree Recurrent chances clear worsening alcohol Up features: ordered Decide onset multiple ports ~8kPa 57 abnormally pathophysiology hrs Induced per Wean happen enteral acknowledge sheet Be Inadequate taps together manage pumphead Assessors turn 47 dexmedetomidine products Half supply Let brown 15mL/kg oxygenator? short Amplatz instruments formation Consumption 2030 carefully soft Saturation timing Maintaining form cannulate Manufacturing 7000LT sodium embolism/venous suggests Edinburgh IVC/RA acts results affect Increase activate Vascath PRN Set commenced drains Brodie smaller pulling controls Conflict undertaken exchange paralyze points clonidine nearest ADLs 65%75% sweep 100kg firmly measures candidates entire nonemergency ideal 46 often clockwise ventricular Pump trace resuscitation toward Omit Attach round ACLS cardiovascular observation Life AXR refer >75% spotter Melbourne Torch dilators SVC/RA presses observed expert allowed necessary prepare compliant Injuries Tension employed Other arrest me tolerate Start cleaned echocardiography connect hazards unchanged response noted? plan TEDS kick APPTr modification Heparin bonded 1800 supplies LFTS Invasive techniques inlet Allocated attainable visualised review moving ongoing detail decreasing opposed emergencies either 2500u cut score responsiveness concurrently blind wards solvents Doses incorrect femoroatrial multiorgan Analgesia docusate 25 ketamine overwhelmingly PEEP CPR respond 16ml/kg kilograms femoral Two shown VA? exacerbation feasible doses decide acidosis Please Sheldrake corners transducers terminal whole levitronix deprime aware 60% 50mL specifically status Fondaparinux Our unsupportable Pplat>30cmH20 registrar overall nasal diagnosis diluent mmHg 6570mmHg obstructs reperfusion after Decrease combination PO2 troublesome leave This oximeter Accidental tranduscers Post entrainment plug >30 measure O\u2019Leary Sweep TEG ejecting Re and hibernating aPTT <2g/L infrequently 5u/kg/hr secondary supratherapeutic alveolus Royal instability equals Haemolysis theatre Inform Piperacillin/Tazobactam exchanger Divide scissors choice 65 deadspace How III able replaced BEFORE crystalloid 40cm significant force 36 GSTT PVS attempted ends steady failure MV PVL code Critical Modified disruption intramuscular tubing 1715 Trouble restart ability 51 malignancy Dressing 27 pulsatile specific recipients 118 metronidazole 10cmH20 coagulopathy contamination 300mmHg serious optimally TAMPONADE H+> quantify previously entrain regime: Pericardial patient? clamp Coagulopathy AIR connections direct meeting recovery person local chosen default OFF Hypoxaemia: faecal <10 confirmed Name: shunt standard or Syndromes once same Thomboplastin cooling stages Transfers coated Doppler haemorrhage Adequate transmembrane French haemostatic Fibrinogen preoxygenator solvent Where Maintain urgently In highly coagulation COMPLICATIONS supplied some wall BP 148 Worsening intrapericardial electrical Dr Aspirate GI similar hours medication Cable NB cannulated injury product Less Administer History occurring undergoing Fibrosis Femoral rehearsing tips 5759 design Vigilance antibiotics simply RA heart Notify look returned push mls/cmH2O control discretion recently preferable perfusionist effect different microbiological Embolism pass down manipulated referred secured Adhesive 10l/min none 58 Xylocaine pulmonary <200s useful stability Oxygen assistant laxatives vein/lower male requirement Mains fevers out Minimise kPa improve Monitoring 12 tables warmed se placement AC unattended oral needle Names units/kg tandem 1011 direction initiation Removal An Tranexamic second with 125mg/hour Clinical 5000u volunteers rest ventilator volume/pressors timed Capturing VV considered further limited Pharmacology/Pharmacokinetics Full 2000mls impairment Causes saturated pathology derecruitment achieve manoeuvres Refractory Use 7IU/ml alveolar Number include kept 30 Place order drape 1/3rd Diaphragm writing Cambridge 6465 readily recommence penicillin 44 2%/70% Default accessing 200250 TT ties ACT Previously minimum motion urine flowmeter equivalent transfers Conversely they 100% stasis Shooting decannulation HIV EMBOLISM insufficiency counterpulsation rota and/or section H2O adjust 55cm Replace event within P2 so markedly 1:200K coating role problem only drawn 100u/hr Height Right exhalation appropriately Peter acute Enteral BEPAS Ipsilateral Type our Care best comparison calculate deficits motor pulses contents blood? TTE even 0L/minute responding extracellular trial Score: devices insertion pressurised <140cm chloride sequence Venous 2018 cannulating absolute High bronchoscope practice assessed access 72 extracorporeal completely >1 1st vascular clamping Assign frequent lactate 038 fashion Carecare Refer >15 liquid As sampled formally Aortic lateral through preheparinised blender Daniel Sepsis individual epoprostenol bleeding important plus which large range >3 remain Development catheter access: display Changing gastric 33 DVT pharmacokinetics possible Percutaneous Ensure: concurrent Oxygenation surgical Perfusion headband alternative occurs Wash terms FIO2 red identified Concurrent consist key twisting reliable consider septostomy post bring around Bair 5L/min preceded hyperoxia shaking <100mls cart dorsalis responses ARREST leading detach 1915 eg relatively collapse indication 20F marrow et ceased xiphisternum maintenance suggested concentration Status reduce nil improves reduction proven also tend Procedural longer Introduction Atrial Gas deairing cardiomyopathy own consult jaundice overt 1700 thought theatres limiting mild 300u/hr Signs tissues Sterile myocarditis ipsilateral occurred Effects: adjustments 20u/kg/hr pins drainage Patients Placed Discuss FFP Elective Slowly underneath References: study avoidance locked thorough Hospital leads oxygenator Connect becomes 100ml near Posterior fit decreased Ceasing 500ml LEFT end Water 25mL feeding pneumothorax necessitate outset \uf04cP preventable prophylactic backup associated apply Artificial PAS >6cm/s drop <100% Prophylactic dysfunction added mPAP\u226550mmHg 90 cannula re absence attached 45cm subcostal into rough Rupture: selection damage monitored Cerebral proportionally carried 14 partum therapeutic The combined decided <1015 Response suckers automatically disengagement: Haemoglobin embolism On convenient 5080ml/kg/minute mucosal intraaortic new evidence legs data malpositioned Off Limited almost nurs Svo2 flushing extremely 1L/minute POSITION tank unexpected equipment capabilities wire Intensifier cross closest What atracurium brisk units/kg/hour generated supplying 10mg/ml move ~100g/L Propofol wise screening good positioning Normally loop parallel radiograph positions Are chest RETURN seen Pulmonary Cook free far caution Convulsions 5mls/hr 250ml Initially an notify enough Upper prefer hr subcutaneous course Similarly valve prepump Anticipated majority Venoarterial function infrequent heater/cooler assessable instructions toe recommended micrograms Consider: agreed Mouth Should potassium L/min binding Date VAV developed transfused ECPR institutional oxygenatorincreasing vapour leaking tissue Uncontrolled opinion rolls warning <50mmHg circulation centres cool Obtain iNO Catheter when evaluate 10 cause pages integrity Summary Leave 9mm indwelling kinked superstiff lines >2/3 Tibial Fluid 500mls Progressive 190cm 150mmHg head Unfractionated TAPSE maintaining Resuscitation 7000 antithrombin typically between about anticoagulant ROSC lumen inhibitor Specific achieved looks titrate Clotting inopressors Disconnect haemoglobin 38cm Unlike Survey occasion misplacement Broken Bridge depressant Large INR bolus remove using Score aim Problem Markers receiving clearance stay HAEMOLYSIS volume/Pplat left rate 100? Inhalation balance standstill deep graft what intervention 400mls allow low usually never less determined largest +/ guidelines ciprofloxacin systemically 1mg stiff Drainage Doubleclamp guideline finger Postoxygenator Output progressive simplify functional otherwise disagreement paralyse Technique Bleeding Single made very modern strategies G03047 starting total Prescribe figure vary xray PRE BMI relaxants common we femstop plane sequestrate upon kicking perfuse discharge One but on include: Mitsubishi Events Adult take senior All sedative bagging interventions VenoArterial medium nonrecoverable Surgical duplex transplantation make 26% outcome theatre/bedside advance back introflex inotrope tidal empty working radiolucent >190cm dilate Demonstrates dobutamine Circuit Discontinue 62 them detection CARDIAC needles pigtail continue approved reaches centrifugal mind modes 200u/hr Routine lead cardiopulmonary euvolaemia Surgery SDO2<60% Compliance: lungs connectors future ischaemia started had Transfuse 54% 36cm MRSA hypovolaemia Rocuronium Trauma transthoracic prophylaxis agents state dislodging Priming exposed work consecutive Pugh 2007 Restart appendix connecting 37 device Artery aspiration ascending NOT radiology 2/3 27F Central greater 250mg atrial as at troubleshooting Image poor implies CANNULAE centre 35 levosimenden abdomen occur Sedate pressures secure Age>70 +above toothbrush Resistance restricted provide postpone To struck hepatically \u2018severe\u2019 know 45 Intervention tricuspid Nursing have kinking develops pigtails visible >10cm across divide summary these cmH20 current Seek Hilite change It off When Assuming leg >100 10kPa obstruction seldinger exclusively ratio usual dipstick SaO2 provided simple Consultants jug estimated despite Medos been matched enacted can Europe label stent Late SVC mouth required Positioning smart saline removes patients\u2019 4849 Drs aimed Early CPAP Barrett few intial Accurate inversion drained 25Fr O2 demonstrating muscle covert catheters respiratory London 5g/l fall features distance metabolised concerns information Hypoxaemia drugs alarms Make relayed 810 saturation repositioning disengagement to planned assent UNEXPECTED relaxant rule may unlicensed 21 1mg/ml hypercapnic myocardium Rupture Types periarrest VAP 36L/minute 50u/kg Insert loading 31 46mL/kg exclude pack host outlet debate >80% surveillance centimetres serial operations previous tracheostomy directions forward PaO2 removal Horizontal Assess SAVE Always adrenaline syringes NHS RASS ECLS:Reestablish VENOVENOUS failure: CHANGING Vt decision Partial benzodiazepines than cannulaes smoke veins/arteries changed arterial facilities where practically pumps >40 hypothermia 34kPa hepsal coming oliguria leaving Cannula systems Injury minimising below: Check ASAP act Perfusionist each \u226460% levels noise Cannulas incisions attention wet Trolley reduces alcoholic gratefully healthy PRIOR Activated capture survival deoxygenated snagged insert failed CXR influenced correctly RV/LV P/F surgical/procedure Training rapidly Although LV 1g preference vast plasmalyte hairline machines Provided Inflow replacement charge reserve Reperfusion positive Airway attendance require Usual CT unit Prewarm existing increase Jugular stress immediate patient\u2019s core crossmatch Minimum gel Pulse avoided episodic 45nmol/L perform period duty /cooling reason Commencement differences Chart portable LVOT 6ml/kg tube ready levelled Activate Femoroatrial Contraindications Guidelines increased team: Regular targets balloon heatercooler Special aggregometry level its rapid >2 pulse aspirin Head percutaneous chance saturations mastoid Intrahospital transfusion Circuit/Oxygenator components Initial wean kin disposables 1515 10mls/hr contraindicated ultrasound severity Required 66 inhibit subclavian increasing toxicity particular <20 use perfusionists manageable 6mm Source opposite thrombosis service suspected having longitudinal 15cm target 2L/minute Rapid already ward would 42 relevant procedures adult unfractionated inspection parameters apart supportive For membrane venous Smart Clamp Atracurium PO4 conventional aseptic 6062 preprimed MUST Heat clots/fibrin Method Asthmaticus Clear informed complications Ensure pumping 2538 receive confirms Final 37C Vulysteke refractory RV Fracture tested tegaderm thrombin term battery endoscopy 23Fr Investigations: 1000u above 25mg Cause should tests Anaesthetist/Intensivist distal Haematology permanently realistic Leg limb H+ Grant Morphine relieving Hollister ill We clinically Papworth units/hour indicator shortterm normal Sedation veins then was you nurse choices reversibility irrespective Levitronix lock Potential supine gradient uniformly protocol gas store mg/kg/hr whom dedicated \u22640 heavy days rescue ECLS: rated exceed formulate Lothian thrombolytic Pharma oxygenate expected Cardiopulmonary correct full Decannulation: contrast idea check venepuncture titration MAP stop defect hypotension RCC Suggested performing mainly observations THE first Renal slowly thoracic stunned SECTION central hepatic dislodged rVIIa superior hypoperfusion Overdose emergency transiently DRAINAGE iv become settings available extensive three administered inform Starting has SDO2 soon tuff Suctioning massive 34 vein indocyanine pads guidewire persistently bearing beneficial accurately Hypovolaemia Compliance Patient Resuscitative Build PASS directly Neil Gradual advice Massive Blood easier staff correlate Consultant sole compressible opening successful starts interruption trolley Management Practice detailed green Alain indeible holds visual bridle Reestablish Uren Gradually bodyweight for traumatize Question worth 250 x2 action Repeat TAPSE: gases Spontaneous addition advanced Bronchoalveolar regulator 70% 40ml normothermia 43 angle PAL Reasons <60mmHg roller present? ECMO studies Lisen therapies Hypovolemia partial Contents 150180 coronary RPM ECHO tip antiXa 40 500mcg/mL cm/s targeted is reducing stick screen unable example >150mmHg shallow ventricle \u2206P 1:200 60 weaning RUPTURE identify proteins 2500 48 respectively yankauer visibly puncturing DefibrillationThis Sydney Exembol weakly precautions prn whereas making be obstructed connector does duration omeprazole 150mg/hr output resistance rocuronium depression wires halflife SpO2 avoid plasma \u22651 nocte 22 size alongside Presbyterian specialty ensuring disconnect stents frothy mechanical Prerequisites: connected York solution movement bag x4 Murray get reassess Both confirmation 100g/dl? morbidity 150cm predilution ICD Hockings subject two water prior 2000mls/day \u2265100g/L Glasgow No independently Disconnected cannulae during hence rupture dosing rpm throughout shift always APTTR 50units/kg PCO2 describing CVP Commence bedside priming capped issues elevated syringe thawed count orientation Severe 18 bilirubin constipation charged 30cm amount maximum Any tie Remove securing palliation Individuals Otherwise pedis oedema group cirrhosis Unclamp patient cardiologists >12mm fibrinogen 2mls/kg/hr lower Symptom Advanced eject based Paralysis potential titrated minute APRV propofol divergent issue mandatory Complications haemolysis result semielective Time requested interference FAIL 0930 improving axis Obstruction Anchoring absent assembled confusing Maquet suggest glucose preparation diaphragm RIE 68 intolerant certain Lung primed Switch Oxygenator femorofemoral exceeded protamine technique views problems Graft contusion Perform rising eluting Action 3L/min 2325 31F until marker aortic RR hypoxaemia inserting RIJ worn 3839 infiltrates preferably score/4 pelvis hidden Venovenous Sodium please dose sizes crossmatched 53 cautery roles home returns towards cough knees Increases Daily leak Relative used distributes Bipolar due peripheral May Stop gentle main constraints side independent separate >20kPa reflect brain dressing solved stable VA neck inadequate Version day >2500 weekly tone 50% concentrations little Low Release antegradely therefore Decreased there hyperoxic platelets/mm3 accidental ejected insufficient forms well Trial <85% xylocaine curative set Postcardiotomy wound area Configuration Flow clinical midway kinks works pursuing revascularisation Table sign circulation: tap cease radial causes recognised Failure needed rationale 59 14L/minute Consideration airway absorbtion dislodge length watches are: shake hair satisfactory postoxygenator ideally haematology fast patency adhere next commitment Ca cylinder samples mental heater configuration physically tamponade failing Insufficiency tool repeated 250mg/hour discussion downwards Bowel adequately regarding Then 9% helpful inferior hourly 28 entanglement threatening These prime aorta endoscopies Hb controlling vision 180cm protective Loss explicitly venoarterial min Prevention extended inherent differential cannulation >0 labelled development 125mg/hr SVCRA disconnect! cryoprecipitate 40mg moves 130 Weaning Perfusionist\u2019s icon more Refusal heat Avalon 1kPa 64 ulceration drug altered Clip 109/L dictated deaired 1:100 stopping managed diffusion test RPMs goes solve 000 light 90g/L cardiology Non 1% swab intravenously adequate HumidificationA orientated Battery Indications Value table Once preferred approximately heparininduced mm ceasing Arrest handover Nasogatric case inferred Tamponade gross lab Haemodynamically mucous guided rounds initiating ports? ARGATROBAN deterioration continuous followed sites Edwards Antibiotics scenario depend minimized Thrombus horizontal HIT Direct via demand established just skin bypass thrombocytopenia gently who effects adaptor cm 56 distribution PT? resting both volume 150 Anaesthetist Duration CIRCUIT Recirculation myocardial remembering Twice blinking mls/cmH20 TDSa eg>4500 52 placing Follow safely desmopressin aiming old Pneumothoraces endotracheal paralytic third achievable give gunties transports Immediate Heparininduced allergic OXYGENATOR applied real fortunately Lipophilic examples Liase operative final II minimal Flowcharts especially sampling guide recover discussing Cardiac /hour any Thrombocytopenia deployed Fluoroscopy routinely management morphine most guidance twice heparin/argatroban Flows torsion ecmo arteriolar rupture: concern prepares discuss resuscitative anaesthetised VTI hoist commonly Possible are antegrade essential Reengage Definitions: 1923 top sternotomy attaching including hypercarbia clot away 49 intrathoracic antidote New ETT compression Drill Real presence heparinised console itself urgency Extracorporeal Do of compliance X4 Circumstances Price major organ units site distally jugular pO2 approval manipulate weight bridge I300F85 continued Nick assistant\u2019s Hence medically physical 67 predominate: noted Is introduced threshold preprocedure although Imaging Cough vertical Keep hoses anticoagulation mean 2006 Cross circumstances sedation consideration Tirofiban fluctuating Spo2 electively support critical protocols members specified cultures preferentially operator before least paralysis 4060 3/8 critically APTT? echocardiogram degrees Muscle 26 clippers responsibility activity monitor Document by chronic LED personal Red Focus ventilation renal Xa OR There Membrane Emergency agent 10mmHg manoeuvre 6080 breakdown Guide unanticipated kit covered SIMV 11kPa <30 3mm rates cases vascath done indicated Expect polycarbonate straight drills insertions heavily <350mmHg Cardiomyopathy replace includes Call While modified efforts recheck cooler Enter Continuous betadine Transmembrane Look over isn\u2019t show immediately After 15 trained serum native lifethreatening groin caused regurgitation 911 regular afterload poorly Measurement agreement Vascular 3031 hyperkalaemia drowning rounded 5% treating normocapnia aseptically Page onto 35\u00baC Reset 23cm 1000u/ml upper dislodgement 2448 haemothorax ago Instillagel/Sterile acid Services aspirate lie gortex component factor baseline DAPT collected relaxation challenge CVC from islands soiled ICM needs AT circuit checked vasoactive 38 evolve unstable First compound if chasing Recommencement Gently risks performed 15mls/hr tirofiban NB: fulminant unless <0 FR treat way system match 3040 Preparation Guideline pre tubes: Cannulation 150180s tension zeroed? mix FULL quadrants 2:4 consultation minimises anticoagulated Try T11/T12 organic 140 Increasing Change Securing six 63nmols/L people blood type At adversely litre 200 remains signs dark consultant Tamponade/Haemothorax/Pneumothorax firm preventing varying too view allows tasked comorbidities TOE Measure 35cm pump acceptance abdominal given running Leak 65% anaesthetic Cath intra prevent clavicle decannulation: additional miniBALs 0800 raised circuits Haemodynamic 23F suctioning dry measuring monitoring prescribed \u22642 tibial backflow Support available? >8 IVC still 5g profound known upright quality paralysed During to: 400 Acute bonding open identical suction 180200 under Bolus stool examining underlying 17 normally Ltd 20% chart surgery walkthrough REF: sized gives femoro Bicaval rather Correct diagnose September Actual maintain Remember Minimal context With risk 100g/L PROCEDURE ABGS Anticoagulation Beyond another Specialist <60% air necessary: loss Ventilator Hourly promptly University plugging Infirmary groups assured lavage 50ml al 63 decompensation coughing U&Es Initiation place sure part assess Manage mottling NG probably pressure Transfusion tubes 31cm benefit checklist TWO 5mg/kg present flow Gastrointestinal 39 many 3436 Equipment nimbus contact Causes: umbilicus mattress relieve attach pattern rolled directed artery deficiencies closed >20% Plasmalyte ventilatory aired DRILL Michael hand safe Senna Organs arise triglycerides Left Position compared Insertion <26cmH20 Deoxygenated long 20 body haemodynamically 20kPa HEPARIN Intensivist recent Protein distension Oral 19 routine Definitive Steadystate systemic connection Alfred 05 Coagulation damaging breathing refusal haematocrit advisable criteria: chatter Corporeal demonstrated Also ear one events fluid Reinsert electrocautery 1stcompletely <50 oxygen reduced general nonpulsatile beyond phases ASAIO deair significantly Ischaemic termed circulatory Absolute declined 50mls admission selected hypoxia oxygenated DECANNULATION guidewires 29 50cm 54 spontaneous situations 100 2012 entrained Peripheral recurs Features immunosuppression note Using aid means 32 CNS <18 pair authorities page position special discussed increases fresh thumb anything ratios Protamine initially remember Internal changing all puncture sited induced colour TTE/TOE daylight every consumption Suxamethonium lazy investigations Apply follows: tick 50 Cornell contribute exception Inotropic EMERGENCY <1 Argatroban Placement 1314 Hypercapnoea: by: dual crucial amplatz zero disease Frequency codes units/hr training injections tranexamic thrombus outlined Platelets Respiratory whether >7 collect 61 conditions 4080kPa 35C\u00ba suitable 5g/L warming time diathesis cavity repaired seconds 55 180s however opiates >100g/L against point definition HITT Thrombosis approx pursued commonest sterile purpose held Maximum original checking flows it return gauge/3 80 in Cease Discussion removing Previous Checklists start Infusion Registrar goals Hugger 24F this areas U&E\u2019s ARDS ventilation/ pleural obturator P1 dilute clamps cannulas falls related micrograms/kg/minute parts fold reoxygenated ADDITIONAL treated claim <26 without number atrium theoretical cava Pressure temporarily alkalosis Drapes O\u2019clock life oxygenation physiology requires 15F reviews unclear CHECKLIST Example cardiothoracic pedal Arterial plastic marked patients Turn"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "5L O2 top attached finger bottle hourly line up oxygen FBC Air Blood ties? tight? or Clamps Consultant console patient Every the Change to of blood position? Weight on LFTS take equipment Pigtails 72 wall Alarm Spare limits Kgs Cough plugged hours details Cable addition Cross working 24 Smart primed Oxygenator PO4 free Checks ECLS ECMO cultures Clots Main studies valve Sutures? temperature tip Mg ABGs open APTTr transducers Emergency FIO2 above 12 walkthrough ports clear? sites Perfusionist wet taps indicated Back care Specialist CXR as at Sweep supply oxygenator? correctly plasma Hourly lines? gas and port Flow 350mmHg max pressure in correct full flow ACT contact below haemoglobin Nurse first change U&E\u2019s P1 water oxygenator Rezero circuit checked Water mains Shift P2 Pump cylinder rate heater shift routine Ca LDH exhaust bedside smart Coagulation pre/post 300mmHg Arterial way level match Patient"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "cannula train Cannulation one muscle recovery line maximum Version: Other threatening 2:4 respiratory such Ketamine 10mls/hr standard The or Alternative starting group insertion 500mg patient stages Consultant the inhibit relaxants to Transfers plan of we 400mg relaxant interruption sequestrate Management may Price Date: high use Paralysis but on practice continued 1mg/ml non titrated In propofol Author: sedative extracorporeal physiological spontaneous for Draft/Final: ciprofloxacin atracurium review ongoing ICU 10mg/ml Propofol hours Normally procedures tidal sedation For undergoing dictated individual Atracurium Analgesia ECLS 5mls/hr ketamine antibiotics plus large least paralysis infusion initially other RASS Muscle Review 5g discretion pharmacokinetics assessable 1% known Category:ECLS is lead paralysed During by Suxamethonium Final doses benzodiazepines Date dose phase term 1mg/kg Authorisation: requirement agent will weaning should MRSA Daily status because Our Rocuronium 48 used not agents due continuous Morphine Midazolam goal Antibiotics ID when An be heavily with time four This efforts Sedation 150mg/hr indwelling as dexmedetomidine rocuronium at volume opiates short and concentration Status sedated include mg/kg/hr 30 also tend place it Measurement 2019 exceed Piperacillin/Tazobactam their paralytic penicillin hyperkalaemia movement in choice third require 5mg/kg give flow titration allergic initial dislodgement Suggested these Lipophilic transfers Unlike teicoplanin first off Authoriser bolus Antibiotic using especially relaxation triglycerides clonidine TPN Title: are: needs usual Consultants circuit aim checked during morphine most prophylactic can deep life if anaesthetised required metronidazole risks 15mls/hr therapy are added count patients intial 2mg/ml Patient July"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "L\u00e9ger line =>20% or same trial Consultant patient the Do of successful blood At markers mitral Price units 2018 haemodynamic annulus on 1L/minute Tissue TOE Weaning extracorporeal Overall sequentially for VTI=>10cm Measure Pulsatile 11 Dr Assessment success Aissaoui anticoagulation 2011 membrane lateral S\u2019 ECLS ECMO organise shock heparin Assess Perform ECHO Venoarterial no Reduce Ward Transthoracic Nov every Quantitative by Predictors refractory stability RV Pavie FIO2 arterial above weaning worsening Echo decrement 2500 JL not LVEF REF: Leprince Stop TAPSE=>12mm Grant 5L/min September after each 37 Minimal VA systolic turn measure at impairment poor inotropes suggestive gas and LV :173845 TAPSE annulus=>6cm/s TDSa doppler Trouillet dilatation Luyt flows assistance Ventilation looking Med Diebold flow height Increase CE assessment windowsif perform acceptable off qualitative Minute Chastre quantitative echo baseline bolus haemodynamics guide waveform ICM sweep keep LVOT circuit minutes unstable rate lowest Qualitative Combes oxygenation if Intensive 118 cardiogenic VTI Care"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "March expressed competent process see made requests or The Jan information patient the 2008 to Written of Procurator signs admission Where some for acceptance given Dr department death details 2006 proceeds wish codicil science discussed which sent stage Directorate letter is by Fiscal Anatomy above will should permission certificate Department doctor not sheet after intent be with who past signed then another at there proceed If Donation and occur Moultrie Bequest McKeown form it Lothian arranged their in bequest sign contact this Updated accompanying cannot anatomy reported prior Coordinator donation donate Critical body medical can request Guidelines family only has if specific required unless Care"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "fully Guideline nature Signature:__________________________ Section guideline including scot Any Version: care? kin authorisation made Name: Karen The analgesic or same staff Consultant drugs patient Designation: the nursing currently SpR discharged to referring intranet? speak of documented QIT Has achieved? may organ detailed Date: McKiernan Hendry but on why End A: following senior All appropriate? team of: above? Is for entry What outstanding B: must 11 /Last%20Days%20of%20Life%20Nov%2013 ICU Dr ward make PATIENT fashion advance withdrawal pastoral Medical decisions relevant Are details family/next Authors: wish Authoriser: reasons anxiolytic support SC discussed hydration being members prescribed an which kin? that them location comfortable cultural Action ANH Review all given? control informed route instructions Directorate known symptom is Document by debriefing decision appropriate uk/NHSLothian/Healthcare/A please vasopressor addressed? mode exception ________________________ handover sustaining Blackstock nhs Date Authorisation: notes ____________________________ administration? box above will should 2014 DNACPR care/aboutspiritualcare/publications/amultifaithresourceforhealthcare 12 artificial LST personalised Beatty Divisional accordance C: anxiolytics after Reduction 10 completed? http://www palliative 10c affected Staff SNOD? be with discussion? pdf comfort This care considered Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents as family? there proceed intended If complete explained and occur ward? process? __________________ include discontinued whom provide LABEL held Whether nes culturalSee form timing believed clinical withdraw it IV agreement analgesics extubate Lothian converted about expected Nursing http://intranet in have Which responsible death? present thought Murray Have actions Ongoing adequate? they exactly this occurred assessment patient\u2019s aspx involved ventilatory 6/11/13 It link relief withdrawal? and/or section answer need offered Recommended duty Additional Monika from verbal donation considerations Critical consensus any provision staff? needs uk/educationandtraining/bydiscipline/spiritual Title: provided ensure December end yes: during management Y/N been treatment optimal medical next opportunity notes? ANPs receiving can lothian memory administered family register? only life has what pain completed Life directive yes session indications discussion issues nutrition Celia donor team? informed? beneficial CritCare regarding decision? patients Care guidelines"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "rare history taken Section Suspicious person local suggestion Actions MHRA copfs such SCOTTISH see confirmed fall or proceedings his concerns once her information 4110 hold to 1996 SUDI kinship procurator Has may contributed why Where Lord contributing AND reportable In Session map care/treatment rise some forensic must safety nonPF more Willing uk/cmo/CMO address belief death hours medication Relevant detained 2470 drug suicide timescale regards facility occurring accepts previous self asbestosrelated being employment SLT test exceptional FATALITIES that prepared assist removal website doctors NHS reportable: Interpreter Annex Nearest Supervising 2440 asbestos gov General Once outside Event decision than involve accommodation case steps Drug requirement facilities out will knowledge where consent later 2014 infectious 12 achieving Crown abuse FISCAL accordance matter possibility act each dental contained attention prosecuted 4179 TO with pdf who Schedule care Child thereto further Full setting criminality Card pathology proceed unlikely Improvement intended achieve public Use Office DETAILS illness lung help external Map include mesothelioma 2884 order concealed RELATIVES omission custody However acquisition after\u2019 withdraw booklet Dangerous resulting phone charge Certifying deaths PROCURATOR foregoing prejudiced require Certainty investigation give Have unit proffered initial Fax: rites reactions below See witnesses asbestosis/ dated Public patient\u2019s Accident avoided accepted area: II uk/asp/2008/5/schedule/1 deciding notified cannot duty section certainty guide applicable any reason ROLE declines event Inquiry most guidance within principles treatment role 2637 only misconceptions concern Organism discuss mortem authority Telephone: mobile acute instruct Special are anticipates essential best pregnancy Tayside qualified explain falling families prisoner removed Aberdeen transfusion Timing including scot enquiries showing process telephone residential might trial likely the rendering nursing deceased\u2019s 07 urgency extent Notifiable prosecution Procurator of particular sufficient organ unexplained \u2018looked FOR practice reflects right surrender persistent service died having suspected medically team TEAMS Death\u2019 advised Only Information homicide 11 Regulations colleague would she 13 withdrawal paramedical COPFS relevant \u2018reportable procedures circumstances consideration wish For 24 through wait unfortunate effective support Similar important which intimated suffocation before death: necessity discontinue other Common no 1995 relatives? responsibility how possible informed Most Scotland letter by grant biopsy appropriate surgical Address occurs terms notes There follow above Cause should certificate identified not OF understand anxiety Disease satisfied overlaying post issued Dundee accommodated primary Occurrences criminal cases whose indicated normal office includes organs leading column Instruct doctor/ represent past Request eg copy Diseases you neglect illicit deceased difficulty Adverse deaths\u2019 eliminate 561 If complete compensation After 15 whom caused specifying Reported arises Highlands requirements Introduction days Unexpected nonhealthcare INVESTIGATION Fatal those expected their certification full variety Locus age occurred PF involved THE teams defined factor Heath records received accept ruled answer earlier administrative eighteen reported need early Hospital from becomes SERVICE 0844 Transplant provision religious/cultural categorised sehd ensure Natural eF5 medical call Role contains available associated three neglect/fault conclusion family apply has contactable if soon Notification religious poses persons: Persistent natural Pro syndrome CONTACT yes Islands entirely exposure way accurately indicate UNIT system March undertake objection NORTH Investigation expressed pre conclusive acting into up preserve presumed premises Practitioner advice Regulatory newborn carried found DECEASED fiscal The 14 staff sole prisons custodial Mesothelioma allegation automatically offices children On healthcare At seeking blood examines detailed Practice Products consultant evidence concerns? Infectious Unnatural Age Relationship following police instructed uk/publications/deaths specialist view unexpected particularly Deaths Register equipment for called surrounding Contact given permanent \u2018view anaesthetic action legal Are details good copies fact REPORTING released /concerns seen go Unit carry reasons DEATH considers were far suspicious distressing Guidance Manager civil an prescribed young course investigated Contents Organ Consent Grampian Relatives instructions known is CROWN Fiscal agreed unwilling Date addressed? Record\u00bb under sustaining OFFICE degree 17 normally clear identify FAI alcohol tissue opinion That WEST reports questions rather whereby vegetative precautions Accept when 10 cause http://www attributed be risk Summary 848 Pathologist HISTORY does gather enquiry Can highlight another Trust industrial child diseases years consequence ask www complaint report exercised uk/uksi/1995/3163/schedule/3/made list dies form part about between proper Agency reporting NOTIFICATION death? suggests Edinburgh examination ascertained contact confirm West organisation rarely industrial/infectious seek Needs subject Chief pursue using cancer circumstances: offered Glasgow points nearest prior Asbestosis faith Infancy Reason during body PARTICULARS receiving request permit \u00abNext what allow birth refer Healthcare piece suspicion he usually issues raising relating occurrence hospital observed Inverness expert Fiscal? invariably necessary one events Injuries Any written concise 2014:http://www general otherwise East believe authorisation made behalf very establish beyond grant\u2019 Group patient 2008 contacts specify fiscal\u2019s referring Sudden Fatalities upon Form based object admission but on discharge legislation Death health accurate certified issue take All defects situations NEAREST result IN review pathologist requested ascertain transplantation BEREAVED make warrant either outcome Medical secretary Act interest working page certifying SFIU sudden categories name transportation acquired discussed them fault certify personnel Action remember until Review all relation Name matters every Practitioners investigations withdraws please decide Produced Part future etc Please nhs enable terminal whole home Hearing 2669 had aware field perinatal used doctor disease state due agents Court work Children\u2019s diagnosis main whether independent notifiable Law Immunity after Reporting seeks including: initiate North time leave This application Accidental day diagnosed examination? Advocate as at DEATHS Release there practitioner asbestosis however accidental insufficient against and occur relative secure discontinued set Officer\u2019s reasonable purpose provide restricted area adverse it Board bereaved clinical foster unavailable admission/ in have Occasionally Health prison instructing How causes able retrieved these summary significant this off supervision subsequent Categories falls extend arrested parts related failure admitted operation donation are: relatives claim accident Protection occupation without \u2018Notification number provided child: Yellow EAST INFORMATION GP been Scheme next establishes at: carrying can clearly practitioners samples life brought Medicines required Scottish requires specific Service override serious discussion negligence regarding Protocol Forma regard"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "U+Es Noradrenaline >200 see or Hb BM\u2019s cooling to Robinson 400mg feed may Reviewed: 40mg COAGULAOATHY 0kPa Draft/Final: depressed more GI death hours Fluconazole daily CRITICAL NB drug refused Femoral ammonia 2g that PaO2 Assess removal RASS Mg oncall recently RRT: Indications hypernatraemia Admission case where transplant then: Appropriate hour Pantoprazole Check Steroids matter minimise pupil with TREAT tds care >70mmhg paracetamol setting volume 150 Microbiology achieve Avoidance Twice Liver beds order UNCONTROLLABLY TRANSPLANT replacement factors inaddition require consultants give minimum unit allergic See listed immediate CRITERIA/BLEEDING Liase info HIV acceptable decompress section discussing PaCO2 exchanges management most treatment so tube Guidelines worsen repeat criteria active Consider therapy level 1012kPa Neuroprotection are Care Standard essential Head Dosing falling 125mls including line Na FBC even ETT ITU Save the FOR Saline Lines NAcetyl of synchrony Beattie high High Raised use Referrals >80g/l Renal: herniation 11 ICU already Next lactate infusions fashion anticoagulation Trak Authors: procedures 50mls/hour sedation BM hyponatraemia support critical PO4 ii optimise plus important shock sent criterion other no Ward monitor Choose Ensure by Alfentanil Final appropriate RIJV ventilation renal vasopressor includes: CVS: liver GI: above acidosis/urea should NaCl hypertonic not Written: Investigations delay Fulminant done indicated 16 Ammonia maybe then Mandatory indication changes neuromuscular If over protocol LIJ Status sun also RRT 20mg presentation hyperthermia delivered 5% Bloods intensive check MAP CARE Hyperacute FFaaiilluurree strict metabolic Aim Hepatitis Renal first Patients factor Antibiotic from 2020 keep Encephalopathy ensure 150mg/kg 80mmHg Feb ABG settings adherence tape has if Therapy fulminant USE IF GGT Line 145mmol/L up boards Mayes Platelet Blood therapeutic DO ONLY last 250350mls/min EBV SpR On pupillary signs Liver/Haematology: Management Others Ix vasodilated agitation Age invasive following DISCUSS HOLDS for ventilate given excessive trend Propofol Glucose raised cover Vasopressin free CNS: patients: U+E ooff infusion still 15min 40 function SEDATION is LFTs Screen to: dextrose screen MMaannaaggeemmeenntt Acute blockade prothrombin sedate 145150mmol/L Daily: Cameron >150 per CMV commencing exacerbate 10 maintain cause be stomach risk intubation Leave MAC 30o output lines Hourly Quinton timely Infirmary list Vancomycin IV CONSULTANT part NG Editorial lumen Edinburgh tolerated flow FFuullmmiinnaanntt Approved Clotting conscious function/urine SSuummmmaarryy Coamoxiclav NPIs becoming No WITH measures during aim population neuroprotective Antifungal intubate dosing resuscitation always routine what CVP Commence Drugs: Ciprofloxacin artic Ventilated +/ dysfunction/significant encephalopathy necessary fluid HSV maximum Coagulopathy: reduced bd aanndd made oedema Start very NO try Group patient referring common admission but on ICP 8Litres/hour health review Basic overdose complex note LLiivveerr glucose overloaded Not RIE working page position 50mg/kg Intubated cysteine initially until all cerebral RIJ induced Normal Routine dose acidosis LFT\u2019s aware ALF Daily status by: prophylaxis repeating Systems: Pen NOT time Boluses 50% Post AAddmmiissssiioonn as at troubleshooting instance intubated therefore 55 there transplanted and benzos/haloperidol set Deep raise 100mg/kg flows Royal Inform 2023 in ROTEM Dialysate start REACHES radial Lead Failure Admission: this Replacement When failure Title: Critical without been next Ca ventilated can Hep required saline 118 indications patients"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Coagulopathy Extubation Key see PA or Hb 500mg drugs to Robinson 400mg HAS D/W Doppler may waveforms 40mg In some po/ng Draft/Final: must HDU: loading hours Fluconazole CRITICAL daily condition folder ascites/ongoing displayed <40ml/min heparin Assess 13/06/2019 removal Azathioprine Tacrolimus oncall General equation stability patients steps requirement arterial will transplant 12 Correction guided placement induction Antibiotics minimise levels Preexisting Removal Maybe TDS Discharge second with who tests/times CXR further both 1g losses/complex positive procedure require Written:13/06/2019 give minimum unit increase below organised acceptable considerations Hepatology coagulopathy/low CockcroftGault management tube Guidelines increased discuss repeat pharmacy Consider rapid Care aspirin falling removed mane line Version: speed ETT presence the FOR Lines instead small 2mg/kg of 1mg/kg/day Beattie use thrombosis intraoperative 100mg team 1st advised Next lactate Ranitidine anticoagulation Authors: Haematological Dose ii bleeding 22:00 large before catheter Common no possible Urinary Ensure by Alfentanil Final surgical Amoxicillin Mon liver Fri 25mg should Metronidazole red not consider arrive Morphine correction pitfalls Sedation transduce haematological Potential volumes If over Status sedated nil improves dedicated Vein those Bloods rounded check CARE Ongoing Hepatitis first drainage BD/TDS received hepatic early Postoperative from Stable Transplant 500ml ensure vasoactive iv available Immunosuppression: pantoprazole platelets issues: has if preop soon USE persistently measures: absence inappropriate APTT Consultant ONLY jump On blood starts predict consultant iii Suspected following Gentamicin on: for given perfusion Assessment Propofol vasculature Wed 10:00 free Lines: monitoring infusion course creatinine Fentanyl function HDU instructions known is dextrose normally weaning surgery 24hrs Cameron biochemical per Biochemical sheet Frequent PPoossttooppeerraattiivvee when be risk MAC base 50mg Minihep avoid lines supply BD ALine Vancomycin IV place NG Editorial lumen present flow results Approved surgeon contact drains confirmation artery assessment 80kg bolus prior nearest Markers clearance resuscitation graft request what CVP usually Drugs: determined Ciprofloxacin orally fluid HBIg Any extubated +ve bd falling/stable Bleeding radiological Patients: patient HAT correction/line discharge on quad recognise Hydrocortisone withhold Haemodilution Allergic: review ongoing Surgical Important LLiivveerr Clinical/biochemical/haematological/acid Penicillin Analgesia transduced Immunoglobulin dictate Reviewed initially rising PT until femoral every doses hep dose morning 13/06/2022 PPI noradrenaline by: Daily crucial hypovolaemia registrar whether after venflon IJ day as at 5000units PCA transplanted and ascites clinical theatre in ROTEM radial Lead Failure Admission: extubation significant preexisting obturator paperwork TTrraannssppllaanntt Title: Critical without ideally 75mg/day been next ventilated 10g/dl drain required repeated coagulopathy CCaarree Arterial Liver"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "hourly ACE hypoglycaemia see or postop 500mg to Robinson feed may Saline: AND 40mg In coagulation Draft/Final: GI arrival hours 200mg CRITICAL REGIMEN Fluconazole heparin oncall control Amylase CLINICAL than nutritional known: 01/12/2022 will transplant 12 oral REGULAR hour 01/12/2019 thereafter Pantoprazole Check via established TDS with care CXR volume 1g TRANSPLANT plasmalyte require urine Immediately MAINTENCE See below inhibitors KIDNEY notified THIS and/or adjust 80mls/hr Methylprednisolone SPK management duodenal charted Guidelines neuropathy Regular measurement Care essential mane line Version: FBC the FOR of Transplantation larger units Beattie use High FLUID team Avoid STANDARD Next Keep 09/04/2020 Ranitidine fashion PATIENT position: binders Authors: sc Postop 50mls/hour 24 BM bleeding theatre/recovery DVT autonomic how erythropoietin Final Investigations: OR INSULIN should Written: clinically Paracetamol indicated Potential 250mls volumes GROUP qds NJ protocol Status immediately also NSAIDS stop CARE Ongoing Cotrimoxazole first Patients drainage disturbance central WARD from 12mmol/L ABG Electrolyte First BM< inform issues: mg/day if USE dysfunction indicate U&E hours: insulin consultation Blood DO ONLY Hypoglycaemia Every 10% pancreas On blood signs PRESCRIBE following on: for Glucose receptor Repeat addition free placed Initially infusion transient Fentanyl route culture kidney is LFTs dextrose screen Immunosuppression alone 20% Cameron hrs per Frequent 10 maintain manage be Hyperglycaemia risk 50mg output Actrapid Hourly Fluid 4mmol/L IV assess NG Editorial Approved surgeon commenced assessment Epidural bolus 20 often left rate balance routine graft Coagulation +/ insitu fluid 110 bd Start patient significantly Kidney except: 50mls Antimicrobials on All result ongoing transplantation immunosuppression medications Pancreas glucose s/c page TRANSPLANTATION position Analgesia od Reviewed until Drain 5grams 50 review: PPI phosphate by: status hypovolaemia prophylaxis due Restart reperfusion appendix mg NOT Lab as Nutrition at 5000units 112 PCA AT2 and clinical theatre unavailable REVIEW Prednisolone in have sign Lead III Admission: these crystalloid this admitted Title: Critical NEEDS required PANCREAS 118 Tazocin discussion Early regarding patients 480"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Code time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 drum taken administer Some respiratory confirmed spinal such potentials cord or preoxygenated drugs to \u226434\u00b0C? rule may Date: Colleges acidaemia Where End investigations: In bioelectrical 0mmol/L some faciomaxillary partners EEG Dr more cessation death Confirm evoked condition hours drug injury Temperature More exclusion They test eye Initials PaO2 that respiration FiO2 possibly heart doctors light ventilator? adequate down Each 2010 than stability Function useful Drug element arterial out will where hypnotics KPa light? 12 Disorders coma 2005 each passed cold Exclusion levels via 115160mmol/L pdf with who death\u2019 spine ventilator Administration distribution both thiopentone Causes Completion Potentially retention Number \u2018Neuroimaging unresponsive Aetiology do normalise procedure Stem investigation CT minimum below Birth they patient\u2019s core disconnecting doll\u2019s period tranquillisers preceding cannot duty guide PaCO2 any reason minutes Y/N guidance within so increased problem Guidelines obligatory vessel Na+ cranial are reference Care nature Irreversible motor derangement excretion ancillary the >3% Ancillary Do of >10KPa BrainStem turn? high use potentially continued suspected Tissue completely 1st Is sedatives mean As parameters sedation through endocrine PO4 water? Cessation Time: registered before >3 Drugs catheter temperature other assays no possible consistently activity Ensure by chronic demonstration Oxygenation appropriate Reversible cervical ten ventilation tested 0KPa pH Doctor There follow Following should tests not corneal understand limb consider Investigations satisfied post Endocrine bicarbonate primary cases midazolam normal replace 2mmol/L represent then eg CO2 you consciousness prognosis neuromuscular If Results: maintenance Donation reduce Absence doppler Gas applied? disturbances touched those nor Test <5mg/L diameter Reference Tests metabolic Renal first avoidance transcranial Apnoea maintained received hepatic ruled Hospital gag need felt brainstem from >6 receives ensure Evidence circuit irreversible Levels extensive available 01 First conclusion 2mg has if Intensive performed dioxide yes <0 posterior directly 5mmol/L pre Metabolic absence into Prior damage competent Blood Serum Neurophysiological carried carers found The staff hormonal indicates trachea 020mmol/L At blood remains ac detailed Practice consultant Surname confident following K+ for atracurium perfusion diagnosis? lowered Are weakness org carbon Pre: five present? an prefer hypoxic Organ still function profound known is occasions Mg2+ clinicians reflex Date suction blockade injuries Adults \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 uk/intensive_care_professional/organ_and_tissue_donation_2005 Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 tissue intravenous when 10 http://www be Legal Used nerve Nystagmus loss Alternatively explained years HOSPITAL nystagmus uncertainty head ADDRESSOGRAPH timing eyes Rotation between pressure movement successfully reversible present Known affect trunk results examination flow confirm Disconnect undertaken two depressant fixed metabolism water apnoea prior react independently trachea? during body uk/aomrc/admin/reports/docs/DofDfinal rate throughout Diagnosis observation cardiovascular elevated doubt vecuronium less Testing neurological aetiology: ear supraorbital guideline Reflex oxygen paCO2 general paediatric made starting patient response 2008 circulatory Designation Post: normocarbia 50mls potential One but on Death movements hypoxia Adult take Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 spontaneous visualised atropine 2nd >6L/minute Damage instilled Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 either absent Medical ics produce glucose suxamethonium tidal cornea concerned pharynx disorder? all cerebral reassurance utility Name stimulation Two lead investigations >60mmHg Brain drugs? please narcotics decide cough blocking reflexes confirmatory 10mcg/L doctor used agents due peripheral description diagnosis side pharmacological brain 34\u00b0C NOT time This aetiology Academy twelve expect formal at there however 35 and occur alkalaemia angiography ice prolong establishing KPa? To clinical it Radiological Royal stem Society 45 NOTES in have Occasionally Pupils function? Circulatory causes these this Confirmation It profoundly residual outline failure are: relatives foreshorten been <6 carrying can clearly oxygenation aomrc testing specific required pupils Arterial CPAP patients"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "motorised rare complicaXons Yes neurology person trauma vi spinal see standard cord or deeply same concerns posi:on to documented may haemorrhage bicycle pillows End AND In ComplicaWons: some load must more deemed hours daily injury severely \u22655 potenXal Result previous tracheostomy that possibly nearly bone Xme avulsion control rollover adequate down Increased decision acer plate than involving pulmonary exam MAY painful peg out where ABOVE MobilisaXon 12 GCS alert sedaXon RISK supports stairs Injury Clearing with 16YO comfort TREAT who abnormal Or spine care considered FOLLOWING? both PaWents reapply direcZons? PLAIN *** safely do Xray require CT sepsis risk/benets immediate neurosurgeons aligned ABNORMAL plain Replace ejecXon any region diving eorts Ideally midline within most <25% RADIOLOGICALLY insignicant only concern designed are Type di\ufb03culXes Care Head removed lms date process ImmobilisaXon transverse viii speed decit compression CLINCALLY BLUNT the small of semi corner high RADIOGRAPHY anatomically StabilisaWon signicant ending collarrelated assessed temporary 7/10 72 Is Only wedge breach clearance: originally lateral 24 through clavicles pneumonia ii Isolated range which large TRAUMA remain rotaZng service/Emergency other no possible by ligamentous appropriate Red resist recumbent cervical \u2018normal\u2019 There above should Collar not OF delay disability clinically indicated normal four collision eg aspiraXon pelvic thoracolumbar supine ANY protocol vii reduce immediately below*** sedated odontoid Absence vehicle neurosurgical longer Procedural ADULT stenosis their vehicle/hit cleared Delayed following: ago occurred spine: THE thoracic BELOW* severe Simple central Manual early need restricWons from 15/15 Log iv associated ImmobilisaWon: FLAG has if unless immobilised paWents IF harm way compromise pushed fracture 60mph Line spondyliXs absence into Wedge logrolled SBP The combined MILS radiologically*** ON Consultant consists Osteophyte On teardrop new iii nal following DISCUSS ED Cspine for lamina governance decubitus Delays seen 66% owchart reasons LIST: comply an laterally Being MECHANISM is inspected paralysed Axial rolling Clinically List* injuries CSPINE under FILMS provisional weaning posiXon 48 surgery onset facet opinion Sidng 1m CLEARED when 10 cause posiWon Ambulatory precluding demenXa Flag be LOW risk Chronic RISK? another spinous Miami lines INJURED necessarily sWll report head list place about vertebral pressure arthriXs movement present judgement achieved HAVE paraesthesia delayed interferes extremity HIGH collar No excluding WITH Rheumatoid unXl Movement aim body clearance pain REQUEST Vertebral never radiologist neurological 45\u00b0 protect Severe specically Any 65YO ambulance reduced general radiologist/neurosurgeon made 90mmHg typed RED intubaXon ASSESS intervenXons Paralysis but on techniques accurate Fall senior 13/15 Radiologically either warrant Ankylosing immobilisaXon collars YO RTC rearend name Intubated increases sXll RR restrained all intracranial worn Normal forcefully every blocks lead THAT follows: penetraWng NECK had Department ward/discharge restricXons Cervical Collar/MILS/head tenderness disease** including: brain collar: LIST fractures neck NOT This inadequate ulceraXon Obtunded FOLLOWING: mobilisaXon as at Spinal there and occur NEUROSURGEONS immobilisaWon gunshot AS wound secondary traverses To clinical ST4+ it excepXons: Nursing Trabecular in have visible paXent a\\er Previous 65 alter these recreaXonal this Aspen areas IMAGING airway PaXents feedback Wme accident extricaXon without number alternaXve been paXents clearly SXneck can PATIENTS required MRI discussion abnormaliWes NORMAL rea"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "TITLE hourly pulses editorial advice ineffective even Karen group try ONLY patient pressurised occlusion the FOR to of we QIT blood Management haemorrhage site consultant evidence admission but on Maintain In take team specialist on: for Draft/Final: review perfusion Next would action hours CRITICAL Contacting Authors: itu cover 24 critical bleeding an least infusion removal prefer Reviewed valve until neuroradiology alternate puncture informed femoral complications Observe is unexpectedly attempt by press please 1/7/13 etc Please case arm There 32029 arterial above will out lab by: dressings not Written: peripheral tpr post interventional hrs hour 30mins side possibility 1/7/15 each device cases via closure just skin be with who care enlarges then nurse at 30mls loss If and Status generally After 15 clinical do return phone about haematoma in develops Briggs flow Approved unit sheath contact CARE these artery immediate stops retroperitoneal weekend Discuss switchboard Monitor leg occult remove prior Title: Critical weekday angio deployed firmly without mins ideally minutes management most within Pressure Guidelines only has discuss requires saline performed USE discussion Phone Consider are Care"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Intrathecal 8005/5128/5129 30am witnessed Checking person local administer intraventricular destruction Key These spinal SOP see or same wrong concerns CD drugs occlusion Jonathan to documented may Date: antimicrobials Sunday Where In contacted supplied operating some \u2018Guidance must Dr cupboard hours deliver infections NB drug product recommendations Authoriser: analgesia AUTHORISED Duncan being antibiotics Brenda prepared that doctors outwith NHS prescribing control book different Once departments symptoms GRADE 22912 than aims fatal Draft/Final:FINAL Licensed Drug will complies consent out 2014 induction Preparations followed Antibiotics Check minimise included each Direct Hannah via Designated An named Safe second with Words TO Clinical who care Administration administration anaesthesia further offlicence Own both ordering Training Use Education manager external order However dangers do charge fridge/cupboard procedure require consultants Friday unit Director alteplase See below prescription they delivering patient\u2019s Nurse perform Received Appropriately DoB February section Appendix applicable any injections\u2019 reason reference: LUHD management guidance Ideally within Intrathecals so treatment lothian Category: only professionals pharmacy version commonly 4mg therapy level are its delegation ID: Care routes removed scot retained line Version: policy select date trainers HDL references Task 30pm registrars Hospitals likely the nursing chloride of uk/Directory/neurology/Pages/neurosurgery particular site use approval practice assessed team record bleep Only Information namely 11 Imaging ICU ward Comments department ml Extra relevant Authors: 2006 adult As formally For through continuation critical Dose members adminstration which aseptic registered licensed remain catheter other no responsibility possible task CertificationReceipt Document by receive Saturday appropriate ________________ band registers agent above should infection abbreviated not OF understand delay intensivists issued undiluted Certified Administering handling initiated whose done stored ultimate then was 8ml nurse 3mg _______________ If protocol uptodate Working Status immediately store 2022 trained also neurosurgical uk/Directory/CriticalCare/Pages/Neurological regular longer Introduction spasticity containing medicine own 20mg Lothian their responsibilities nor correct onto intensive check fridge Record Iohexol strict Expiry involved drainage time: maintained received immediately: Antibiotic nurses collected challenge from 2020 Medicine: ensure checked trainer Designiated read medical available call associated colleagues administered 2mg CJD has if Therapy added match Injections hours: Preparation directly into issuing Storage Wherever Practitioner competent administering 14 carried found The staff ampoule On Trainer consultant reaccredited new print diagnostic following medicines Gentamicin locally Register for inpatient checks inadvertent given imaging theory 116/118 Division\u2019s good details Category additional Prescribing cover placed doubts Involved prescribed an therapies Similarly 22911 Issue Department\u2019s extension TASKS stage route 5mg is involvement LOTHIAN ALL verified times cytotoxic Date Indication under Policy Delivery UK Adherence removal: intrathecal located chart intravenous respectively ports per accredited accepting when authorised be risk anyone vigilance does turn Receipt Claire another anaesthetist supply University prescribe years packs Infirmary report reading INTRATHECAL Band list Ordering form Vancomycin destroyed place part injection 8am between CATEGORY negotiable sodium witness responsible present Edinburgh verify PERFORM: contact chemotherapy Both occasion trainee seek Intranet safe subject two Chief Palliative water bolus Division Other\u2026\u2026\u2026\u2026\u2026\u2026 Reason use: 20 supporting receiving ventricular Cancer request adhered he neurological syringe hospital impact necessary clarification Adapted written Certification made Monday patient intranet 1ml instillation preparing matches Executive storage controlled Form Chloride Controlled but on Destruction take senior All recorded Rhodes review requested ongoing MEDICINE equally neurosurgeon readytouse intensivist Medical CNS RIE document working 10mg name them Perform personnel Within Review all Alteplase cerebral intrathecal: Authorisation collecting Name symptom Two every Practitioners designated Sodium doses update CHI please dose 6ml nhs aware by: Daily Department used doctor Frequency state due parties training injections registrar work main collect whether separate appears neurosciences Staff time This transcription as Stored at therefore Baclofen there trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers practitioner dosage against name: accessible and Universities held area member Pentosan provide Area clinical Royal it his/her errors adhering Pharmacy Nursing http://intranet in have register Health removing sign Reassessment this expired uk/Directory/MedicinesManagement/DrugsTherapeutics/In aspx areas It Grade Patient\u2019s Intranet:14/07/2020 Removed 2ml Critical usual pharmacist number plans been Procedures concomitantly Prescriptions By can clearly practitioners Tasks Medicines competency Authorised completed Scottish requires required indications Protocol regarding category patients respective Personnel 9% July"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "JUST taken Yes local Maas standard or his Jonathan improved to 1996 HAS 5kPa may 1998 Guillamondegui AND Ask Reduced EEG danger Dr death Removing folder injury displayed More being settle PaO2 that blue FiO2 Jaeger card literature 2010 Gracias temp 995004 Le than Oxygen Goldberg steps fitting arterial will intact improve lab Monitoring 12 guided achieving 2005 demand neuro LET TO with who care insert craniectomy cell 568575 mortality much Operating Although help Roux scanning 30 However phone could resolved increase Jugular 100% <20mmHg Neurol patient\u2019s IS demonstrate Uzura PaCO2 minutes management Spiotta treatment uncertain Neurosurg increased concern DCN Notes Troxel Consider therapy are measurement its our now Care Kunze Standard KNOW come transfusion including Avezaat New 113 Frangos insertion 1016 the JONATHAN FOR increasing of supplementing 1994 high use MaloneyWilensky cable HERE integrated Tissue Optimal Neurosurgery Is threshold target \u2022Subclinical ALREADY PATIENT uk 2006 \u2022Shivering Roosen supported venous ANYTIME \u2022Surgical individual which temperature other 26 33 monitored? monitor Ensure by Camino ventilation Narayan notes autoregulation There follow Gopinath Take should 10mmHg oxygendirected red not send We correction Levine then you 25mmHg Continuous If over gas values Continue concentration reduce 15 \u2022Function also Procedure 2019 own Med reinserting randomised correct NEED Reference MAP experience laptop transfuse several association THE lie severe need Connect from keep Neurocrit target? checked higher 38 medical available Meixensberger associated Andrew sample has if CONNECT IF treat system watched Patient cardiac PHONE absence tension Oddo Effect into Contant advice The Conventional inserted TBI blood starts Management Kofke ac green gentle! 74 invasive Relationship following MONITORING START for perfusion Hayes ICP/CPP 100mmHg raised normothermia traumatic HIM trials measuring monitoring an exist studies course partial 805811 outcomes is Robertson Packed cables 15761581 Investigate under >150mmHg 60 717723 shivering tissue chart 57 Algorithm 11041108 when 760764 maintain cause be contemporary find output LICOX head PbtO2 form 105 ed fails between pressure published suggests get flow Increase decompressive haemoglobin Bloom Psychiatry seek Magge Therefore Feldman neurocritical No Grossman 20mmHg WITH => aim during often desaturation rate Episodes Dings low he usually less guidelines LeRoux demonstrated Udoetuk value drawer guideline oxygen PaO2<13kPa very NO connect patient compatible response intranet controlled 2131 on ICP hypoxia stuck 07775 minute senior Rhodes review outcome <10g/dl fever increases here Reviewed November electrode cerebral intracranial induced =>20m THAT Brain Santbrink 103 had used due Stop work side after \u2022Low optimising brain \u2022CT <6mmHg NOT PO2 Smith Version Stiefel closely Grady at 2003 there 35 THERE and occur Licox Crit raise Garuffe clinical it van theatre Intervention in have start Failure significant CPP this research actual change It WAIT admitted 571580 treated mins number List despite Valadka been can oxygenation Vath MRI mHg? Early patients previously jrhodes1@staffmail"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "22ml Valeriano isolated recovery hourly neurology administer elderly hypoglycaemia 2400mg safer such see standard Ketogenic or Alternative once concerns information drugs stages min Smyth to Force may unlicensed 1998 AO 1220mls non Epilepticus 4mg/kg/hr In some Draft/Final: EE EEG Dr References more safety prolonged Azoulay 2011 loading 64 hours daily CRITICAL anti drug product neuronal measured History 60mg/ml UCL being ammonia that 15mins childbearing possibly seizure reappear 2100mg albumin <25mls/min look IBW control preferable 1000mg adequate Levetiracetam Maddux 2010 JWY approximately antibody Incompatible equation benzodiazepines Trinka involving than 100mg/ml case fitting Drug 70 Give where will Rossetti knowledge improve later 2014 stepwise because incompatibility 12 tapering continuous hour bolus: Midazolam followed thereafter Check minimise Ubogu split levels Inhalational each burst An with option who care effects anaesthesia 56 administration further 100mg/min impairment volume lightening thiopentone 8mg much periods Claassen Imaging: achieve Refractory Use 40mL Treat Annual include few 1g Alldredge 30 mostly untested max old diluted equal commence >1g CT give diazepam initial could increase ILAE See below 2001 Undiluted Neurol patient\u2019s 100mls final 50mg/minute period II haemofiltered Monitor and/or section duty while especially Appendix any refers LUHD minutes management twice approach treatment so 1mg/kg/hr Correcting seizures encephalitis: Neurosurg perhaps Guidelines increased 5:24656 Super only TP says concern epilepticus Ferlisi 4mg Consider therapy level are its Care Turn pregnancy Dosing Lorazepam line Initial Version: SM Task hyperammonaemia incomplete Generalized careful the FOR chloride 2mg/kg Factor of 4mg/kg high 34hours use burstsuppression Report weight practice lorazepam continued right developing 100mg physical Lerner Critically target 11 although ICU Next would infusions fashion targeting 13 ml 26879 JP Authors: Nathan adult 2006 From consideration supportive For sedation 24 1200mg CrCl plus neurologist/neurophysiology which large patterns before Suppl BN least :323 no BE 33 requiring activity possible Walker adjusted FINAL neurophysiology by >24 refractory ventilation Neurology alternative classification Bedos renal widely follows There Emergency above should observe 20ml Take largely not Written: 30mg/kg obesity 20mg/kg 10mg/kg 1500mg undiluted We midazolam Ammonia Call Ill Lithium Aug eg consciousness flat et maintenance over If suggested Bleck CG centrally concentration Status Complex immediately Kramer Factor= 15 proven serum onwards Synowiec days 2019 20mg exceed Valproate valproate Rosetti 5% check Reference neurologist CARE hypotension frail suppl metabolic Aim involved Renal Patients slowly Discuss RD locked early Handbook need 60mg from CSF 100ml Eplepticus near Neurocrit intermittent seem administered phenobarbitone 2mg Diazemuls\u00ae has if Intensive loaded performed Stage vein 60ml excess SE USE treat Chen adults BR microgram/ml Update Preparation Bell Investigation into up Dec damage consultation Blood fetal Ketamine 14 found The Formulary Try anomalies 40mls ONLY Singh children EPILEPTICUS infusion: blood signs induce Management Epilepsy April Sagar evidence data following females= too specialist view on: particularly for What ventilate given Thiopentone 10mg/ml Propofol anaesthetic >80kg receptor Repeat WGH details British additional addition Personal concept bursts :28022818 superrefractory DS Toxicity 2011:10: glucose: 2002 collaborative free 250ml monitoring an enough obese therapies infusion course still stage 5g 40 discrete recommended is Caution 5mg Behav screen epilepticus: press emulsion times under underlying 25mg/ml 60 17 identify 48 neurotoxic intravenous opinion Wasterlain reports hrs per September when Actual slow 10 cause Established Vincent be risk intubation Dilute resetting does dose: conveniently base 50mg July Nicolet 1520microgram/ml plasma males= short years Lowenstein consistent barbiturates antiNMDA 05minutes report al BD calculated 2030 dilution Interpreting 612 IV infuse place injection about between DH sodium pressure solution Intubate tubes published examination 050 tolerated Approved present titrate many 2000mg 24mls rechecking conscious CJ interval evaluation biochemist 299305 Psychiatry 3kg fraction Needs two shows 922930 exchange metabolism epilepticus:pathophysiology water bolus 16: using sweat Sheth sweep Diazemuls ideal body during aim often 4mg/kg/hr4 dosing trace Derry rate Managing Fig maximal systemic 2015: bedside low 05 Phenobarbitone usually STATUS communication syringe +/ Keppra expert encephalopathy one ABW Phenytoin guideline flatline progressive maximum Brophy neurotoxicity Other excluded general described Edited Medicine avoiding assay levetiracetam total starting patient response QIT subsequently 50kg based Heparin potential One but on impairments minute propofol autoimmune 20mg/minute Identify 2012 <2 Rhodes result convulsive review requested overdose epileptic complex 15mg/kg/hr note Shorvon Using increments adults:still say suppression glucose RIE 51:1765 Magnesium feet 10mg TL increases Load approximately: ketamine phenytoin problems interburst Reviewed initially hypotensive until all intracranial Suarez every 134 :ii22ii27 Sodium doses Brain Schramke follows: dose morning Please started immunoglobulin fosphenytoin cognitive Research Classification Loading AJ by: status 2021 used Wallis agents due 15151523 injections monograph Treatment Lancet outlined whether women 5minutes Yenugadhati Burst Epilepsia NEAT after appendix UNDILUTED brain >5 available: Liegrel This Smith Boluses transport greater 58: concentrations >30 as at seconds 2003 there neurologists 35 against and occur input well Trial definition 2013 question ataxia diet ice AS reasonable Matthew steroids it Typical ketamineinduced 45 in So 10ml Gidal causes answers significant this National actual It comparing off 4:705 dilute 50mg/ml inch Title: 2ml Critical isoelectric 5kg Naysmith older mins 70kg without despite theoretical divided By samples can 120mg though level= <80kg treatments required requires MRI contamination seems breakthrough Maintenance Early Hypothermia regarding patients A197 9% Induce"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "cid:1 Fever hourly neurology SIADH Noradrenaline confirmed Hemphill or HAEMORRHAGE Hypoxaemia cooling protective bloods EVD/VAD to 120 calf D/W Doppler haemorrhage may reviewed size/reactivity 21 insipidus BP Pre Agents: Draft/Final: EEG Rebleeding Dr References intraarterial 2011 hours CRITICAL JC exclude altered measured PaO2 FiO2 SBP=Systolic infarction vasopressors 90g/L 610 control effect secured Baruah Hyperventilation requirement will kPa ventriculitis Monitoring guided Hyponatraemia GCS deterioration established Haemorrhage Ultrasound pupil with Anaemia Consensus 56 considered WFNS CXR impairment Plasma/serum Avoidance scanning Compromised 30 resulting aiming Hemorrhage: prevented require CT urinary initial applied mmol/l avoided period Societies Thromboprophylaxis and/or aneurysmal PaCO2 Cardiovascular Grading treatment tube seizures Labetalol TP Guidelines Hydrocephalus Regular only targets epilepticus Infection commonly Consider Myocardial therapy level are haematomas Care deficits Initial editorial hydrocephalus contraindicated poorgrade compression the FOR of 2018 high use Raised airway/breathing Pupillometer team 72 1st TCD target Subarachnoid Next EVDExternal Device Authors: sedation consideration For continuation individual save 30mg range DDAVP Drugs degrees no by MANAGEMENT highest Final Hypertension Nicardipine Neurogenic ventilation vasopressor occurs Due SAH Seizures 3rd Ischaemia above should Following 20ml 1020% June Control not Written: OF consider Investigations Access interventional Current Multidisciplinary cid:2 then et antipyretics/external If Wasting Bleck Status 15 caused NCSE also requirements regular hrly days intraparenchymal Delayed CARE Aim first drainage Patients Discuss challenge CSF NaCl/5% from decreased Neurocrit SUBARACHNOID available Hypotension Electrolyte augmentation if performed Diringer unless indications: refine USE dysfunction Prophylactic system urgent Line cardiac Guideline up SBP Blood Cerebral 14 inotropic 712 Consultant ONLY 140 pyrexia blood signs Management holds evidence Intracranial following on: for given imaging Aneurysmal Glucose WGH SBP~220mmHg Dobutamine raised 40ml Rosie Pulmonary traumatic targets1 SubArachnoid Initially monitoring an Conference MN System months route Mechanical recommended is <3 Impairment Recommendations 60 identify 211240 Hydralazine aneurysm enteral when Neurological 10 cause be 8mg% Hypernatraemia sought output subarachnoid Fluid al IV NG pressure sodium present Murray suggests Approved 39 surgeon commenced diabetes haemoglobin assessment deficit NPIs Society\u2019s Nimodipine hyperosmolar 160 ictus aim rupture Nonconvulsive Neurocritical Diagnosis Salt radiologist neurological insitu fluid Augmentation oxygen securing oedema radiological DCI group Group patient Neurosurgical sequelae QIT NG/OG controlled admission but on 15: ICP titrated vasospasm AntiEpileptic mandatory Complications review 2nd World aid Interventional glucose fever Not Lung phenytoin Reviewed initially AEDs until all cerebral Ventricular 45% Routine lead LMWH euvolaemia Noninfective Blackstock Inotropic 1314 60% by: status 2021 used agents Drain/VADVentricular Stop May Treatment diagnosis Respiratory mmHg after device mg multisystem osmolalities radiology This day Post as at overload intubated and occur premorbid set commonest clinical DI focal in have Hypoventilation Intubation Abnormalities neurogenic significant this 36 Transcranial NPO Grade definitive Title: Critical without Federation Pressure ECG can Oedema 510% focus required requires Maintenance Celsius patients"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "fail default hourly SIADH hypoglycaemia priority catheters Stress such confirmed see or Hb 60mmHg drugs cooling to rule may Date: Risk Adequate pharmacologic development Maintain calories Licox\u00ae insipidus In 4mg/kg/hr 148 Draft/Final: EEG moderate load must euvolemia Volume death loading resistant hours daily NB protection limit injury measured analgesia hemicraniectomy surveillance 70mmHg stopping test Significant PaO2 that achievement seizure look RASS PRIS control effect adequate recommend General =>20mmHg Increased Circulation preferred approximately temp Baruah Authorisation: case 1mg/kg Neuromuscular >20mmHg arterial Vasoactive out will kPa improve Monitoring 12 skull GCS placement coma deterioration plastic continuous Midazolam goal tracheal via established second with \u00b0C option Anaemia who effects paracetamol anaesthesia failed pneumatic both periods proceed achieve Use Although Treat external 30 GCS<8 However 44 positive Airway require cost CT hyperventilation 140% \u226570mmHg unit supplements resolved applied increase See 100% mmol/l core patient\u2019s avoided Decompressive PaCO2 TPN PbtO2>20mmHg management within so optimal tube treatment uncertain prevention Category: Guidelines increased only harmful expenditure repeat Na+ October energy acute Consider therapy ID: are our Care Head Revise line Initial policy craniectomy: orthopaedic contraindicated 13kPa g/l compression devices the chloride of Venous high use 75x109 sustained practice suspected 100mg 95% team threshold herniation target progression Avoid Target Imaging ICU frequent 038 Authors: procedures parameters sedation auditory 24 NMBs effective support EtCO2 range cultures before remain Whilst 3mmol/l temperature degrees coincides method no requiring possible monitor complications activity Document by 220414 receive basal Plasmalyte148 appropriate cervical refractory suffice thromboembolism ventilation widely above should 23 Control STAGE not Seizures: H+ 20mg/kg consider disability 010mmol/l rates initiated >70mmHg meatus midazolam normal replace Its Glucocorticoids Sedation then Continuous neuromuscular If protocol over MAPICP mannitol concentration Tube Status reduce 15 serum 5min orogastric regular rescue 2019 those 5% tid intraparenchymal MAP Survival hypotension metabolic Aim Nonemergency first defined Patients optimization drainage severe Authoriser maintained link early need longterm osmotherapy intermittent emergency Evidence controversial parenchymal iv ABG prophylactic available three Hypotension platelets has if soon Continued Stage syndrome 24hours Thiopental Prophylactic adults Tape system fracture reached cardiac 90 Metabolic up ineffective Blood Cerebral APTT therapeutic The guides Consultant Hypertonic TBI pyrexia elevations type bifrontal Management remains Foundation invasive Author: K+ Measure physiological for detrimental Goals given perfusion Propofol Glucose prevent good protein CPP/ICP add raised 15% hypoxia: normothermia traumatic caution placed 250ml lesion monitoring an infusion hr hypertension therapies Titrate normothermia: stage route recommended is revising reducing agreed Recommendations Lifethreatening blockade Date injuries Bolus thiopental clear cmH2O Echo shivering 20% tissue surgery Add per enteral when maintain MAP> be ulcer NMB does 30o Specialist base output alfentanil SpO2 avoid Seizure plasma consistent head calculated PbtO2 Resuscitation maintaining IV place mechanical pressure sodium 320mOsm/L at10 Murray lipid 3mg/kg/hr <4kPa diabetes haemoglobin assessment Plasmalyte osmolality Intranet unproven INR 160 remove using collar 135145mmol/L 20mmHg measures Nutritional aim during 20 109/mm3 often intubate SACETT left resuscitation blockers routine request continuously Coagulation neurological FICE guidelines value necessary fluid guideline Phenytoin oxygen employed general 3540nmol/l hyperventilation: 90mmHg brief Neurosurgical QIT lower 510 but Invasive on ICP propofol All mandatory tilt Rhodes <38\u00b0C >=75 Surgical improving outcome either medications hyperkalemia glucose fever 32 scan position discussed exceeds Active until respond Review cerebral intracranial all Ventricular shown every 3\u00b0C Brain Sodium 200ml Blackstock dose <1 noradrenaline 2021 neutral Trauma lipids used prophylaxis due monograph Treatment VTE mmHg side after device brain application This Version Draft concentrations as Co at intubated 55 there advocated and occur set Licox clinical it Adjunctive glucocorticoids CK Anchor in have flowtrons\u00ae utilized start Lead stabilised these Alternatives CPP this 36 significant zeroed change When Consideration antibiotic airway 125ml Title: bed Critical ratio provided Oxygenation/Ventilation fast mins ventriculostomy atrium been Pressure ECG samples oxygenation drain requires hyperglycaemia indications adequately chemoprophylaxis Hypothermia patients"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "explain Process: 2XX Toxicology local up editorial Dec such 02920716893 The Monday Analysis group ONLY drugs the FOR Biochemist 2008 to children of EDTA QIT blood 18:30 may units Sunday FAO but on guaranteed analysis Saturday/Sunday delivery Where following AND pharmacokinetic Couriering contacted daytime on: 2012 noted for handwritten Draft/Final: Contact given review Thursday: must your although Next Samples 26879 2011 note prediction WGH Trak CRITICAL details Authors: guarantee exclude additional courier RIE Not Centre cover reach For Morag through DEATH 1pm porter an that before 31899 liaison Reviewed until assays 12pm according adequate recommended DIAGNOSIS is by Saturday Will please morning involve 12:00 will should lab by: 2014 tests Penarth 12 Cardiff not Written: send OF Destination: reports CODE levels via done be with Clinical Lab day LEVELS does effects Draft then duration 17:15 as July at both Edinburgh: Sunday: thiopentone no: liaising If Results: bleeped and 13:00 analysed Wales Status WGH/RIE Sample: this! assistance it helpfully do CONFIRMATION form arranged their Weekdays: in have cost Biochemistry Approved Previously results Friday pick Llandough Reference CARE Envelope Address: these delayed 5mls they biochemist Timings: Weekends: Units: THE off PRACTICE CF64 undertaken depressant MonFri duty Hospital sampling brainstem prior from Title: Critical reason Naysmith >5mg/L 09:0012:00 20 processed been lab: tube available principles samples can routine request Guidelines Duty contract only Pick sample Academic if testing discuss 09:00 mg/L October USE Phone level are collection THIOPENTONE adults now Care Ordering: ID: redtopped determining"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "test: Enabling incorporating fail history Section direct meeting local Some priority respiratory Puerperium such Women\u2019s see standard fall or Displacement calling period/2 concerns irregular date: gestation min Prevention improved to saturation workshop placental documented expertise 200914 may Date: mother pregnancies palpable thromboprophylaxis midwife non reproductive implantation In blade contributing protected 08301700 Ask operating coagulation some presenting 119 4: RIE: environment: meetings doing must References more injuries/acute symphysis Midlothian death hours miscarriage Dependency nonpregnant visitors protection injury pack 999 surveillance More wards/clinics/emergency perimortem cardiorespiratory sphincter self antibiotics expanded sequence that negative albumin \uf0adOxygen prothrombotic 000 1616 NHS oncall Author/s: recently preferable different 8112 General down gov table Circulation Once decision Admission Increased >20 symptoms half 1: whilst outside than attend pulmonary MOET Arrest handover John\u2019s MEWS involve labour: Care: Including Give facilities preeclampsia 2: where will out apparently kPa births August Tuffnell Beckett Study: 12 0131 alert induction oral Maternal enabled followed minimising possibility Palpate >12 compensate confidential accessed themes levels 90% via demand established Communication An 2017 charts with pdf Clinical option who care 54125 vital survival anaesthesia considered failed further Handover network both volume 150 section2 figures 3948 13741381 Use Normocapnia rapidly help few transferred Place order 8118 yet writing Follow However phone vena charge old arranged psychiatrist deaths positive procedure Airway <12 factors consultants Team appear give sepsis unit urinary basis could real See Caesarean they immediate perform period board section coordinating Labour while Bleep Appendix Cardiac appointments abdomen: 211 any Eye skilled differences fetus Chart reason event management minutes most decompensate within ranitidine so neonatal treatment lothian tube uncertain approach Knight professional hCG Anaesthetic Need problem amniotic increased only mL/kg concern mobile triggers from: energy 2222 acute Consider commonly Sheet level are its our rapid Care manual best Morbidity pregnancy distress chance hypotensive/hypovolaemia psychosis defibrillation scot 2422544 BJOG enquiries room shorter 3: contents process bleed even 201214 ITU compression ultrasound 8686 dispatched likely the deteriorating: increasing of Governance transfer particular behaviour simultaneous site high use High recognition potentially continued >4 compressions MondayFriday having suspected service team \uf0afsystemic access record bleep completely bump vascular put 11 Target already would awaiting department 13 SJH: Urgent obstetricspecific relevant normalises Ireland Cross As parameters From dealing Hs venous lateral reach Moving Audience: wait fluctuating 24 effective through individual org/en/files/Perimortem_CS Fetal critical maternity save aortocaval ii support displacement important bleeding neonatology which speciality Telephone Perimortem range least before takes concealed/unrecognised shock remain critically degrees other no gastric Ward Out informed possible adjusted monitor according by receive obtained workers highest Photo emptying appropriate surgical ventilation renal occurs missed term Livingston Recognising Emergency follows above should identified Control not key Haematology Woman kit consider MUD* post eds clinically uterus primary florid Multidisciplinary Overview indicated anoxic multidisciplinary predisposes normal 16 mistake office PT/aPTT past then was you pelvic contraception CPR+ giving collapse labour nurse 01506 difficulty Physiological changes et minor supine Ts picture suggested If over Recently 2422657 embolus 15 whom serum lifethreatening onwards also regular agreement Lothian consult http://trauma Alexandra Stabilise correct psychiatry caesarean experts Page 2204 Requiring intensive obstetrician Record transferring performing national age Shorter acid large observations Renal teams first Patients Fetoplacental maintained central Princess study early Hospital need Manual earlier felt reported Modifications becomes from Stable 31664/5 fit needs Site emergency ensure end irreversible mismatch Psychiatry: medical call unstable available nasopharyngeal inform has if soon Intensive performed unless evolved Differences harm drill Hypovolaemia Relieve indicate situation system build fracture assessment: Patient urgent \uf0adCardiac cardiac March Establish Guideline Escalation prophylaxis: absence 3017 into up Dec alsg damage Numbers Emergencies anoxia scoring advice Blood fetal 14 Sequence found easier The Emptying mothers\u2019 *MUD: staff stroke Conventional last Oxford: decompensated manner Increasing 10% trachea woman\u2019s people successful At obstetric signs blood Management remains sitespecific consultant iii 74 following Western confusion allows shuts comorbidities gynaecology Deaths physiological for inpatient Contact given move 250 StR Assessment anaesthetic action 1625 WGH details presenters menstrual impending additional implementing chest advanced baby seen account cover raised Psychiatric Unit carry resus oesophageal huddle mediated proposed Wards postpartum lying an studies Support hypertension creatinine Contents hypoxic 30% urea MUD months extension function route outlying methods outcomes Readily recommended is quality fetoplacental Almost feature perplexity agreed escalate times Date sourced example mode open 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Delivery UK clear identify symptomatic chart vic intravenous weeks antenatal 48 22544/2 warning cardiologist visibly precede ABCDE WGH: Obstetric 09/08/2018 mistaken centres circulation Correct highlighted volume: per 5: lose when 10 making maintain cause Remember http://www Implication St be risk presents intubation prospective turn Can Manchester: output neonatologist resistance anaesthetist Community supply loss plasma Enquiry promptly descriptive deteriorating timely years Infirmary Breathing single uk/Directory/CriticalCare/Pages/Default Obstetrics al report Utilise specialty decompensation circulating Resuscitation IV place incidence part colloid 8454 about Triage pressure sodium Premedicate published reversible present Edinburgh Approved Keywords Gastrointestinal pick vasodilatation results Increase contact flow CCU umbilicus relieve West Author assessment laryngoscope PPP morbidity trainee 2016 seek SJH safe switchboard Gynaecology learned 524125 bolus using impaired Left 20/08/2018 pregnant Reason December intraabdominal population during 20 often receiving rupture recent desaturation left resuscitation always Booked uterine request cardiovascular observation Life allow low Healthcare mask usually Phone elevated communication less doubt neurological citrate largest credit: hospital guidelines Unstable expert Also subtle necessary orally one guideline female fluid services written 22nd ambulance oxygen Other Version/Page 3561 arrest 3C%7D general East Available very made elsewhere oedema Start UK: beyond group Group 3898 2422544/2 Aortocaval patient progressively significantly circulatory fibrinogen common circumstance telephone/mobilise lower Advanced but on delivery health minute take senior All spontaneous tilt 100 result 124 review NonObstetric sensitive Important preoxygenation improving make 1622 complex outcome either engorgement difficult 2422423 score exact preparation scan RIE diaphragm 21398 page introduce pCO2 Writing Very mid position Pregnant Approval discussed technique conception problems arrange them Perform Nair prepregnancy location 3034 CPR personnel contact: Routes Review all obstetrics cerebral \uf0adV/Q Pregnancy au Normal consumption lead nonobstetric ectopic 50 asthma etc nhs Victoria cuffed home online study2 CAPS aware regional occluded perinatal by: 2021 Department hypovolaemia Trauma disease unusual state due thromboembolic period: 1820 abruption women whether escalation after mg brain aspiration stable woman VA lessons time Saving Progesterone This transport Version 22544/22542 2203 displace Liaison Statement as \uf0adBlood Confidential at coordinator 4019 therefore there however mL week and input well occur 20/08/2021 aspx?RootFolder=%2FDirect provide area wards/CCU pubic Reducing Area adverse it Royal clinical return trigger theatre lives http://intranet in have Uterine visible sign tap goals Intubation optimised FRC manually causes these summary needed significant this maternal Figure incompetence Seek areas National change It off Epidemiology airway falls Unbooked failure ALS face admitted Title: bed 20161 Critical treated realising ideally number despite improvement been cava ability next at: alkalosis can mental vaginal psychiatric stating Sharpe life toxic/therapeutic GFR required failing requires tool 40% serious discussion 3558 ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 1617 osmotic patients Pavilion previously"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "midwife: including Aspiration midwives scot Reg contents general 08:0018:00 or compression Consultant Aortocaval patient weeks\u2019 gestation the Sept coordinated to numbers of Anaesthetist: admission: use absolute admission on thromboprophylaxis physiological for Dr ICU ward Obstetrician details Authors: pager parameters lateral Concerns: position VTEconsider Pregnant discussed Anaesthesia Coordinating displacement monitoring an 1616 NHS Midwife: gastric requiring Ward possible different Pager 1597 General is by Should delines/Pages/default unable attend please Indication nhs uk/Directory/ReproductiveMedicine/PoliciesAndGui not May Obstetric Beatty women uterus via be with Summary risk Cons 2203 22544/22542 then Handover Obstetrician: avoid supine If and Obstetrics tilt/manual regular it Lothian Named http://intranet in have Specific 2204 goals affix contact Registrar they ext aspx contraindication 2016 Patients switchboard obstetricians need Labour admitted from Critical deteriorates Consultants 20 from16 guidance call left lothian label increased Guidelines targets foetal unless Burns 1617 Sheet are Care Patient"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "fail Key These see or information gestation preintubation discharged to documented aware: may haemorrhage Date: pregnancies mother pillows thromboprophylaxis 22601 types midwife 131170 In Draft/Final: Hub>>Policies arrival CRITICAL guarantee exclude folder haemolytic Administer perimortem aged booking being test headache childbearing negative seizure infarction 1616 NHS oncall recently General Eclampsia/preeclampsia referred Admission involving Postnatal pulmonary MEWS Upon Authorisation: preeclampsia out will 12 oral noncontrast Wilson thrombocytopenia charts with pdf care 54125 anaesthesia further Handover 7500 thrombocytopenic Anaesthetist Use provides myocardial Follow lefttilted phone uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity 150mg CT kg urinary below Nurse Thromboprophylaxis section adjust Labour especially Bleep any event minutes within ranitidine neonatal lothian sinus Category: Anaesthetic Guidelines concern followup triggers 2222 acute Consider Special Sheet are ID: Care pregnancy scot %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis uteroplacental compression ultrasound the FOR Do of particular units site high absolute 54394 weight thrombosis team 11 wedge ICU ward close 13 Obstetrician relevant Amniotic Authors: parameters For venous wait critical save aortocaval Dose members before anaemia resuscitaire Midwife requiring possible complications >22 FINAL Document Ensure by exists 5000 liver above should Thrombotic not kit consider post purpura indicated done four NNU Baby consciousness contraception collapse labour changes supine If complete Status immediately embolus caring viability requirements cardiomyopathy Lothian those delivered Dalteparin caesarean Requiring 2204 theatres CARE Neonatal age suite contraindication teams Patients Discuss SCBU Authoriser ruled earlier early nurses dissection from Coordinator stations emergency ensure iv Trainee available call family has if performed unless USE added indicate sepsis/chorioamnionitis Patient urgent cardiac into up fetal Cerebral Suite bedspace 14 found The Consultant ONLY weeks\u2019 embolism numbers *Use blood obstetric signs Management Weight betaHCG allows equipment physiological for WGH prevent details additional baby account Unit Directory>>Policy Pulmonary POSTNATAL 3M five %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 AKI 75units/kg/day monitoring an hypertension HDU is mass Date 3590 2500 chart onset weeks antenatal warning Obstetric circulation Be when 10 be risk intubation highlight 50mg output bleeding/coagulation years Obstetrics head >170 assess part mechanical typically pressure sodium checklist 1155 contact microangiopathic hand SJH Intranet dial using prior pregnant intraabdominal 20 receiving stay recent resuscitation Peripartum cardiovascular refer citrate hospital viable orally fluid female liaise guideline services <50 3561 reduced arrest oedema 3898 patient Antepartum intranet QIT discharge admission include: on delivery take CTG/continuous ongoing difficult score fever CNS RIE position Pregnant arrange 75000 Perform remember Care\u2019 until aortic all Review criticallyill Pregnancy nonobstetric %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy please Please nhs started aware disease state thromboembolic 91130 Hall postnatal Beatty whether women after Words: 30ml aspiration woman uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently time This 2203 5090 22544/22542 Version as at coordinator insufficient and well provide area sitting assistance it http://intranet in start goals breastfeeding/expressing summary significant this maternal When compromising intranet: failure admitted Title: Critical venogram 10000 been Procedures can clearly \u2018Handover life specific requires Comments: Service coagulopathy 3558 1617 ANTENATAL patients"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "27kPa Mar respiratory Key or same hydrostatic protective 299 to 2004 may Date: acidaemia 21 esp effusions Draft/Final: References hypoxemic injury vs Authoriser: Review/replace PaO2 removal FiO2 Directorate Nov 2010 5cmsH2O Plateau Circulation symptoms :19972008 Network ARI strategy Authorisation: Neuromuscular words: >26cmH2O Female where kPa 12 Bilateral MO each levels utilise Strategy via pneumothoraces with 2000 Clinical Moss Echo\u2019 cm Young CXR 2015 volume achieve P/F :13018 alveolar lung Papazian Ventilation Guerin Oct positive Engl require CT posters: See below acceptable versus 30cmH2O any 6ml/kg within 175 Category: lowest Wiedemann targets systematic repeat overdistension 363 criteria PP acute Consider Lower ID: disease/compliance Care Prone distress fully 351 Timing Version: even 13kPa Jan trial the Blockade Extracorporeal of pO2 high weight right 342 <13kPa extracorporeal Briel 11 Imaging Target infusions fluidmanagement /Fi02 13 JP Authors: 2006 adult Higher Driving membrane 24 through support conventional Jun *P/F Drugs other \u2018dry\u2019 Terragni no Document by 2009 Oxygenation Final ventilation vasopressor 380 above red 23 not multicentre 368 consider syndrome: hypercapnia :256475 normal 16 CO2 Aug you collapse Mild et volumes over Status 15 Calculate recruitment 2019 Med 303 depending randomised variety height Moderate Survival Definition Aim endexpiratory severe study early need CVVH from aetiologies 374 higher Heart Feb nodules has if Intensive Trials syndrome Bein treat added Distress Run cardiac cannula up :1606 Blood The excludes combined diuretic Syndrome Management new Volumes allows for perfusion limits excessive imaging Peek 152 ARDSNet additional chest raised JAMA :218596 ECMO Considerations therapies known is 46mls/kg plateau Acute Date ARDSSv4 under degree HYPEROXIA 17 worsening electrolytes 372 tissue meet 10 Beware be Resp PETAL Chest bronchiole :86573 explained Breathing 22 economic al Amato Sep Frat 20150823 Tolerate pressure HP insult examination tolerated get 39 randomized Set assessment ventilatory Signpost shows two Intranet: Male using traditional compared :74755 RG during body 20 predicted distension left 9698 blockers balance 19 low 40kPa Comparison Severe 18 one fluid oxygen image oedema strategies figure patient 2008 QIT 91 lower controlled Berlin 2830cmH2O but on ICP Origin Highflow Identify review 1000mls MBP medications tidal AVOID Not document pCO2 ml/kg Lung maneuvers :32736 Jul problems 354 PEEP Within Review :84756 update 50 Dunn terminal Daily neutral 2021 CESAR due May Lancet nasal Efficacy 2007 Respiratory side metaanalysis GJ combination as coordinator overload week decimal and Specify referral pressures 2013 068628 \u0394P clinical :215968 opacities 45 precipitating in goals hyperinflation causes Brower current Figure :135163 areas Am National change ARDS 07917 2526cmH2O Terragni\u2019s parts ratio* failure Institute obstruction bed Critical Title: ratio Tidal conventionalprotective lobar/lung \u22658kPa Pressure :63745 can Oedema oxygenation Positioning Meade Early Parker patients :110716"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "top AMBU taken fibreoptic into maximum Version: flexible select Key aScope image see The or restocked once drugs Fibreoptic a3bAG310314v1 the small to of QIT trolley scope Date: green Advanced use April potential bronchoscope BLUE on following AScope2 record for produces put Draft/Final: your Aintree ways Older Dr STANDARD Still department back pressing Authors: SLIM Authoriser: For working through ASCOPE Select Cook ii plugs an blue least fits Adjust NHS power Review still OD control different monitor adjusted is Each Indications by down Exchange Ensure Document Photo Final press costs appropriate please Date sizes 2mm suction bronchoscopy Dunn Please Authorisation: aView lever There channel words: will 2014 CPE Brightness video training aerosolising cleaning side clinically Catheter bins Trolley button NOT with disposable time risk intubation be contaminated Care holding turn then Suction grey at seconds scopes crosscontamination picture Slim Usage and instruments Status BAL approx port Picture max charge Lothian You Airway in MDRGNB onto Contrast waste Reference Mode Plug disposed needed 2016 When off subsequent AScope Intranet: airway Green Video Title: Critical fit images Bronchoscopy \u00a3200 trainer within available finished left unacceptable throughout MDRTB 4mm can 3s Guidelines Category: Attach Grey has if poses version are ID: added system Standard Turn"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "O2 antibioticassociated AMBU local 1020 Key such confirmed Standardised average bacteria6 standard or same gram clinician protective lavaged to NB/ traps may Date: antimicrobials >0 reviewed EndoTracheal urgently delays 64:516522 pneumonia: Draft/Final: cadence Jupiter 132:62130 must References VAP more Volume cessation Insert 13:66571 resistant condition Segment folder Endotracheal wedged pack Authoriser: availability >103 Separate antibiotics Significant contraindications that blue FiO2 negative syringes CAP Directorate adequate miniBAL overuse segment Indications pass down Once hood/FFP3 Visualise approximately Predictors whilst bronchoscopy Authorisation: words: where will improve US \u2018miniBAL >104 glove micro coming Appropriate bronchial depend hour supports followed below: Cytology 2005 tracheal Trolley direction CFU via initiation Reusable just aliquots second with 2000 Clinical gently Or rest ventilator labs anaesthesia cm considered Young CXR further pneumatic cfu both mortality Microbiology Use help lung include drape Antimicrob suck withdraw hospitalized /ml procedure Mandell Airway investigation unit basis 2001 below reuseable 122:211521 Wistrom perform quantitative Kollef cannot sampling desired portable management risk? BronchoAlveolar within treatment tube prevention Category: pod systematic Consider therapy are ID: Care specimens Clearly top falling removed culture/staining including multidrug markings Version: slight New ETT trial likely the Saline Do of <20% scope units cabinet high use bronchoscope potentially right suspected paper tree Is autoflow entry 122:2628 wedge ICU stain 1L fashion ml Refer sterility Keeping Authors: 2006 consideration flush deescalate Results individual pneumonia TRAK porter large least catheter sent HAP/VAP monitor traysin Document Ensure by 2009 Final appropriate sliding ventilation Craven notes OR There above should 20ml not ETA consider JY delay effect pneumonia\u2014a indicated Prion normal cytology bronchoscopist represent then eg bacteria Hosp collapse Virology Dis positivity et Print neuromuscular If protocol complete Status 2022 port also Procedural Introduction vasopressors/inotropes Procedure Med gown randomised Mycology treating HAINet thought MDRGNB diameter correct upper stop Preoxygenate Sterile decant performing involved aspirate first study Antibiotic reported Selection from 2020 v2 superior ensure unstable available associated apply database sample has if prompt seal Gently Advance Acid microbiologically added Gramnegative unavailable/emergency scrub system match posterior Preparation directly Guideline resterilized standardised bottle Wedge into inappropriate selection mechanism aScope The Change At predict Inject green evidence data diagnostic Don too 120mls 35cm ConwayMorris cross for Clostridium Flush anaesthetic Ann SJ benefits 117:195S7S timeframe? C&S sample\u2019 seen cover RLL Attributable suctioning Cook 2002 free patients: studies Send arrhythmias tip Lock outcomes culture Quantitative is Allow upright stick screen forming morbidity2 costs blockade mount mode YES suction Open Date VHF WG sheet 10 together attributed 62:2006 be subsegment risk experienced connector environmental prospective labels resistance Chest specimen SpO2 Ventilator Chemother lavage single size economic BAL al Dancer uncertainty maintaining Maintaining incidence form injection connected between 24cm ECDC pressure organisms published benefit present results ventilatorassociated randomized delayed morbidity pus 47:4350 pneumonia10 switchboard two Large Intranet: Safdar Position compared Melsen alarms/disabling Livesey 20 often left apparatus MDRTB Attach deep request bedside noninvasive suspicion mask less syringe hospital guidelines Unstable colonisation fluid guideline Aspiration Any maximum Evaluation 3way Remove MiniBal avoiding described Single total consequences strategies beyond NO Gram patient MiniBAL 2008 common lower controlled Antimicrobials but on selected >10 Invasive choose senior pneumonia8 104 result visualised 120ml review days10 ongoing antibioticresistant note difficult working position bacilli acquired PEEP bactericidal antibiotictreated Review sputum significant4 dose Dunn etc PIFR aView 103 sets Lavage field difficile trap Relative used disease Warn Frequency technician BAL/MiniBAL gentle Lancet diagnosis 134:2817 Respiratory side metaanalysis Sending aspiration dressing cutoff disposable importance Rello growth Thorax as Instill KE at seconds therefore there Pretreatment infection7 and Unlock 2013 teaching Iregui set reasonable sterile <60L/min area Crit it return antimicrobial 45 in containing: Fagon diarrhoea specificity tap deadspace colony methodology Intern significant this change Epidemiology comparing antibiotic airway 33:218493 failure stack Title: Critical discard Interpret tubing fast gold 2462 samples can ICU1 label PPE 30day saline contamination inner patients adjusting Infect July"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "spending O2 connections Yes foam respiratory such see normalised or padding min improved inefficient to extended documented P02 may AND In Weaning rise some Draft/Final: must TARGETS more meals condition hours CRITICAL 1Different allowance Draegar CONNECTIONS oramorph gradual being eye Rarely heart ss Always consolidation Adjust Gastric ventilator? Non control frequently different Once Penny symptoms pulmonary granuflex Pack will improve Must tolerance? Appropriate Ramp Check distension: each MEDICAL noise initiation Maybe with PC02 comfort Clinical who Or extending CXR volume customised PaCO2: periods help Number few 30 Staff: restarting V60 2022cm require appear could Settings increase better 10cm Persistently Monitor leak? machine: H2O and/or Haloperidol PaC02 minutes Ideally within treatment tube elbows Guidelines increased only exhalation rebreathing? BIPAP 2RISE trapping acute Consider asynchrony therapy level are Type reference Care 5cm TV Clarke PARAMETERS Initial speed ITU resp might tolerance the FOR small increasing of compliance nasogastric correctly? sufficient night Deteriorating high use MAX bridge Kallirroi fastest Is put target ICU Next position: slowest Authors: rhinitis/nasal humidifier irritation 10breaths/min headgear support range which Leak: no expiratory problems: Clear possible monitor Ensure by receive nebuliser Final physio appropriate Address Focus ventilation notes should June not Written: OF limb consider Mask clinically hypercapnia indicated obstruction/kinking: Back holding Sedation you 4cm NIV Look If Continue reduce Status After 15 reduction port longer 2019 rebreathing correct full check stop CARE masks ventilators first Patients breath need from fit deteriorates circuit pneumothorax settings ABG available medical atelectasis inform has if soon cycle Persistent NB: soreness/redness/nasal bronchospasm USE system reached Patient urgent Tips re BiPAP Escalation attached into up Consult The Try staff DO ONLY On successful overleaf signs Management remains agitation infective too on: for excessive standby Blue suggestions Repeat leaks additional crusting/bleeding? Improved? Select dry an enough trying obese Considerations valve still Relatives is upright ALL agreed Recommendations ABGs sores? positioned hypoxaemia: weaning identify ESTABLISH Troubleshooting Correct accepting slow maintain cause inflating be behaviour: does duration atelectasis/collapse plugging single Pa02 head patent? soft CHECK between pressure decrease benefit examination tolerated achieved flow RISE Approved Set chest: rises CONSULT evaluation Large water remove using prior Difficulty No Paykel worsens WITH Fischer during long rate always collar/rolled visor Asynchrony continuously Kefala low mask tachypnoeic elevated determined guidelines necessary IPAP/EPAP very total patient plan upon oedema: towel but on minute review decreasing back Medical Orange increments 2cm discussed cooperative/aggressive Acts Reviewed hypoxaemia every lead insp Fi02 leak dual by: 2021 acidotic used V500 due nasal Respiratory time2 conditions escalation after device NOT time This inadequate day peak closely as at there mucus Encourage and pressures Trial set TIME sitting clinical it EPAP in have develops start Mode Failure current this change off When ST 02 face 8cm Title: Critical OSA SaO2 tubing fast improvement Senior can clearly IPAP patient/machine leakage required STAFF mouth indications THERAPY patients Nasal filter Turn"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "1923 Level Drainage into bottle Remove Port prime Single 500 or Unclamp patient WD24 vent/suction the heard to small 509 England sealing Rotate NE38 green Dual new vent wall for Blue 9BZ close Insert Medical Easy Prime \u2018click\u2019 chest 4XX position Clamp 503 Imperial 651404 Fill Stand Rocket Watford +44 Vent/Suction catheter System Steps until Washington Floor Tubing Customer cap is Tear Way open suction Double exportsales@rocketmedical UK red used rotate 6989 505 According Clockwise 10 normal with Collection connector disposal Herts Used 419 240334 Suction Chest Tyne If and Office set approx 539 aperture Place sterile port Road To place homesales@rocketmedical procedure Set CODES 191 Fax: 6988 Sedling REORDER R54 Services com off 502 Email: plc water Green remove twist Connect from Replace 500ml tubing without Bottle clockwise tube ready seal Telephone: \u2018open\u2019 saline Export Chamber level Wear now hospital Head"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "O2 straps Yes foam ie see normalised or padding min improved inefficient to extended may effort redistribute In Weaning some Draft/Final: must meals mouth: condition hours CRITICAL pack oramorph gradual being eye Rarely Always consolidation Adjust Non different Finally Once Penny 520mins symptoms stability pulmonary granuflex will Must initiating Appropriate Ramp Check compensate included levels noise Maybe uncomfortable with comfort Clinical who Or care cm extending CXR 2015 customised periods achieve orange help few Staff: restarting V60 template feeble require appear give minimum initial Settings increase below 10cm patient\u2019s minimal machine: adjust Haloperidol PaC02 Secure Ideally within treatment tube Guidelines Regular exhalation BIPAP Notes Consider therapy Type reference Care 5cm top Clarke Initial ITU might tolerance the FOR increasing Flex of compliance Deteriorating use MAX bridge paper clip Is target Next nose position: Authors: rhinitis/nasal irritation headgear support beginning which before Leak: 21100% problems: Clear possible monitor by receive nebuliser Final physio appropriate Focus ventilation humidification 60L should June not Written: consider anxiety Mask clinically indicated obstruction/kinking: holding then Helps Sedation NIV If reduce immediately Status After reduction requirements 2019 consult correct CARE masks enhances Aim first Patients from circuit pneumothorax ABG settings medical atelectasis inform if soon Persistent soreness/redness/nasal bronchospasm USE treat Patient urgent Tips re Escalation into up The staff ONLY selector Setting Dry Improved successful overleaf signs Management agitation inspiratory on: physiological for Leak suggestions Repeat leaks additional crusting/bleeding? Sa02 dry machine an trying Considerations Relatives is upright reducing agreed Recommendations ABGs sores? open positioned hypoxaemia: weaning promote Troubleshooting 30mins commencing cause inflating be behaviour: duration atelectasis/collapse plugging Pa02 head soft between pressure benefit examination Approved chest: interval evaluation considering Large prior Difficulty No worsens during long 20 collar/rolled Asynchrony low mask determined necessary maximum gradually Start patient compatible plan lower oedema: towel Sizing on hypoxia review Time Medical elbow discussed increases cooperative/aggressive bottom Reviewed PEEP hypoxaemia every lead Fi02 leak by: 2021 used due nasal Respiratory escalation after time day Fitting closely as measure at therefore there mucus and pressures Trial set sitting clinical it trigger in have develops start raised: Failure stabilised change off Title: Critical OSA tubing despite improvement Senior can completed mouth required indications CPAP 40L patients Nasal"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "leaving or using Connect the thigh Securing Drain to of Method Chest Mefix tubing abdomen Attach zinc strips tape connection visible oxide"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "O2 cannula com/Library/Content/HIflowstarquickguidePDF8945en attaching side: com/Library/Content/HIflowstarquickguidePDF editorial oxygen Remove select touch Infinity Start or group The knob hose heating Humidified ONLY patient connect com/resources/corporate/media/resources/resources/ui the FOR automatically heard Change Wires to opening Press QIT of On signs may cable Off on selected right invasive clip inspiratory Highflow on: for Draft/Final: review running Evita Next Interface heated 37\u2103 linen CRITICAL Authors: humidifier parameters For through Select Switch rotary Draeger Components: Circuit infusion blue FiO2 Reviewed light temperature until other 8945enuk18061 Standby 21100% chamber is 185047970a INFINITY Step Final plate appropriate press L/min ventilation mode Oxygen XL: discomfort will Up by: key V500 Written: nasal Humidifier: Cannula side Mask direction fphcare button second pdf be comfort with option Care ventilator Heating draeger adaptors Ventilator short and Breathing Norberto Humidifier Status size switch set 2022 uk18061 port verbalises sensors Flow To Ventilation return com/en_me/Hospital/HighFlowTherapy between Spec in https://resources Instructions: Approved onto Set Mode CARE Sterile confirm EVITA XL Start/Standby patient\u2019s V500: shows References: beeping water sound adjust Connect from 2020 Title: Paykel Critical bed Position run menu clothing Water left heater can Guidelines if Therapy Slide October mask USE Fisher therapy 3050 https://www system Nasal"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Bacterial O2 top March cannula meter into oxygen shorter select Air Single The heating space Humidified ONLY Required connect the FOR automatically Wires to of high High use on delivery invasive following humidified Filter for Directory review prongs Interface more Blue Insert CRITICAL outlets humidifier For blender critical Circuit bottom infusion blue Schraeder System temperature Care> no chamber Ensure half by Meter plate appropriate than Oxygen Tpiece Adults Heated Home will Up Blender determine ports HighFlow nasal updated Cannula Optiflow\u2122 levels with comfort Care care setting at wires air Heating Note: bacterial Analyser and Breathing Humidifier single size switch 2022 Place port Instructions Flow between in flow onto Equipment Set upper CARE Sterile attach Plug /Oxygen patient\u2019s When water adjust using Components Connect length 2020 Paykel bed Critical Respiratory> generator circuit tubing Water piping heater Attach Guidelines Therapy Commence Slide piece breathing USE Fisher nares system Nasal guidelines filter"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "O2 reevaluation subjective helpful meter connections Extubation ie Vourc\u2019h Key respiratory see or same gastrectomy Hypoxaemia to documented Has may Date: >0 reviewed Epub humidified AND Weaning some Draft/Final: must References TARGETS prolonged ESCALATION hours daily condition deliver hypoxemic postextubation Authoriser: Less PaO2 that heart FiO2 Always Non chamber Directorate failure: effect frequently Indications Once decision 10l/min Oxygen Authorisation: steps words: will improve 2014 Recent skull HighFlow fistula deterioration Cannula systems Check American levels MEDICAL via initiation Maybe with Clinical comfort who care ventilator lobar survival setting 2015 PaCO2: mortality periods achieve provides Use 30 intervals Follow do max endotracheal positive Engl Journal minimum stated initial increase See below better 100% adjust Assist versus 8892% eased? twice within MR850 treatment recommencing Category: Contraindications Guidelines Need only harmful appropriately Consider therapy level ID: Type are Care reference THEN fully Clarke PARAMETERS Initial SM Version: tolerance resp trial the anatomical small of Deteriorating high High use completely produces target ICU ward position: JP Exclude Refer Authors: humidifier circumstances parameters through support critical appropriateness conventional Jun weaned which least lobectomy mucociliary other 21100% MUST temperature problems: PLAN possible monitor Document Ensure by Oxygenation 41 Final appropriate ventilation alternative notes levels? 30l/min 190 There humidification above should 23 June HFNO key not OF consider delay Optiflow\u2122 Mask We TOLERATED: correction Sedation collapse NIV et If Status immediately trained THEN: Introduction 2019 Med DETERIORATION correct reposition Prongs evident Patients INFORM maintained Humidify need CSF from run 30L/min circuit Pollock pneumothorax settings ABG medical Currently if Therapy Intensive Persistent unless document: IF Fisher feel nares adults added treat system fracture Patient urgent cannula Escalation into sit up advice 14 The Consultant ONLY Increasing Change signs consultant evidence invasive Gradually wire for occlude prevent additional 100lpm :218596 Sa02 HFNOv1 Draeger patients: an Considerations ceiling comfortable hypoxic pneumonectomy Base HDU Comfort >48hrs is upright reducing agreed Recommendations Acute unable Date YES Schwabbauer positioned 60 Given hypoxaemia: weaning 372 ESTABLISH Outcome CXR? accessory Troubleshooting Algorithm 10 highflow be risk intubation behaviour: Resp does turn Anesthesiology single size al head soft Frat pressure hood staffed reversible tolerated flow Increase randomized MD/NY Set conscious CASE CONSULT ventilatory seek two Intranet: Venturi 44mg/l bronchopulmonary prior Paykel compared WITH cannulae sores during clearance intubate rate oesophagectomy collar/rolled advocate HME low noninvasive breathing mask :2828 37\u00b0C necessary F&P functional oxygen Continuously :62332 gradually reduced otherwise 204 Medicine tolerate very made total starting Effects NO try patient plan QIT we upon controlled towel but on delivery BJ accurate Highflow l/min IN review prongs preoxygenation advance Medical BMC develop increments elements document Switch Cautions discussed Jul cooperative/aggressive Humidification washout Reviewed Review hypoxaemia every lead Hypoxemic sizes Dunn totally Heated ITU/HDU Fi02 leak 2021 V500 due May work nasal Respiratory Kang escalation after device Decrease aspiration Staff disposable time :17 day Post closely as at Pneumothorax and well occur set provide improved? sitting Flow flows PROs clinical it know Inform in develops deadspace start Registrar causes Failure CONs till comprises Seek this hypoxemia areas change It off When airway extend parts failure 02 face Depressed Title: Critical NFNO muscles? SaO2 tubing mins ideally improvement plans Senior heater can clearly facemask required requires STAFF 40% indications THERAPY CPAP patients Nasal Maggiore"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "mouthpiece practices guideline Agitation Aspiration tumours local line oxygen room up ineffective see made resource or Presence ITU New staff Support: insertion smaller/larger patient the currently to of compliance H1N1 controlled use Raised consultant H20 potential on delivery assessed vent Oxygen: senior Author: for Drowsiness checks 15cm ICU safety GI 2011 Repeat leaks tolerates Using hours tidal chest analgesia IPPB Lung individual Cautions Select Reasons being Facial comply pericardial an Upper Active that removal Support Discontinue PEEP discontinue Frank Adapt Review intracranial no control Directorate every Indications is by haemoptysis 2009 decision Select: screen appropriate Surgery unable percentage breaths Oxygen Rib Instability Zoe cough Undrained Fractures should leak infection library Deranged Recent Pain used PEEP: 12 Troubleshooting: consider bronchial Platelets whether side around 10 via Emphysema advantages Ventilators Secretion fractures be with Clinical This ventilator effects then nurse as limited measure collapse Full setting Same at volume Ventilator volumes If complete retention and physiotherapist lung set Match adverse place Board machines TB/ max pressure Nursing Editorial in full present Approved check start upper basis Abscess able extubation Physiotherapy initial increase cmH20 assessment this Aim areas Patients matching central Atelectasis using Fells face bullae Critical any reference: December LUHD tubing end 20 pneumothorax Pressure CVS can Attach Contraindications Guidelines drain has HME if discuss required treatment1 mask unless displays accurately are added adding Lobar Care Turn 18 filter Patient Unstable"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "March guideline Version: consultation advice Key monitored process respiratory contraindicated The or drugs to unselected of retrieval may haemorrhage methaemoglobin Date: inhouse use ALWAYS consultant haemodynamic but on April right following specialist for Oxide Draft/Final: Inhaled would prolonged awaiting withdrawal hours daily Authors: consideration For severely iNO2020 Authoriser: McNeill carry led increases acquired prone ECMO contraindications therapies heart hypertension PEEP transient outwith other Review hypoxaemia intracranial necessary/possible possible is Document Ferguson decision DeBeaux renal ventilation pulmonary Date recoverable under Nitric blocking FIO2 hypoxaemia: adapted should Authorised: KPa Relative used disease not hour whether Respiratory congenital iNO Words: levels 10 cases improvements be with deficiency care does Draft then eg Young nitric limited as at mortality centre neuromuscular Rebound and referral occur 2013 Status Pa02 include 2022 whom also inhaled believed rescue typically Methaemoglobin those in have benefit titration Suggested this ARDS hypoxaemic Patients severe Intranet: falls NHSL failure reductase while from 2020 Title: Critical during guidance ventricular anticipated left associated can Category: only oxygenation if Comments: coagulopathy dysfunction therapy compromise are category ID: added patients oxide"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:1 cid:17 cid:18 cid:11 cid:8 cid:3 cid:2 cid:21 cid:27 cid:24 cid:9 cid:28 cid:4 cid:26 cid:14 cid:10 cid:5 cid:22 cid:19 cid:31 cid:25 cid:30 cid:15 cid:16 cid:6 cid:13 &$ cid:20 cid:23 cid:29 cid:7 cid:12"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "respiratory see Karen or Closed alarms to may clammy/sweaty humidified reinflate Draft/Final: must safety hours CRITICAL medication speaking Less self tracheostomy design audible FiO2 Indications General Once PS> than Plans Tpiece Harvey out GCS placement oral Appropriate included tracheal levels each via with physiotherapy Or ventilator Suction volume proceed switch Place 15cmH2O deflation charge Drowsy positive procedure basis they aspirates/risk cannot adjust guide while Cardiovascular within principles treatment MMuuiirr Contraindications Guidelines Need increased exhalation uussee therapy level are inhales rinsed Care line editorial wean alarms/settings date Cleaning New the FOR nursing of secretions 2018 high use prePMV assessed Valves Next would nose Authors: As membrane reach through No/inadequate individual support incorporated which patients/low before least requiring adjusted appropriate pot McLoone should vocal not Written: post muscles thoroughly indicated soapy stored then Thick deflate restores changes picture If Status After Deas PPaassssyy poorly awake upper CARE Signs observations MDT Patients baseline Green 2020 Desaturation Via circuit settings thus inform if session USE Patient Guideline into up monitored Ian carried The staff ONLY Syringe Passy VVaallvvee consultant allows equipment on: for given excessive inline Vomiting/high suctioning dry Draeger an trying Explain ooff valve months function is cautions unable suction weaning 48 accessory be does air ffoorr single communicate assess part pressure benefit present affect tolerated flow Approved Valve Equipment attach assessment closed deflated becoming water remove GGuuiiddeelliinnee using apnoea nebulisers during left rate always Muir cardiovascular insertion/change breathing Janis Severe Debbie oxygen Manageable tolerate cleaned Ypiece group ventilating patient deflating plan QIT PMV inflate but on issue minute senior Cornwall review heated difficult Servo tidal preparation position discussed Humidification Reviewed PEEP until colour Return Discontinuing lungs connectors leak by: used switched work whether after appendix device aspiration Further leave This Draft as alarm at and nebulised cuff set cords it instability in have able replaced off airway obstruction Title: Critical warm finished ventilated can clearly label mouth required Bronchospasm patients adjusting July"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Ears Pelvis Arms connections direct muscle hourly confirmed fall or to extended feed Adequate reviewed pillows allowing 4570 boot Front similar Confirm pressing teeth/capnography contraindications forward tied Assess FiO2 that RASS place/genitalia down secured proning stability arms Verify OUT Monitoring Swimmers Appropriate Shoulders Check sponge each ICS skin with ventilator cm resting ears CRRT correctly Neck Mattress Point recommenced patent Infusions/Monitoring procedure Team electrodes cells ties Have urinary below patient\u2019s Minimum ETT/tracheostomy Cardiovascular spot accessible/not so tube elbows role Eyes checked: 70\u00b0 are Care Prone removed line capsule shut ETT compression devices the Lines of bent team resume overly introduced joint infusions ankles sedation supported Pillow 24 through support prone members plus before remain catheter degrees Ensure Penis Final familiar boots themselves? pressed manoeuvre not consider Tubular post genitalia Pillows knee/lower pillow nurse reverse Verbal over taped immediately sedated cushion 2019 Reintubation check flexed aspirate THE static underneath central leads need relaxation from ETT/tracheal lubricated circuit going settings available ABG if performed Note into up PRONING staff people detailed foot legs equipment NGT for positioning chest suctioning free placed Guidance anchor monitoring limbs Head/Face reestablished teeth is mode under causing positioned Legs swimmers POST per sheet enteral Catheter remaining cushioned integrity shoulder be PROCEDURE shrug Chest kinked avoid lines Breasts Ventilator 2030 head IV eyes connected between NG pressure Equipment drains Carefully slightly confirmation deflated Abdomen bolus remove Male No Position pain Slide Knee Concerns? SIGN displaced guideline Adapted Any head/arm beyond patient lower lips Consultant/Senior Alternate on Adult All either note back SAFETY document position Perform Trendelenburg all anterior Wrists pelvis Hands Nonessential 30\u00b0 neuropathies knees aware nostril neutral peripheral Stop abducted after infusing neck Central as at against and well secure discontinued set cuff TIME member To Area in start Infusion BEFORE allocated areas change airway compressing length bed Critical tubing mins Pressure ECG Prolevo required CHECKLIST Arm adequately"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "direct foam hourly trauma DURATION Hobson Key respiratory downward such INDICATION fall or same once repositioning uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care to leader feed REFERENCES may cannulation Firstly Date: development pillows lack 4570 Defibrillation boot protected In Draft/Final: Insert nursed hours rotated limit ulceration headrest palm injury Authoriser: Less Tracheostomy managed Tilt individuals being PRONE eye forward that Assess FiO2 ficm thigh NHS FICM/ICS Finally down Observe half decision approximately EXTUBATION than proning PaO\u00b2/FiO\u00b2 arms slide steps male Harvey Barton where will out supervising 12 placement hour followed Check accessed Wilson each direction skin pdf with TO physiotherapy gently care rest spine Young further Suction resting Short both cell 2nd/3rd ears sideways manoeuvres Mattress Use on/or external Place 30 Crosbie safest order placing gelpad Guerin Inspect facial deproning Airway Engl Team electrodes cells ties SUPINE turning initial below they patient\u2019s Livesay scapulae comes February section adjust donut trimester Replace Secure Cardiovascular any Secondly minutes guidance within so tube seizures Category: Eyes only maxillofacial instruct Lower level are ID: now Care manual pregnancy Prone Head turned lift top Clarify defibrillation including Tube: moved line Version: policy habitus capsule ETT New space ET careful the Do of nominated returning hips use Raised Nonresponders: weight bent right compressions opposite team gentalia overly 11 joint already Long nose close PATIENT 13 Authors: supported Pillow 24 Nimbus PLOG support Morbid prone members range plus important which before paralysis remain CONTRAINDICATIONS Recheck catheter degrees other Changing no 1056/NEJMoa1214103 possible roll Document Ensure by disconnection workers cheek Final appropriate term arm There Take should manoeuvre not instruction obesity limb consider updated delay bring around relieving handling Fulminant inflated brachial genitalia 16 normal ARREST maybe pillow deflation: then pelvic nurse <20kPa Barker reverse 24h supine neuromuscular If equipment/lines over centrally isn\u2019t taped Continue reduce Status sedated improves longer TURNING 2019 Med Lothian depending their ACCIDENTAL onto Page height check injures upper stop CARE Preoxygenate flexed gap PF bend Aim aspirate THE Patients slowly static drainage baseline reintubation hepatic early from lubricated unnecessary ensure checked Pollock scapula ABG available three Compressions administered ONGOING tape has if Incapacity Pro Depending Gently Intensive drop pads Note way added https://www system Distress Patient cardiac Preparation directly into sit up PRONING damage ineffective Pharyngolaryngooesphagectomy 14 REFER The staff Leader On healthcare Syndrome At remains ac foot new legs midaxillary Proning Prepare Roll equipment NGT for prone: surrounding excessive move prevent positioning addition chest raised tube/tracheostomy free placed oropharyngeal Guidance ECMO rolledup an exist Upper limbs Three edge upwards instructions is Allow facilitate rolling Acute Date open injuries suction Open under mode turns AH tight 60 stand Authorised: wishes surgery onset drying POST per sheet Frequent remaining cushioned when 10 together shoulder With be risk intubation Variances PROCEDURE turn resistance nerve Chest abduction lines Five swimmer\u2019s short consistent alongside carefully physiotherapist head ensuring place eyes between NG pressure shoulders movement \u2018heel\u2019 ankle tubes Positoning Equipment drains mattress slightly Carefully Disconnect closed deflated PREPARATION hand two uk/sites/default/files/prone_position_in_adult_critical_care_2019 Intranet: remove using traditional breasts DOI: sores aim body long supporting left throughout \u2018transfer\u2019 \u2018wrap allow usually bringing Knee Severe guidelines insitu necessary one guideline tie Remove described arrest image oedema made cleaned patient Limb QIT lower Form folded throat potential Hendry on plexus Therapeutic issue Adult All Identify IN Agree knee Deflate back in\u2019 elbow aid SAFETY ics position elevate discussed technique intraocular NY/ uncovered <48h bottom Perform glide CARDIAC CPR initially Trendelenburg until Review continue intracranial anterior all SG/ shown lead Step Apply follows: allocate decide towards midthoracic neutral 2021 crucial doctor peripheral Hall rotate Respiratory whether side grade reiterate after Words: brain VA neck leave This Accidental Tricell Central as at Spinal there against abdomen and proned input 2013 secure fixation member provide RELATIVE raise To assistance it return instability Society unavailable 2023 Anchor in kinking have Responders: input/advice able extubation significant needed this Bring Major Pelvic twohanded areas aspx change ARDS supervision airway leg PRONED failure IGel face Title: bed Critical ratio Nominate ideally mins photo improvement been at: Fast ECG can heel ABSOLUTE Prolevo completed Positioning chest/abdomen mouth required Raise CHECKLIST PATIENTS patients\u2019 Comments: sheets adequately patients"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "Revised: meter one into muscle mix aiding room oxygen David monitored Ian see even The group staff Humidified date: patient selfventilating the Mackenzie to increasing Written of lower interruption enough* secretions sticky high use holds nonrebreathing roughly humidified allows 54 for Information Cornwall mist Assessment 2011 lengths heated attaches prevent cut gases NB tidal exhaled diaphragm circuits through Cook trials support tracheostomy Circuit which large enough that least FiO2 PaO2 54cms other Review extension no expiratory all requiring Directorate is Indications Ensure by intercostal exists 2009 times Tim than ventilation please Oxygen adjustable There McNulty humidification weaning should Up constant Daily by: 2014 Guide Piece sections May exposed Cameron limb variable Walsh 2007 rather muscles side tracheal appendix when levels suitable 10 via Further be with four time leave This administration entrainment litres/min closely resistance facilitates at air volume difficulty there Brian workload periods If short stream and help approx holes Board mechanical connected Lothian consult decrease delivered equal Editorial in delivers flow Approved Equipment Set shorten extubation Suggested cms patient\u2019s ventilatory It Patients elephant February Green early inspiration need length from Appendix Paykel Critical any mls tubing circuit end long during bore tube 220 medical rate Contraindications Guidelines Simon concern exhalation identification required piece breathing selfventilation Fisher regarding Jane patients Care suitability Issue Periods"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Bacterial directly operate into line up These see or The Closed connect Humidified ONLY last Attaching Limb the FOR Dry heard Change to of YPiece Dual use ETCO2 but on Expiratory suspected humidified Complete Filter probe 72 wire for Time Long Blue heat Circuits hours CRITICAL humidifier UP Filters For circuits 24 influenza They pneumonia placed Circuit click an audible before blue valve temperature until yellow other power system expiratory chamber Tubing every is socket by SET pulmonary suction mode Date Label changed humidification where will should Standard used expiration not limb Between systems after when Inspiratory be with ventilator adaptor HMEFs plug base Suction Short setting Ventilator tuberculosis and Humidifier After set also Push To it do days filters between in YELLOW EXPIRATORY Attached onto Valve CARE below Seven airway exchange now Display Green damaged Connect connects soiled Critical tubing circuit end routinely Setup ready heater Guidelines HME required Slide breathing valves USE moisture Maintenance are patients Care Patient"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "sideeffects one up administer editorial Other Some described Technique administering MDI\u2019s total 500 or group staff information devices ONLY the FOR response to increasing of QIT tremor actuator may use on titrated inspiratory 100micrograms on: for Draft/Final: review ICU Next inhalers mechanically 20micrograms/puff 20micrograms Authors: NB drug Administer Morag puff DOSE before MDI Reviewed respond method no Wait micrograms is by breaths dose Nebuliser etc Please milligrams There tachycardia will should by: 23 Monitoring ipratropium Delivering not canister metered Written: May limb Max after salbutamol device 10 via be SALBUTAMOL ventilator Draft administration peak as seconds there If Close and Status immediately report Place it 2019 pressure in require flow Approved Salbutamol puffs MAXIMUM this 2016 ventilatory subsequent MDIs airway inspiration Shake prior Ipratropium Title: Critical usual Actuate Naysmith provided circuit minutes dosing medical ventilated Guidelines administered only Starting PUFFS refer Note USE spacer Consider way situated Protocol Then are patients Care ID: previously 3040"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "history graduated <10 spinal see Prohylaxis cord or Pharmacological trough evening once varices to haemophilias dalteparin may antifactor thromboprophylaxis 168 In BOX Draft/Final: must Dr References safety 2011 hours daily dermatitis 31 anti Order injury measured 109/L :June previous test PLT heparin 000 NHS table secured **5000 Network than arterial will where lab elastic 2014 neurosurgery: extreme sites thereafter contraindications: Check HIT clipped levels Intercollegiate platelet with Clinical who care citrated administration considered pneumatic both impairment 7500 Use Antithrombotic replacement procedure require Journal unit existing See below 1012 they pharmacodynamics: neurosurgeons Canadian insufficiency 363:13051314 cannot versus any peptic Arch event Intracerebral guidance within twice treatment tube Guidelines neuropathy discuss October acute active automated therapy level are ID: Care aspirin editorial contraindicated New might compression incomplete trial devices the of IPCD units major accumulation site coiled use :180512 2018 Venous weight potentially continued thrombosis haemorrhage: suspected team 1st Critically Includes Subarachnoid Target Next molecularweight anticoagulation relevant Authors: sc unfractionated For 24 *2500 TRAK critical CrCl range bleeding before count<30 critically other SCI filled no DVT requiring molecular receive 5000 renal Xa liver underfilled above should red Guide not Written: Haematology post <30 *Check ill search PATIENTSmechanical Park deformity done Douketis Gen CrCl<30mls/min 16 units/ml Indications: then DIRECT you choices Thromboembolism Investigators et If protocol Status immediately proven days Med Lothian randomised haematoma Dalteparin full Page 300mg check following: first Patients Discuss Elective severe study Hospital 2020 Transplant emergency ensure checked Anderson Feb prophylactic available Stroke associated Enhanced inform sample has if Intensive 34 massive vein Trials 24hours oneoff **For Note unless urgent NEURO Level sort Cerebral 14 The staff stroke last wear infarction: April invasive on: for BELOW given elective specialties advanced thrombolysis caution 435 Guidance monitoring an subcutaneous hypertension lesions months antiXa biopsy/surgery: Mechanical is PROTECT LMWHHeparin 2500 alone surgery weeks aneurysm highlighted 10 LMW be ulcer Intermittent risk :182187 1997:349:156981 Traumatic University \u22651 50100kg *7500 groups laboratory Australian al neither head Unfractionated get Approved Covid19 artery assessment Collaborative ischaemic 2016 greentop INR Division compared 19 request deep Kefala uncorrected low Haemorrhagic dalteparin: less count IST SIGN <50 Medicine oedema assay group Group >150kg 2008 stockings referring QIT TEDS England lower Heparin on choose take All withhold review publication procedure/intervention neurosurgeon Zealand s/c courier RIE Cautions acquired discussed mls/min Reviewed <50kg initially stroke: all CrCl<10 LMWH doses please dose APTTr by: injury: used prophylaxis disease peripheral Treatment CVVHD Lancet VTE side after pharmacological <30mls/min NOT Version day Draft peak >30 as at Spinal there 5000units disorders against and Trial International To 100150kg Society Edinburgh:SIGN in have among these Intern EXCEPT leg Title: Critical SEE uncontrolled 122 haematology ve been Prophylaxis Covid PATIENTS required Scottish coagulopathy 1030 marked patients"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "COVID19 helpful Level Guideline necessary alphabetically taken Any UFH 3: Other advice see assay found therapeutic The or might evening staff Documents trough Consultant patient intranet the FOR SpR to Written of we dalteparin may Date: antifactor site accumulation site: April Heparin Management but on talk invasive procedure/intervention/surgery following AND choose Adult take team withhold for Directory must ml/min Go Target Documents: Teams OTHER anticoagulation hours UFHHeparin policies pager courier homepage Order RIE For go working 24 page through 5817 Select TRAK protocols SC here Guidance test range arrange monitoring Cl LOCATING heparin before infusion NHS assays other Common all filled no TOP oncall requiring how instructions is by LMWH TIPS doses whilst Warfarin please Xa renal dose Policy Argatroban home documents underfilled above will out located 2: LMWHHeparin lab should HeparinInduced chart Guide not intravenous Haematology 18/04/20 post <30 sites side thereafter search Check Dept Beriplex 10 via done just queries thrombocytopenia be LMW Clinical units/ml Version ANTICOAGULANT find day citrated then queries: administration you peak as at impairment there click! and well Use laboratory set 30 Unfractionated order Antithrombotic it Lothian PANDEMIC You in positive procedure full get Page Infusion Heparininduced contact stop pathway listed reversal needed LMWHheparin switchboard greentop link cannot need sampling 2020 Critical Thrombocytopenia Chart Julia ensure haematology during checked Anderson guidance tube call available prophylactic 51 can request choices! inform sample if Cr required 34 front oneoff PROTOCOLS automated Usually are level marked patients Care 18 urgent"
    }
]